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Abstract 
Knee osteoarthritis (OA) is considered a common chronic musculoskeletal disease affecting the 
medial compartment more than the lateral compartment and leading to disability and a reduction 
in activity level. Lateral wedge insoles (LWI) are a conservative treatment that aims to reduce the 
knee loading (External knee adduction moment (EKAM), which is increased in individuals with 
knee OA compared to healthy individuals. Although, LWI reduce EKAM in individuals with knee 
OA, no significant difference was seen in pain when compared to the control treatment (neutral 
insole). Patients and healthcare practitioners are driven by pain more than by mechanics. 
Therefore, reductions in pain and loading could be achieved with LWI if combined with other 
conservative treatments, such as a simple knee sleeve. 
The overall aim of the thesis was to investigate the biomechanical and clinical effects of combining 
LWI with a knee sleeve, compared to each treatment used on its own. To accomplish this research, 
four studies were conducted. Firstly, a reliability study amongst healthy individuals was 
conducted. Secondly, a reliability study of individuals affected by knee OA was conducted. Both 
studies showed that most biomechanical and clinical outcomes have excellent reliability and low 
measurement error, which supports using them. Thirdly, a randomised crossover study was 
conducted among healthy individuals to investigate the immediate effects of the combined 
treatment and the single treatments. The results showed that a knee sleeve significantly reduced 
the knee joint frontal plane range of motion (ROM) but not the EKAM or muscle co-contraction. 
Furthermore, a significant reduction in the EKAM with use of LWI was noticed. The combined 
treatment showed both a reduction in the EKAM from LWI use and a reduction in frontal plane 
ROM, which supports the use of these treatments in individuals with knee OA.  
In the fourth and main study, thirty-four participants with medial knee OA were enrolled and 
randomised into 3 groups (LWI, simple knee sleeve, LWI and simple knee sleeve). The immediate 
and six-week effect on biomechanical and clinical outcomes were measured and compared 
between and within groups. At baseline there was no significant difference between the groups. 
The results showed a significant reduction in the magnitude of change in EKAM for the combined 
group and the LWI group compared with the sleeve group. The magnitude of change in muscle 
co-contraction was higher in the sleeve group and the combined group compared to the LWI group. 
  X 
The combined group (31.88%) showed greater reduction in pain than the LWI group (21.1%) and 
the sleeve group (11.16%); however, this was not statistically significant. Only the combined 
group and the LWI group showed improvement in balance and functional tests compared to their 
baseline. Finally, the pain pressure threshold did not change after treatment in all groups.  
Overall, the findings of this thesis support combined treatment. A larger trial to investigate 
combined treatment and single treatments in a larger sample size is needed to make the findings 
more conclusive.
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 Introduction  
 Introduction  
Osteoarthritis (OA) is considered to be one of the most common chronic musculoskeletal diseases. 
The knee is the joint most often affected by OA, and it is perhaps the most important site with 
regard to pain and disability, affecting some 30% to 40% of the population by the age of 60 years 
(Felson, 1990; van Saase, van Romunde, Cats, Vandenbroucke, & Valkenburg, 1989). A higher 
prevalence has been anticipated in the future due to rising levels obesity and an ageing population 
(Zhang & Jordan, 2010). In the United Kingdom (UK), 10% of individuals between 35 and 75 
years old are affected by OA (Sangha, 2000). Furthermore, the cost of osteoarthritis is estimated 
to be 1% of the gross domestic product (GDP) in the UK, which shows the high impact of the 
disease and the need for effective treatment (National Institute for Health and Care Excellence 
(NICE), 2006). Recent research has shown that  knee OA prevalence has increased two fold since 
the mid-20th century (Wallace et al., 2017). In 2016, the OsteoArthritis Research Society 
International (OARSI) announced that osteoarthritis is now considered as a serious disease. 
OA is one of the most common secondary causes of death due to disability. Interestingly, disability 
caused by OA and severity of  hip and knee OA has been found to significantly association with 
all-causes mortality and cardiovascular event (Hawker et al., 2014).  Recent literature has shown 
that participants with knee OA are at a high risk of cardiovascular disease due to disability and 
inactivity (Nüesch et al., 2011). In Australia, OA is the third most common secondary cause of 
death, equal to asthma (4.8%) and exceeded only by dementia (5.6%) and depression (8.0%) 
(March & Bachmeier, 1997). It has been estimated that approximately 60,000 deaths occurred in 
2000 as a result of OA disability (Mathers & Penm, 1999). 
The typical symptoms of OA are pain, stiffness, crepitus, reduction in range of motion (ROM) and 
muscle spasm (Brandt, 1989). The risk factors which increase the prevalence and accelerate the 
progression of the disease have been divided into two groups (Heidari, 2011b). The first is the 
systemic group, which encompasses factors such as age, sex and race. The second group is the 
biomechanical group, which is determined by factors such as obesity, malalignment and muscle 
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weakness. Once the knee joint is affected with knee OA the mechanical progression is the leader 
(Felson, 2013). 
The clinical and radiological changes related to knee OA are more commonly observed in the 
medial compartment than in the lateral compartment of the knee (Ahlbäck, 1968; Ledingham, 
Regan, Jones, & Doherty, 1993). This has been attributed to the higher load, which is transferred 
during walking, on the medial side than the lateral side (Mündermann, Dyrby, & Andriacchi, 
2005). Another possible explanation for the higher load in the medial compartment of the knee is 
higher muscle co-contraction or co-activation, which can be defined as the synchronised activity 
of two muscles (agonist and antagonist) (T P Andriacchi, 1994; Sirin & Patla, 1987). Good muscle 
strength is required to bear these excessive loads; however, excessive muscle co-contraction might 
cause high loading Quadricep strength and activation were found to be decreased among 
individuals with knee OA (Fisher & Pendergast, 1997; Hurley, Scott, Rees, & Newham, 1997; 
O’Reilly, Jones, Muir, & Doherty, 1998; Wessel, 1996). Moreover, knee joint proprioception was 
shown to be impaired for people with knee OA (Hassan, Mockett, & Doherty, 2001; Hewitt, 
Refshauge, & Kilbreath, 2002; Hortobágyi et al., 2005). 
The distribution of the load depends on the magnitude of the adduction/abduction moment and the 
forces of the ligaments and muscles balancing the moment at the knee joint. The ground reaction 
force (GRF) passes medially to the knee joint which increases the external adduction moment 
(EKAM) and therefore higher loading to the medial compartment (Johnson, Leitl, & Waugh, 1980; 
Schipplein & Andriacchi, 1991). EKAM can be measured by using a motion analysis system 
combined with force plate (Kim, Richards, Jones, & Hegab, 2004). EKAM is a common valid 
indirect surrogate measurement for medial contact force (Kutzner, Trepczynski, Heller, & 
Bergmann, 2013; Schipplein & Andriacchi, 1991). EKAM has been found to be higher in 
individuals with OA than healthy ones (Baliunas et al., 2002; Huang et al., 2008; Hurwitz et al., 
2002; Kim et al., 2004; Mündermann, Dyrby, Hurwitz, Sharma, & Andriacchi, 2004; Rudolph, 
Schmitt, & Lewek, 2007; Thorp et al., 2006). 
During walking, the EKAM and external knee adduction angular impulse (KAAI) have been 
linked to knee OA initiation (Amin et al., 2004; Andriacchi & Mündermann, 2006), severity (Kean 
et al., 2012; Sharma et al., 1998), progression (Chang et al., 2015; Foroughi et al., 2009; Miyazaki 
  3 
et al., 2002) and symptoms (Bennell et al., 2011; Foroughi et al., 2009; Kim et al., 2004; 
Prodromos, Andriacchi, & Galante, 1985). Furthermore, EKAM and KAAI are associated with 
medial cartilage thickness loss in individuals with OA (Bennell et al., 2011; Chang et al., 2015). It 
has been anticipated that each 1% increase in the EKAM is associated with a 6.46 times increase 
in the risk of knee OA progression (Miyazaki et al., 2002). The EKAM has been identified as the 
single best predictor variable for proximal medial and lateral tibial bone density in situations of 
both knee OA (Thorp et al., 2006; Wada et al., 2001) and healthy knees (Hurwitz et al., 1998). The 
EKAM has been identified as the main determinate, not only for total load across the knee joint, 
but also for lateral-to-medial load distribution (Schipplein & Andriacchi, 1991; Zhao et al., 2007). 
EKAM has shown a good correlation with medial knee joint loading across subjects and activities  
(Trepczynski, Kutzner, Bergmann, Taylor, & Heller, 2014). However, a recent study highlighted 
the importance of considering the internal force (muscles) which cannot be measured by EKAM 
or KAAI (Trepczynski et al., 2014).  
Surprisingly, higher muscle co-contraction in the medial side was correlated with the loss of medial 
cartilage in individuals with knee OA (Hodges et al., 2015). It is believed that increased muscle 
co-contraction comes at the expense of higher joint loading (Lloyd & Buchanan, 2001; Meyer et 
al., 2013; Schipplein & Andriacchi, 1991) and associated OA risk (Heiden, Lloyd, & Ackland, 
2009; Wu, Burr, Boyd, & Radin, 1990; Zeni et al., 2010). Previous studies have demonstrated 
higher muscle co-contraction in individuals with knee OA than in healthy individuals (Hubley-
Kozey, Hill, Rutherford, Dunbar, & Stanish, 2009; Zeni et al., 2010). 
Balance is considered to be a complex neuromuscular process, which includes motor, sensory and 
integrated components (Hinman, Bennell, Metcalf, & Crossley, 2002). Balance can be defined as 
the ability to maintain (control) the centre of gravity provided by the feet. In the elderly population, 
poor mobility and the risk of falls are associated with lower balance (Campbell, Borrie, & Spears, 
1989). Balance can be assessed in static or dynamic techniques (Patla, Frank, & Winter, 1990; 
Winter, Patla, & Frank, 1990). Both dynamic and static balance have been identified as being 
impaired in individuals with knee OA, with the former being more greatly affected (Hinman et al., 
2002; Wegener, Kisner, & Nichols, 1997). Impairment in balance in individuals with knee OA can 
be associated with the ageing process, muscle weakness and/or proprioceptive deficit (Koceja, 
Allway, & Earles, 1999; Lin, Lin, Lin, & Jan, 2009; Slemenda et al., 1997). Although balance 
  4 
deficits has not been found to correlate with radiological severity of knee OA (Jadelis, Miller, 
Ettinger, & Messier, 2001), treatment of knee OA is expected to improve balance to reduce the 
risk of poor mobility and falling.  
Unfortunately, OA has no cure and management ranges from conservative to surgical modalities. 
Although surgical modalities have had high rates of success among individuals with knee OA, it 
is a great expense to the National Health Service (NHS) and has great influence on individual 
interim of functional independence and the recovery time. Additionally, surgery is not without the 
risk complication, which might not suit all patients (Bhatia, Bejarano, & Novo, 2013; Griffin et 
al., 2007; Lindenfeld, Hewett, & Andriacchi, 1997; Marks & Penton, 2004). Therefore, surgical 
management should not be at the forefront line and conservative treatment should be tried first. 
Pharmacological treatment, exercises and other modalities are available, however these only target 
the symptoms, such as pain, and might cause the disease to progress if not used wisely (Dieppe, 
1995). Therefore, other treatment modalities which target biomechanical factors such as the 
EKAM and muscle co-contraction should be the primary focus if we are to find a way to delay the 
progression of knee OA and mitigate the impact on overall public health. 
Conservative biomechanical treatments, referred in this thesis, are ones that aim to reduce the 
biomechanical factors which have been related to progression of knee OA. These include, gait 
modification, valgus knee braces, simple knee sleeves and functional foot orthoses. Gait 
modifications such as lateral trunk sway and altering foot angle have shown a reduction in EKAM 
(Hunt et al., 2008; Hunt, Wrigley, Hinman, & Bennell, 2010; Shull et al., 2013a, 2013b). However, 
higher trunk sway might increase the risk of falling, back pain and other associated back injuries 
(Rogers & Mille, 2003; Toriyama et al., 2011). Furthermore, this requires permanent adaptation 
which takes time and effort and might not be applicable by some individuals. Therefore, assistive 
device such as braces and insoles should be the focus. 
The valgus knee brace is an effective treatment in pain reduction (Arazpour et al., 2013; Fu et al., 
2015; Jones et al., 2013; Moyer et al., 2014), loading reduction (Laroche et al., 2014; Moyer et al., 
2015; Toriyama et al., 2011). and muscle co-contraction (Fantini Pagani et al., 2013; Ramsey et 
al., 2007). The mechanism relies on providing three-point forces which place the knee in a valgus 
position to reduce the load on the medial side of the knee joint. Despite the good clinical and 
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biomechanical effects, brace compliance is a major issue (Barnes, Cawley, & Hederman, 2002; 
Finger & Paulos, 2002; Van Raaij, Reijman, Brouwer, Bierma-Zeinstra, & Verhaar, 2010; Wilson, 
Rankin, & Barnes, 2011). Several reasons have been highlighted for the low compliance, such as  
skin irritation, mechanical problems, awkward shape, bulkiness and difficulty in putting on and 
taking off the brace (Barnes et al., 2002; Fu et al., 2015; Giori, 2004; Squyer, Stamper, Hamilton, 
Sabin, & Leopold, 2013; Van Raaij et al., 2010). 
The lateral wedge insole is another modality which aims to reduce the loading of the medial side 
by targeting the EKAM. Previous studies have shown a significant reduction in EKAM and KAAI 
with lateral wedge insole use (Chapman, Parkes, Forsythe, Felson, & Jones, 2015; Duivenvoorden 
et al., 2014; Fu et al., 2015; Jones, Chapman, Forsythe, Parkes, & Felson, 2014). This is achieved 
by placing the foot in a more everted position which places the mechanical axis in a more upright 
position and creates higher ankle eversion moment. This will lead to shifting in the centre of 
pressure (COP) more laterally and therefore a reduction in EKAM throughout, reducing the 
moment arm (Jones et al., 2014; Kakihana, Akai, Yamasaki, Takashima, & Nakazawa, 2004; 
Levinger et al., 2010; Sasaki & Yasuda, 1987; Yasuda & Sasaki, 1987).  
In a previous systematic review they included 12 studies which have shown a significant reduction 
in pain with lateral wedge insole use compared to the baseline (Parkes et al., 2013). Interestingly, 
when pain, while using the lateral wedge insole, is compared to that with a neutral insole, no 
significant difference was identified (Baker et al., 2007; Barrios et al., 2009; Bennell et al., 2011; 
Campos et al., 2015; Maillefert et al., 2001; Pham et al., 2004). One of the possible uses of a lateral 
wedge insole is in combination with another modality to achieve higher reduction in pain and 
maintain the effect of load reduction.  
Combining the lateral wedge insole and the valgus knee brace showed greater EKAM reduction 
(Al-Zahrani, Herrington, Liu, Hutchins, & Jones, 2013; Fu et al., 2015; Moyer et al., 2013) and a 
reduction of pain (Fu et al., 2015) compared to a single treatment. However, due to the low 
compliance with the valgus knee brace, the simple knee sleeve is an alternative to the valgus knee 
brace. The simple knee sleeve is a straightforward and inexpensive treatment (Bryk et al., 2011). 
Previous studies have shown a decrease in pain with sleeve use (Bryk et al., 2011; Cudejko et al., 
2017, 2018a; Kirkley et al., 1999; Mazzuca, Page, Meldrum, Brandt, & Petty-Saphon, 2004; 
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Schween, Gehring, & Gollhofer, 2015). This decrease in the pain is proposed to be related to 
several causes such as a reduction in muscle co-contraction (Collins et al., 2011). Previous studies 
have showed contradicting results regarding the effect of knee sleeve on EKAM amongst 
individuals with knee OA (Collins et al., 2014; Schween et al., 2015) therefore, more studies are 
needed to show the effect of sleeve in EKAM. Encouraging results have showed a greater number 
of participants walked without knee pain on uneven ground with a combination of the lateral wedge 
insole and the simple knee sleeve compared to the lateral wedge insole alone (Keyaki & Toda, 
2010). However, the biomechanical (EKAM, muscle co-contraction) effect, which is a key factor 
in terms of the progression of the disease, has not been investigated up to this point. It would be 
deemed that an ideal solution would have both positive clinical and positive biomechanical results 
and up to this point, this has not been established. Therefore, the aim of this thesis was to 
investigate the effect of combined treatment (lateral wedge insole and simple knee sleeve) on 
clinical and biomechanical outcomes and compare this treatment with that of each treatment 
individually. 
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 Specific aims 
In order to achieve the above aim, the following has to be established: 
To investigate the reliability of different outcome measurements among healthy individuals 
(Chapter three). 
To investigate the reliability of biomechanical and clinical outcomes in individuals with knee 
osteoarthritis (Chapter three) 
To investigate the effect of combined treatment (simple knee sleeve and lateral wedge insole) on 
healthy individuals and additionally compare their effectiveness to the lateral wedge insole and 
simple knee sleeve on knee loading and muscle co-contraction during walking (Chapter four).  
To investigate and compare the immediate clinical and biomechanical outcomes and the effect 
after six weeks of using single treatments (simple knee sleeve or lateral wedge insole) and 
combined treatments (simple knee sleeve and lateral wedge insole together) (Chapter five). 
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Chapter 1: Introduction
-Introduction
-Thesis aims
-Thesis structure
Chapter 2: Literature review
Chapter 3: Methodology
- General methodolgy
-Test– retest reliability for healthy
individuals (study-1)
-Test– retest reliability for
individuals affected with knee
osteoarthritis (study-2)
Chapter 4: 
The immediate effect of single and
combined treatments on knee
kinematics and kinetics on healthy
during walking (study-3)
Chapter 5: 
Effect of a lateral wedge insole and
simple knee sleeve as a single and
combined treatment in biomechanical
and clinical outcomes in individuals
with knee osteoarthritis (The IN-
SLEEVE study) (study-4)
Chapter 6: 
General conclusion and future studies
 Thesis structure 
The structure of the thesis is depicted in the below figure which gives an overview of the 
different chapters which are progressively built on in this thesis. 
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 Literature review 
 Chapter overview 
This chapter seeks to investigate the current literature in terms of conservative management of 
individuals with medial knee OA. The review covers all aspects of OA and a wide range of medial 
knee OA treatment. This was to develop the research question and hypothesis based on scientific 
research methods. This chapter starts with definitions of OA followed by prevalence and incidence 
focusing on medial knee OA. Risk and progression factors are then discussed following on with 
the biomechanical assessment of individuals with medial knee OA with focus on EKAM moment 
and muscle co-contraction. The link between the EKAM and muscle co-contraction and the 
progression of the disease was presented followed by how to modify them. 
 
The second part of this chapter is focusing on current treatment available for individuals with knee 
OA. The orthotic management of individuals with medial knee OA was then reviewed and 
appraised. The chapter was then concluded with the aims and the hypotheses which look at 
investigating the effect of lateral wedge insole and simple knee sleeve as a combined treatment. 
 
 Osteoarthritis 
Osteoarthritis (OA) is considered the most prevalent type of musculoskeletal disease, causing a 
reduction in quality of life with increasing disability (Lawrence et al., 2008). OA is considered a 
worldwide health problem. The prevalence of OA is expected to increase in the future due to 
obesity and the aging population (Zhang & Jordan, 2010). In 2017, Wallace et al, have found that 
the prevalence of the hip and knee OA has more than doubled since the mid-20th century (Wallace 
et al., 2017). A recent study showed that the diagnosis of symptomatic knee OA based on self-
report questionnaire occurs relatively earlier in life (median 55 years), which suggests that 
prevention programmes should be offered earlier (Losina et al., 2013). OA can be defined as a 
heterogenous group of disorder which lead to symptoms and clinical signs combined with 
degeneration of the articular cartilage (Altman et al., 1986). 
  10 
 Etiopathogenesis of OA 
The pathological features of OA include the loss of articular cartilage, abnormal remodelling and 
abrasion of subarticular bone, osteophyte formation and bone cysts (Iannone & Lapadula, 2003). 
Articular cartilage loss in OA may begin as a focal lesion and increasingly expand to engage 
specific joint compartments, thus leading to modifications in articulating surfaces (Lohmander, 
Lark, Dahlberg, Walakovits, & Roos, 1992) and causing the progressive loss of articular cartilage 
(Dieppe, Cushnaghan, Young, & Kirwan, 1993). The catabolism of the extracellular matrix 
exceeds its anabolism, which causes a net reduction in the quantity of the cartilage matrix that may 
lead to the complete erosion of the cartilage covering the bone on the joint surface (Sarzi-Puttini 
et al., 2005). Therefore, for a better understanding to the size of the problem and the proper 
planning to tackle the disease, the prevalence of OA must be considered. 
 Prevalence and global burden of OA 
OA is considered a worldwide health problem affecting approximately 8% to 15% of the 
population (Rat et al., 2006). A recent report has shown that in the United Kingdom (UK), 1 out 
of every 3 (8.75 million) individuals over the age of 44 old is affected by OA (Arthritis Care, 2012). 
In the United States (US), arthritis and other rheumatic diseases cost $128 billion in 2003, equal 
to 1.2% of the gross domestic product (GDP), which was a 24% increase in from 1997 cost, 
according to the Centers for Diseases Control and Prevention (Yelin, 2007). Nevertheless, in the 
US, more than 27 million people suffer from OA, and the incidence of the disease is estimated to 
be about 3.1% annually (Blumenfeld et al., 2013; Lawrence et al., 2008). 
In China, the prevalence of OA is estimated to be nearly 16% of the population (Jiang et al., 2012). 
In developing countries, studies on OA estimated the prevalence to range from 8% to 48% in India, 
Pakistan and Bangladesh (Haq et al., 2010). The cost of OA is estimated to be 1% of the GDP of 
the UK (NICE, 2006). In 2010, Arthritis Research UK estimated the cost of arthritis to the 
economy to be 8 billion pound a year. This shows the high impact of OA on the economy and 
emphasises the urgent need for effective treatments to reduce the cost. 
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 Disability and co-morbidity from OA 
OA is considered a common progression disease that has a major effect on an individual’s function 
and ability. OA is one of the most common secondary causes of death due to disability and 
inactivity. Significant associations have been identified between the severity of disability caused 
by OA and all-causes mortality cardiovascular event (Hawker et al., 2014). The recent literature 
has shown that participants with knee OA are at high risk of cardiovascular disease due to disability 
and inactivity (Nüesch et al., 2011). In Australia, OA is the third leading secondary cause of death, 
equal to asthma (4.8%), and it is exceeded only by dementia (5.6%) and depression (8.0%) (March 
& Bachmeier, 1997). It has been estimated that approximately 60,000 deaths occurred in 2000 as 
a result of disability from OA (Mathers & Penm, 1999). Globally, OA has been ranked amongst 
the top 10 causes of disability (Lawrence al., 2008).  
The impact of OA on disability is substantial, with the disability risk—defined as the need for 
assistance in walking and climbing stairs—being equal to that of cardiovascular disease and 
surpassing that of any other medical condition among the elderly population (Guccione et al., 
1994). The dependence on others in performing daily living activities increases with the incidence 
of radiological OA, even in cases involving the non-appearance of symptoms (Guccione, Felson, 
& Anderson, 1990). In the presence of a chronic condition, the likelihood of disability increases 
even further (Ettinger, Davis, Neuhaus, & Mallon, 1994). However, the disability depends on the 
joints which are affected by OA. The clinical importance of focusing on disability is that disability 
is considered as risk factor for major diseases such as diabetes, obesity and cardiovascular disease 
(Warburton, Nicol, & Bredin, 2006).  Furthermore, the low-activity level was associated with high 
loss of cartilage volume (Lin et al., 2013; Stehling et al., 2011). Therefore, it is hoped that when 
treating individuals with knee OA an improvement in physical activity is seen to reduce the risk 
for major disease.  
 Joints affected by OA 
The joints most commonly affected by OA are the knees, hips and hands, although the disease 
occurs with a lower prevalence in other joints, such as the spine, feet, wrists, shoulders and ankles 
(Table 2-1) (Arthritis Care, 2012). OA of the hip and OA of the knee have the greatest impact on 
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the population, because the disease is more common in these joints than in others and because the 
resulting stiffness and pain significantly affect ability and morbidity. Symptomatic knee OA when 
defined by pain is more common than hip OA, which highlights the increasing importance of knee 
OA in disability and inactivity (Lawrence et al., 2008). Thus, there is a direct need to understand 
the role that knee OA has on the population. 
Table 2-1 Estimated number of individual consulted the GP about OA in the UK (Arthritis Care, 2012).   
Site Age 45+ 
Knee Osteoarthritis 4.71 million 
Hip Osteoarthritis 2.12 million 
Hand/wrist Osteoarthritis 1.56 million 
Foot/ankle Osteoarthritis 1.77 million 
More than 1 joint 1.76 million 
Other/unspecified 0.61 million 
 
 Prevalence and incidence of knee OA 
The prevalence of OA differs depending on (1) the definition (e.g. clinical or radiological), (2) the 
studied population characteristics and (3) the studied joint. The prevalence of radiological knee 
OA in individuals over 44 years old was 19.2% in the Framingham study and 27.8% in the 
Johnston County project (Lawrence et al., 2008). A higher prevalence (approximately 37%) was 
observed in individuals aged 60 years and older in the third National Health and Nutrition survey 
(Lawrence et al., 2008). In the UK the number of individuals affected with knee OA over the age 
of 44 years old in 2010 was estimated to be 4.71 million. This number is estimated to increase up 
to 5.4 million in 2020 and will rise again to 6.4 million in 2035 (Arthritis Care, 2012). 
In 1990, Ahlberg, Linder and Binhemd conducted a study to identify the prevalence of knee and 
hip OA in the population of the eastern province of the Kingdom of Saudi Arabia (KSA) and the 
prevalence of knee and hip OA was 3.5%. More recent study in KSA found in a house-to-house 
survey that the prevalence of clinical knee OA was 13%. This percentage was found to increase 
with age, reaching 60.6% of the population aged between 66 and 75 years old (Al-Arfaj et al., 
2003).  
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There is a lack of meaningful data on the cumulative incidence of OA. The period over which OA 
risk is calculated is vital, but not always clearly defined or known. Furthermore, OA is a chronic 
condition occurring more commonly in the elderly, challenging risk, and death from other medical 
conditions makes it difficult to estimate the cumulative incidence of OA. The rate of the  incidence 
of knee, hip and hand OA in USA was estimated to be 100/100,000 person-years, or 88,240 
individuals in total (Oliveria, Felson, Reed, Cirillo, & Walker, 1995). This incidence rate increases 
sharply around the age of 50 and then stabilises around the age of 70, which is likely to be due to 
the reduction in physical activities, resulting in less joint damage and pain.  
 Financial impact of knee OA  
In the UK, the national tariff for total knee replacements (TKR) due to OA was £5,198, resulting 
in an estimated cost of £426 million for primary TKR in 2010 (Chen, Gupte, Akhtar, Smith, & 
Cobb, 2012). However, this is only the hospital costs and not the associated costs, so the actual 
figure is much greater. In Canada, Gupta, Hawker, Laporte, Croxford and Coyte (2005) estimated 
that the indirect costs associated with hip and knee arthritis patients to be much higher than the 
direct annual cost. In 2016, 108,713 knee replacements were carried out in the UK which shows 
an increase of 3.8% compared to 2015 (Arthritis Research, 2018). Interestingly, 98% of the knee 
replacements in 2011 were due to the knee osteoarthritis (Arthritis Care, 2012). It has been 
estimated that the direct cost of osteoarthritis and rheumatoid arthritis on the healthcare system is 
£10.2 billion for 2018 (Arthritis Research, 2018). Osteoarthritis and rheumatoid arthritis were 
estimated to cost £2.58 billion due to working days lost and the figure expected to reach £3.43 
billion in 2030 (Arthritis Research, 2018).   
 Classification of knee OA 
Knee OA is classified by etiology into two types: primary (idiopathic) and secondary (i.e. trauma) 
(Lespasio et al., 2017). Idiopathic knee OA cause is unknown. This could have been attributed to 
abnormalities in body biomechanics, such as the many cases of hip OA that were considered 
primary because of an unrecognised deformity (Arden & Nevitt, 2006; Ganz, Leunig, Leunig-
Ganz, & Harris, 2008). Many disorders have been documented to be causes of secondary OA, and 
they can be categorised into four groups (Table 2-2). 
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Table 2-2 Secondary causes of osteoarthritis 
Types Example 
Anatomic Epiphyseal dysplasias, Slipped femoral epiphysis, Legg–Perthes disease, 
Blount’s disease 
Traumatic Joint fracture or osteonecrosis, surgery in joint (e.g. meniscectomy), Major 
joint trauma, Chronic injury (occupational arthropathies) 
Metabolic Acromegaly, Calcium crystal deposition, Ochronosis, Haemochromatosis 
Inflammatory Septic arthritis, whichever inflammatory arthropathy 
 
Knee OA can also be divided based on the location of the affected side into three categories: medial 
(tibiofemoral) knee OA, lateral knee (tibiofemoral) OA and patellofemoral OA. It is possible to 
have isolated knee OA (i.e. medial) or combined knee OA (i.e. medial + patellofemoral). 
 Diagnosis of knee OA 
Knee OA may be defined radiographically and clinically.  
Radiographic: 
There are many radiographic methods, and the most commonly used is the Kellgren–Lawrence 
(K/L) scoring and atlas grading scheme (Zhang & Jordan, 2010). This joint score grading system 
divides knee OA into five categories from 0 to 4, defining OA by the existence of explicit 
osteophytes (grade 2 or above). The more severe categories are characterised by the consecutive 
appearance of narrowing in the joint space, sclerosis, cysts and, finally, deformity (Bayramoglu, 
Toprak, & Sozay, 2007; Kellgren & Lawrence, 1963) (Table 2-3 and Figure 2-1). 
Table 2-3 Kellgren–Lawrence OA Grading System (Kellgren & Lawrence, 1957) 
 
Kellgren–Lawrence 
OA Grading System Description 
0 (normal) No characteristics symptoms of OA 
1 (Doubtful) Narrowing of joint space is doubtful and probably osteophystic lipping 
2 (Minimal) Definite osteophytes and probable joint space narrowing  
3 (Moderate) Definite joint space narrowing and moderate osteophytes, some sclerosis and probable bone contour deformity 
4 (Severe) Severe joint space narrowing and sclerosis, large osteophytes and definitive bone contour deformity 
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Figure 2-1 Kellgren–Lawrence OA grading system (Link et al 2003): (A) grade 1, (B) grade 2, (C) grade 3, (D) grade 
4. 
However, population-based studies have revealed inconsistencies between radiological OA and 
symptomatic OA (Dieppe, Cushnaghan, Tucker, Browning, & Shepstone, 2000), defined as 
radiographic findings accompanied by pain or aching on most days (Dahaghin et al., 2005; 
Hannan, Felson, & Pincus, 2000). It has been proven that only half of radiological knee OA 
patients experienced knee pain (Hannan et al., 2000). Inconsistency between the radiological  
criteria and symptomatic OA are likely due to the limitations in radiological method to evaluate 
the tissue involved in the knee OA as synovium (Heidari, 2011b; Kinds et al., 2011). This shows 
the limitation in radiological criteria to diagnose this subgroup which stimulate the development 
of new methods of diagnosis of OA based on knee pain.  
Clinical 
The American College of Rheumatology (ACR) has developed several criteria to diagnose 
individuals with knee OA (Heidari, 2011a) via using a) history and a clinical examination; b) 
history, radiological findings and a clinical examination; or c) history, lab findings and a clinical 
examination. 
History and clinical examination: 
The patient is considered to have knee OA if knee pain was reported on the majority of the days 
of the previous month and accompanied by three out of the following: A) aged older than 50 years, 
B) 30 minutes of joint stiffness, C) bony enlargement, D) bony tenderness or E) crepitus. 
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History, radiological findings and clinical examination: 
The patient will be considered to have knee OA if he or she complains of knee pain for the majority 
of the days in the prior month plus osteophytes and combined with one of the three following 
criteria: 1) aged older than 50 years, 2) more than 30 minutes of joint stiffness or 3) crepitus 
History, laboratory findings and clinical examination: 
The patient is considered to have knee OA if knee pain was reported on the majority of the days 
of the previous month and accompanied by five of the following eight criteria: A) aged older than 
50 years, B) 30 minutes of joint stiffness, C) bony enlargement, D) crepitus E) erythrocyte 
sedimentation rate (ESR) higher than 45 mm/hour, F) synovial fluid signs of OA, G) no palpable 
warmth or H) rheumatoid factor higher than 1/40. 
The key symptom of knee OA is pain, which occurs with joint movement and is relieved by joint 
rest, with the pain typically aching in nature and poorly located (Brandt, 1989). There is no strong 
correlation between joint symptoms and the degree or extent of radiographic or pathological 
change (Westacott, Webb, Warnock, Sims, & Elson, 1997). In severe and advanced knee OA, pain 
persists at rest and may cause a patient to awake from sleep due to a loss of defensive muscular 
joint guarding, which prevents painful movement during the day. Acute and sub-acute 
inflammations are sometimes associated with OA (Heidari, 2011b). 
Morning stiffness is also a common complaint. Articular gelling, a temporary stiffness lasting only 
for several flexion-extension movements, is extremely common in elderly patients, especially in 
weight-bearing joints. Limitations in movement develop as the disease progresses as a result of 
joint-surface incongruity, capsular contracture, muscle spasm and contracture and mechanical 
block because of loose bodies or osteophytes. Crepitus, a grating or crackling sound as the affected 
joint is moved, may be due to joint surface irregularity and cartilage loss. Joint swelling may be 
caused by secondary synovitis or marginal thickness and changes in bone or cartilage 
(osteophytes). Advanced stages of the disease are associated with gross subluxation and deformity 
due to cartilage loss, subchondral bone collapse, bone cyst formation and overall bony overgrowth 
(Felson et al., 2000). 
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 Risk Factors for knee OA  
Studies of knee OA reveal that it has a multifactorial aetiology, and its onset risk factors can 
involve either systemic, local factors or their interplay (Heidari, 2011b). The importance of each 
factor may vary from one joint to another, depending on the stage of the disease and gender. Felson 
et al. (2000) suggested that risk factors for OA might even act in different ways according to 
individual radiographic characteristics, such as joint space narrowing and osteophytes. Individuals 
may have an inherited tendency to develop OA but will never develop the disease unless injured. 
Whether some of these variations are spurious or genuinely caused by different study populations, 
analytical methods or statistical powers, the definition of OA risk and risk factors are points of 
open debate.  
2.11.1 Systemic risk factors 
 Age 
Age is considered one of the strongest risk factors in knee OA and other joints (Blagojevic, Jinks, 
Jeffery, & Jordan, 2010; Felson, et al., 2000; Felson & Zhang, 1998; Lawrence et al., 2008). This 
increase in prevalence with age is likely due to the consequence of accumulative exposure to 
different risk factors and cellular changes that occur with increasing age, which makes a joint less 
capable of coping with adversity, such as muscle weakness, cartilage thinning and poor 
proprioception (Shane Anderson & Loeser, 2010). Interestingly, a recent study has shown that the 
higher prevalence’s of knee OA since the mid-20 century were not explained by increased aging 
or BMI which highlights the need for more studies on the risk factors (Wallace et al., 2017). 
 Race 
Ethnic variation in knee OA has been investigated in white Caucasians and African Americans, 
with the results conflicting. There appears a higher incidence of knee OA in African American 
women, which was highlighted in one large national study (Anderson & Felson, 1988). In contrast, 
in the Johnston County Osteoarthritis Project study, no variation in disease prevalence in the south 
rural area was found (Jordan, Linder, Renner, & Fryer, 1995). In studies assessing the difference 
between western and Asian populations, a Beijing OA study identified a higher prevalence of both 
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symptomatic and radiological knee OA than in the Framingham study (Zhang et al., 2001). In the 
middle east, the prevalence was identified as 53.3% in males and 60.9% in females, with the medial 
side more affected than the lateral side (96.6%) (Al-Arfaj & Al-Boukai, 2002). Interestingly, recent 
study showed that even pain and disability were worse in African American than non-Hispanic 
white individuals (Cruz-Almeida et al., 2014).  
The relative contribution of socioeconomic, lifestyle and biological factors to ethnic variation are 
vague. Although body mass index differences in different ethnicities might explain some variation 
in the prevalence of radiological OA, the variation in radiological OA biomarkers suggests genetic 
and biological factors also play a role (Clark et al., 1999). 
 Sex 
In studies that investigated gender differences, a higher prevalence of knee OA was highlighted in 
women after the age of 50 compared to men (Felson et al., 2000; Kohatsu & Schurman, 1990; 
Srikanth et al., 2005). Recent published data showed that estimated number of female sought 
treatment for knee OA to be higher than male (Arthritis Care, 2012). Moreover, the severity of the 
knee OA in females tends to be higher than in males (Srikanth et al., 2005a). In contrast, males do 
tend have a higher prevalence of knee OA under the age of 50 (Felson et al., 2000), which is likely 
due to hormonal factors. 
 Nutritional factors 
Vitamin D deficiency was identified as a risk factor for developing knee OA through regulating 
the mineralisation in bone and cartilage (Misra et al., 2013). The continuous exposure to oxidants 
has been identified as a contributor to many age-related disorders involving OA (Frei, 1994). 
Nevertheless, a study that investigated the role of vitamin C highlighted the importance of this 
vitamin in OA. The risk of radiological knee OA was found to be reduced by threefold in 
individuals with a high and moderate intake of vitamin C compared to the low intake group 
(McAlindon et al., 1996). Vitamin C supplementation was found to reduce the risk of knee OA 
after controlling other confounding factors (Peregoy & Wilder, 2011). 
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 Genetics 
Several studies have shown that OA can be inherited and may differ from joint to joint 
(Osteoarthritis: National Clinical Guideline for Care and Management in Adults - NCBI, 2008; 
Zhang & Jordan, 2010). Family and twin studies have illustrated that the heritability component 
of OA is high in the hand and knee (35%–65%), hips (60%) and spine (70%) joints (Spector & 
MacGregor, 2004). Many genes are known for their interactions with OA, such as the receptor 
gene for vitamin D, which has an influence on bone density and is close to the location of type II 
collagen, gene factor I insulin-like growth and others (Felson et al., 1998; Spector, Cicuttini, 
Baker, Loughlin, & Hart, 1996). 
 Bone density  
A higher bone mineral density is considered a risk factor for knee OA (Hannan, Anderson, Zhang, 
Levy, & Felson, 1993; Hardcastle, Dieppe, Gregson, Davey Smith, & Tobias, 2015; Nevitt et al., 
1995). The mechanism by which bone mineral density increases the risk of knee OA remains 
elusive (Hardcastle et al., 2015). In contrast, once the disease has been initiated, a higher bone 
mineral density might protect against disease progression, as shown by the Framingham study 
(Zhang et al., 2000). Moreover, a reduction in bone mineral density in individuals with knee OA 
might accelerate the progression of the condition. These previous arguments show the complex 
and conflicting roles of bone density.  
 Hormonal status 
Oestrogen is a factor that might affect bone mass density. Women with higher exposure to 
exogenous and endogenous oestrogen have higher bone mass density, which increases the risk of 
knee OA (Hannan et al., 1993; Hardcastle et al., 2015; Nevitt et al., 1995). On the other hand, 
oestrogen use might decrease the progression of the disease in individuals with knee OA (Felson 
et al., 2000).  
These systemic risk factors for knee OA have been identified and the majority are non-modifiable; 
therefore, modifiable factors, local risk factors or biomechanical factors have also been proposed. 
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2.11.2 Local risk factors and biomechanical factors 
Local factors that affect the risk of developing knee OA are thought to work through an abnormal 
joint mechanical loading that alters local forces across the joint. The following are factors that 
have been associated with a greater incidence and the progression of knee OA. 
 Obesity 
Individuals who are overweight and obese have been identified as at a high risk for developing 
OA in the knee joint (Felson et al., 2000; Silverwood et al., 2015). In the Framingham study, 
women who lost 5 kg of mass showed a 50% risk reduction in developing symptomatic knee OA, 
which highlights the strong effect of mass on OA (Felson, Zhang, Anthony, Naimark, & Anderson, 
1992). A weight loss of two units or more on the body mass index was also associated with a 
reduction in the risk of developing radiological knee OA by 50% (Felson et al., 1992) whilst a 5 
unit increase was associated with 35% risk increase (Jiang, Tian, et al., 2012). The basic 
mechanism for the correlation of obesity and knee OA is likely to involve the effect of excessive 
weight on overloading of the knee and hip joints during activity and changes in body biomechanics 
during walking, leading to damage to the ligaments and the breakdown of cartilage and other 
support tissues (Messier, 2008).  
The overall force across the knee joint during a single leg stance was suggested to increase by two 
to three pounds by each one pound increase in the mass of the individual (Bliddal, Leeds, & 
Christensen, 2014; Felson et al., 2000). Several studies have highlighted the successful effect of 
weight reduction as a conservative treatment solution for pain reduction and improvements in the 
disability of individuals with knee OA (Christensen, Bartels, Astrup, & Bliddal, 2006; Messier et 
al., 2004). Meta-analysis results concluded that weight loss reduction in obese individuals with 
knee OA by 5% in mass was associated with significant improvements in physical function 
(Christensen et al., 2006). 
 Knee malalignment  
Robust evidence proposes that joint malalignment play an important role in knee OA progression 
(Tanamas et al., 2009). A study by Sharma et al. (2001) showed the importance of joint 
malalignment in individuals with knee OA. Abnormal limb alignment was strongly correlated with 
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knee OA progression in the deteriorated compartment (Felson et al., 2013; L Sharma et al., 2001). 
Individuals with a varus deformity had a fourfold risk of knee OA progression (medial 
compartment), while individuals with a valgus deformity have a fivefold increase in the risk of 
progression of lateral compartment knee OA. The link between malalignment and the incidence of 
knee OA is less clear, with one study showing an association (Brouwer et al., 2007) while others 
have not (David J Hunter et al., 2007). Varus knee alignment has been identified as one of the best 
indicators of a high knee adduction moment (Barrios, Higginson, Royer, & Davis, 2009), which 
has been proposed as a risk factor for the progression of medial knee OA. 
 Acute joint injury and joint deformity 
Ligamentous and meniscus tears, articular surface fractures and dysplasia followed by the 
development of OA in the affected joint at a high percentage (Lohmander, Ostenberg, Englund, & 
Roos, 2004; Roos, Ostenberg, Roos, Ekdahl, & Lohmander, 2001; Silverwood et al., 2015). A 
study by Roos (2005) concluded that knee OA is more common in young adults after injury (Roos, 
2005). In soccer players who have sustained an anterior cruciate ligament rupture, 51% of females 
showed radiological changes after 12 years (Lohmander et al., 2004), while 41% of men showed 
knee OA after 14 years (Von Porat, 2004). The prevalence of meniscal damage was much higher 
in individuals with radiological knee OA than in those with no OA (82% and 25%, respectively) 
in the Framingham study (Zhang & Jordan, 2010). The risk of TKR among individuals with knee 
OA was found to increase seven times with ACL injury and 15 times with meniscal injury which 
highlight the effect of such injuries on the development of end stage OA (Khan et al., 2018), hence 
the emerging and established work on the prevention of OA. 
 Occupational overuse 
Occupational activities that require the overworking of joints through repetitive task movement, 
leading to fatigued muscles, increases the risk of developing OA in the involved joints (Coggon et 
al., 2000; Cooper, McAlindon, Coggon, Egger, & Dieppe, 1994; Felson et al., 1991). The risk of 
developing OA was found to increase by more than twofold in men whose occupation required 
squatting/kneeling and carrying than in individuals whose jobs did not require such activities 
(Felson et al., 1991). The load across the knee joint is increased in a squatting or crouching 
position, and it is further increased by lifting weight, and turning in such a position further 
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increases torsional stress (Felson et al., 2000). A recent systematic review concluded that exposure 
to certain physical activities may be considered a risk factor for knee OA and pain (Silverwood et 
al., 2015) 
 Physical activity/sports 
It has been demonstrated via epidemiological studies that the risk of developing knee OA increases 
with certain types of sporting activities (Cheng et al., 2000; Verweij, van Schoor, Deeg, Dekker, 
& Visser, 2009). Silverwood et al. (2015) concluded that habitual high physical activity appears 
to increase the risk of developing knee OA, whereas in individuals who participate in less intensive 
exercise do not appear to be at a high risk of developing knee OA. In a recent systematic review 
and meta-analysis which included 25 studies, they concluded that competitive runners have a 
higher risk of developing knee and hip OA than recreational runner (Alentorn-Geli et al., 2017). 
In contrast to the previous study Timmins, Leech, Batt and Edwards (2017) systematic review and 
meta-analysis concluded that it is not possible to determine the effect of running on the knee OA 
with current evidence. 
 Muscle Weakness 
Longitudinal studies have shown that quadriceps weakness is a risk factor for knee OA (Brandt et 
al., 1999; Hootman, Fitzgerald, Macera, & Blair, 2004; Slemenda et al., 1998) and is common in 
individuals with knee OA (Alnahdi, Zeni, & Snyder-Mackler, 2012; Lewek, Rudolph, & Snyder-
Mackler, 2004b). Furthermore, a recent study showed that quadriceps weakness is a predictor of 
symptomatic knee OA, but not radiological knee OA (Segal et al., 2009). It might be argued that 
muscle weakness may be due to disuse atrophy (Baker et al., 2004). However, individuals with 
radiological OA without knee pain or quadriceps mass loss have shown a reduction in the 
quadriceps muscle strength (Slemenda et al., 1997). A relatively small improvement in quadriceps 
strength (approximate mean of 25% for females and 20% for males) was estimated to cause a 20% 
to 30% decrease in the odds ratio of having knee OA (Slemenda et al., 1997). Moreover, recent 
systematic review supported that quadriceps weakness is a risk factor for developing knee OA 
(Øiestad, Juhl, Eitzen, & Thorlund, 2015). 
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The local biomechanical factors all predispose the individual to having a greater chance of 
developing OA, but when the disease is present, mechanical progression is the rule (Felson, 2013). 
Therefore, an understanding of the biomechanics of individuals with OA is necessary to determine 
which treatments for the individual are required. 
 Biomechanical changes in knee OA  
Biomechanics as a word consists of two parts: ‘bio’ which refers to the living body, and 
‘mechanics’ which refers to forces acting on objects and the consequence of this force in term of 
movement and equilibrium (Rau, Disselhorst-Klug, & Schmidt, 2000). Therefore, biomechanics 
as whole means the application of mechanics and its principles in the human body. Biomechanics 
of movement is the implementation of Newton’s laws with regard to the neuromuscular system, 
which include the forces that cause movement and the inner forces that act within our body (Rau 
et al., 2000; Rose & Gamble. 2006). Before discussing the biomechanical gait changes that occur 
in individuals with knee osteoarthritis, typical biomechanical gait patterns will be discussed. 
2.12.1 Walking gait cycle  
As the human body moves forward, one of the lower limbs act to support the body, while the other 
advances itself forward to a new position, and then the limbs reverse their functions. This 
reciprocal event is repeated by each limb until the body reaches its final destination. A single 
sequence of these events (support time, forward movement time) is defined as a gait cycle (see        
Figure 2-2). The gait cycle is divided into two phases; stance phase, which starts as soon as the 
foot comes into contact with the ground, until the foot leaves the ground, and this consists 60% of 
the gait cycle; and  swing phase, which represents the period when the foot is in the air, consisting 
40% of the gait cycle (Kharb, Saini, Jain, & Dhiman, 2011). 
The stance phase can be subdivided into three parts, starting with early-stance, mid-stance and 
finally late-stance. The three parts occur from 0% to 20%, 21% to 40% and 41% to 60% for the 
stance phases respectively. During the stance phase, five events occur respectively, which are the 
following heel strike (HS), foot flat (FF), mid-stance (MS), heel rise (HR) and finally toe-off (TO). 
During the swing phase, three events occur, which are initial-swing, mid-swing and terminal-swing 
respectively (Levine, Richards, & Whittle, 2012; Perry, Burnfield, & Cabico, 2010). 
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In each stance phase there are one period of single leg support and two periods of double leg 
support (10% each). However, the proportion of stance phase and swing phase varies with 
increases in speed. As the speed increases, the swing phase increases and the stance phase and 
double support period decreases. The stance and the swing phases can be divided into eight 
functional sub-phases; initial contact, loading response, mid-stance, terminal stance, pre-swing, 
initial-swing, mid-swing and terminal-swing (Levine, Richards, & Whittle, 2012; Perry, Burnfield, 
& Cabico, 2010). Each of the previously (eight) mentioned sub-phases has a functional goal, which 
is accomplished via a critical pattern of synergistic motion. The consecutive combination of the 
sub-phases also allows the limb to achieve three basic functions. The first one is weight acceptance 
(WA), which occurs in the first two sub-phases, the second one is single limb support (SLS) which 
happens in the next two sub-phases, and the third one is limb advancement (LA) which occurs in 
the last four sub-phases (Kharb et al., 2011; Perry, 1992, Perttunen, 2002). 
At initial contact, the foot contact by the heel, the hip in flexed, the knee is extended while the 
ankle in dorsiflexion to neutral position. During the first 10% of the gait cycle (double limb 
support) the body mass is hold by hip flexion, knee flexion and ankle neutral position in order to 
absorb the shook. Then the body mass is progressively controlled in first period of single leg 
support (10-50%) by hip extension, knee extension and ankle dorsiflexion. In the second period of 
double support which starts from 50 % to 60%, the body weight starts to be transferred to the 
contralateral limb by hip and knee flexion and ankle plantarflexion. In the early swing phase (60% 
-75%), the hip and the knee reach the maximum flexion angle while the ankle is in planter flexion 
as the weight transferred to the other limb. In the mid swing (75%- 85%) the knee starts to extend 
and the ankle start to dorsiflex while the hip remains in extension until the tibia reach vertical 
position. Finally, in the terminal swing, the limb progression is completed by knee extension and 
the hip reached its earlier flexion and the ankle in dorsiflexion to neutral position (Kharb et al., 
2011; Perry et al., 2010).    
Each stride includes continuous changes in the alignment between the body and the supporting leg 
throughout stance, and the advancement of the leg throughout the swing phase, in order to deliver 
the required basic functions necessary for walking. These responses result in sequences of motion 
patterns being accomplished by each joint (hip, knee, ankle) (Kharb et al., 2011). 
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Figure 2-2 Walking gait cycle (Meng, Zhang, Sun, Wu, & Wong, 2012). 
Several studies have investigated the impact of knee OA on gait characteristics and will be 
discussed in the following section. 
2.12.2 Biomechanics of medial knee OA 
 Knee OA spatiotemporal, kinematics and kinetics 
Studies into knee OA have shown that individuals with knee OA have shorter step lengths, slower 
walking speeds, longer double support periods, and a reduction in both knee and hip range of 
motion angle (Al-Zahrani & Bakheit, 2002; Andriacchi, Ogle, & Galante, 1977; Baliunas et al., 
2002; Brinkmann & Perry, 1985; Kaufman, Hughes, Morrey, Morrey, & An, 2001b; Messier, 
Loeser, Hoover, Semble, & Wise, 1992; Messier et al., 2005). 
Stance time has also been shown to increase (Al-Zahrani & Bakheit, 2002; Astephen, Deluzio, 
Caldwell, & Dunbar, 2008; Landry, McKean, Hubley-Kozey, Stanish, & Deluzio, 2007), whereas 
cadence and stride length were decreased compared to the control group (Al-Zahrani & Bakheit, 
2002). Furthermore, individuals with knee OA have increased mid-stance external knee adduction 
moments as well as decreased peak knee flexion moments, peak hip adduction moments and peak 
hip extension moments compared to an age-matched control group (Astephen et al., 2008). 
As proposed by Mündermann et al. (2005), reductions in walking speed in individuals with knee 
OA is probably in order to reduce knee load (Mündermann, Dyrby, & Andriacchi, 2005). 
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Mündermann et al. (2005) states that the secondary gait changes noticed in individuals with knee 
OA reflect a possible technique used to shift the load quickly from the contralateral leg to the 
supported one. The study showed that individuals with medial knee OA landed in a more extended 
knee, had greater vertical GRF loading rate, had higher knee and hip abduction moment, indicating 
lateral shifting in the truck and rapid shifting in weight from contralateral limb to the supported 
limb. This strategy was successful in reducing the knee joint loading in individuals with less severe 
OA, but not the severe group. Mundermann et al. (2005) stated that increasing the loading rate in 
the knee, hip and ankle joints may increase progression of knee OA and lead to the onset of OA in 
the adjacent joints. Supporting evidence has also showed that 90% of individuals with medial knee 
OA had contralateral knee OA or went onto develop it within 10 years (Jones et al., 2013). In 
individuals with unilateral knee OA, the peak hip and knee flexion angle have been seen to reduce 
significantly compared to the non-affected side during early-stance during walking (Briem & 
Snyder-Mackler, 2009). 
The knee joint plays an important role in absorbing the load generated when the leg comes in 
contact with the ground at early-stance at approximately 15 degrees of flexion. The faster the body 
moves, the higher the force, which requires the knee to move into more flexion to absorb the load 
(Winter, 1991). This increase in knee flexion depends on the eccentric contraction of the 
quadriceps muscles (Winter, 1983), which have been found to be weak in individuals with knee 
OA (Slemenda et al., 1997). Another mechanism that has been proposed to increase the 
compressive knee load is to increase the muscle co-contraction, which is found to increase in 
individuals with knee OA (Lewek, Rudolph, & Snyder-Mackler, 2004a). Additionally, higher 
walking speeds cause higher muscle co-contraction in individuals with knee OA (Zeni, Rudolph, 
& Higginson, 2010). Therefore, individuals with knee OA might additionally use this reduced 
speed strategy to reduce the knee joint load.  
A reduction in maximum knee flexion angle (Astephen et al., 2008; Childs, Sparto, Fitzgerald, 
Bizzini, & Irrgang, 2004; Lewek et al., 2004; Schmitt & Rudolph, 2007) and knee external rotation 
moment (Landry et al., 2007) through the early-stance phase has also been identified in individuals 
with knee OA. Several reasons have been proposed as causes of such as pain (Kaufman et al., 
2001), quadriceps weakness, landing on extra-flexed knee during initial contact (Childs et al., 
2004), and knee instability stiffness strategy (Schmitt & Rudolph, 2007). Childs et al. (2004) stated 
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that a reduction in the sagittal plane range of motion (stiff knee) occurs when an individual lands 
on the more flexed knee, which leads to higher muscle co-contraction and, consequently, to higher 
loading as the contact area in the knee is smaller as well. A reduction in peak knee flexion moment 
during early and late-stance has also been identified (Astephen, Deluzio, Caldwell, Dunbar, & 
Hubley-Kozey, 2008; Baliunas et al., 2002; Kaufman et al., 2001b; Rudolph, Schmitt, & Lewek, 
2007), which is believed to be a strategy used to reduce the knee joint load and therefore reduce 
pain during knee extension, as it demands less eccentric quadriceps contraction.  
In individuals with medial knee OA, several biomechanical changes have been proposed to directly 
linked to increasing the medial compartment load or the progression of disease and this will be 
discussed in the following section. 
 External knee adduction moment 
Previous literature has shown that the medial compartment is affected more than the lateral 
compartment (Bartel, 1992; Dearborn, Eakin, & Skinner, 1996; Hasan & Shuckett, 2010; Wise et 
al., 2012) by a factor of 4 to 10 times (Ahlbäck, 1968; Ledingham et al., 1993). One of the potential 
reason for the more common of medial compartment OA that the medial compartment bears higher 
loads during activities like walking and climbing stairs than the lateral compartment (Hurwitz, 
Ryals, Case, Block, & Andriacchi, 2002). The higher load on the medial compartment results from 
the way that the line of gravity passes through the medial compartment to the centre of the knee 
joint (Johnson, Leitl, & Waugh, 1980; Schipplein & Andriacchi, 1991). During walking, the 
medial compartment bears around 2.5 times higher load than the lateral compartment (Schipplein 
& Andriacchi, 1991).  
The force distribution of the knee joint between the lateral and the medial compartments relies on 
two factors: the magnitude of the external abduction and adduction moments acting about the joint 
(Hurwitz et al., 1998; Schipplein & Andriacchi, 1991) and the contribution of the forces of the 
ligaments and muscles balancing the moment.  
Therefore, evaluating the effects of biomechanical factors (i.e. loading) on knee OA progression 
are important. The gold standard method to measure the medial loading compartment loading 
during activity is to use the knee implantation; however, this method is impractical and invasive 
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(Chang et al., 2015). The other method is to use indirect measurement of the medial compartment 
loading such as the External Knee adduction moment (EKAM) ( Figure 2-3). EKAM can be 
defined as the turning moment (torque) acting on the shank due to a ground reaction force passing 
medially to the knee joint centre and it is argued that 60% to 80% of the knee compression load is 
distributed to the medial side of the knee joint by the knee adduction moment (Andriacchi, 1994). 
 
Figure 2-3 External knee adduction moment (Hinman & Bennell, 2009). 
The perpendicular distance from the centre of the joint to the ground reaction force is called the 
moment arm. The product of multiplying the force by the moment arm is the adduction moment, 
which moves the knee inward (adduction). External forces, including the EKAM, can be measured 
by using a force plate to measure the ground reaction force accompanying the motion analysis 
system (Kim et al., 2004). The EKAM consists of two peaks and one trough (Figure 2-4). The first 
peak occurs during early-stance between 0-20% of the gait cycle, followed by the trough which 
occurs during mid-stance between 21-40% of the gait cycle, and the second peak takes place in 
the late-stance between 41-60% of the gait cycle (Hurwitz, Ryals, Case, Block, & Andriacchi, 
2002; Newell, Hubley-Kozey, Stanish, & Deluzio, 2008). 
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Figure 2-4 EKAM graph during walking. 
Individuals with knee OA tend to walk with greater external knee adduction moments than 
individuals without knee OA; this adds an extra load to the medial side (Schipplein & Andriacchi, 
1991; Sharma et al., 1998). 
Several studies have investigated the difference in EKAM between individuals with knee OA and 
healthy which will be discussed next.  
 Knee OA and EKAM 
Several characteristics of the EKAM outcome variables (1st peak, trough, 2nd peak, maximum) 
have been investigated in previous knee OA studies (Baliunas et al., 2002; Huang et al., 2008; 
Hurwitz et al., 2002; Kim et al., 2004; Mündermann, Dyrby, Hurwitz, Sharma, & Andriacchi, 
2004; Rudolph, Schmitt, & Lewek, 2007; Thorp et al., 2006). 
Baliunas et al. (2002) and Hurwitz et al. (2002) showed that the peak EKAM is higher in 
individuals with medial knee OA compared to healthy when matching for speed. Additionally, 
EKAM was found to be higher than three groups of healthy participants (young, middle, elderly) 
(Rudolph et al., 2007) with further research showing that individuals with mild and severe OA 
predominant in the medial compartment had higher peak EKAM across the stance and 1st peak 
EKAM than healthy (Thorp et al., 2006).  
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In the mid-stance phase, trough EKAM presented similar results to 1st peak EKAM showing higher 
value in individuals with severe (Huang et al., 2008) and mild to moderate (Landry et al., 2007) 
knee OA than healthy individuals. Furthermore, individuals with severe knee OA were found to 
walk with higher second-peak EKAM than healthy people did (Huang et al., 2008; Thorp et al., 
2006). Kim et al. (2004) developed a new technique for assessing the EKAM in individuals with 
knee OA. The new method is called the single leg stance EKAM as a measurement for loading. 
The rationale for using this technique is that, during walking, EKAM can be affected by several 
factors, such as walking speed, the toes’ outward angle, stride length and deviation of the trunk 
toward the effected limb. Using a single leg stance would eliminate the effect of compensatory 
mechanisms while allowing EKAM measurement. The results of the study showed that the 
maximum, minimum and average EKAM during single leg stance are higher in individuals with 
knee OA than the measurements are in healthy people. Interestingly, a previous study showed that 
individuals with more severe knee OA had more varus and higher maximum EKAM than less 
severely affected individuals did (Mündermann et al., 2004). Therefore, mid-stance EKAM (from 
34% to 67% of the stance phase) and second-peak EKAM (from 68% to 100% of the stance phase) 
should also be considered when conducting a study. 
Contradicting results to the previous studies showed that individuals with mild knee OA has no 
significant difference in maximum EKAM (Mündermann et al., 2004), trough (Huang et al., 2008) 
and 2nd peak (Huang et al., 2008; Thorp et al., 2006) than healthy. Moreover, individuals with 
more severe knee OA were found to has lower 2nd peak EKAM than healthy (Astephen, Deluzio, 
Caldwell, Dunbar, et al., 2008). A recent systematic review and meta-analysis investigated if 
individuals with medial knee OA exhibit gait changes including higher EKAM than healthy (Mills, 
Hunt, & Ferber, 2013). The study concluded that there is a lack in the evidence to support that 
individuals with knee OA show higher EKAM than healthy. The authors stated that gait 
modification adopted by some individuals with knee OA could be the cause for this. 
The contradiction in previous literature regarding the difference between the individuals with knee 
OA and healthy in respect to the different characteristics of EKAM variable outcomes may be due 
to different reasons. Individuals with mild knee OA may adopted strategies to reduce the knee 
loading via truck lean or any other gait modification in order to reduce the EKAM and therefore it 
is important to separate individuals based on severity to see difference compared to healthy (Mills 
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et al., 2013; Mündermann et al., 2005). Walking speed is an important factor affecting EKAM as 
an increase the walking speed results in higher EKAM because EKAM is the product of GRF and 
moment arm (Mündermann et al., 2004). Therefore, self-selected speed and other confounder 
factors (age, MBI) should be controlled between the groups to see difference. Previous studies 
have showed that the statistical difference in trough EKAM between individuals with knee OA 
and healthy diminished after asking participants in both group to walking at faster speed (Landry 
et al., 2007). The variation in the selection criteria could be another potential factor as some studies 
used the ACR criteria and others have used radiological criteria specifying that only medial 
compartment participants included. Therefore, only individuals with medial compartment may 
show this high EKAM to healthy and not in individuals with patellofemoral compartment or OA 
in more than one compartment on radiograph. 
Although the EKAM (first peak, trough, second peak) has been used often in previous studies, it 
represents joint loading at only a specific part of the stance phase and this may have been the 
reason why it has not been able to differentiate between individuals with severe and mild knee 
OA. Therefore, it is necessary to use an outcome that can reflect loading during the whole of the 
stance phase.  
 External knee adduction angular impulse 
In 2006, a team of researchers were the first to adopt a new variable, used previously in running 
literature by Stefanyshyn, Stergiou, Lun, Meeuwisse and Worobets (2006) for characterising the 
EKAM in knee OA (Thorp et al., 2006). This variable is called the knee adduction angular impulse 
(KAAI), which represents both the duration and the magnitude of the EKAM during the stance 
phase (area under the curve in the positive side only) (see Figure 2-5). KAAI represents the 
adduction moment in the whole stance phase, and not at specific times, as first or second peak 
EKAM. KAAI has been identified as being a more sensitive variable for identifying the difference 
between moderate and mild radiological OA than EKAM. In contrast, peak EKAM during early-
stance has not been able to identify the differences between mild and moderate knee OA groups 
(Kean et al., 2012; Thorp et al., 2006). This might be attributed to the slower walking speed as the 
disease progression correlated with speed with more severe knee OA showing lower speed. 
Therefore, once the speed is reduced the stance time is increased and the KAAI is increased. 
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Individuals with knee OA showed higher KAAI than healthy individuals in previous studies 
(Landry et al., 2007; Linley, Sled, Culham, & Deluzio, 2010; Newell et al., 2008). Furthermore, 
Thorp et al. (2007) found higher KAAI in symptomatic knee OA individuals compared to 
asymptomatic and healthy participants as well (Thorp, Sumner, Wimmer, & Block, 2007). 
 
Figure 2-5 External knee adduction angular impulse (KAAI) graph. KAAI represented by the shaded area 
Several studies have investigated the use of EKAM and KAAI as indirect measurements for 
loading and relationship between EKAM and symptoms and progression of the disease which will 
be discussed next.  
 EKAM relationship with load 
Several studies attempt to investigate the relationship between the EKAM and the knee loading 
among healthy and individuals with knee OA. In 1991, Schipplein and Andriacchi used a 
musculoskeletal model to predict the knee loading in healthy and participant with knee varus 
deformity and OA. The study showed that in individuals with a varus deformity and OA had higher 
medial compartment loads than healthy individuals. This higher load tends to open the lateral 
compartment and EKAM was found to correlate with the lateral to medial load distribution. The 
study concluded that EKAM can be used to estimate the distribution of the force in the knee during 
walking. 
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The study showed that EKAM as the main determinate not only for total load across the knee joint, 
but also for lateral-to-medial load distribution. To test the validity of prediction of the knee 
dynamic load based on gait characteristics Hurwitz et al. (1988) conducted a study. The study 
measured the gait characteristics and bone density dual energy x-ray absorptiometry to 28 healthy 
participants. The result showed that peak EKAM is the best predictor variable for medial to lateral 
knee load distribution ratio (R2 =0.31) which lead the authors to concluded EKAM is a valid 
outcome to predict the medial to lateral force distribution. Others studies showed similar results 
regarding the EKAM and showing that EKAM is the single best predictor for proximal medial and 
lateral tibial bone density in individuals with knee OA (Thorp et al., 2006; Wada et al., 2001). 
In one participant with an implanted knee tray two studies investigated the relationship between 
EKAM and the knee load (Mündermann, Dyrby, D’Lima, Colwell, & Andriacchi, 2008; Zhao et 
al., 2007). Both studies used similar method in which the tray only measure the total load and 
therefore dynamic contact model was needed to investigate the distribution of the load between 
the knee compartments. Zhao et al, (2007) found that at 20% of the gait cycle, a high proportion 
of the load (70%) is transmitted by the medial compartment. Furthermore, a significant strong 
correlation was identified between the peak EKAM and the medial contact force (R2= 0.77) and 
medial to total force (R2= 0.69) across the gait cycle. Mundermann et al. (2008) stated that in most 
activities (walking, squatting, stair ascending, stair descending, golf swings, sit to stand, stand to 
sit) greater load is placed in the medial compartment. Interestingly, the medial to lateral knee load 
ratio in peak compressive force was found to be 1.7 during walking (Mündermann et al., 2008). 
More recently, a study investigated the relationship between EKAM and medial loading across 9 
subjects and 10 activities (Trepczynski et al., 2014). All subject had an implant tray and the results 
showed significant strong correlation across subjects and activities with R2 equal to 0.88. All 
previous study supports that EKAM is valid surrogate measurement to measure the dynamic 
loading in medial compartment. Zhao et al. (2007) stated that the load distribution between the 
medial and the lateral knee compartments is likely to depend on the limb alignment and other 
characteristic which influence EKAM. 
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 EKAM and relationship with clinical symptoms 
If loading is greater on the knee joint, one may infer that the pain would also be greater. A recent 
study investigated the effect of EKAM on pain and found that individuals with bilateral medial 
knee OA had higher pain in the limb with the higher EKAM. The odds ratio of pain after walking 
was found to increase by 3.05 with between limb EKAM difference higher or equal to 1.0 
%BW*Ht (Marriott et al., 2017). Interestingly, in a study which included 132 elderlies, individuals 
who developed knee pain after 3 to 4 years had higher baseline peak EKAM by 8% to 39% than 
the individuals who did not develop knee pain (Amin et al., 2004). In individuals with medial knee 
OA the first peak EKAM also showed a significant correlation with the total WOMAC with an R 
equal to 0.33 (Hurwitz et al., 2002). In similar population (medial knee OA) Miyazaki et al. (2002) 
also showed a significant relationship between pain and EKAM (R=0.33). However, both of these 
studies did show weak correlations. Stronger correlations were found between WOMAC pain 
(R=0.63), WOMAC function (R=0.66), total WOMAC (R=0.63) and mean single leg EKAM in 
individuals with medial knee OA (Kim et al., 2004). Further, Thorp et al. (2007). showed that 
symptomatic individuals with knee OA grade 2 had higher peak EKAM and KAAI than 
asymptomatic individuals with knee OA grade 2 or healthy individuals. 
Interestingly, EKAM was identified to be a predictor of clinical outcomes of high tibial osteotomy 
(Prodromos, Andriacchi, & Galante, 1985). Follow up (3 to 8.9 years) with the same groups of 
patients revealed that 9 of the 14 patients in the high adduction moment group and 3 of the 14 in 
the low adduction moment group had a varus deformity on the back before surgery (Wang, Kuo, 
Andriacchi, & Galante, 1990). 
All previous studies support that notion that increase pain is correlated to an increase in the EKAM 
and this could be due the higher load. The previous claim is supported by studies which showed 
that using intra-articular pain relief in individuals with knee OA lead to further increases in the 
knee loading  (EKAM) (Henriksen et al., 2006; Paoloni et al., 2012; Schnitzer, Popovich, 
Andersson, & Andriacchi, 1993). In 2009, a systematic review included 14 studies concluded that 
the 1st peak EKAM is correlated with WOMAC total score and WOMAC pain score is correlated 
with the mean EKAM in individual with medial knee OA (Foroughi et al., 2009). 
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 EKAM and OA progression 
One of the earlier studies which aimed to investigate the relationship between EKAM and knee 
OA progression was Miyazaki et al., (2002), who assessed the EKAM for 106 participants with 
medial knee OA at baseline. Of those 106, 76 participants were reassessed after 6 years. The results 
showed a significant negative correlation between the EKAM and knee joint space widths and 
positive correlation between EKAM and the mechanical axis (varus alignment) after 6 years. 
Furthermore, the risk of the knee OA progression was found to increase by 6.46 times with a 1 
unit increase in the EKAM. In 12 healthy participants. Koo and Andriacchi (2007) showed that 
the peak adduction moment correlated significantly with the ratio of medial to lateral cartilage in 
the tibial (R2=0.32) and femur (R2=0.43). Furthermore, a significant correlation was found 
between loss of knee cartilage volume over 12 months and the KAAI (Bennell et al., 2011). Since 
EKAM and associated variables have been shown to be an indicator of the knee OA progression, 
the reduction in these variables must be achieved if one is aiming to reduce the progression of the 
disease. 
However, Walter et al, (2010) stated that the reduction of the EKAM alone does not always 
guarantee the reduction in medial joint loading and this is likely to be due to the increase in knee 
flexion moment (KFM) which might reduce the benefit of reducing the EKAM. However, this 
study only included one participant with an implanted knee plate tray, and with the knee in neutral 
alignment, which likely reduces the generalisability of the result. Furthermore, individuals with 
medial knee OA has varus alignment (Sharma et al., 2001) and this might cause different results. 
In 2014, a study showed that both peak EKAM and the KFM has an effect of knee joint progression 
(R2=0.60), however this was in two different anatomical sites. The study found that KFM has an 
effect of the tibial cartilage while EKAM has an effect on femoral cartilage (Chehab, Favre, Erhart-
Hledik, & Andriacchi, 2014). The previous studies highlight the importance of considering the 
change in the KFM when investigating the effect of any treatment in EKAM 
In contrast to the previous studies (Chehab et al., 2014; Walter, D’Lima, Colwell, & Fregly, 2010) 
recent studies investigated the relationship between the knee OA progression and other 
biomechanical factors (KAAI, EKAM, KFM) over two year (Chang et al., 2015). This large (212 
knee OA) longitudinal cohort study with participant recruited from community allowed for 
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adjustment for confounder factors which increase the generalisability of the study. The result 
showed that peak EKAM and KAAI at baseline were significantly correlated with disease 
progression. However, peak KFM did not showed any significant correlation with joint space 
narrowing, cartilage damage, medial or lateral tibial surface damage.  
In summary and based on the previous studies EKAM is an important measurement for the load 
distribution, the knee OA progression, and symptoms. Therefore, in order to reduce the progression 
of the knee OA and reduced the symptoms EKAM should be targeted (reduced). Furthermore, 
KFM does have less evidence supporting it but this should not be neglected in clinical trials. 
Additionally, Trepczynski et al. (2014) highlighted that estimating the change in medial contact 
force depending solely on the EKAM may be less accurate in presence of muscle co-contraction. 
The higher levels of intersegment force could also be due to higher muscle co-contraction, even in 
cases of the same external moment and joint forces, as calculated by the inverse dynamics theory 
(Lu, Taylor, O’Connor, & Walker, 1997). Therefore, it is important to understand the role of 
internal forces (muscles) in the knee loading and the change in co-contraction with treatment. 
 Muscular response 
Several studies have identified neuromuscular alterations in individuals with knee OA. These 
alterations include prolonged activity duration in vastus lateralis (VL), medial hamstrings (MH), 
medial gastrocnemius (MG) and tibialis anterior (TA) (Childs et al., 2004) and increased co-
contraction between VL/MH, TA/MG  (Childs et al., 2004), vastus medialis (VM)/MG (Lewek et 
al., 2004a) VL/lateral hamstring (LH), VM/MG (Ramsey, Snyder-Mackler, Lewek, Newcomb, & 
Rudolph, 2007). This emphasises the importance of considering the role of internal forces in 
producing joint loading especially when assessing biomechanical treatments to reduce joint 
loading. 
2.13.1 Muscle co-contraction 
Muscle co-contraction refers to the concurrent recruitment of synergic muscles (Sirin & Patla, 
1987), where the term “synergic muscle” refers to all muscles around the joint that contribute 
towards generating a moment of force during dynamic activities (Nigg, MacIntosh, & Mester, 
2000). Increased medial muscle co-contraction has been correlated with medial cartilage volume 
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loss rates in individuals with knee OA and varus alignment (Hodges et al., 2015). It is believed 
that increased muscle co-contraction comes at the expense of higher joint loading (Hubley-Kozey, 
Hatfield, & Stanish, 2013; Lloyd & Buchanan, 2001; Meyer et al., 2013; Schipplein & Andriacchi, 
1991) and associated OA risk (Heiden, Lloyd, & Ackland, 2009; Wu, Burr, Boyd, & Radin, 1990; 
Zeni et al., 2010). Recent studies have concluded that a careful selection of muscle co-contractions 
(VM/MG) can be used to represent medial joint loading  (Winby, Gerus, Kirk, & Lloyd, 2013). 
Three justifications for altered neuromuscular responses in OA have been identified; Firstly, higher 
lateral muscle co-contraction to oppose the high medial joint loading (Andriacchi, 1994); secondly, 
higher medial joint muscle co-contraction in response to greater joint space narrowing (laxity) 
(Lewek et al., 2004a); thirdly, higher medial joint muscle co-contraction in response to instability 
concomitant with medial joint space narrowing (Childs et al., 2004). 
There are two types of muscle co-contraction; the first one is generalised co-contraction, while the 
second one is directed co-contraction (Lloyd & Buchanan, 2001). In the former, all agonist and 
antagonist knee activities are equal, whereas in the latter the lateral agonist and antagonist co-
contract to support the external knee adduction moment. Direct co-contraction is thought to be 
important in supporting the external knee adduction moment to prevent lateral condyle lift off and 
reduce the force concentration on the medial side (Schipplein & Andriacchi, 1991). The 
generalised co-contraction can have the same effect as direct co-contraction, but due to the non-
directionality, it is less effective in preventing condyle lift off and may excessively increase the 
articular loading (Andriacchi, Andersson, Ortengren, & Mikosz, 1984; Lloyd & Buchanan, 2001; 
Zhang, Xu, Wang, & Hendrix, 2001). Co-contraction has been noticed during crossover cutting 
and sidestepping (Besier, Lloyd, & Ackland, 2003a; Besier, Sturnieks, Alderson, & Lloyd, 2003b), 
when individuals support isometric abduction/adduction moment (Lloyd & Buchanan, 2001; 
Zhang et al., 2001). Direct co-contraction has been identified as resisting adduction/abduction 
perturbations at the knee in ligamento-muscular reflexes (Buchanan, Kim, & Lloyd, 1996). 
Nevertheless, voluntary direct co-contraction has been revealed to support static knee 
abduction/adduction moment (Andriacchi et al., 1984; Zhang et al., 2001), and during side 
stepping it supports abduction moments (Besier et al., 2003a, 2003b).  
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Several studies have investigated the muscle activities and co-contraction in individuals with knee 
OA. These studies show higher co-contraction in individuals with OA in the medial side and lateral 
side of the knee joint compared to the control group. The lateral co-contraction occurs between the 
following muscles: lateral quadriceps (LQ)/semimembranosus (SM) (Zeni et al., 2010), VL/MH 
(Childs et al., 2004), TA/MG (Childs et al., 2004), biceps femoris (BF)/VL (Hortobágyi et al., 
2005), lateral gastrocnemius (LG)/TA (Hortobágyi et al., 2005), VL/LH (Hubley-Kozey, Hill, 
Rutherford, Dunbar, & Stanish, 2009; Ramsey et al., 2007), VL/LG (Hubley-Kozey et al., 2009), 
LQ/LH (Schmitt & Rudolph, 2007); while the medial co-contraction is between the following 
pairs: medial quadriceps (MQ)/MG (Rudolph et al., 2007; Schmitt & Rudolph, 2007), VM/MG 
(Lewek, Ramsey, Snyder-Mackler, & Rudolph, 2005; Lewek et al., 2004a),  VM/MH (Hubley-
Kozey et al., 2009), and MQ/MH (Schmitt & Rudolph, 2007). 
Other studies have shown no significant differences between the OA group and control group 
regarding muscle co-contraction. This is between the following muscles: VL/SM (Collins, 
Richardson, & Higginson, 2014), BF/VM (Liikavainio, Bragge, Hakkarainen, Karjalainen, & 
Arokoski, 2010), VM/MH and VL/LG (Lewek et al., 2004, 2006; Ramsey. et al., 2007), VL/LH 
(Lewek et al., 2004, 2006), and LQ/LG, LQ/LH, MQ/MG, MQ/MG (Rudolph et al., 2007). This 
contradiction between the results might be due to different factors, such as differences in age, 
disease severity, muscle weakness, knee alignment, and walking speed.  
Muscle co-contraction has been found to increase with age. Greater disease severity has shown 
higher co-contraction between VL/LH, VL/LG , VM/VM , VM/MG compared to controls, while 
the less severe group only showed VL/LH higher than the control group (Hubley-Kozey et al., 
2009). Child et al. (2004) have shown that co-contraction increases significantly between self-
selected and fast walking speeds. Quadriceps weakness is correlated with higher VM/MG and 
VM/MH co-contraction before the knee malalignment correction, but not afterwards (Ramsey et 
al., 2007).  Nevertheless, other factors such as knee laxity show correlations with VM/MG and 
EKAM (Lewek et al., 2004a). Self-reported instability in individuals with OA, which affects their 
activities of daily living (ADL), showed higher medial co-contraction than individuals with no or 
with instability not affecting ADL (Lewek et al., 2005).  
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As the OA progresses, the medial compartment degenerates and the space between the two medial 
condyle reduces, which can lead to laxity in the medial soft tissue, reducing its contribution to joint 
stability (Lewek et al., 2004; Sharma et al., 1999). This impairment to passive stabilisation 
increases the demand on active stabilisation (muscle co-contraction) to compensate for the lack of 
stabilisation. The inability of the active stabiliser to perform this mission has been hypothesised to 
lead to frequent episodes of joint instability and additional degeneration changes (Lewek et al., 
2004; Sharma et al., 1999). Studies on knee OA with laxity has been reported to increase the medial 
thigh and shank muscles’ co-contraction. This highlights the importance of laxity as one of the 
main causes of increased muscles co-contraction (Lewek et al., 2004a; Rudolph et al., 2007). 
A recent study was conducted to investigate the correlation between joint loading, muscle co-
activation and joint moment, using an electromyography-driven model. The results show that only 
the sum of the activation measurements for the medial hamstring and gastrocnemius muscles 
correlate significantly with medial joint loading. On the lateral side, the sum of both EMG 
measurements (quadriceps/hamstring), lateral quadriceps/lateral hamstring, lateral 
quadriceps/lateral gastrocnemius) and activation measurements (lateral quadriceps/lateral 
hamstring, lateral quadriceps/lateral gastrocnemius) were correlated with loading. Other outcomes 
(first peak EKAM, peak flexion moment) were correlated with medial and lateral loading, with 
higher correlation for the former (Winby et al., 2013).  
Two peaks have been identified in knee joint contact force during walking (Harrington, 1976; 
Hurwitz et al., 1998; Morrison, 1970a). The first one occurs at contralateral toes-off, which 
corresponds to quadriceps muscle action, while the second one, at contralateral initial contact, 
corresponds to gastrocnemius action. The quadriceps and gastrocnemius muscles are the dominant 
muscles in resisting the knee external adduction moment. Nevertheless, the quadriceps and 
gastrocnemius were found to be the main contributors to the joint contact force. Therefore, the 
previous mentioned explanation of the muscle co-contraction studies should be included as an 
outcome in intervention studies aiming to reduce medially directed loads. 
Muscle weakness is well documented in individuals affected with knee OA in addition to high 
muscle co-contraction (Alnahdi et al., 2012; Palmieri-Smith, Thomas, Karvonen-Gutierrez, & 
Sowers, 2010). However, previous studies have showed no correlation  between muscle strength 
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and EKAM (Lim, Hinman, Wrigley, Sharma, & Bennell, 2008). Furthermore, a recent study 
showed that individualised muscle strength exercises do not reduce the knee loading (EKAM) in 
individuals with knee OA (Henriksen et al., 2017).   However, one of the area’s that can be affected 
by muscle weakness and knee laxity is dynamic balance. Individuals with knee OA suffer from 
progressive loss in lower extremity tasks, such as walking, and ascending and descending stairs 
(Guccione et al., 1994). The impact of knee OA on balance may be a possible explanation for the 
disability in these individuals as  balance is a fundamental component of these daily activities and 
the risk of falling increases with impaired balance (Chuang et al., 2007; Dionyssiotis, 2012; Muir, 
Berg, Chesworth, Klar, & Speechley, 2010). 
 Balance 
Balance is considered a complex neuromuscular process, which includes motor, sensory and 
integrated components (Hinman, Bennell, Metcalf, & Crossley, 2002). Balance can be defined as 
the ability to maintain (control) the centre of gravity provided by the feet. In the elderly population, 
poor mobility and the risk of falling are associated with reduced balance (Dionyssiotis, 2012; Muir 
et al., 2010). Balance can be assessed statistically or dynamically. Assessing dynamic balance is 
more important, since it mimics the demands of physical activities better than using static 
assessments (Gribble, Hertel, & Plisky, 2012).   
Both static and dynamic balance deficits have been identified in individuals affected by knee OA, 
but dynamic balance deteriorates more (Hinman et al., 2002; Wegener, Kisner, & Nichols, 1997). 
Balance defects could be related to the ageing process, muscle weakness and/or proprioceptive 
impairment (Koceja et al., 1999; Lin et al., 2009; Muir et al., 2010; Slemenda et al., 1997; Stevens, 
Lang, Guralnik, & Melzer, 2008). Although no relationship has been found between balance and 
progression of knee OA (Jadelis et al., 2001), balance impairment increases the risk of falling and 
disability in the elderly, and therefore should be assessed (Dionyssiotis, 2012) especially when a 
new intervention is introduced. 
Previous studies have assessed balance by using expensive (force platform) (Hassan et al., 2001; 
Hurley, Scott, Rees, & Newham, 1997a; Wegener et al., 1997) and non-expensive (step test) 
measures (Hinman et al., 2002; Lim, Hinman, Wrigley, Sharma, & Bennell, 2008). In the step test 
the participant is asked to balance on single leg and try to step up and down 15cm step high as fast 
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as possible for 15 second. The number of times with which the participant is able take the 
contralateral limb up and down the step is the outcome of the test (K. D. Hill, Bernhardt, McGann, 
Maltese, & Berkovits, 1996). Previous studies have showed significantly lower number of steps in 
individuals with knee OA (12 steps) compared to healthy individuals (17 steps) (Hinman et al., 
2002).  However, the step test is dynamic standing test with two major limitation. Firstly, the step 
test measures the dynamic balance in one direction (anterior) and secondly the step test neglect the 
distance between the standing base and the step which might play an important role in balance. 
Therefore, other methods of measuring dynamic balance is advocated to be used  
The Star Excursion Balance Test (SEBT) is an inexpensive and quick method used to assess 
balance. SEBT is used in laborites and clinics to measure the effect of treatment intervention or to 
investigate if one returned to normal condition (Gribble et al., 2012). In the SEBT the participant 
is asked to stand on one leg and using the contralateral leg to reach as far as possible in 8 directions 
(anterior, medial, lateral, posterior, anterolateral, anteromedial, posteromedial, posterolateral) 
(Olmsted, Carcia, Hertel, & Shultz, 2002). The distance at which contralateral leg reaches is the 
outcome of the test. The SEBT might be considered as a challenging test for individuals with knee 
OA as they are more likely to be elderly and have a balance deficit. SEBT might be more 
challenging on the neuromuscular system than step test and be considered as true dynamic test. 
However, one of limitation for SEBT is the length of the testing session if it were tested in all 
directions (Munro & Herrington, 2010; Robinson & Gribble, 2008).  
One of the methods to overcome this problem is to focus on certain direction which focus more on 
specific muscles (Earl & Hertel, 2001; Herrington, Hatcher, Hatcher, & McNicholas, 2009; 
Olmsted et al., 2002). In the presence of chronic ankle instability SEBT is recommended to be 
tested in the medial, posteromedial and anteromedial directions snice these directions were the 
most affected compared to healthy (Hertel, Braham, Hale, & Olmsted-Kramer, 2006). In 
individuals following an ACL tear, SEBT is recommended to be tested in anterior, medial, lateral 
and posteromedial directions as these directions were significantly affect compared to healthy 
(Herrington et al., 2009). However, in knee OA performing SEBT in anterior and medial directions 
are the most relevant to this population and proposed to be used in this thesis for two reasons. 
Present of muscle quadriceps and gluteus muscle weakness in individual with knee OA (Alnahdi, 
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Zeni, & Snyder-Mackler, 2012; Hinman et al., 2010; Slemenda et al., 1997) and to reduce the risk 
of falling from performing the test in all directions. 
SEBT has shown good reliability in its studies which supports the use of this method (Hertel, 
Miller, & Denegar, 2000; Kinzey & Armstrong, 1998). SEBT has been used in individuals with 
knee OA to assess the effect of exercise and valgus knee braces (Al-khlaifat, 2012; Al-Zahrani, 
2014), however it has not been used to assess other conservative approaches in knee OA patients.  
 Physical function tests 
The ability to perform daily activity (physical function) is considered one of the main outcomes 
for individuals with knee and hip osteoarthritis (Bellamy et al., 1997). Physical activities are 
concerned with ability to move around and perform the daily activities. Assessing physical 
function test using performance–based tests are often assessed by measuring the time, distance or 
repetitions methods and are assessor observed (Stratford, Kennedy, Pagura, & Gollish, 2003; 
Wright, Hegedus, Baxter, & Abbott, 2011). They assess what each individual can do rather than 
how precise he/she can do, which is measured by using the patients reported outcomes (Terwee, 
Mokkink, Steultjens, & Dekker, 2006). Patient performance test is recognised to measures 
different construct component of physical function than patient reported outcome (Stratford & 
Kennedy, 2006; Terwee et al., 2006) and the former may be better in differentiating between 
function and pain than using patient report outcome (Faucher et al., 2002; Stratford, Kennedy, & 
Woodhouse, 2006; Thumboo, Chew, & Soh, 2001). Undestanding the effect of disease on 
functional impairment is impotent to better understanding the functional ability of the patients. 
The Osteoarthritis Research Society International (OARSI) in 2013 developed a recommended set 
of physical function tests for testing the physical ability of the individuals with knee osteoarthritis 
individuals (Dobson et al., 2013). The minimal number of core set of tests which should be used 
in any knee OA study are three (40-metre fast-paced walk test, 30-second chair-stand test, a stair-
climb test). 30-second chair-stand test, 40-metre fast paced walk test and stair-climb test have been 
used in previous studies to test the effect of the treatment in individual with knee osteoarthritis 
(Dobson et al., 2013). The reliability for such outcome measurement were encouraging (Gill & 
McBurney, 2008; Kennedy, Stratford, Wessel, Gollish, & Penney, 2005; Wright, Cook, Baxter, 
Dockerty, & Abbott, 2011). 30 second chair test showed high Intra-class Correlation Coefficient 
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(ICC) ranging between ICC=0.93 to 0.98 (Gill & McBurney, 2008).  While stair-climb test showed 
0.90 ICC and identified to be able to detect deterioration and improvement in individual with knee 
OA underjoining TKR (Kennedy et al., 2005). 
 Pain 
Pain is the primary reason individuals seek medical treatment (Dubois, Gallagher, & Lippe, 2009). 
Pain is defined by The International Association for the Study of Pain as ‘an unpleasant sensory 
and emotional experience associated with actual or potential tissue damage, or described in terms 
of such damage’ (Neogi, 2013). Pain is a complex and subjective phenomenon, which makes it 
difficult to study. Each individual has his or her own perception of pain, and several factors, 
including biological, social and psychological ones, can interact with pain (Institute of Medicine, 
2011) (see Figure 2-6).   
The way in which the central nervous system (CNS) transmits and processes pain information is 
affected by several genetic factors. In general, these factors affect an individual’s sensitivity to 
pain by either decreasing or increasing the transmission of signals. The body’s ability to release 
hormones as adrenaline (the pain starving effect) is dependent on genetic factors, which may 
impact the survival rate of neurons and therefore affect the strength of the nociceptive afferents 
(Institute of Medicine, 2011). Furthermore, response to pain (emotional, physical and cognitive) 
is generally learned during childhood. Hence, these learned responses are critical to how adults 
cope with pain. For example, previous studies have shown that children with an unhealthy response 
(somatic and emotional) to recurrent pain are more likely to develop chronic pain later in life 
(Macfarlane, 2010; Walker, Garber, Van Slyke, & Greene, 1995). These may underlie the theory 
that the body’s cumulative efforts to adjust to acute stress may eventually harm various tissues, 
organs and body systems (Institute of Medicine, 2011).  
Under normal circumstances, a pain signal is a warning signal that indicates something is wrong, 
such as when injuring a ligament or touching hot material. In these situations, pain plays a 
protective role, signalling to individuals to rest or to withdraw from danger (Neogi, 2013).  
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Figure 2-6 Diagram illustrate the multifactorial nature of the pain (Neogi, 2013). 
2.16.1 Knee OA and pain 
Knee pain is a critical symptom in knee OA. Interestingly, more than half of individuals affected 
with knee OA have stated that knee pain is their worst problem (NICE, 2014). Furthermore, pain 
is a risk factor for disability and total knee replacement (Hochberg, 1996; Lee et al., 2013; Maly, 
Costigan, & Olney, 2006).  Previous prospective studies showed that knee pain at baseline 
represents a risk for both disability and radiological progression (Creamer, Lethbridge-Cejku, & 
Hochberg, 1998; Hassan, Doherty, Mockett, & Doherty, 2002). This highlights the importance of 
treating pain in individuals with knee OA. 
Knee pain in the early stage of OA occurs and is aggravated during activities such as walking and 
further increases with long periods of weight bearing (Dieppe & Lohmander, 2005). In advanced 
cases of knee OA, the pain intensity increases and may persist at rest and at night (Hafez, Alenazi, 
Kachanathu, Alroumi, & Mohamed, 2014; Roach & Tilley, 2007). This pain leads to avoidance of 
moving the painful joint and therefore to impaired functional activity (Dandy and Edwards, 2009). 
Knee OA pain normally occurs in the area of the knee or around the knee and in some situations 
in the upper leg or above the joint (Peter et al., 2011). The knee pain is described as aching or 
throbbing during rest and as sharp stabbing pain during activity (Kidd, 2006). Unlike any other 
conditions that resolve or heal with time, knee OA pain is a disease which does not heal (Neogi, 
2013).  
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2.16.2 Source of knee OA pain 
The mechanism of knee OA pain is complex and is not fully understood to date (Hunter, Guermazi, 
Roemer, Zhang, & Neogi, 2013; NICE, 2014). Knee cartilage has no blood supply or nerve supply, 
which makes it incapable of generating pain directly. However, other tissues around the joint, such 
as the synovium, subchondral bone, joint capsules and ligaments, are rich with pain receptors, 
which makes them a source of pain (Dieppe & Lohmander, 2005; Felson, 2005). As previously 
mentioned, knee OA is a disease of the whole joint and not the cartilage, which highlights the 
importance of the surrounding tissue in pain production. Previous magnetic resonance imaging 
(MRI) studies showed a correlation between pain and subchondral bone change and synovitis (Hill 
et al., 2001, 2007; Roemer et al., 2009; Torres et al., 2006), which suggests that these tissues could 
be a source of the pain in knee OA.  
Mechanical pain is one important source of knee pain in knee OA (Trouvin & Perrot, 2018). 
Interestingly, a weak correlation has been identified between the radiological severity of knee OA 
and knee pain (Dieppe, 2005; Hannan, Felson, & Pincus, 2000). Several reasons can be attributed 
to the previous weak correlation. As described earlier in this section, knee pain is a subjective 
measurement, and other confounding factors may affect the severity of the pain or contribute to 
the pain. These factors include but may not be limited analgesic treatments, expectation, mood and 
coping strategies (Bradley, 2004; Colloca & Benedetti, 2006; Gamsa, 1990; Villemure, Slotnick, 
& Bushnell, 2003; Wager, 2005; Zubieta et al., 2001). In addition, impaired joint proprioception 
has been associated with pain progression and functional limitation (Felson et al., 2009). In a 
situation where tissue injury occurs, inflammatory mediators like bradykinin are released, which 
leads to nociceptor nerve fibre sensitisation. Subsequently, the release of inflammatory agents 
leads to increased sensitivity around the injured tissue, a phenomenon known as hyperalgesia 
(primary sensitisation). As a result of repeated depolarisation of the primary afferent, central 
sensitisation occurs by the continuous release of neurotransmitters (Enohumah & Imarengiaye, 
2008). 
Central sensitisation, which is abnormal pain processing of signalling from the CNS, is a common 
mechanism in chronic OA. In central sensitisation, pain is perceived as stronger due to increased 
firing of spinal neurons, with or without peripheral stimulation (Staud, Robinson, Weyl, & Price, 
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2010). These changes explain the increased sensitivity to painful stimuli (hyperalgesia) and the 
increased perception of mild stimuli as very painful (allodynia) (Crombez, 1993). Recently, 
psychosocial factors (anxiety, depression, mood and stress) have been identified as sources of pain 
in central sensitisation (Arendt-Nielsen et al., 2010; Graven-Nielsen & Arendt-Nielsen, 2002). 
Thus, pain perception is a sum of multiple factors that are necessarily to quantify.   
Without controlling the factors that lead to variations in individual pain, the correlation will be 
confounded (Marriott et al., 2017). Without doubt, some of the confounding factors cannot feasibly 
be measured or gathered in most studies. By using a within-subject study design to control for 
these factors throughout, a strong correlation have been found between radiological severity and 
the incidence (new pain), presence and severity of pain (Neogi et al., 2009; Niu, Jingbo, Felson, 
David T., Neogi, Tuhina, Zhang, 2012). Furthermore, a strong correlation has been found between 
loading and pain (Marriott et al., 2017). Such studies highlight the importance of loading and other 
factors in the knee pain. 
Therefore, modification of any of the factors that affect pain could results in a reduction in pain. 
Previous studies have shown that higher EKAM is correlated with higher loading (Trepczynski et 
al., 2014). Interestingly, modelling studies showed that alterations in muscle patterns, which is a 
feature of individuals with knee OA, may lead to increased joint loading while walking (Brandon, 
Miller, Thelen, & Deluzio, 2014; Sritharan et al., 2017). Furthermore, a previous study showed a 
correlation between higher muscle activity and knee pain (Wilson, Deluzio, Dunbar, Caldwell, & 
Hubley-Kozey, 2011). An increase in muscle co-contraction may lead to an increase in joint 
loading and therefore to greater pain. There is also some evidence that higher loading could be 
linked to bone marrow lesions (Alliston, Hernandez, Findlay, Felson, & Kennedy, 2018; Felson et 
al., 2003), which might be due to higher stress on the bone. Therefore, targeting loading by 
reducing EKAM and muscle co-contraction is a sensible option to reduce pain and the progression 
of knee OA. Laxity and patients’ confidence in their knees could be factors that contribute to higher 
loading through increased muscle co-contraction and muscle activity. As has been mentioned 
previously, proprioception has been correlated with pain severity, so improving proprioception 
may lead to pain reduction. 
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2.16.3 Measuring the knee pain 
In studies and cohort trials on knee OA several methods are typically used to measure pain. For 
assessing knee pain, the most common methods are a numeric rating scale (NRS) or a visual 
analogue scale (VAS), which assess pain via single questions about a specific period of time or by 
using subscales such as the Knee injury and Osteoarthritis Outcome Score (KOOS) or the Western 
Ontario and McMaster Universities Arthritis Index (WOMAC). In the latter (subscales), the pain 
is assessed for a specific activity such as walking or ascending and descending stairs (Neogi, 2013). 
More recently, pain assessment has integrated a more comprehensive approach, such as 
quantitative sensory testing (Trouvin & Perrot, 2018), which will be discussed in the following 
section. 
2.16.4 Pain pressure threshold 
The knee pain in individuals with knee OA considered a key symptom (Dieppe & Lohmander, 
2005). Knee pain pathophysiology is complex and local contributors probably involve raised 
mechanical stress on intra-articular and pre-articular tendons and ligaments, intra-osseous pressure 
and synovial inflammation (Brandt et al., 2008; Dieppe & Lohmander, 2005; Kidd, 2006). In 
addition to the previous local mechanisms, quantitative sensory testing studies supported that the 
neurogenic responses in osteoarthritis pain (Arendt-Nielsen et al., 2010; Imamura et al., 2008; 
Kosek & Ordeberg, 2000). This change in pain modulation was identified to contribute to the pain 
severity in individuals with OA (Lundblad, Kreicbergs, & Jansson, 2008). 
Quantitative sensory testing technique (QSTT) is one method which has been used to evaluate the 
mechanism of OA pain. QSTT involves assessing the somatosensory response to the applied 
external stimulus (Pavlaković & Petzke, 2010). The QSTT can be applied at the affected side to 
identify the localised somatosensory changes or to distal part to identify the widely spread 
somatosensory (Arendt-Nielsen & Yarnitsky, 2009). Pain on the affected side suggests a local 
sensitisation while to distal part suggest a combined central and local sensitisation (Graven-
Nielsen & Arendt-Nielsen, 2002).  
Previous studies have shown that individuals with knee OA have lower pain pressure threshold 
than the control group (Arendt-Nielsen et al., 2010; Imamura et al., 2008; Wessel, 1995). 
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Furthermore, high ICC ranging from 0.93 to 0.98 was identified by a previous study for using such 
measurement which indicated the importance of using it (Mutlu & Ozdincler, 2015). Mutlu & 
Ozdincler (2015) concluded that pain pressure threshold was sensitive to detect the change caused 
by a treatment. Another study found that the reliability of pressure pain threshold increased from 
(ICC=0.53-0.87) to (ICC=0.84-0.91) in knee OA individuals when using an average of two trials 
instead on one trial (Søren Thorgaard Skou, Simonsen, & Rasmussen, 2015). Therefore, to 
quantify the pain pressure threshold might be an important factor to understand the contribution of 
it to pain severity and to investigate the treatment effect on pain pressure threshold. 
In summary, mechanical factors are indicated as some of the primary factors that are related to 
progression of the disease in individuals with knee OA. The previous sections have identified 
increased EKAM and higher muscle co-contractions along with greater disease progression. This 
is associated with clinical changes and also balance impairments.  Therefore, reducing EKAM and 
muscle co-contraction appear to be important aspect and one would postulate that treatments 
intended to reduce these variables will help to reduce pain, improve physical function and reduce 
the effect of the disease on public health. The following sections will review the different 
management approaches in the treatment of medial knee OA. 
 Management of medial knee osteoarthritis 
Although, currently, there is no cure for OA, treatments are aimed at preserving and/or improving 
the individuals’ joint mobility, decrease pain and limit disability (Zhang et al., 2010). The 
management of OA ranges from surgical to conservative approaches which will be discussed in 
the following sections. 
2.17.1 Surgical treatment 
Surgical approaches such as arthroscopy, osteotomy and knee arthroplasty are used as treatments 
for knee OA. Surgical interventions are generally considered to be suitable treatments for OA 
when all other approaches have failed to treat or relieve the symptoms (Dieppe & Lohmander, 
2005; Rönn, Reischl, Gautier, & Jacobi, 2011).  
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Khan, Evaniew, Bedi, Ayeni and Bhandari (2014) conducted a systematic review and meta-
analysis which investigated the effect the effect of arthroscopic surgery in individuals with knee 
OA including debridement, partial meniscectomy or both by comparing it to sham or exercise or 
medical treatment. The review included 9 trials and concluded that arthroscopic intervention has 
a small effect on pain compared to control 2.4mm in 100mm visual analogue scale. The study 
stated that the effect of arthroscopic intervention is limited in time up to 6 months and showed 
absence of effect after one and two years. Furthermore, arthroscopic intervention showed no effect 
on functional improvement and associated with harms (Khan et al., 2014). This conclusion was 
supported by a more recent systematic review which showed that arthroscopic surgery had a small 
effect on pain and function compared to conservative approach in short term for individuals with 
knee OA. The study stated that the long term effect (2 years) for the arthroscopic surgery on pain 
and function is very small or no effect (Brignardello-Petersen et al., 2017).  
High tibial osteotomy is another surgical procedure used to transfer the mechanical axis from 
medial to slightly lateral to the midline of the knee to decrease the load which has the potential to 
enhance the clinical symptoms and delay the course of the OA process. Based on 13 studies, a 
coherent systematic review identified strong evidence for supporting the use of osteotomy to 
improve pain and function outcomes (Brouwer et al., 2007). The study concluded that there is no 
evidence to compare high tibial osteotomy to conservative approach. The same authors updated 
the review in 2014 and stated although the review included more studies, the conclusion of the 
study was the same as in 2007 study (Brouwer et al., 2014). Significant improvements have been 
observed with high tibial osteotomy in knee instability, laxity, muscle co-contraction (VL / MG) 
and EKAM after six months, which increases later on (Ramsey, Snyder-Mackler, Lewek, 
Newcomb, & Rudolph, 2007). However, successful outcomes rely on the stage of the OA, proper 
patient selection, and the achievement of adequate correction.  
Under- or over-correction of the alignment might lead to speeding up the progression of knee OA 
(Briem, Ramsey, Newcomb, Rudolph, & Snyder-Mackler, 2007) and that the degree of correction 
was among the factors that affect the post-operative results in 10 year longitudinal study (Schuster 
et al., 2018). Furthermore, individuals with a high body mass index are associated with poor 
outcome results in osteotomy (El-Azab et al., 2011). Quadriceps weakness and flexion contracture 
may persist after the alignment correction, even with knee function improvement, which suggests 
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that the movement strategy continues the joint destruction and hinders long term improvement. 
Quadriceps and hamstring intensive exercise preoperatively have been shown to improve post-
surgical outcomes, which highlights the importance of pre-surgical rehabilitation (Kean, 
Birmingham, Garland, Bryant, & Giffin, 2011). Prodromos et al., 1981 showed that only 50% of 
individuals with high EKAM pre-operatively had good to excellent results 2.3 years 
postoperatively compared to 100% in individuals whom had a low EKAM. Furthermore, recurrent 
varus deformity was significant in individuals with high EKAM which led to failure to reduce the 
loading in such group. Unfortunately the next step from this point would be a joint replacement / 
arthroplasty. 
The effect of various techniques for joint arthroplasty, which involve changing the articulating 
surface of a joint, is well documented in the literature (Altman et al., 2005; Zhang et al., 2005). 
Various studies and systematic reviews have acknowledged arthroplasty as being an effective 
procedure and have reported a reduction in pain, improvement in function, increasing tolerance 
for the performance of activities of daily life, and improving health related quality of life (Aujla & 
Esler, 2017; da Silva, Santos, de Sampaio Carvalho Júnior, & Matos, 2014; Shan, Shan, Suzuki, 
Nouh, & Saxena, 2015; Skou et al., 2015).  
Uni-compartmental knee arthroplasty (UKA) preserves proprioception, and evidence shows a 
higher range of motion than TKR arthroplasty (Lonner, 2009). For some individuals with knee 
OA, UKA is the step taken before a TKR becomes necessary (Lonner, 2009). Systematic reviews 
which have compared total TKR and UKA showed similar outcomes after five years regarding 
pain and function. Survival of the prosthesis is higher in TKR at 10 years, whereas deep vein 
thrombosis is lower in UKA than TKR (Griffin et al., 2007; Health Quality Ontario, 2005). In a 
recent randomised clinical trial which included 528 participants this showed that TKR is not 
superior to UKA in participants with medial knee OA. UKA showed 1.9 points higher in oxford 
knee score, lower complications and lower failure rate than TKR after one year (Beard et al., 2017). 
Individuals with knee OA treated with UKA revealed cadence, step and speed improvements, and 
also the single leg support period increased, which reflects a more symmetrical gait (Weidenhielm, 
Olsson, Broström, Börjesson-Hederström, & Mattsson, 1993). Moreover, the double support 
period decreased, which supports quicker weight transfer during walking. Despite the vast 
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evidence that highlights the improvement in function and reduction in pain from using 
arthroplasty, evidence regarding time and indication of surgery could not be found. However, 
surgeon and non-surgeon related factors including technical skill are really important in the 
survival rate and achieve better outcome for UKR (Campi, Tibrewal, Cuthbert, & Tibrewal, 2018). 
Study showed that malalignment of prothesis with after UKR by 2 degree my predispose implant 
failure (Lonner, 2009).  
Although surgical interventions have had good success (Briem et al., 2007; El-Azab et al., 2011; 
Ramsey et al., 2007), they represent great expense for the National Health Service (NHS), and 
have a significant impact on affected individuals in terms of recovery time and functional 
independence. There may also be some individuals for whom for surgery is not appropriate (e.g. 
too young) or who do not want surgery (Bhatia et al., 2013; Marks & Penton, 2004). Another 
important aspect to be seen after TKR and other surgery is the patient satisfaction. Patients tend to 
be less satisfied than surgeon and pre-operative expectation was among the factors that has an 
effect on patients satisfaction (Choi & Ra, 2016; Lau, Gandhi, Mahomed, & Mahomed, 2012; 
Matsuda, Kawahara, Okazaki, Tashiro, & Iwamoto, 2013). A recent study comparing the effect of 
TKR and THP on patients’ satisfaction showed significantly lower satisfaction after TKR (60.44) 
compared to THR (69.7) (Neuprez et al., 2016). The study stated that patients’ pre-operative 
expectation was the single best predictive factor for post-operative satisfaction results. This study 
raises a big question regarding why THR provide better satisfaction than TKR. Given the reduced 
level of satisfaction and increased cost, to name a few, conservative management should be the 
primary consideration when treating individuals with medial knee OA. Interestingly, in a 
randomised controlled trial that compared physiotherapy and surgical treatment to physiotherapy 
as treatments for individuals eligible for TKR, this revealed that the surgery group’s KOOS score 
(32.5) was more improved than that of the physiotherapy group (16). However, the surgery group 
experienced more adverse events than the physiotherapy group (Skou et al., 2015). This 
emphasises a further need for conservative approaches. 
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2.17.2 Conservative approaches  
 Pharmacological modalities   
In 2012, the ACR published recommendations for the use of pharmacological modalities in 
individuals with knee osteoarthritis (Marc C. Hochberg et al., 2012). These recommendations 
include using different varieties of drugs and intra-articular injections such as Acetaminophen, 
non-steroid anti-inflammatory drugs, and intraarticular corticosteroid injections. 
Though, pharmacological treatments have disadvantages, such as not being suitable for all patients, 
gastrointestinal (GI) complications, and the risk of toxicity with an increase in the dosage or in 
individuals with special conditions (Felson et al., 2000). Furthermore, these pharmacological 
modalities only treat the symptoms of disease for knee OA, such as pain, and do not treat the 
disease itself, and they may cause OA progression if not used wisely (Dieppe, 1995). Although 
pain is significantly decreased in individuals with knee OA injected with intra-articular pain relief, 
knee loading was found to be significantly increased, which might accelerate the degeneration 
process (Henriksen et al., 2006; Paoloni et al., 2012; Schnitzer et al., 1993). Lane et al., (2010) 
evaluated the effects of Tanezumab (inhibits nerve growth factor) and showed a high reduction in 
pain for individuals with knee OA ranging from 45% to 62 % compared to baseline, although the 
rate of adverse effects was high (68%). Furthermore, since the start of the trial in 2006 until 2010, 
16 participants required total joint replacement due to the progression of the OA which led the 
Food and Drug Administration to halt the trials for the Tanezumab (Lane et al., 2010). This study 
showed that such treatment might lead to progression of the OA and therefore should be used 
wisely. Furthermore, Henriksen et al. (2006) and Schnitzer et al. (1993) demonstrated that with 
pharmacological treatments aimed at reducing pain, increasing in the EKAM were seen.    
 Physiotherapeutic based treatments 
Physiotherapy is a common conservative treatment used for individuals with medial knee OA to 
reduce stiffness and pain, and improve muscle strength and range of motion (Brosseau et al., 2014; 
Fisher et al., 1993; McAlindon et al., 2014). Different types of exercises are advocated for use in 
treating knee OA. These include aerobic exercises, strengthening exercises  and Tai Chi exercises 
(Bennell & Hinman, 2011; Lee et al., 2009; Song, Roberts, Lee, Lam, & Bae, 2010; Ye, Cai, 
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Zhong, Cai, & Zheng, 2014), stretching exercises and postural control exercises (Pelland et al., 
2004; Sazo-Rodríguez, Méndez-Rebolledo, Guzmán-Muñoz, & Rubio-Palma, 2017). Manual 
therapy, including stretching and range of motion exercises, has been found to increase ROM, 
modulate pain, improve soft tissue healing, improve function, and induce relaxation (Deyle et al., 
2000). Combined or individual treatment via a self-management programme and strengthening 
programme have been found to be effective in individuals with early OA, and the researchers 
conclude that self-management programs may offer the least burdensome option for the treatment 
of knee OA patients (Landry et al., 2007; McKnight et al., 2010).  
Exercise interventions have shown good results with respect to different outcomes, such as pain 
(Aoki et al., 2009; Baker et al., 2001; Carvalho, Bittar, Pinto, Ferreira, & Sitta, 2010; Chaipinyo 
& Karoonsupcharoen, 2009; Fransen et al., 2015; McCarthy et al., 2004; Ravaud et al., 2004; Sled, 
Khoja, Deluzio, Olney, & Culham, 2010) and function (Baker et al., 2001; Deyle et al., 2005; Sled 
et al., 2010) and should be the first course of treatment. In 2015, a randomised clinical trial 
compared the effect of surgical intervention (TKR) to non-surgical intervention in individual with 
knee OA including exercise, education, nutritional advices and insole over 12 months. The study 
showed 16 and 32.5 points reduction in KOOS pain score for non-surgical intervention group and 
surgical intervention group. Although, reduction in pain was significantly higher for surgical 
intervention group, the number of adverse effect was significantly higher in surgical intervention 
group. Furthermore, although all groups were eligible to TKR, most participants in nonsurgical 
intervention group did not undergo TKR (Skou et al., 2015).  
Considerable functional improvement (Baker et al., 2001; Deyle et al., 2005; Sled et al., 2010), 
pain reduction (Aoki et al., 2009; Baker et al., 2001; Chaipinyo & Karoonsupcharoen, 2009; 
McCarthy et al., 2004; Ravaud et al., 2004; Sled, Khoja, Deluzio, Olney, & Culham, 2010), and 
improvement in range of motion and gait speed (Aoki et al., 2009), has been noted in individuals 
with knee OA as a result of home based exercises with well thought out appropriate guidance. 
However, whilst clinical outcomes are favourable, a combined reduced loading to occur at the 
knee joint is needed.  
Muscle weakness is amongst the risk factors for knee OA and numerous studies have demonstrated 
improvements in muscle strength following physiotherapy treatment (Blagojevic et al., 2010; 
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Neelapala, 2018; Zacharias, Green, Semciw, Kingsley, & Pizzari, 2014). In an early study by 
Brandt et al. (1999) they found that having strong quadriceps was not associated with the 
progression of the knee OA after 2.5 years. Contrastingly, quadriceps strengthening exercises were 
found not to reduce the progression of the knee OA (Segal, Findlay, Wang, Torner, & Nevitt, 
2012). Surprisingly, the higher quadriceps strength was associated with the increase the likelihood 
of tibiofemoral OA progression in presence of knee mal-alignment and laxity (Sharma, Dunlop, 
Cahue, Song, & Hayes, 2003).  
Hip adductor and abductor muscles weakness have been identified in individual with knee OA 
which have been suggested to have a role in the knee OA progression. Hip abductor and adductor 
muscle strengthening was also proposed as a potential solution to reduce the EKAM (Mündermann 
et al., 2005) and longitudinal study found that individual with reduced hip external adduction 
moment showed faster OA progression (Chang et al., 2005). Bennell et al. (2010) investigated the 
effect of hip strengthening exercises on the EKAM, pain and physical function over 12 weeks. 
Although pain and physical functional improved with hip strengthening exercises compared to 
control group, no significant difference was identified in EKAM (Bennell et al., 2010). The effect 
of lower limb strengthening exercises on EKAM in individual with knee OA was investigated over 
6 weeks (Al-Khlaifat, Herrington, Hammond, Tyson, & Jones, 2016) and 6 months (Foroughi et 
al., 2011). Both studies found no significant effect on EKAM which was supported by systematic 
review which concluded that exercise has no effect on EKAM (Ferreira et al., 2015). Recently, the 
effect of individualised strength exercise for trunk, hip and knee among individual with knee OA 
was investigated over 12 weeks. The study included two groups (exercise group, control group) 
and the results showed no significant difference between the groups in EKAM (Henriksen et al., 
2017). A recent systematic review investigated the effect of the hip abductor muscles strengthening 
in individuals with knee OA concluded that the hip abductor muscles strengthening is not effective 
in reducing EKAM (Neelapala, 2018).  
One of the main limitation of exercise therapy in individuals with knee OA is the lack of dosage 
(Bennell & Hinman, 2011). This conclusion was supported by a systematic review saying that 
evidence is not sufficient to provide a recommendation regarding the exercise dosage for 
individuals with knee OA (Fransen et al., 2015). A recent systematic review which investigated 
the completeness of clinical trials that form 10 clinical guidelines with knee OA stated that 
inadequate of the recommendation for knee OA exercise is a major issue including dose and 
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application which limit the adoption of such treatment into the clinical practice (Bartholdy et al., 
2018).  
In terms of muscle co-contraction which has been identified as a factor related to knee OA 
progression and pain, lateral muscle co-contraction was significantly reduced following a six week 
intervention but medial muscle co-contraction did not significantly reduce (Al-Khlaifat et al., 
2016). Medial muscle co-contraction is more important than lateral side since this is correlated 
with knee OA progression (Hodges et al., 2015). Recently, the effect of the Alexander Technique 
which aims to provide neuromuscular re-education was investigated in individuals with knee OA. 
The treatment was given for 12 weeks and showed significant reduction in pain which was 
maintained over 15 months. Significant reduction in medial co-contraction was seen after the 
treatment compared to the baseline. Although, the study showed good results, the study lacked a 
control group and also a lack of demographic and clinical characteristics of the study individuals. 
Therefore, whilst interesting, currently it is not known if this technique will reduce co-contraction 
in individual with medial knee OA in the longer term (Preece, Jones, Brown, Cacciatore, & Jones, 
2016).  
Therefore, whilst exercise treatments are at the forefront of treatments for medial knee OA, the 
lack of evidence in regards to biomechanical loading and also adherence problems with the 
treatments, other easier to use treatments which target EKAM to reduce the loading would  be the 
focus of knee OA treatment. In addition, more gait modifiable interventions are required due their 
impact on OA progression, and this could be the solution if we are to find a way to mitigate the 
impact of knee OA on public health (Kim et al., 2004; Sled et al., 2010).  
Other interventions in the hands of physiotherapists are walking devices. It has been found that 
using assisted walking devices such as canes increase the base of support, which means larger 
displacement of the centre of gravity can be tolerated before losing balance (David J Hunter, 2009). 
Assistive devices produce stabilising reaction forces at the hands (Murray, Gore, & Clarkson, 
1971), and help reduce the weight on the lower extremities by shifting part of the body weight 
onto the assistive device, which means less load on the affected joints (Berman, Zarro, Bosacco, 
& Israelite, 1987); as well as producing horizontal ground forces that help with stopping or 
propulsion during walking (Bateni & Maki, 2005; Blount, 1956; Neumann, 1989; Zhang et al., 
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2008). EKAM was found to decrease significantly with the use of a cane in the contralateral hand 
compared to no cane among individuals with medial knee OA (Kemp, Crossley, Wrigley, Metcalf, 
& Hinman, 2008; Simic, Bennell, Hunt, Wrigley, & Hinman, 2011). Simic et al. (2011) showed 
that the higher the weight is placed over the cane the lower EKAM results. However, the training 
to use the cane probably seems to be an issue since three participants out of 36 were not able to 
perform the appropriate gait needed. However, using an assisted device is not preferred by some 
individuals with knee OA for reasons of cosmetic appearance as previous study showed that vanity 
is the main reason for not using cane in individuals with OA (Shrier et al., 2006). This lack of 
adherence has also been demonstrated Netherlands showed that 44% of individuals with hip and 
knee OA own walking aid and 32% of them did not use the walking aid (Van der Esch, Heijmans, 
& Dekker, 2003).  
Therefore, there is great need for other treatments strategies and modalities which aim to reduce 
the knee loading (EKAM) since this variable has been linked to knee OA progression and to help 
determine best possible treatments for the individuals. 
 Gait strategies 
Different walking strategies might be used by individuals with knee OA to reduce the EKAM and 
shift the load from the medial compartment. This is achieved by altering the mechanics and gait 
parameters which include the following strategies: 
Toe-out gait: 
Walking with an increased toe out foot angle in relation to the direction of progression, has been  
found to reduce EKAM in individuals with knee OA (Guo, Axe, & Manal, 2007; Jenkyn, Hunt, 
Jones, Giffin, & Birmingham, 2008; Lynn & Costigan, 2008). The underlying mechanism is 
divided into two parts. First, the external rotation of the knee axis converts part of the adduction 
moment into flexion moment which contributes to the first peak EKAM reduction (Jenkyn et al., 
2008). Second, toe out leads to lateral displacement of the center of pressure, which leads the 
ground reaction force (GRF) to pass more medially to the knee thereby reducing the second peak 
EKAM (Jenkyn et al., 2008). However, a toe out angle seems to be more effective in reducing the 
second peak EKAM than the first peak. An inverse correlation has been found between second 
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EKAM and toe out angle in individuals with knee OA (Chang et al., 2007; Hurwitz et al., 2002) 
and healthy individuals (Andrews, Noyes, Hewett, & Andriacchi, 1996; Teichtahl et al., 2006). 
During stair descending, no significant change has been observed using a toe out gait, while during 
ascending, the first EKAM significantly increases, and the second EKAM significantly decreases 
(Guo et al., 2007). Jenkyn et al. (2008) stated that in order to show a reduction in first peak EKAM 
with a toe out angle gait modification the movement needed to be produced by the hip and not the 
ankle. Recently Hunt et al. (2018) conducted a randomised clinical trial investigating the clinical 
and the biomechanical effect of toe out gait in individuals with medial knee OA. The study 
included two groups, the first one treated with progressive walking while second group with 
progressive walking plus increasing toe out gait. The treatment was provided for 4 months and the 
measurements were taken at baseline, after 4 months and one month later to investigate if the 
participants were able to maintain gait modification (retention). The results showed a significant 
increase in toe out gait after 4 months and participants were able to sustain this gait modification 
after one months with slight reduction in toes out gait compared after treatment. 2nd peak EKAM 
and KAAI reduced significantly after 4 months compared to baseline, however this significant 
reduction was lost after one month. Interestingly, the authors stated that both groups pain and 
function improved with slightly higher value (no statistical difference) for the toe out group (Hunt, 
Charlton, Krowchuk, Tse, & Hatfield, 2018) 
Toe-in gait: 
Previous research has shown that internally rotating the foot while walking can reduce the first 
peak EKAM (Shull, et al., 2013; Shull, Lurie, Cutkosky, & Besier, 2011; van den Noort, Schaffers, 
Snijders, & Harlaar, 2013). The first peak EKAM was reduced by 18% in Shull et al.’s (2013) 
study and 45% in van deer Noort et al.’s (2013) study. Laterally shifting the centre of pressure and 
medially shifting the centre of the knee at the early-stance is thought to be the reason for this 
reduction (Shull et al., 2013). However, in all previous studies, participants were healthy, which 
might not reflect many individuals with knee OA. One study showed that a six-week retraining 
program for individuals with knee OA reduced the first peak of EKAM by 20% and improved 
VAS by 2 points (Shull et al., 2013). The drawback of this strategy is that it requires permanent 
adaptation, which takes time and effort, and some patients might not be able to adopt it due to 
advanced age. Interestingly, a recent study showed that walking with toe in gait in individuals with 
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medial knee OA led to increased  muscle co-contraction on the medial side of the knee (VM/MH) 
which suggests higher loading in the medial side of the knee (Charlton, Hatfield, Guenette, & 
Hunt, 2018). 
Lateral trunk sway: 
Lateral trunk sway could be used as strategy to reduce the EKAM during walking. The mechanism 
underlay in that lateral trunk sway shifts toward the affected weight bearing side during walking 
moves the centre of mass (COM) laterally closer to the centre of pressure which reduce the EKAM. 
The ground reaction force acts through the body’s COM. This shifts the GRF closer to the knee 
joint and therefore reduces the adduction moment. Lateral trunk sway has been suggested as being 
a gait alteration mechanism used to reduce EKAM in individuals with knee OA (Hunt et al., 2008; 
Linley, Sled, Culham, & Deluzio, 2010; Mündermann et al., 2005). An inverse correlation has 
been found between the EKAM and lateral trunk sway (Hunt et al., 2008). In healthy individuals, 
a reduction in EKAM by 65% has been found for lateral trunk sway (Mündermann, Asay, 
Mündermann, & Andriacchi, 2008). Higher lateral trunk sway was noticed in severe knee OA 
individuals rather than in the mild group (Hunt, Wrigley, Hinman, & Bennell, 2010). As a 
compensatory mechanism to unload the affected side, greater lateral trunk sway requires this 
mechanism. Caution should be taken when introducing such mechanisms due to the risk of falling 
because of the greater upper body shift. Additionally, the high lumber forces might increase the 
risk of back pain. 
Medial thrust gait: 
Medial thrust gait involves deliberately pushing the knee joint in the medial direction. This re-
positions the joint closer to the ground reaction force, and therefore a reduction in the moment arm 
and adduction moment occurs. Studies of individuals who have adapted this mechanism show 
marked reductions in EKAM and medial knee contact force (D’Lima, & Colwell, 2009; Fregly, 
Reinbolt, Rooney, Mitchell, & Chmielewski, 2007). Richards, van den Noort, van der Esch, Booij 
and Harlaar (2018) investigated the effect of biofeedback training for individuals with medial knee 
OA by combining three gait modifications (medial thrust, toes-in gait, increased step width) on 
EKAM. The results showed that participants were not able to reduce their EKAM with biofeedback 
without instruction on how to achieve the reduction. After the training, EKAM was found to 
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significantly reduced by 14% and participants were successful to maintain 9% reduction without 
the biofeedback. However, this study only showed the immediate effect and more studies need to 
investigate application of such method in the long term. The authors did identify a significant 
increase in the knee flexion moment and ankle adduction moment which may increase the load in 
the knee and place extra load on the ankle.   
Walking barefoot: 
Studies have found that walking barefoot reduces the EKAM by between 7 to 13% compared to 
walking with thick-soled shoes or normal shoes (Shakoor et al., 2010; Shakoor & Block, 2006). 
Some authors have attributed the reduction in EKAM while walking barefoot to a reduction in 
walking speed (Kerrigan, Karvosky, Lelas, & Riley, 2003), as previous studies have shown that 
walking speed reduction results in EKAM reduction as well (Mündermann et al., 2005; Robbins 
& Maly, 2009; Zeni & Higginson, 2009). However, when walking speed was controlled, doing so 
barefoot also showed a reduction in EKAM compared to wearing shoes (Kemp et al., 2008; 
Shakoor et al., 2010; Shakoor, Lidtke, Sengupta, Fogg, & Block, 2008; Shakoor & Block, 2006). 
Jones, Chapman, Parkes, Forsythe & Felson. (2015) showed significant reductions in the first peak 
EKAM when walking barefoot compared to shoes by 7.6% among individuals with medial knee 
OA. Surprisingly, the knee pain was found to increase while walking barefoot compared to 
participants own shoes. Even though walking barefoot could be a potential solution for EKAM 
reduction, it is clear that this it is not practical. 
Walking with reduced speed: 
A positive correlation has been identified between EKAM and walking speed in individuals with 
knee osteoarthritis, which means this is a possible solution for EKAM reduction and therefore 
reducing medial joint loading (Mündermann et al., 2004). Individuals with severe knee OA have 
been shown to adopt this mechanism, showing a reduction in walking speed and stride length 
during stair ascending (Kaufman et al., 2001) and walking on ground level (Astephen & Deluzio, 
2005). Interestingly, in a study which aimed to investigate the gait and neuromuscular changes 
between two groups of individuals with knee OA (moderate, severe) and asymptomatic individuals 
showed significant difference in walking speed between all the groups. The severe knee OA group 
showed the lowest walking speed followed by moderate knee OA group then the asymptomatic 
  60 
individuals and the authors stated that this could be reduction in speed could be due to increased 
pain (Astephen et al., 2008).  
Altering foot and ankle position: 
A strong relationship has been identified between knee OA and alteration in the centre of pressure 
(Lidtke, Muehleman, Kwasny, & Block, 2010; Reilly et al., 2009) with a reduction in EKAM 
found in individuals with knee OA who demonstrate pronated feet (Lidtke et al., 2010). Therefore, 
any alteration in foot position will lead to GRF modification, and dynamic and static alterations in 
lower limb alignment (Guichet, Javed, Russell, & Saleh, 2003). 
Despite these being easy and simple gait strategies for EKAM reduction, they require permanent 
gait adaptation by patients, which demands a lot of time and effort. Therefore, other options which 
reduce loading with less effort need to be investigated. These interventions are routinely labelled 
orthotic or footwear-based devices and includes biomechanical footwear, bracing and insoles.  
2.17.3  Footwear and orthotic based devices 
The next section will review the current literature around foot-worn and orthotic devices. The aim 
of these devices is to alter the system of forces which are applied at the knee joint through 
correcting the increased moments seen in medial knee osteoarthritis. Whilst each has its place in 
the treatment paradigm, some are more convenient than others.  
 
 Footwear devices 
 
Different types of shoes have been identified in the literature which aim to reduce the EKAM in 
individuals with knee OA including the following: 
Mobility shoes: 
Mobility shoes are designed to be flexible and light with special groves in the outsole at the major 
flexion point to mimic the foot motion (Shakoor et al., 2008). The mechanism is through that 
mobility shoe work on is that it has no heel which has been approved to increase EKAM, allowing 
for better GRF contract with the flexible shoe sole and improve sensation from skin contact the 
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ground. Shakoor et al. (2008) found that walking with mobility shoe showed significant reduction 
in peak EKAM by 8% and 12% compared to self-selected shoe and control shoe respectively in 
individuals with knee OA. Recently Jones et al. (2015) compared the effect of different types of 
insole and shoes on the EKAM for individuals with medial knee OA. The results were in contradict 
to the previous study showing no significant change in 1st and 2nd peak EKAM with the use of 
mobility shoe compared to control shoes although pain reduced to control shoe. This contradiction 
between the studies might be attributed to several factors such as type of the mobility shoes as the 
design look different between the study or/and different in population characteristics. 
Variable stiffness shoes: 
In this type of shoe, the lateral side of the outsole is stiffer than the medial side which aim to reduce 
the EKAM. The mechanism behind the reduction in EKAM proposed to be due to reduction in 
medial GRF, medial shifting in COM which is caused by dynamic adaptation to the different 
stiffness in of the shoe and reduction in moment arm which induced by eversion of the foot which 
placed the knee in valgus thrust (Teoh et al., 2013). In one year study in individuals with medial 
knee OA, the  variable stiffness shoe showed a significant reduction in pain compared to baseline 
and in EKAM compared to same day (Erhart-Hledik, Elspas, Giori, & Andriacchi, 2012).  
A modified version of the concept of the variable stiffness shoe – the Gel-Melbourne OA (Asics) 
was developed by researchers in Australia. This also have a stiffer lateral midsole than the medial. 
The shoe also contains lateral wedge insole with 5-degree inclination attached to the sockliner. 
The Gel-melbourne shoes were successful at shifting the foot pressure more laterally compared to 
control shoe among individuals with knee OA which will lead to a reduction in the EKAM (Van 
Tunen et al., 2018). In 2013, a study showed that using the Gel-melbourne shoes significantly 
reduced the peak EKAM and KAAI in individuals with knee OA compared to the control shoes 
(Bennell, Kean, Wrigley, & Hinman, 2013). Interestingly, when assessing the clinical effect they 
showed that the pain was not found to differ between Gel-melbourne shoe and the conventional 
shoe after 6 months of treatment in individuals with knee OA although both group showed 
significant reduction compared to baseline. The authors concluded that the shoes which aim to 
modify the load had no additional benefit over conventional shoe (Hinman et al., 2016). One of 
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the main limitation of the study is not showing the biomechanical effect (EKAM reduction) of the 
shoe which is considered as the key mechanism to reduce the pain. 
APOS therapy: 
The APOS therapy (All Phases Of Step) shoe is a customised treatment which aims to modify the 
COP to reduce the EKAM and generate perturbation to change to neuromuscular system and 
improve control (Haim, Rubin, Rozen, Goryachev, & Wolf, 2012). In a 9-month longitudinal study 
which looked at the effect of AOPS therapy in individuals with medial knee OA the EKAM and 
pain were identified to reduce significantly. The reduction in pain was supported with another 
study which showed 49.2% significant reduction in pain after 6 months of treatment compared to 
baseline in individuals with medial knee OA (Haim et al., 2013). In a recent randomised clinical 
trial, Reichenbach, Heldner, Lenz, Felson and Juni (2018) demonstrated a positive effect on pain 
in a randomised clinical trial with APOS therapy.  
Although many footwears have been successful at reducing the EKAM and/or knee pain in 
individuals with medial knee OA, footwear has several limitations. Firstly, the prices are too high 
for some kind of footwear as APOS therapy where the price reach £2480 or Gel-melbourne shoe 
where the price is approximately £137 (ASICS, 2018; AposTherapy, 2018). Secondly, the use of 
such treatment will restrict the individuals with medial knee OA to use one type of shoe with no 
alternative which might not suit all type of clothes. This might reduce the use of such treatment 
therefore other type of treatment such as valgus brace and insole might be more appropriate to be 
used. 
 Valgus knee braces 
A knee brace is a rigid orthotic device that is secured around the thigh and shank to provide knee 
valgusation and is customised throughout the day (Figure 2-7). It has been suggested by NICE and 
OARSI guidelines as a conservative treatment method for individuals with medial knee OA 
(NICE, 2014; McAlindon et al., 2014). 
The underlying mechanism in using such a device for pain reduction is applying valgus knee force 
to the knee, which reduces the external adduction moment during walking, and therefore unloads 
the medial condyle of the affected knee (Gaasbeek, Groen, Hampsink, van Heerwaarden, & 
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Duysens, 2007; Komistek et al., 1999; Lewinson et al., 2014; Lindenfeld, Hewett, & Andriacchi, 
1997; Pollo, Otis, Backus, Warren, & Wickiewicz, 2002; Self, Greenwald, & Pflaster, 2000). The 
small enhancement in knee alignment caused by the brace is believed to shorten the moment arm, 
and consequently reduce the external knee adduction moment. Meanwhile, the compressive load 
is repositioned closer to the lateral side, which improves the distribution of the compressive load 
over the joint surface. This can be achieved through a three point pressure system by applying 
abduction force via an adjustable condylar pad or strap while two opposing forces (emerging from 
upper and lower brace components) act proximally and distally to the joint (Ramsey & Russell, 
2009; Reeves & Bowling, 2011). 
 
Figure 2-7 The left picture show a picture of valgus knee brace while the right picture represents the mechanism of 
valgus knee brace to reduce the medial knee loading (Gaasbeek et al., 2007). 
The biomechanical and clinical effects of braces on medial knee OA have been investigated in 
many studies. Several studies investigated the clinical and biomechanical effect of valgus knee 
brace on individuals with knee OA and showed good results in relation to biomechanical outcomes 
(i.e. EKAM reduction) (Laroche et al., 2014; Toriyama et al., 2011), radiological outcome 
(increase condylar separation) (Komistek et al., 1999) and clinical outcome (pain reduction using 
questionnaires such as visual analogue scale (VAS), The Western Ontario and McMaster 
Universities Osteoarthritis Index (WOMAC)) (Gaasbeek et al., 2007; Jones et al., 2013; Ramsey 
et al., 2007; Van Raaij et al., 2010).  
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In 2015, a systematic review and meta-analysis investigated the effect of orthosis and brace on 
individuals with knee OA (Duivenvoorden et al., 2015). The authors concluded that the evidence 
is not conclusive to support the effect of the valgus knee brace. One reason for this is might be to 
the low number of the studies included in the review (4 studies). Moyer et al. (2015) conducted a 
systematic review and meta-analysis to investigate the biomechanical effect of valgus knee brace 
in individuals with medial knee OA (Moyer et al., 2015). The review included 30 studies and 
concluded that valgus knee brace is effective at reducing EKAM and has moderate to high effect 
size. The same authors conducted meta-analysis to investigate the effect of valgus knee brace on 
pain in individuals with medal knee OA. The study concluded that valgus knee brace can produce 
small to moderate reduction in pain (Moyer et al., 2014). A more recent systematic review 
supported the previous conclusion of the effect of valgus knee brace in pain among individuals 
with knee OA stating that valgus knee brace is an effective treatment modality to reduce the pain 
secondary to medial knee OA (Gohal et al., 2018). 
However, valgus knee brace compliance is low (Barnes, Cawley, & Hederman, 2002; Jones et al., 
2013; Wilson et al., 2011). This can be attributed to several reasons, such as skin irritation, brace 
mechanical problems, poor fit, awkward shapes, difficulties taking the brace off and putting it on, 
difficulties wearing the brace with clothes, and brace bulkiness (Barnes et al., 2002; Fu et al., 2015; 
Giori, 2004; Squyer et al., 2013; Van Raaij et al., 2010). In terms of the consistency of patient 
brace use, authors have found that in the first year after being prescribed a brace, 76% of patients 
used a brace, followed by 69% in the second year and 61% in the third year. Twenty percent of 
patients stopped using a brace in the first 6 months, and only 6% of patients used a brace full time 
(Van Raaij et al., 2010). Compliance was defined as using the brace at least once a week which is 
low and might not be sufficient to provide pain reduction in the long term. In two studies with a 
longer follow up, only between 41% to 42% of participants still used their brace at 2.7 years 
(Barnes et al., 2002; Wilson, Rankin, & Barnes, 2011), while none still used them at 11.2 years 
(Wilson et al., 2011). However, when using a more restrictive definition of compliance (e.g., an 
hour twice a week), compliance dropped to 28% for more than 1 year, 25% for 2 years, and 21% 
for 3 years (Squyer et al., 2013). Most patients did not use the brace as much in the long term as 
in the first few years, and 26% stopped using their brace in the first year. There was a significant 
difference in rates of compliance when comparing insoles (71%) to braces (45%) (Van Raaij et al., 
2010). Nevertheless, age was found to be correlated with compliance; 65-year-old individuals were 
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1.82 times more likely to stop using the brace than 49-year-olds (Giori, 2004). In 6 month study 
only 5 patients out of 28 were still using the brace all the time (Finger & Paulos, 2002). Squyer et 
al, (2013) stated that no clinical and biomechanical factors were associated with valgus knee brace 
compliance. 
One of the main limitation which might hinder the adoption of Valgus knee brace to the clinical 
practice and the use by self-paid patients is the high price of valgus knee brace around £200. 
Therefore, the low compliance and high cost of valgus knee braces highlight the need for other 
treatments with better compliance and low cost such as simple knee sleeves and lateral wedge 
insoles.   
 Knee sleeve 
A simple knee sleeve is an attractive option for individuals with knee OA (Figure 2-8). The use of 
orthoses such as a knee sleeve, are recommended by the ACR, the European league against 
rheumatology (EULAR), the Royal Australian College of General Practitioners, and as another 
guideline as a non-pharmacological treatment for individuals with knee OA (Beaudreuil et al., 
2009; Gamble, 2000; Jordan et al., 2003; Melbourne, 2009). Knee sleeves are inexpensive and 
simple interventions that can be used by patients (Bryk et al., 2011). They are easy to recommend 
by providers and may suit those individuals with an allergy. On the other hand, knee sleeves are 
elastic and provide less mechanical stability than other forms of treatment such as braces and do 
not provide valgus or angular change in valgus position. Therefore they do not provide sufficient 
ligament and joint fixation (Schween et al., 2015). Some authors have mentioned that wearing a 
knee sleeve for several hours continuously might lead to joint swelling, which could hinder 
lymphatic and venous return around the knee joint (Chuang et al., 2077; Raja & Dewan, 2011). 
However, no studies have identified such an adverse effect from among those studies which have 
been conducted to investigate the impact of knee sleeve use on participants with knee OA. 
Four underlying reasons have been speculated for the improvement outcomes with knee sleeve 
use. First, providing thermal effect; however, this mechanism has not been supported in the 
literature, as study which compared heat retaining sleeves did not show any superiority from this 
sleeve compared to a normal sleeve (Mazzuca et al., 2004). Furthermore, a study which showed 
the effect of a sleeve on skin and intra-muscular temperature, concluded that a sleeve has no effect 
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on the intra-muscular temperature before or during exercise, and that there is only a small effect 
on skin temperature (Miller, Knight, Feland, & Draper, 2005). Secondly, enhance proprioceptive 
sensation which is thought to be caused by stimulating skin receptors around the knee joint. 
Thirdly, reduce knee load throughout redistribution of the load between the patellofemoral joint 
and tibiofemoral join (Bryk et al., 2011), and a reduction in joint compression forced by reducing 
the joint muscle co-contraction (Schween et al., 2015). Fourthly, perceived increased stability, as 
indicated in two studies, which showed significant increased stability rates recorded by patients 
(Cudejko et al., 2017; Schween et al., 2015). 
 
Figure 2-8 Simple knee sleeve (Chuang et al., 2007). 
Proprioception has some been defined in the literature in different ways (Bayramoglu et al., 2007; 
Jerosch & Prymka, 1996). The most common definition is conscious and/or unconscious 
awareness of the position and movement of limbs or joints in space (Collins et al., 2011a; Grob, 
Kuster, Higgins, Lloyd, & Yata, 2002; Hurley, Scott, Rees, & Newham, 1997; Lephart, Pincivero, 
& Rozzi, 1998; Sharma, 1999). Knee proprioception arises from the various signals integrated 
from different receptors in the knee structure  (Marks, Quinney, & Wessel, 1993; Pai, Rymer, 
Chang, & Sharma, 1997; Sharma, 1999). However, this may be influenced by other receptors such 
as the visual system, vestibular organs and other joint proprioception (Jerosch & Prymka, 1996; 
Sharma, 1999).  
Three assumed functions have been described for the knee proprioception. First, guarding the knee 
joint from excessive and probable injuries by using reflex responses  (Barrett et al., 1991; 
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Bayramoglu et al., 2007; Jerosch & Prymka, 1996; Pai et al., 1997; Wada, Kawahara, Shimada, 
Miyazaki, & Baba, 2002). Second, accuracy of knee proprioception is proposed to be required to 
stabilise static knee posture (Jan, Lin, Lin, Lin, & Lin, 2009; Lin, Lin, Chai, Han, & Jan, 2007). 
Third, it is assumed that knee proprioception is vital in the organisation of complex motion and 
precise knee joint motion movements (Jan et al., 2009;  Lin et al., 2007). 
Previous studies have shown that knee proprioceptive accuracy seems to be impaired in knee OA 
individuals compared to age-matched control group for both motion sense  (Barrack, Skinner, 
Cook, & Haddad, 1983; Hewitt, Refshauge, & Kilbreath, 2002; Koralewicz & Engh, 2000; Pai et 
al., 1997; Sharma et al., 1997) and position sense (Barrack et al., 1983; Garsden & Bullock-Saxton, 
1999; Hassan et al., 2001; Hortobágyi et al., 2005; Hurley et al., 1997; Marks et al., 1993). 
Proprioceptive defects have been speculated to contribute towards or be caused by knee OA 
(Barrett et al., 1991; Sharma et al., 1997).  
Sharma et al. (1997), theorised that different parts of the neuromuscular reflex pathway is disturbed 
in individuals with knee OA, which consequently results in detrimental loading of the joint. 
Therefore, improvement in the impaired proprioception may lead to better spatiotemporal 
coordination of the extremity position, resulting in more normal joint loading distribution. 
Proprioceptive defects have been suggested to have a role in uncoordinated muscle co-contraction, 
increased impact loading and joint instability in individuals with knee OA (Fitzgerald, Piva, & 
Irrgang, 2004; Hortobágyi et al., 2005; Mündermann et al., 2005; Radin, Yang, Riegger, Kish, & 
O’Connor, 1991; Schmitt & Rudolph, 2007; Sharma et al., 1998).  
The studies which have investigated the effect of wearing a knee sleeve in individuals with knee 
OA can be divided according to the follow up period into two categories. The first category are 
those which investigated the immediate effect of a sleeve on individuals with knee OA (Bryk et 
al., 2011; Chuang et al., 2007; Collins et al., 2013; Collins et al., 2011a, 2011b, 2012; Cudejko et 
al., 2017; Schween et al., 2015). The second category investigated the effect of the knee sleeve on 
individuals with knee OA in an eight week follow up  (Mazzuca et al., 2004) and after six months 
(Kirkley et al., 1999). 
Immediate effect of knee sleeves: 
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Clinical effect: 
The most recent study that investigated the immediate effect of sleeves among individuals with 
knee OA was conducted in 2017 by Cudejko et al. The study included 55 participants and had 
good methodological quality. The study compared wearing no sleeve to a sleeve and wearing a 
tight sleeve to a non-tight sleeve. The researchers concluded that wearing a sleeve significantly 
reduced knee pain after level or perturbed walking and reduce the time required to perform the 10-
m walking test and get up and go test. Furthermore, the results showed significant improvement in 
self-reported knee instability and confidence with the knee after level walking and perturbed 
walking. Comparing the tight to non-tight sleeve, the study showed no significant difference except 
a significantly better time result for the 10-m walk test. The findings supporting the results reported 
by Schween et al. (2015), who demonstrated a significant reduction in pain and improvement in 
self-reported knee stability with immediate use of the sleeve compared to no sleeve. Bryk et al. 
(2011) studied the immediate effect of a knee sleeve on pain and functional capacity in a 
randomised control trial. The study included 80 participants with knee OA. Significant 
improvements were seen in the VAS for pain after the stair climb power test, combined with 
significant reductions in the time required to perform the 8-m walking test and timed up and go 
test. However, the time for the stair climb power test did not show any significant change with 
sleeve use.  
Knee sleeves have been shown to have a proprioceptive effect. Collin et al. (2011) conducted a 
study for investigating the effect of stochastic resonance electrical stimulation and sleeve on 
participation among individuals with medial knee OA. The study measured the proprioception via 
measuring the joint position sense in non-weight-bearing and partial weight-bearing position. The 
results showed a significant reduction in absolute error with sleeve use in partial weight position 
and not in the non-weight-bearing position. Interestingly, all the WOMAC subscales (pain, 
stiffness, function), total WOMAC and self-reported knee instability showed significant 
correlations with absolute error in partial weight-bearing and non-weight-bearing position. The 
main study limitation was including lower sample size than predicted sample size needed to 
achieve 80% power which may have increased the risk of type 2 error. 
Biomechanical effect: 
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The effect of sleeve on kinetics and kinematics for individuals with medial knee OA was first 
investigated by Collins et al. (2011). These researchers showed significant increases in the knee 
flexion angle at initial contact, lower heel strike transient peak, loading rate calculated from initial 
contact to heel strike transient peak and loading rate calculated from initial contact to maximum 
heel strike transient with sleeve use. This study was followed up with an immediate crossover 
study (Collins et al., 2014) for investigating the effect of sleeve and stochastic resonance electrical 
stimulation as single and combined treatments. The study did not show any significant effect of 
the sleeve on the maximum EKAM in the first half or second half of the stance phase. The sleeve 
showed a significant increase in the maximum and minimum flexion angles in the first and second 
halves of the stance phase. The study also showed a significant reduction in the maximum external 
extension moment in the first half of the stance phase. However, Schween et al. (2015) showed 
results that contradicted those of the previous study regarding EKAM, with 10.1% and 12.9% 
reductions in first-peak EKAM and KAAI, respectively. The reduction in EKAM was combined 
with reductions in the adduction angle at initial contact and maximum adduction angle. Therefore, 
there is conflicting evidence on the immediate effect of knee sleeve on the biomechanics in knee 
OA (EKAM) , and short-term effects have not been considered. 
Muscle co-contraction: 
Only one study has investigated the immediate effect of sleeve on the muscle co-contraction in 
individuals with medial knee OA in a crossover design (Collins et al., 2011). The authors 
calculated the muscle co-contraction on the lateral side VL/LH of the knee joint. Fifty-two 
participants were included, and the data revealed significant reductions in muscle co-contraction 
with sleeve use in the preparatory, weight acceptance and midstance to terminal stance phases 
compared with no treatment 
Balance: 
The effect of knee sleeve on static (Chuang et al., 2007; Collins et al., 2012) and dynamic balance 
(Chuang et al., 2007) were measured among individuals with knee OA. Different methods were 
used for collecting the static balance data in both studies with the single leg stance platform test in 
Collins et al.’s (2012) study and standing on unstable platform with both limbs in Chuang et al.’s 
(2007) research. Collins et al. (2012) did not show any effect of the sleeve on static balance. 
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Chuang et al. (2007) divided the participants with knee OA into two groups. Group A performed 
the balance test without the sleeve first, then with the sleeve; group B did the opposite. The results 
showed a significant improvement in static balance in group A but not group B. Dynamic balance 
showed a significant improvement in both groups A and B in this study. The different results in 
static balance between the studies may be attributed to differences in the testing method, 
population characteristics and sleeve type. 
Short-term effect of knee sleeves: 
Clinical effect: 
One of the earlier studies was conducted by Kirkley et al. (1999), and it included three groups of 
individuals with knee OA in a parallel groups study. All the groups were given a leaflet to provide 
some information about knee OA and maintain flexibility and use of painkillers when needed. The 
treatment groups included the valgus knee brace group and sleeve group. There were 119 
participants included the study, and the results showed a significant reduction in the magnitude of 
change in pain after the 6-minute walk test and 30-second stair test in all the groups. The valgus 
brace group showed the highest reduction in pain, followed by the sleeve group. In the other study, 
performed in 2004, Mazzuca et al. compared the effect of a heat-retaining sleeve compared with a 
normal sleeve among individuals with tibiofemoral knee OA in a double-blinded randomised 
clinical trial. The study included 52 participants and showed that, in both groups, the pain score 
reduced significantly compared with baseline after 4 weeks, with no significant difference between 
the groups. After withdrawing the sleeve, both groups showed an increase in pain in the following 
4 weeks  
Types of the sleeve: 
None of the previous studies that have investigated the effect of knee sleeves among individuals 
with knee OA have adopted selection criteria for the sleeve, which may have reduced the feasibility 
of the studies. Different off-the-shelf sleeve types have been used in previous studies including 
GENUTEX A2 (Cudejko et al., 2017), GENUTRAIN 7 (Schween et al., 2015), Safe-T-Sport 
Model # 37-350 (Collins et al., 2011a, 2011b, 2012) and Tensor-ANVISA/MS (Bryk et al., 2011). 
One study used custom-manufactured sleeves CB060 (Chuang et al., 2007). Other studies did not 
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mention the type of sleeve used in the study, thereby reducing the quality of the research (Kirkley 
et al., 1999; Mazzuca et al., 2004). Therefore, different types of sleeves have been used in previous 
studies, and it can be concluded that the sleeve type is not a key element in the pain reduction 
and/or functional improvement among individuals with knee OA.  
Based on the previous literature, it can be concluded that the knee sleeve has an effect on knee 
pain in individuals with knee OA. This effect appears to be caused by one or a combination of the 
following factors: reducing the muscle co-contraction, improving stability, improving the 
confidence of the knee, reducing self-reported instability, improving balance and improving 
proprioception. In a recent systematic review investigating the effect of knee sleeves on knee pain 
and physical function (Cudejko et al., 2018a), 11 studies and the population with tibiofemoral and 
patellofemoral knee OA were included. The review concluded that sleeves have a moderate effect 
on pain and small to moderate effect of self-reported physical function in the long and short term, 
which supports our previous conclusion. The review highlighted the need for more studies with 
high quality to support the finding, since all the included RCTs were of low quality. 
Several gaps can be identified in the previous literature investigating the effects of knee sleeves. 
The effects of sleeves on muscle co-contraction were investigated in one study, with a focus on 
VL/LH muscle co-contraction. However, MQ/MH co-contraction is more important, since this 
outcome has been correlated with the disease progression. No study has investigated the effects of 
sleeve on other muscle co-contractions, such as MQ/LG or LQ/LG, in healthy or individuals with 
knee OA. Therefore, more studies are needed that investigate the effect of knee sleeves on muscle 
co-contraction across different muscle pairs in healthy people and individuals with knee OA at 
different timepoints (immediate, short term). Furthermore, the immediate kinematic and kinetic 
effects of the knee sleeve were investigated in three studies, and conflicting results were found 
regarding EKAM. No previous study has investigated the effect of sleeves on the kinematics, 
kinetics and muscle co-contraction parameters in the knee among healthy people. Therefore, there 
is a need for more studies that investigate the effects of knee sleeves on the kinematics and kinetics 
of individuals with knee OA immediately, over time and in healthy populations. No previous study 
has compared the effect of sleeve with other types of treatment in individuals with knee OA and 
healthy people. Therefore, controlled trials are needed comparing the effects of sleeve with those 
of other treatment options in individuals with knee OA and healthy people. The effects of sleeves 
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on balance was investigated in two studies, with one study only testing the dynamic balance, and 
more studies are needed to support the improvement in dynamic balance with knee sleeves among 
individuals with knee OA. Finally, no previous study has investigated the effects of knee sleeve 
on the pain pressure threshold, which highlights the need for more studies on this topic. 
 Lateral Wedge Insoles 
A lateral wedge insole (LWI) is an orthotic device that is placed inside the shoe (Figure 2-9). It 
has different thicknesses, with the lateral side being thicker than the medial side. This difference 
in thickness leads to the lateral side being higher than the medial side, with a different angulation. 
The degree of angulation in lateral wedge insole studies ranges from 4 degrees to 16.8 degrees 
with 5 degrees being the most common. The length of the lateral wedge insole in studies also has 
ranged from rearfoot only to full-length insole length, however the full length lateral wedge insole 
has showed improved biomechanical results than rearfoot lateral wedge insole (Hinman et al., 
2008). Two Japanese researchers were the first to investigate and propose the biomechanical and 
clinical effectiveness of lateral wedge insoles (Sasaki & Yasuda, 1987; Yasuda & Sasaki, 1987). 
The mechanism underlying the insole as a load-modified treatment will be discussed in the 
following sections.  
 
Figure 2-9 Lateral wedge insole (Jones et al., 2014) 
 
  73 
Mechanism: 
The key biomechanical feature of using lateral wedge insoles is to modify the knee load by 
modifying the kinetics and kinematics of the ankle and the subtalar joint. The use of lateral wedge 
insoles leads to valgus of the calcaneus, which causes the femur and the tibia to have a more upright 
position. This laterally shifts the centre of the foot pressure leads to reduce the knee adduction 
moment (Kakihana et al., 2004; Levinger et al., 2010; Sasaki & Yasuda, 1987; Yasuda & Sasaki, 
1987). The mechanical axes will therefore be more upright as well, which will ultimately decrease 
the medial loading in the medial side and the tensile force on the lateral side of the knee (Kakihana 
et al., 2004; Levinger et al., 2010; Sasaki & Yasuda, 1987; Yasuda & Sasaki, 1987).  
Other investigators have studied the connection of lateral wedge insole use and the EKAM. The 
lateral wedge insole was found to align the foot into a pronation position which results in valgus 
moment in the ankle, which laterally shifts the centre of pressure of the ground reaction force 
(Crenshaw, Pollo, & Calton, 2000; Jones et al., 2014; Kerrigan et al., 2002; Maly, Culham, & 
Costigan, 2002). Lateral shifting in the centre of pressure reduces the knee moment arm and 
therefore reducing the adduction moment acting on the knee joint (Figure 2-10) (Hinman, Bowles, 
Metcalf, Wrigley, & Bennell, 2012). A linear relationship was found between both the medial 
compartment loading and EKAM, and the lateral displacement of the centre of pressure (for every 
1mm lateral shifting in the centre of pressure 1% and 2% reduction in medial compartment loading 
and EKAM respectively) (Shelburne, Torry, Steadman, & Pandy, 2008).  
 
Figure 2-10 Mechanism of lateral wedge insole (Reeves & Bowling, 2011) 
 
Laterally shifting 
the centre of 
pressure with the 
lateral wedged 
insole would 
reduce the 
moment arm and 
therefore reduce 
the adduction 
moment. 
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Since 1987, many different studies have examined the biomechanical and clinical effects of lateral 
wedge insoles. The first study which investigate the effect of LWI and medial wedge insole 
(MWE) on gait was conducted in 1997 (Ogata, Yasunaga, & Nomiyama, 1997). This study 
included 50 healthy and 40 medial knee OA participants. The study used uniaxial accelerometer 
to investigate the effect of LWI on medial and lateral thrust. The results showed that using LWI 
reduced the lateral thrust while using the MWI increase the thrust. Although concluded that LWI 
is recommended to be used by individuals with medial knee OA as the thrust is reduced and the 
pain is reduced, no kinetics were measured which did not allow the mechanism of insole to be 
investigated. Therefore, the next section will evaluate the effect of LWI on EKAM. 
External knee adduction moment (EKAM): 
The first study which investigate the effect of LWI in kinetics (EKAM) was conducted in 2000 
using 17 healthy participants (Crenshaw et al., 2000). The study compared the effect of LWI (5 
degree) to no insole in an immediate crossover study. The results showed no significant change in 
spatiotemporal characteristics and a significant reduction in first peak EKAM by 6.65%. The study 
used analytical model and showed that the medial compartment loading reduced due to EKAM 
reduction.  
Since then several studies have investigated the effect of LWI in healthy and individuals with 
medial knee OA. Several studies showed significant reduction in the EKAM when using LWI 
(Alsancak, 2012; Chapman et al., 2015; Hinman, Bowles, & Bennell, 2009; Hinman et al., 2012; 
Hinman, Bowles, et al., 2008; Jones et al., 2013a, 2014; Jones, Zhang, Laxton, Findlow, & Liu, 
2013c; Kakihana, Akai, Nakazawa, Naito, & Torii, 2007; Kerrigan et al., 2002).  
Chapman et al. (2015) showed that using LWI (5 degree, 60 density) reduces the peak EKAM and 
KAAI by 5.85% and 7.95%, respectively. The study included a large number of participants (70 
with medial knee OA) in an immediate randomised crossover study. The study controlled the shoe 
that participants wore to reduce its effect on EKAM; an Ecco Zen shoe was used for all the 
participants. Supporting evidence showed that using LWI (6 degree) significantly reduced the 
mean EKAM in individuals with medial knee OA and healthy people compared with no insole. 
This study was conducted on barefoot with the insole taped to the foot (Kakihana et al., 2007). In 
2012, Alsanack et al. support the previous claim, showing a significant reduction in first-peak and 
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second-peak EKAMs with LWI (6 degree). The patients reported a reduction in pain, improvement 
function and reduction in analgesic use. 
Hinman et al. (2008) investigated the immediate biomechanical effects of using LWI (5 degree, 
high density) in a randomised crossover study. The study included 40 participants with medial 
knee OA. The results showed significant reductions in first-peak EKAM (0.22 Nm/Bw.Ht, 4.5%), 
trough EKAM (0.25 Nm/Bw.Ht, 9%) and second-peak EKAM (0.15 Nm/Bw.Ht. 4.1%). This 
reduction was combined with a significant immediate reduction in pain during walking (24%). In 
2009, Hinman et al. showed a similar immediate reduction in EKAM with LWI in individuals with 
medial knee OA. This reduction was maintained after 1 month, and the authors concluded that 
high-density LWI can maintain the reduction overtime and do not compress. In a similar 
population, Hinman et al. (2012) showed a significant reduction in first-peak EKAM (5.8%) and 
KAAI (6.3%) with the use of 5-degree high density LWI. The moment arm showed a significant 
reduction and the centre of foot pressure showed a significant lateral shifting with LWI use. The 
study included 73 participants and exhibited the mechanism behind the reduction in EKAM in the 
study. The study concluded that the reduction in EKAM is primarily caused by the reduction in 
the moment arm due to the change in the GRF position and orientation.  
Other studies showed similar trends with reductions in EKAMs (first peak, trough, second peak, 
KAAI) ranging from 4.84% to 15.8% with LWI (5 degree) use (Jones et al., 2013, 2013c, 2014). 
The populations were individuals with medial knee OA in two studies (Jones et al., 2013a, 2014) 
and healthy individuals in one study (Jones et al., 2013c), and the design was similar among all 
three studies (randomised crossover investigating the immediate effect). In the long term (1 year), 
the effect of LWI was investigated in a randomised control trial (Barrios, Butler, Crenshaw, Royer, 
& Davis, 2013). Thirty-eight participants with medial knee OA were and randomly assigned to 
neutral insole (19 subjects) or LWI (19 subjects) with 70 density durometer. The study showed 
that LWI reduces EKAM and that the reduction is sustained over 12 months, while the neutral 
insole showed an increase in the EKAM after 12 months compared with their baseline. This 
provides a clear evidence that the mechanical effect of LWI is sustainable and may reduce the 
progression of the disease in the long term. 
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The biomechanical effectiveness of a lateral wedge insole on EKAM was supported by several 
systematic reviews. In 2012, a systematic review stated that LWI is associated with a reduction in 
peak EKAM among healthy people and individuals with medial knee OA (Radzimski, 
Mündermann, & Sole, 2012). A recent systematic review and meta-analysis included 18 studies 
and highlighted that using LWI resulted in small but statistically significant reduction in first-peak 
EKAM, second-peak EKAM and KAAI among individuals with medial knee OA (Arnold, Wong, 
Jones, Hill, & Thewlis, 2016). This conclusion was supported by a systematic review and meta-
analysis that investigated the effect of LWI in individuals with medial knee OA. The review 
included 27 studies and showed that the included studies had moderate to high methodological 
quality. The results showed a significant small to moderate reduction in first-peak EKAM, second-
peak EKAM, overall peak EKAM and KAAI in individuals with medial knee OA (Shaw et al., 
2018). It can be argued that a small reduction in EKAM is important given the high increase in the 
risk of OA progression, which increases 6.46 times with only a 1% increase in EKAM (Miyazaki 
et al., 2002). Furthermore, this small reduction in EKAM may be highly important in the long run, 
given that individuals with knee OA are encouraged to increase their activity level in clinical 
guidelines (Roddy & Doherty, 2003). 
Contradictory to the previous results, some studies have not identified significant reduction in 
EKAM with use of lateral wedge insole compared to no insole (Abdallah & Radwan, 2011; Maly 
et al., 2002; Moyer et al., 2013; Segal, Foster, Dhamani, Ohashi, & Yack, 2009). This might cause 
by several factors which have been shown to effect insole effectiveness including LWI design 
(angulation, length, arch support, materials) (Baker et al., 2007; Hinman et al., 2008). 
Different angulation of LWI: 
The difference in LWI angulation is plausible reason for the difference in EKAM reduction in 
previous LWI literature. Theoretically, the higher the angulation is, the higher EKAM reduction 
will be. However, this higher angulation may lead to ankle pain, foot discomfort and difficulty 
fitting the LWI into the shoe. Two previous studies examined the effects of different LWI 
angulations on the tibiofemoral angle and found that there was a significant reduction with using 
higher angulation (Rafiaee & Karimi, 2012; Toda, Tsukimura, & Kato, 2004). Interestingly, Jones 
et al. (2014) showed a correlation between LWI comfort and pain reduction, highlighting the 
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importance of this factor. Kerrigan et al. (2002) investigated the effect of using different 
angulations on EKAM among individuals with knee OA in an immediate crossover study. The 
results showed a significant reduction in first-peak EKAM (5.3%, 8.3) and second-peak EKAM 
(6.5, 8%) with 5-degree and 10-degree LWI compared with no insole. Although the use of 10-
degree LWI showed higher reduction in EKAM, the LWI was accompanied with foot restriction 
and discomfort for nearly all the subjects. The authors stated that all the subjects were comfortable 
with the use of 5-degree LWI. 
Length of LWI: 
The length of the lateral wedge insole could be one of the main reasons for not identifying 
biomechanical and clinical effect with LWI use. The length of LWI in previous studies varied from 
long to rear foot LWI. The mechanism by which the rear LWI reduces EKAM requires the heel to 
contact the ground, as the inclination is found in the rear foot. However, the knee OA population 
may contact the ground with the foot flat; thus, using full-length insole will preserve the 
biomechanical and clinical effect of LWI. In a previous study, Hinman et al (2008) compared the 
effects of rear foot and full-length LWIs. The full LWI was found to reduce first and second peaks 
EKAM significantly compared with no insole, while the rear foot insole did not have any effect 
on either first or second peak EKAM. When the results for both LWIs (full length, rear length) 
were compared, a significant difference between the LWIs for second peak EKAM was found with 
better for full length (Hinman et al., 2008), highlighting the importance of choosing full length 
over the rear foot insole. 
Arch support within the LWI: 
Incorporating an arch support into the LWI could be another key factor that may increase patient 
compliance and produce a better clinical effect. The arch support in the LWI helps to reduce foot 
eversion, and therefore, it will reduce the eversion moment. Jones et al.’s (2013b) study showed 
that using LWI without arch support significantly increased the maximum eversion angle 
compared with LWI with arch support, which may place an extra load on the ankle joint. The 
previous  claim was supported with recent study showing that reduction in pain was higher when 
using LWI with an arch compared with no arch or an insole with a strap (Fu et al., 2015). In a 
randomised clinical trial which used healthy subjects, which sought to study the effects of LWI 
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with an arch versus no arch, the LWI with arch showed a better biomechanical effect. The study 
included four conditions, as follows: neutral insole, neutral insole with arch, LWI with arch and 
LWI without arch. The results showed that the mean reduction in EKAM was higher in LWI with 
an arch. The authors stated that the LWI with an arch allowed the participants to walk in a more 
natural way, so the maximum biomechanical benefit from LWI was sustained (Nakajima et al., 
2009).  
LWI materials: 
Different LWI materials have shown significant differences in outcome, even if the same 
angulation was used. This shows that higher density materials may improve stability, comfort and 
deformability compared with low-density materials (Toda & Tsukimura, 2004a). Lower density 
materials may compress during walking or over time, and thus, the effect of the lateral wedge 
insole will be lost. 
Medial compartment loading: 
A small reduction in medial loading was observed with use of the lateral wedge insole compared 
with no insole (Kutzner et al., 2011). This study included six participants with implanted knee 
trays to measure the load in the medial knee compartment. In addition, Crenshaw et al. (2000) 
conducted a study to calculate the medial contact force based on kinematic and kinetics data using 
an analytical model. The study included 17 healthy participants. The results showed a significant 
reduction in peak medial contact force and EKAM with LWI use. The authors concluded that most 
of the reduction in medial contact force is caused by the reduction in EKAM by LWI (Crenshaw 
et al., 2000). Using a finite model, a study found that the medial contact force decreased 
significantly, by 16.7% and 26.5%, using 5- and 20-degree lateral wedged insoles compared with 
neutral insoles (Liu & Zhang, 2013). 
Muscle co-contraction and muscle activity: 
To the best of our knowledge (to date), no previous study has been performed that investigated the 
effect of LWI in muscle co-contraction. One study was identified that investigated the overall 
effect of LWI in LQ and MQ muscle activity (Giffin, Stanish, MacKinnon, & MacLeod, 1995). 
The previous study did not find any effect for LWI on this activity. However, no change in EMG 
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activity was expected, since no change in EKAM was observed with LWI in the same study. This 
can be attributed to two factors; namely using rear-foot LWI and including participants with severe 
knee OA who were candidates for osteotomy. Measuring the change in muscle co-contraction is 
important, given that increased muscle co-contraction leads to increased knee compression force 
(Brandon et al., 2014; Winby et al., 2013), thereby accelerating the knee OA progression (Hodges 
et al., 2015) and increasing the likelihood of TKR (Hubley-Kozey, Hatfield, & Stanish, 2013). 
Therefore, there is a need for studies considering the effects of LWI on muscle co-contraction 
among healthy people and individuals with medial knee OA. 
Clinical effects: 
Several studies have examined the effects of lateral wedge insoles on clinical outcomes in 
individuals with knee OA. The clinical effects (pain, analgesic intake) of LWI was first 
investigated in 1987 by Sasaki and Yasuda. This study included two groups of individuals with 
medial knee OA and monitored the participants for 1–5 years. Two parallel groups were used; one 
group was treated with LWI combined with indomethacin (600 mg/day), while the other group 
only used indomethacin (600 mg/day). The results of the study showed significant reduction in 
knee pain and walking ability in the LWI group compared with the other group. Since then, several 
studies attempted to measure the clinical effects of LWI (Arazpour et al., 2013; Ashraf et al., 2014; 
Baker et al., 2007; Barrios et al., 2009; Campos et al., 2015; Fang et al., 2006; Hatef, Mirfeizi, 
Sahebari, Jokar, & Mirheydari, 2014; Jones et al., 2013c; Rafiaee & Karimi, 2012).  
In 2006, Frag et al. investigate the effect of LWI (4 degree, 60 durometers) on 28 individuals with 
knee OA. After 4 weeks of treatment, the group demonstrated significant improvement in the 
WOMAC pain (17%), stiffness and function subscales and in pain during ascending and 
descending stairs. Fafiee and Karimi’s (2012) study supported the previous finding, showing a 
significant reduction in pain and quality of life after 2 months of 6-mm LWI use among individuals 
with medial knee OA compared with their personal baselines. A recent study compared the 
effectiveness of LWI with 10 mm (6 degree, 60 durometers) and a bespoke valgus knee brace in 
individuals with medial knee OA (Rafiaee & Karimi, 2012). The study showed significant 
reductions in peak EKAM and VAS pain in the LWI group after 6 weeks compared to their 
personal baselines, from 6.75 to 3.91 out of 10. With a similar aim to the prior study, Jones et al. 
(2013) compared the biomechanical and clinical effectiveness of LWI (5 degree) and off-the-shelf 
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valgus knee brace. The study was a crossover and included 28 participants with 2 weeks of 
treatment and 2 weeks’ washout. The LWI demonstrated significant reductions in peak EKAM, 
KAAI and WOMAC pain and function compared with the baseline. 
Two other studies were conducted in 2014 showed significant reduction in pain with LWI 
compared to the same OA group baseline. The first study was a randomised controlled trial 
including included 75 participants treated with medial knee OA (Hatef et al., 2014). The pain 
(mean reduction 29.3 from a 100-point VAS scale), function and number of NSAIDs used in the 
last 2 weeks of the study reduced significantly after 2 months of using LWI (5 degree). The second 
study had a similar design and similar population (medial knee OA) to those of the first study. The 
results were in agreement with the first study, showing significant reductions in pain and function 
after 3 months of LWI use compared with the same group baseline (Ashraf et al., 2014).  
Looking at the other side of equation, in studies that compared a LWI group with a control group 
(neutral insole), no significant difference in the effects was identified (Baker et al., 2007; Barrios 
et al., 2009; Bennell et al., 2011; Campos et al., 2015; Maillefert et al., 2001; Pham et al., 2004). 
All these studies had matched populations (medial knee OA) and the design was parallel group 
(Baker et al., 2007; Barrios et al., 2009; Bennell et al., 2011; Campos et al., 2015; Maillefert et al., 
2001; Pham et al., 2004) or crossover with 4 weeks of washout in between (Baker et al., 2007). 
The treatment periods ranged from 6 weeks to 2 years, with 6 weeks in Baker et al.’s (2007) study, 
6 months in the studies by Maillefer et al. (2001) and Campos et al. (2015), 1 year in the studies 
by Barrios et al. (2009) and Bennell et al. (2011) and 2 years in Pham et al.’s (2004) study. The 
degree of inclination of LWI was fixed across all LWI group in the studies by Campos et al. (2015) 
8 degree, Bennell et al. (2011) and Baker et al. (2007) 5 degree. In contrast, Barsion et al. (2009) 
used individualised LWI degrees of inclination based on the lateral step-down test, with average 
of 9.1 degrees. Two studies did not mention the degree of inclination, which is considered a 
limitation, although they did state that it was individualised based on pedometer evaluation 
(Maillefert et al., 2001; Pham et al., 2004).  
The results of the previous studies showed no significant difference between the LWI and neutral 
insole in terms of WOMAC pain (Baker et al., 2007; Barrios et al., 2009; Bennell et al., 2011; 
Campos et al., 2015; Maillefert et al., 2001; Pham et al., 2004), WOMAC stiffness and function 
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(Barrios, Crenshaw, et al., 2009; Bennell et al., 2011; Maillefert et al., 2001; Pham et al., 2004), 
physical function tests (Baker et al., 2007; Barrios et al., 2009), medial cartilage volume (Bennell 
et al., 2011) and the joint space narrowing rate (Pham et al., 2004). When looking at rescue 
medication use, one study found no significant difference between the LWI and neutral insole 
groups, while two studies showed significant reductions in NSAIDs compared with baseline 
(Maillefert et al., 2001) and neutral insole use (Pham et al., 2004).  
One of the major limitation of all the previous studies is that they have not included the 
biomechanical effect of the treatment, which is the key mechanism of LWI. Furthermore, Bennell 
et al. (2011) used a high-density LWI made from ethyl-vinyl acetate (similar to running shoes) that 
was not comfortable for participants. In 2014, Jones and other collages found a significant 
correlation between insole comfort and pain, which means that the comfort of the insole may affect 
the pain score change. 
A recent systematic review showed similar results to the above review exhibiting no significant 
difference in pain and function between using an LWI and neutral insole among individuals with 
medial knee OA (Penny, Geere, & Smith, 2013). This led the authors to conclude that there is 
limited evidence to support the effect of LWI on pain. Parkes et al. (2013) conducted a meta-
analysis for investigating the effect of LWI on pain. Twelve studies were included, of which 7 
used neutral insoles as a control treatment. The results of the meta-analysis showed no association 
(statistically, clinically important) between LWI and pain, leading to no support for the use of LWI 
(Parkes et al., 2013). A recent systematic review and meta-analysis concluded that LWI has no 
benefit on pain when compared to neutral insole (Zhang et al., 2018). 
To conclude this section based on the previous review, LWI appears to reduce the EKAM with 
immediate use and over the long term. LWI with a 5-degree medial inclination and arch support 
made of high-density material has a great effect on EKAM, providing comfort to users and 
exhibiting the ability to maintain the reduction over the long term. Therefore, using LWI (5-degree, 
arch supported) made with high-density material seems to be the most appropriate type for clinical 
trials. When looking at the effect of LWI on pain, the evidence supports the reduction of pain 
compared with the baseline. However, when considering a competitor (neutral insole), LWI failed 
to show a higher reduction.  
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The non-significant difference between LWI and neutral insole may have been caused by several 
factors. It may be that the treatment is not effective at targeting pain or the placebo treatment 
provides some effect similar to treatment. The mechanism of treatment should be known, and the 
placebo treatment should not provide the same mechanism or there is a significant chance that the 
trial will fail to detect a difference (Felson et al., 2016). In this situation, the neutral insole does 
not have the mechanism of shifting the centre of pressure laterally, and this emphasises that the 
LWI does not reduce pain. In addition, previous studies showed that some subjects do not respond 
to LWI (no reduction in EKAM or EKAM increase) (Butler et al., 2007; Crenshaw et al., 2000; 
Hinman et al., 2008a, 2008b, 2012,; Kakihana et al., 2005, 2007; Kerrigan et al., 2002). Including 
such subjects (non-responders) in the data analysis may mask the effect of pain reduction in those 
that respond to treatment. However, Jones et al. (2014) found no difference in pain reduction 
between responders and non-responders. Although several studies have shown good LWI 
compliance, pain reduction may affect long-term compliance for such treatment, since patients are 
interested in pain reduction. Other possible explanations for the non-significant difference between 
the LWI and neutral insole is that the EKAM reduction provided is not sufficient to provide pain 
reduction or that pain depends on EKAM and other factors as well, such as laxity, self-reported 
knee instability, proprioception and muscle co-contraction.  
 Gaps in the literature 
One of the potential uses of LWI that has been shown to have a positive mechanical response is 
combining them with a device with better pain-relieving results. A combination of a LWI and a 
valgus knee brace has been investigated in three studies, of which two were randomised crossover 
trials (Al-Zahrani et al., 2013b; Moyer et al., 2013) and one was a non-randomised crossover trial 
(Fu et al., 2015). In all the studies, combination treatments showed a higher reduction of first or 
second EKAM than individual treatment did. Fu et al. (2015) investigated the effects of a 4-week 
treatment on pain and showed a higher reduction in the case of combined treatments; however, 
compliance was lower in the combined treatment group (valgus brace and LWI) than it was in the 
other insole groups. 
Due to the low compliance with using valgus knee braces, a simple knee sleeve, which has been 
shown to have good compliance (Callaghan et al., 2015), could be used with LWI. Furthermore, 
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the simple knee sleeve, unlike the valgus knee brace, is easy to use and apply, as well as being 
cheaper. Through this combination of reduced muscle co-contraction, simple knee sleeve use and 
the EKAM via the LWI, it may be possible to achieve a consistent reduction in pain and loading. 
A reduction of the loading means lower knee OA progression, lower knee OA health costs and 
improved patient activity levels. All of these factors will minimise the potential secondary 
complications of knee OA. Furthermore, the use of a sleeve with LWI targeting the pain may also 
help in improving long-term LWI treatment compliance.   
In 1999, Kirkley et al. conducted a study that compared the valgus knee brace with a simple knee 
sleeve. The results of this study showed a significant reduction in most clinical outcomes between 
the valgus and control group but not the sleeve group. Nevertheless, the simple knee group showed 
a significant reduction compared with the baseline in clinical outcomes (pain, function) but was 
not mentioned if statistically significant. As the sleeve provides little mechanical stability, another 
mechanism, such as co-contraction reduction, may have been responsible for this improvement. 
Supporting evidence showed a reduction in VL/LH muscle co-contraction with a simple knee 
sleeve use during walking in individuals with knee osteoarthritis (Collins et al., 2011).  
Encouraging results showing that using both a LWI with subtalar strap and knee sleeve as a 
treatment exhibited a greater increase in the number of individuals who could walk without pain 
on uneven ground than a lateral wedge insole alone did (Keyaki & Toda, 2010). However, more 
details about the study could not be gathered because it was published in the Japanese language.  
No study has evaluated the effect of a sleeve on the MQ/MH co-contraction among healthy and 
individuals with medial knee OA, and this is important, since it was correlated with the progression 
of the disease in individuals with medial knee OA. Furthermore, the effect of a sleeve on EKAM 
in individuals with knee OA requires more studies, since one study showed a reduction (Schween 
et al., 2015) and one showed no significant change (Collins et al., 2014). Moreover, no study has 
investigated the effect of sleeve on kinematic, kinetics and muscle co-contraction in healthy 
participants in one study. Moreover, it is important to compare the effect of a sleeve among OA 
and healthy individuals with that of other types of treatment, such as LWI or combined treatment 
(LWI + sleeve). No previous study has investigated the effects of combined treatment among 
healthy people or individuals with knee OA. Designing such a study will help in the 
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recommendation for treating individuals with medial knee OA, as combining the reduction in 
EKAM and muscle co-contraction may lead to reduced progression of the disease and reduce pain. 
Balance is another important element that is expected to be improved by the treatment, as this is 
considered as a risk factor for falling among elderly people (Hinman et al., 2002; Wegener, Kisner, 
& Nichols, 1997). No previous study has investigated the effects of a sleeve, LWI and combined 
treatment (sleeve + LWI) on dynamic balance among individuals with medial knee OA. Therefore, 
there is a clear need for more studies. Finally, the effects of the sleeve, LWI and combined 
treatment on the pain pressure threshold has never been investigated, and this is important, since 
individuals with knee OA have been found to have lower pain pressure thresholds (Arendt-Nielsen 
et al., 2010; Imamura et al., 2008; Wessel, 1995). 
To fill the gap in the literature, two studies were conducted. The first one investigated the 
immediate effect of LWI, sleeve, combined treatment (LWI + sleeve) and no treatment on 
biomechanical outcomes among healthy people in a crossover design. The second study 
investigated the immediate and 6-week effects of LWI, sleeve and combined treatment (LWI + 
sleeve) on the biomechanical and clinical outcomes in individuals with medial knee OA in a 
parallel group design. 
 Thesis aims 
2.19.1 General aim of the thesis 
The overall objective of the thesis is to understand the effects of combined treatments (simple knee 
sleeve and lateral wedge insole) and additionally to compare their effectiveness to the lateral wedge 
insole and simple knee sleeve, both biomechanically and clinically. 
First study (healthy study) null hypotheses   
Primary null hypothesis: 
1-  There is no significant immediate change in knee loading (first peak EKAM, trough 
EKAM, second peak EKAM, KAAI) when using the combined treatment (lateral wedge 
insole, simple knee sleeve) or individuals treatment compared to individual treatment, 
combined treatment or no treatment. 
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2- There is no significant immediate change in muscle co-contraction when using the 
combined treatment (lateral wedge insole, simple knee sleeve) or individuals treatment 
compared to individual treatment, combined treatment or no treatment. 
Secondary null hypothesis: 
1- There is no significant immediate change in GRF, knee flexion moment, knee joint angles 
in sagittal plane (knee flexion angle at initial contact, maximum knee flexion angle at 
loading response, minimum knee angle at mid-stance, maximum knee flexion angle at 
swing) and ROM of the knee joint angle in frontal plane when using the combined 
treatment (lateral wedge insole, simple knee sleeve) or individuals treatment compared to 
individual treatment, combined treatment or no treatment. 
Second study (medial knee OA study) null hypotheses:  
1- There is no significant difference in EKAM when using combined treatments (lateral 
wedge insole and simple knee sleeve) compared to individual treatment (lateral wedge 
insole or simple knee sleeve) (immediate, 6 weeks). 
2- There is no significant difference in pain after 6 weeks when using combined treatments 
(lateral wedge insole and simple knee sleeve) compared to individual treatment (lateral 
wedge insole or simple knee sleeve). 
3- There is no significant difference in muscle co-contraction when using combined 
treatments (lateral wedge insole and simple knee sleeve) compared to individual treatment 
(lateral wedge insole or simple knee sleeve) (immediate, 6 weeks). 
4- There is no significant difference in dynamic balance after 6 weeks when using combined 
treatments (lateral wedge insole and simple knee sleeve) compared to individual treatment 
(lateral wedge insole or simple knee sleeve). 
5- There is no significant difference in pain pressure threshold after 6 weeks when using 
combined treatments (lateral wedge insole and simple knee sleeve) compared to individual 
treatment. 
6- There is no significant difference in functional tests (40-metre fast-paced walk test, 30-
second chair-stand test, a stair-climb test) after 6 weeks when using combined treatments 
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(lateral wedge insole and simple knee sleeve) compared to individual treatment (lateral 
wedge insole or simple knee sleeve). 
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 Methods 
 Chapter overview 
This chapter describes the generic methods that have been used in the thesis, which are applicable 
to all of the studies. Specific changes to other study protocols are considered in subsequent 
chapters. This chapter starts with an overview of the research environment and the criteria used to 
define healthy and individuals with medial knee OA. Following this, the criteria which were 
developed and used to select the appropriate type of the treatment to be used in this thesis are 
clearly stated, before a clear gait analysis description is provided. The second part of this chapter 
comprises two studies that were undertaken to guide the researcher for developing future studies. 
The first study investigates the reliability of biomechanical outcomes among healthy individuals, 
while the second considers the reliability of biomechanical, balance and other clinical outcomes 
used to investigate the treatment efficacy for individuals with knee OA. 
 Research Environment 
The gait analysis work was completed in the two gait laboratories of the University of Salford in 
the United Kingdom and the gait laboratory of University of Hail in Saudi Arabia. Three gait 
analysis systems were used to complete the studies reported in this thesis. 
3.2.1 Podiatry gait analysis lab at Salford University 
A 16 camera motion analysis system (Oqus infra-red motion cameras, Qualisys AB, Gothenburg, 
Sweden) was used for motion capture at a sampling rate of 100 Hz. The gait lab is 15 metres long 
and six metres wide. Four force plates (Advanced Mechanical Technology Incorporation (AMTI) 
force plate, Type BP400600, Watertown, USA) installed in the floor along the walking track of 
the gait lab were used to collect force data at a sampling rate of 1,000 Hz (Figure 3-1). 
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Figure 3-1 The Podiatry gait lab at the University of Salford 
3.2.2 The Brian Blatchford gait analysis lab at Salford University  
A 10-camera Vicon motion analysis system (T30/40 infra-red motion cameras, Oxford Metrics, 
Oxford, UK) was used at a sampling rate of 100Hz. Four force platforms (Kistler force plate, Type 
9286AA and Type 9281B, Winterthur, Switzerland) are mounted in a 15-metre long and six-metre 
wide lab. The sampling rate of the Force platforms is 1,000 Hz (Figure 3-2). 
 
Figure 3-2 The Brian Blatchford gait lab at the University of Salford. 
3.2.3 Hail University gait analysis lab at Hail University 
A 10-camera Vicon motion analysis system (Vicon-Bonita infra-red motion cameras, Oxford 
Metrics, Oxford, UK) was used at a 100Hz sampling rate. Two force platforms (Advanced 
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Mechanical Technology Incorporation (AMTI) force plate, Type OR67, Watertown, USA) are 
mounted in a 12-metre-long and seven-metre wide lab. The sampling rate of the Force platforms 
used is 1,000 Hz (Figure 3-3). 
 
Figure 3-3 The gait lab in the University of Hail. 
 Relation between labs 
As three different labs were used to collect the data in this thesis, it was expected that each lab 
would provide similar kinetics and kinematics results, but it was necessary to ensure this. One 
subject attended the three labs (Podiatry lab, Hail lab, Brain Blatchford lab) where one investigator 
placed all markers. The individual performed self-selected walking trials in each of the labs to 
determine whether there was any difference in the primary outcome measure (EKAM) between 
labs. The knee sagittal angles and ROM were also compared between the three labs. As can be 
seen from the Table 3-1, all the labs provided similar EKAMs value. Furthermore, the knee angles 
and ROM in sagittal plane were similar across labs, which supports that all labs provide similar 
kinetics and kinematics value results during walking, regarding the type and location of the system 
(Table 3-1). Although three labs were used in current thesis, each participant visited one lab so 
they were their own control and thus any differences between the labs would not have an influence 
on this. 
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Table 3-1 EKAM and knee joint angles in sagittal plane and ROM during walking in the three labs for one participants. 
Variable  
Mean 
Podiatry gait 
analysis lab 
The Brian Blatchford 
gait analysis lab 
Hail University 
gait analysis lab 
1st peak EKAM (Nm/Kg) 0.67 0.68 0.66 
2nd Peak EKAM (Nm/Kg) 0.47 0.49 0.49 
KAAI (Nm/kg*s) 0.21 0.20 0.22 
Knee flexion angle at initial 
contact (degree) 2.49 6.45 4.93 
Maximum knee flexion peak angle 
at loading response (degree) 19.81 22.87 21.11 
Minimum knee flexion angle at 
loading mid-stance (degree) 7.86 6.09 5.32 
Maximum knee flexion peak angle 
at swing (degree) 76.01 77.70 76.26 
Knee sagittal plane ROM during 
walking (degree) 76.39 73.95 74.01 
 Recruitment 
As there were two centres involved in the data collection, the recruitment of these individuals is 
detailed for each source: 
University of Salford  
The participants were recruited by advertising on posters, which were placed around the university 
campus, as well as invitation letters, which were sent to individuals on the Knee OA database held 
by Professor Richard Jones. Recruitment incorporated referrals from the Salford Royal NHS 
Foundation Trust at Hope Hospital, Salford; the Salford Health Matters group; and the Stockport 
NHS Foundation Trust. Additionally, individuals eligible through private musculoskeletal and 
orthopaedic clinics were recruited. Salford University ethically approved the experiments to be 
conducted in their labs (see Appendix A and B). 
University of Hail 
The participants were recruited by the researcher and physiotherapy staff at King Kalid Hospital. 
Hail University agreed for the experiments to be conducted in their labs (see Appendix C). 
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 Inclusion and exclusion Criterial 
  Healthy subject  
Individuals who met the following criteria were eligible to participate in this study: healthy adult 
aged 20–60 years old with no lower limb deformity or history of injury of the pelvis, back or lower 
limbs in the previous year and ability to walk without the assistance of devices or aids. Individuals 
with any neurological or musculoskeletal disorder known to affect their ability to walk were 
excluded. Any individual not able to give informed consent or with an obvious deformity of the 
foot or lower limb was excluded. Any subject who was unable to understand and follow the 
procedure was eliminated as a participant. 
 Individuals with knee OA 
To be eligible to participate in the study, individuals had to have medial knee OA confirmed 
radiologically by a physician and using the ACR criteria by the researcher. The ACR criteria define 
OA as pain reported on most of the days of the previous month, accompanied by three of the 
following characteristics: A) age older than 50 years, B) 30 minutes of joint stiffness, C) bony 
enlargement, D) bony tenderness on the medial side of the knee or E) crepitus. Furthermore, 
participants had to be between the ages of 35 and 85 years old and able to walk without assisted 
devices for 100m non-stop, ensuring that they would be able to complete this study’s protocol. 
The age range (35–85 years) was selected because this range has been identified as having highest 
incidence of knee OA (Losina et al., 2013); people older than 85 years were not included due to 
the high amount of walking they would need to complete. Individuals needed to have a diagnosis 
of pain during walking on a flat surface, determined via a VAS questionnaire (at least 3 out of 10) 
to allow room for reduction in pain with the treatment.  
Individuals with knee OA were excluded if they had more pain localised to the patellofemoral or 
lateral joint than the medial knee side on examination. The individuals could not have had any 
neurological impairment or orthopaedic surgery known to affect their ability to walk at another 
joint. Individuals were also excluded if they had previous high tibial osteotomy, any other 
realignment operation or a total knee replacement on the contralateral side. Any condition 
contraindicating orthosis (sleeve or LWI) use. Steroid injection to the affected intra-articular knee 
  92 
joint space in the previous 6 months. Current use of any orthosis or previous use in the last 6 
months. Any participant who was unable to understand and follow the procedure was eliminated. 
 Treatments selection criteria 
3.6.1 Lateral wedge insole 
Five degree, full length, arch supported, lateral wedge insoles (70 durometer) were used in this 
study (see Figure 3-4). The rationale for using this LWI is that arch support LWI have been 
revealed to show better results than LWI without arch support (Fu et al., 2015; Jones et al., 2013c; 
Nakajima et al., 2009). Furthermore, the maximum eversion angle is significantly higher in LWI 
with no anti-pronated device, which may place an extra load on the joints (Jones et al., 2013c). 
Full length LWI have been found to reduce the EKAM (surrogate measurement of the loading) 
significantly, while the rearfoot LWI has not shown a significant reduction (Hinman et al., 2008a). 
Insole comfort has been identified as being correlated with pain reduction (Jones et al., 2014), 
which highlights the importance of this variable in choosing the most appropriate insole. A 
previous study has shown that all subjects were comfortable with the use of five degree lateral 
wedge insoles, while higher angulation was not comfortable (Kerrigan et al., 2002). Nevertheless, 
five degree lateral wedge insoles have shown significant reduction in EKAM (Alshawabka et al., 
2014; Hinman et al., 2012; Jones et al., 2013c). 
 
Figure 3-4 Salford lateral wedge insole. 
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3.6.2 Combined treatment selection criteria 
Before proceeding to the next step, it was necessary to build up a criterion to help to select which 
treatment to combine with LWI.  The following criteria were developed to select an adjunct therapy 
along with LWI to help reduce pain. This is consistent with our aim to provide successful 
treatment, which was defined as treatment that can reduce joint loading and improve pain. To 
select the combined therapy, the treatment had to meet the following criteria: 
• Previously proven to reduce pain 
• Has low side effects or no side effects 
• Has good compliance  
• Not expensive 
• If the device can reduce loading, this will be preferred 
The following Table 3-2 shows conservative treatments and application of the selection criteria 
based on studies from the literature review in chapter two. Based on the following table, it can be 
seen that a simple knee sleeve is the best choice, as it is capable of reducing pain and muscle co-
contraction (loading) and has good compliance and low cost. Moreover, the sleeve is easy to use, 
which makes is easily and widely applicable in clinical practice. 
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Table 3-2 Application of the selection criteria to conservative treatment. 
Treatment Pain EKAM Muscle co-contraction 
Compliance and 
ease of use 
Side effects and 
limitations Cost 
Valgus knee 
brace Improved Decreased Decreased 
Low compliance and 
difficult for some 
patients to use 
May cause 
irritation Moderate to high 
Pharmaceutical 
modalities Improved Increased 
Not 
previously 
investigated  
Compliance may be 
good and easy to use 
May cause a lot of 
side effects and 
toxicity 
High 
Gait strategies Improved Decreased Increased Requires high effort from patients 
May not be 
applicable to all 
patients 
High due to the 
need for training 
courses 
Physiotherapist 
modalities 
(exercises) 
Improved No change Decreased Low 
No clear evidence 
which program is 
best and evidence 
on dose is limited 
High due to 
physiotherapy costs 
Footwear devices  Improved Decreased Not investigated 
Depends on each 
device. However, 
compliance may be 
limited due to the 
need to use one shoe 
for all occasions 
Not mentioned Moderate to high 
Simple knee 
sleeve Improved 
Contradictory 
study results. One 
study showed a 
decrease and one 
showed no 
change 
Decreased Good compliance and easy to use Minimal or none Low 
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3.6.3 Simple Knee sleeve 
Based on the previous chapter two, several mechanisms can be attributed to the pain reduction and 
functional improvement observed with sleeve use, as illustrated in the Figure 3-5 below. 
Theoretically, it is possible that one sleeve provides better pain reduction than other sleeves due 
to the design of the sleeve or other factors. The most important finding is that in all previous sleeve 
studies, in individuals with knee OA showed pain improvement, which indicates that all sleeve 
types reduce pain. Therefore, from a clinical practice perspective, sacrificing some of the effects 
(pain reduction) in favour of better compliance in the long term seems to be more important.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A previous study has investigated the effect of three different knee sleeve treatments (thermal 
sleeve, hinged brace, simple knee sleeve), and it showed a higher number of withdrawals for the 
hinged sleeve at 68.4 %, compared to 21.1% for the simple knee sleeve (Toda, 2009). Another 
study compared the effectiveness of lateral wedge insoles with strap use with two groups of 
combined treatments for the same insole (long simple sleeve, short simple sleeve). The results of 
the study showed a significant increase in the number of individuals who could walk without pain 
on uneven ground in the combined treatments groups. However, the withdrawals were higher for 
Sleeve use 
Joint compression 
­ Joint stability 
¯ Muscle co-
contraction 
¯ pain 
­ physical function 
­ Joint 
proprioception 
Figure 3-5 Mechanism of pain reduction with sleeve application 
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the long sleeve in the combined treatment group (36.1%) than in the short sleeve combined 
treatment group (8.1%) (Keyaki & Toda, 2010). A sleeve that is wrapped around the joint is easier 
to be used than a slide-on sleeve because reduced ROM is supposed to be a characteristic for 
individuals with OA (Dekker, van Dijk, & Veenhof, 2009) and have limited knee ROM in flexion 
(Holla et al., 2011; C. R. C. Walker, Myles, Nutton, & Rowe, 2001).  
Thus, the focus of the selection criteria was compliance, and the following criteria were adopted. 
To confirm previous studies about the preference and better compliance for short sleeves, three 
sleeves were chosen from the market. The characteristics of the sleeves and the possible 
mechanism of the effects are presented in Table 3-3. 
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Table 3-3 Sleeves’ characteristics and possible mechanisms of the effect. 
Characteristics Sleeve A Sleeve B Sleeve C 
Method of wear Wrapped around the joint Pull-through sleeve Wrapped around the joint 
Tightness Adjustable, with two straps Non-Adjustable Adjustable, with three straps 
Materials Stretchable and rough Stretchable and soft Stretchable and soft 
Anti-slip rubber  No Yes, on the top of the sleeve Yes, on the top and bottom 
Length (cm) 29.4 33 18.5 
Patellar opening  Yes No Yes 
Patellar pad No Yes Yes 
Support Two spirals for support on each side One spring for support on each side Two springs for support on each side 
The link between 
the possible 
mechanisms of 
the three sleeves 
and their designs 
-Two spirals for support, which may 
provide more support, increase self-
confidence and reduce muscle co-
contraction. 
 
-Rough material may stimulate skin 
receptors, improve proprioception and 
decrease pain signal transmission by 
stimulating skin receptors. 
 
-Adjustable straps, which may help 
increase pressure, reduce oedema and 
improve proprioception. 
 
 
- One spring for support, which may 
provide support, increase self-confidence 
and reduce muscle co-contraction, 
although less so than sleeves A and B. 
 
- Soft material may simulate skin 
receptors, improve proprioception and 
decrease pain signal transmission by 
stimulating skin receptors, although 
possibly less so than sleeve A. 
 
- Constant pressure may increase pressure, 
reduce oedema and improve 
proprioception, although possibly less so 
than sleeve A and B.  
- Two springs for support, which may 
provide more support, increase self-
confidence and reduce muscle co-
contraction. 
 
- Soft material may simulate skin 
receptors, improve proprioception and 
decrease pain signal transmission by 
stimulating skin receptors, although 
possibly less so than sleeve A. 
 
- Adjustable straps, which may help 
increase pressure, reduce oedema and 
improve proprioception. 
 
Disadvantages 
- The sleeve may migrate down the limb 
during activity. 
 
- Materials are rough and uncomfortable. 
- No strap (constant pressure)  
 
- Difficult to wear 
- Covers less area and therefore has less 
area to stimulate. However, this may 
improve compliance. 
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A small randomised trial was conducted on five individuals with knee OA. Three different types 
of sleeves were given to each participant to test for comfort and ease of use; the participants were 
asked two questions (see Table 3-4). The sequence of each sleeve’s use was random, and the results 
show that sleeve C (see Figure 3-6) was the best for both comfort and ease of use (see Table 3-5), 
and therefore it has been selected for use in this study. 
 The selected sleeve met three criteria:  
• Comfortable, therefore will have better compliance. 
• Easy to use, therefore will have better compliance. 
• Short, which confirms the previous study showing better compliance for a short sleeve than 
a long sleeve. 
• Has no hinge support. 
Table 3-4 Questionnaire to evaluate the comfort and ease of use of three different sleeves. 
Out of ten how do you rate the 
comfort of this sleeve during 
walking and sitting? 
Not comfortable at all 0-1-2-3-4-5-6-7-8-9-10 max comfort 
Out of ten, how do you rate 
the ease of sleeve use (put on 
and take off)? 
Difficult 0-1-2-3-4-5-6-7-8-9-10 really easy to use 
 
Table 3-5 The results of questionnaire to quantify the comfort and ease of use of three different sleeves 
 Comfort Ease of use 
Sleeve type A B C A B C 
Average score out of ten 5.2 8.4 8.6 7.6 5.4 8.4 
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Figure 3-6 Different types of sleeve. 
 Data collection procedures 
Prior to the participants’ arrival, the gait lab was prepared, and all equipment was checked and 
calibrated. A clear verbal description of all of the equipment and the testing procedure was given 
to each participant. Each participant was given time to ask any questions they had before they were 
given the consent from. Each participant was given enough time to read and sign the consent form 
before starting the experiment. Each Participant then was asked to change into t-shirts and shorts, 
since this was important for measuring the necessary data.  Demographic details such as date of 
birth, height, mass and shoe size were recorded.  
Kinematic data were collected using motion capture cameras that emit infrared light, which is 
reflected from the markers to the camera in order to provide the two-dimensional position of each 
marker. The three-dimensional position of each marker is then calculated from the two-
dimensional position and the relative position of the cameras to the laboratory’s global coordinate 
system (Kaufman and Sutherland, 2006). The Qualisys Track Manager and Vicon Nexus programs 
used diverse types of external and internal camera parameters, such as the orientation of the 
infrared camera sensor relative to the global coordinate system and the focal length of the infrared 
camera lens, to modify the markers’ 2D positions into a beam. This beam emitted from the infrared 
camera and ended (before it was reflected) at the marker location. At least two infrared cameras, 
A C B 
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and more than one beam, are needed to identify the 3D positioning of a given marker in the global 
coordinate system. Three non-collinear markers or more in each segment needed to be seen by the 
cameras in order to identify the segment location and alignment for each marker placement adopted 
in this study. When adjacent segment locations and alignments were obtained in the same way, the 
angle between segments could be identified. 
 Calibration 
3.8.1 Qualisys system 
To calibrate the system two steps were followed. A static calibration in which the L-Frame (Figure 
3-7) is used to determine the position and orientation of the cameras. The L-Frame which has 4 
markers and was placed on the corner of the force plate parallel to edges (Figure 3-7). The second 
step was to perform the dynamic calibration in order to calibrate the volume using the T-shaped 
calibration wand (Figure 3-7). After placing the L-Frame on the parallel to edges of the force plate 
dynamic calibration start by waving the L-shaped wand in the desired volume for 60 second. Once 
the calibration finished the calibration residual bar will indicate if the procedure was successful or 
not. For the calibration to be accepted the residual volume results should be below 1mm for each 
camera. 
 
Figure 3-7 Left picture show the L-shaped frame while right picture shows the T-shaped calibration wand frame for 
Qualisys system. 
3.8.2 Vicon system 
The calibration of Vicon system is slightly different than Qualisys system although it has two steps 
in which each step is done separately. The first step is called cameras calibration. In this step T-
shaped calibration wand with five LED markers (Figure 3-8) is waved in the desired volume until 
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a red light turn into green in each camera on the screen which indicate successful calibration. The 
image error in each camera should be equal or below 0.2 to indicate a good calibration if not the 
process was redone. The next step is to set the volume origin after finishing the first step. In this 
step the T-shaped wand is placed on the force plate parallel to two edges of the force plate (Figure 
3-8). Next, the program set origin button is used to place the origin volume.  
 
Figure 3-8 T-shaped calibration wand for Vicon system. 
The laboratory global (co-ordinate) system is represented by the three axis L-Frame. The X axis 
is denoting for anterior to posterior axis, the Y axis denoting for medial to lateral axis while the Z 
axis is denoting for the vertical axis (up and down). In this thesis the X axis anterior is forward, 
the Y axis medially to the lift and Z axis vertical to upward. 
 Biomechanical assessment 
Several biomechanical models have been suggested for use in gait studies. The most common in 
clinical studies is the Helen Hayes (HH) model, which has different variations (Kadaba, 
Ramakrishnan, & Wootten, 1990). The disadvantage of the HH model is that it provides only three 
rotational movements of the knee and hip joints and only two degrees of freedom of the ankle 
joint. One of the main reasons for implementing this model is that it was developed based on a less 
advanced measurement system (low-resolution imaging system), and so fewer markers, with larger 
distances between them, so the marker signals can be captured successfully (C-Motion, 2018; 
Della Croce, Leardini, Chiari, & Cappozzo, 2005). Moreover, the anatomical markers that were 
used to track the segment movements may result in errors in the distal segment due to inaccuracies 
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in the movement of the proximal segment. This introduced errors in the measured data (Cereatti, 
Camomilla, Vannozzi, & Cappozzo, 2007; Schwartz, Trost, & Wervey, 2004). 
A later model, with six degrees of freedom, has since been developed, using technical markers to 
track each segment’s movement separately, allowing for six degrees of freedom (three 
translational, three rotational) (Aurelio Cappozzo, Della Croce, Leardini, & Chiari, 2005; Cereatti 
et al., 2007). Reductions in measurement errors have been achieved using this new model (versus 
the old model)  (Cereatti et al., 2007). Therefore, this model (Calibrated Anatomical System 
Technique (CAST)) is preferred for use because it overcomes some of the old model’s theoretical 
limitations, while also producing comparable performance (Collins, Ghoussayni, Ewins, & Kent, 
2009). 
Marker placement 
In the study, the lower limbs were assumed as seven segments, which were the pelvis, and the right 
and left thighs, shanks and feet. To calculate the joint kinetics and kinematics of the lower 
extremities in 3D, the positions and orientations of each segment that is represented by its local 
coordinate system must be determined with skin retro reflective markers during motion. Each foot 
was treated as a single segment and its motion was tracked with the four markers on the head of 
the first, second, and fifth metatarsal and heel (Calcaneus). The hip, knee, and ankle joints were 
determined by the skin mounted markers on the anatomical landmark, which were the posterior 
superior of the iliac spine (PSIS), the anterior superior iliac spine (ASIS), the iliac crest (IC), the 
greater trochanter (GT), the medial femoral condyle, the lateral femoral condyle, the lateral 
malleolus, and the medial malleolus (see Table 3-6).  
These anatomical landmarks match the CAST method (Cappozzo, Catani, Croce, & Leardini, 
1995), which has been proven to be reliable for biomechanical data collection (Benedetti, Catani, 
Leardini, Pignotti, & Giannini, 1998; Reinschmidt, van den Bogert, Nigg, Lundberg, & Murphy, 
1997). To minimise skin artefacts, custom cluster plates made of rigid plastic material (with four 
markers on each) were placed on each thigh and shank, with one on the pelvis (Khan, Jones, Nokes, 
& Johnson, 2007). The shank and thigh clusters were securely fastened to the anterior lateral aspect 
of each segment at the mid-segment level using double-side tape and elastic super-wrap bandages 
(Fabriofoam, USA) to reduce the downward migration and rotation of these cluster pads. The 
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pelvis cluster pad was placed on the sacrum at the mid-point between the posterior superior iliac 
spines using an elastic pelvic belt with Velcro fastenings to permit the secure placement of the belt 
and any adjustments that were required (Figure 3-9). 
 
                                                                  Figure 3-9 Markers placement. 
 
Table 3-6 Anatomical landmarks. 
Anterior superior iliac spines Lateral malleolus 
Posterior superior iliac spines Medial malleolus 
Iliac crests The first metatarsal head 
Greater trochanters The fifth metatarsal head 
Lateral femoral condyle The second metatarsal head (dorsal aspect) 
Medial femoral condyle Calcaneus 
 Measurement of muscle activity 
Muscle activity data were measured using surface electromyography (EMG). The EMG systems 
used in this study were a Noraxon Telemyo system (noraxon.com) and Delsys Trigno system 
(delsys.com). The sampling rate of the EMG systems was 1,500 Hz. In order to identify the 
position where the electrode was to be placed, Surface Electromyography for the Non-Invasive 
Assessment of Muscles (SENIAM) website guidelines (seniam.org) were followed.  
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Firstly, each participant was asked to lie down in prone position for the placement of EMG 
electrodes on the biceps femoris (lateral hamstring (LH)), the semitendinosus (medial hamstring 
(MH)), the medial gastrocnemius (MG), and the lateral gastrocnemius (LG). For the biceps femoris 
(LH), the electrode was placed on the middle (50%) point between the ischial tuberosity and the 
lateral epicondyle of the tibia. For the semitendinosus muscle (MH), the electrode was placed on 
the middle point between the ischial tuberosity and the medial epicondyle. For the lateral 
gastrocnemius, the electrode was placed one-third of the distance from the fibular heads to the 
heel. For the medial gastrocnemius electrode was place on the most prominent bulge of the muscle 
parallel to the muscle fibres. After that, each patient sat on the bed with his/her upper body leaning 
slightly backward and his/her knee slightly flexed, in order to place the medial quadriceps (MQ or 
Vastus medialis) and lateral quadriceps (LQ or Vastus lateralis) electrodes. For the medial, 
quadriceps the electrode was placed at 80% of the distance from the anterior superior iliac spine 
to the joint space in front of the medial ligament anterior border. For the lateral quadriceps the 
electrode was placed at two-thirds on the line from the anterior superior iliac spine to the lateral 
side of the patella.  
Before placing the electrodes, two to three centimetres of the area was shaved. Then, to decrease 
the skin impedance and improve the quality of the EMG signal, the area was rubbed using hypo-
allergenic gel, which was left to dry. Then, the area was wiped with an alcohol swab. The next 
step was preparing the electrode before placing it on the muscle belly parallel to the muscle fibres. 
Following the guidelines for muscle placement will reduce the risk for crosstalk. 
Higher level of muscle co-contraction occurs when the muscle activation level is equal and 
reasonably high. There are different methods for calculating muscle co-contraction that contribute 
to the joint loading, including assessing the ratio of peak muscle activity (muscle 1/ muscle 2) 
(Hortobágyi et al., 2005) and the timing of concurrent activities (muscle 1+ muscle 2) (Unnithan, 
Dowling, Frost, Volpe Ayub, & Bar-Or, 1996). When the former method is used to quantify the 
muscle co-contraction, muscle with similar low magnitude will appear to have the same level as 
muscle with similar higher magnitude. However, when the latter method is used, the condition of 
muscle co-contraction occurs between muscles, one with low magnitude EMG and one with high, 
will be similar to other conditions when muscle EMG magnitude is equally low or high. Lewek et 
al., (2005) used a method of combining the ratio by multiplying the ratio by the sum of the EMG 
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magnitude. This method will be used in this study, as it is better at quantifying muscle co-
contraction that reflects joint loading (Lewek et al., 2005).  
 Maximum voluntary isometric contraction (MVIC) collection  
Prior to the gait test and after the placement of the EMG electrodes, the maximum isometric 
voluntary contractions for the hamstring, gastrocnemius and quadriceps muscles were collected.  
For the hamstring, the participant was asked to lay prone, and the pelvis was strapped with a belt. 
The knee joint was then flexed 55 degrees, and the participant was asked to bend his/her knee as 
hard as possible. For the gastrocnemius muscle, each participant was asked to stand on a single leg 
and asked to raise his/her feet off the floor as forcefully as he/she can. For the last group 
(quadriceps), each participant was asked to sit on a chair and face an adjustable metal bar. After 
securely strapping the pelvis and the femur, the participant’s knee was adjusted to 45 degrees of 
flexion. The participant was then asked to extend his/her knee as hard as possible against the metal 
bar’s resistance. Due to the lack of metal bars in Hail gait lab the quadriceps MVIC was conducted 
using a different method. Manipulation belt was secured in the bed and around the participant 
shank just above the ankle after sitting on the edge of the bed. The length of the belt was adjusted 
to get the right angle (45 degree of knee flexion) though electronic goniometer (                                                           
Figure 3-10). Another manipulation belt was secured around the participant’s thigh to prevent any 
chance of changing intended angle. The participant was then asked to extend his/her knee as hard 
as possible against the belt’s resistance. Isometric voluntary contraction was conducted three times 
for each muscle within each subject with verbal encouragement (e.g. “push harder” or “push as 
much as you can”) and sustained for five seconds. Before conducting the true trials, each 
participant was given a clear explanation as well as practical trials with 50% force to avoid fatigue 
and ensure a clear understanding of the task. 
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                                                           Figure 3-10 Electronic goniometer 
 Data collection 
Prior to the testing procedure, 10 minutes of familiarisation time were given to all participants to 
ensure that they were comfortable with the procedure. At the beginning of each condition, each 
participant was asked to stand over one force plate to obtain a static position of the markers. 
Dynamic trials were then recorded for each participant. 
 Task and events undertaken 
3.13.1 Walking task 
The participants were asked to walk at their own self-selected speed. All participants were asked 
to perform five successful walking trials. A successful trial requires an occurrence of the contact 
phase on the force plate at self-selected speed with the required limb. 
 Data processing  
After collecting five successful trials for each condition based on the study, the data for each 
participant were processed using Qualisys Track Manager Software or Vicon Nexus. In these 
programs, markers were labelled for each static and dynamic trial. Then, all of the trials were 
exported as C3D files for further computation. In the Visuals 3D program, the model of the sixth 
degree of freedom was built for each segment. 
The six degrees of freedom for each segment, as described in the 3D space, are vertical, medial-
lateral, anterior-posterior (translational movement) sagittal, frontal, and transverse (rotational 
movement). Each participant’s mass and height, which were measured prior to starting the trials, 
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were entered into the Visuals 3D program for kinetic calculations. Foot, shank, thigh and pelvic 
segments were determined with distal, proximal and tracking markers as descripted in the 
following Table 3-7.  
Table 3-7  Visual3d segments model. 
Segment Proximal markers location Distal markers location Tracking markers 
Pelvic Right and left anterior superior iliac spine markers 
Right and left posterior 
superior iliac spine markers 
4 markers in pelvic cluster 
built 
Thigh Hip joint center Medial and lateral condyle markers 4 markers in thigh cluster 
Shank Medial and lateral condyle markers 
Medial and lateral 
malleolus 4 markers in shank cluster 
Foot Medial and lateral malleolus markers 
1st and 5th metatarsal head 
markers 
Heal marker, 1st metatarsal 
head marker, 2nd metatarsal 
head marker and 5th 
metatarsal head marker 
The hip joint centre is calculated by visual3d program automatically based on posterior and anterior 
superior iliac spine markers throughout using the regression equation (Bell, Pedersen, & Brand, 1990). 
After that, all kinematics data were interpolated with maximum fill of ten frame and filtered with 
a low-pass filter. A Butterworth fourth-order bi-directional filter was used for both the kinematics 
and the kinetics data. The cut-off frequency for the kinetic data was 25 Hz (Schneider & Chao, 
1983), and for the kinematics data was 6 Hz (Winter, 2009).  
The moments at the hip, knee and ankle were resolved into a coordinate system fixed to the 
proximal segment. The sign conventions which were used in this thesis are presented in the 
following table (Table 3-8). For the center of foot pressure (COP) the positive side was considered 
as lateral.  
Table 3-8 Sign conventions used in current thesis 
 Plane Hip Knee Ankle 
Joint 
angles 
Sagittal  Flexion +ve flexion +ve Dorsiflexion +ve 
Frontal  Adduction +ve Adduction +ve Inversion +ve 
Transverse  Internal rotation +ve Internal rotation +ve  
Joint 
moments 
Sagittal Extension +ve Extension +ve Dorsiflexion +ve 
Frontal Adduction +ve Adduction +ve Inversion +ve 
Transverse  Internal rotation +ve Internal rotation +ve  
+ve = positive  
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To identify any changes in muscle contractions, muscle activity profiles were used. EMG data for 
each walking trial were synchronised with the motion and ground reaction force data. The raw 
EMG data for each muscle were analysed with software VISUAL 3D (V.5.02.26, C-MOTION. 
INC, USA). The EMG data were filtered with high pass filter 20 Hz to remove the moving artifact 
and the noise. Then, the waveform was fully rectified, and a fourth order bi-directional low pass 
filter with 6 Hz cut-off algorithm was used to produce a linear envelope (Hubley-Kozey, Deluzio, 
Landry, McNutt, & Stanish, 2006). Data from each muscle activity were exported to Microsoft 
Excel. Then, each muscle was normalised by its maximum voluntary isometric contraction 
(MVIC), which was applied for each trial. After that, the average muscle activity for each 
normalised trial was used. 
Then, the gait events were created after the construction of a six degrees of freedom model. Firstly, 
initial contact and toes off were determined based on the force plate data when force accessed or 
reduced below 10 Neutron. The following gait events were created automatically base on the 
kinematics data of the first gait cycle using automatic pipeline throughout using pattern recognition 
technique. To calculate the KAAI two manual events were created base of the data of knee y 
moment. The first event is called start and was labeled on the curve as soon as the value of EKAM 
pass zero value to the positive. The second gait event was called stop and created once the value 
of EKAM reach zero value moving to the negative.  Kinetic, EMG, GRF and centre of foot pressure 
(COP) data were normalised to the stance phase, while the kinematic data were normalised to the 
gait cycles in walking.  
Muscle co-contractions between the antagonist and the agonist were calculated based on the 
following equation (EMGS/EMGL*(EMGS+EMGL)). EMGS is the muscle activity for least 
active muscle between the agonist and antagonist whereas the EMGL is the muscle activity for the 
high active muscle between the agonist and antagonist. Muscle co-contraction value is a unitless 
measurement that represents the activation between agonist and antagonist muscles. 
 Determining gait events 
The kinematics and EMG data were recorded in the stance and swing phase while the kinetics, 
GRF and COP data were recorded in the stance phase. All the joint moments (hip, knee, ankle) 
presented in this thesis were the external moment. The kinematic data were normalised to 100% 
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of a gait cycle and Kinetic and EMG data were normalised to 100% of a stance. The mean of five 
trials was used to calculate the maximum, minimum or average of each interested outcome in the 
kinematic, kinetics, GRF data and muscle co-contraction. The joint ROM was calculated by 
subtracting the minimum value from the maximum value throughout the entire range (0-100%). 
The curve of kinematics in the hip frontal angle was divided into first peak (0-33%), trough (34%-
67%) and second peak (68% to 100%). The curve in the kinematics of the knee sagittal plane was 
divided into four phases defined as the following: the initial contact phase (0%), the loading 
response phase (1%-20%), mid-stance phase (21%-50%), terminal stance phase (51% to 61%) and 
swing phase (62%-100%). The curves in the kinetics data in hip y moment, knee y moment and 
GRF were divided into first peak (0 to 33%), trough (34 to 67%) and second peak (68% to 100%). 
The maximum and minimum across the 101% data of the gait cycle were calculated for the 
following outcomes: hip x angle, hip x moment, hip y angle, knee x angle, knee x moment, knee 
y angle, ankle x angle, ankle x moment, ankle y angle, and ankle y moment. The average mean of 
muscle co-contraction was calculated in the following stance phases: early-stance (0-33%), mid-
stance (34%-67%) and terminal-stance (68-100%). 
Biomechanical variables were exported as spreadsheets into Microsoft Excel to conduct the 
analysis and construct a graphical illustration. Statistical analysis was carried out with Statistical 
Package for the Social Sciences (SPSS) (IBM SPSS Statistics 23). The gait cycle, which is defined 
as lasting from the initial contact of a foot to the subsequent initial contact of the same foot, was 
represented in the graphs as a sequence of 101 numbers, where 0 represented the start of the initial 
contact and 100 represented the start of the next cycle. 
 Variables were calculated in current thesis.  
Joint angles, which were assessed in this thesis, include hip angle in the sagittal plane (the first 
peak, trough, the second peak) and frontal and transverse planes (maximum, minimum), knee angle 
in the sagittal (initial contact, loading response, mid-stance, mid-swing), frontal and transverse 
planes (maximum, minimum) and ankle angle in sagittal and frontal planes (maximum, minimum). 
Different aspects of joint moments were assessed in this study, namely, sagittal moment in the hip, 
knee and ankle (maximum, minimum), frontal moment in the hip and knee (the first peak, trough, 
the second peak), frontal moment in the ankle (maximum, minimum), transverse moment in the 
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hip and knee (maximum, minimum) and vertical ground reaction force (the first peak, trough, the 
second peak) (Figure 3-11). Muscle activity in MQ, LQ, MH, LH, MG, LG. For more details about 
the gait phases and calculation of joint angles, moments, GRF and muscle co-contraction please 
see sections 3.14 and 3.15.  
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Figure 3-11 Variables of interest in kinematics, kinetics and GRF data. 
 Statistical analysis 
The data were checked for a normal distribution using the frequency distribution (histogram), 
stem-and-leaf plot, boxplot, P-P plot (probability-probability plot), and Q-Q plot (quantile-quantile 
plot). Additionally,  due to the unreliability of visual inspection for normality (Altman & Bland, 
1995; Öztuna, Elhan, & Tüccar, 2006), Shapiro-Wilk tests were performed to compare the scores 
in the sample to a normally distributed set of scores with the same mean and standard deviation 
(Field, 2013). The Shapiro-Wilk test was chosen over the Kolmogorov-Smirnov (K-S) test due to 
the latter’s high sensitivity to extreme values (Peat and Barton, 2005). Studies have shown that the 
Shapiro-Wilk test is the best option for testing normality due to its high power (Field, 2013; 
Ghasemi & Zahediasl, 2012; Razali & Wah, 2011; Steinskog, 2009; Thode, 2002). 
Assessing the normality distribution is an important step as it helps to determine whether 
parametric statistical tests should be used or not, to assure correct statistical tests to be used. If the 
data are normally distributed, parametric tests were used, otherwise non-parametric tests were used 
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based on each of the different studies. Statistical significance level in this thesis was considered to 
be at alpha <0.05. 
As multiple visits were needed by the individuals in some of the studies, it was essential to know 
that the researcher was reliable in placing the markers and the data collection. Therefore, the 
following sections will detail the reliability studies which were undertaken to demonstrate 
competence.  
The next part of the methods section investigates the reliability of biomechanical outcomes in 
healthy individuals and individuals with medial knee OA. Moreover, the reliability of clinical 
outcomes in individuals with knee OA were investigated. Undertaking this step was necessary to 
understand the researcher’s ability to apply the markers and conduct the same clinical test method 
with high consistency. The rationale for conducting the reliability procedure on healthy and OA 
individuals is that healthy individuals have no known deformity or injury affecting the ability to 
walk, while in individuals with knee OA, the symptoms or disease severity may increase the 
variability in walking from one week to another. Therefore, for better understanding of the 
measurement error and minimal detectable change in each population (healthy, knee OA), two 
studies were conducted, the first in healthy individuals and the second in individuals with knee 
OA.  
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 Test–retest reliability for healthy individuals.  
3.18.1 Introduction 
Clinical gait analysis is considered an important outcome measurement for assessing different 
treatments’ effects on kinetic and kinematic data, which can be affected by different factors during 
measurement. Several factors, such as marker positioning, walking speed and data processing can 
be controlled to reduce measurement errors (Schwartz et al., 2004). Positioning markers on bony 
landmarks can create variability and increase measurement errors (Cappozzo, Catani, Leardini, 
Benedetti, & Croce, 1996). These bony landmarks are more difficult to palpate due to the muscles 
and the adipose tissue covering these (Baker, 2006). The location of the markers is also important 
with regard to calculating and identifying joint centres, and any mistakes in marker placement can 
lead to errors in calculating kinematic and kinetic data (Baker, 2006; Croce, Cappozzo, Kerrigan, 
& Lucchetti, 1997; Stagni, Leardini, Cappozzo, Grazia Benedetti, & Cappello, 2000). A recent 
systematic review concluded that an error in joint angle of five degrees or less is acceptable for 
use in clinical situations. Several studies have shown an encouraging results in the test and re-test 
reliability of gait measurement in healthy participants (Andrews, Noyes, Hewett, & Andriacchi, 
1996; Kadaba et al., 1989) and individuals with knee OA (Birmingham et al., 2007). 
Electromyography (EMG) is commonly used as an outcome measurement to assess muscle 
function (Dowling, 1997). To achieve an effective EMG signal, the user should be aware of the 
factors that can potentially affect the data (Soderberg & Knutson, 2000). Several intrinsic and 
extrinsic factors which can affect the signal have been identified (De Luca, 1997). Electrode 
configuration is among the extrinsic factors, which include size, shape and the electrode’s position 
in relation to the muscle fibre. The electrical signal is highly dependent on whether the electrode 
overlaps the muscle of interest. The electrode location determines the electrical view of the muscle; 
thus, consistency in the electrode placement is an important factor in EMGs taken over repeated 
measurement sessions.  
Therefore, this study will investigate the reliability of EKAM (1st peak, trough, 2nd peak) and 
EMGs in healthy subjects during walking. This study was an important step before starting any 
study aiming to measure the effect of treatment because changes in outcome results might be due 
to inconsistent methods of application, rather than to the treatment itself. This study will, therefore, 
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examine the intra-rater reliability within the same session and between-day measured one week 
apart by the same investigator. This will help to improve the researcher’s understanding of the 
measurement error.  
3.18.2 Methods   
The participants’ data collection was conducted in Podiatry gait analysis lab at Salford university 
with ethical approval number HSCR 15-131. 
 Inclusion criteria and Exclusion criteria 
Healthy adult between the age of 20 to 60 years old were included in the study and for more details 
regarding the inclusion and exclusion criteria please see section 3.5.1.1. 
 Study design and procedure 
This is a reliability study which investigated the reliability of gait and EMG variables in healthy 
individuals within the session and over a week. The task which was investigated was level ground 
walking. 
In brief, a 16 Oqus camera motion capture system integrated with four AMTI force plates was 
used. Data was captured at 100Hz for kinematics and 1000Hz for kinetics. Following calibration 
(section 3.8.1) the markers were applied to the individual (section 3.9). Surface electromyography 
electrodes were applied on the following muscles: LH, MH, LG, MG, LQ and MQ (section 3.10). 
MVIC was collected for these muscles using the same method in section 3.11. The test procedure 
was explained to each participant and given enough time to ask and practice before signing the 
consent form. 
The participants were asked to walk on a 10 metres’ walkway at their own self-selected speed. All 
participants were asked to perform walking until five successful walking trials were achieved. A 
successful trial required an occurrence of the stance phase on one of the force plate (AMTI), 
walking speed was within 5% of each participant’s self-selected speed.  The speed was controlled 
with a Brower Timing Gate system (TC-Timing System, USA) set at approximately hip height.  
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 Variables of interest  
Variables which were assessed in this reliability study were EKAM (the first peak, trough, the 
second peak and muscle activity in MQ, LQ, MH, LH, MG and LG. For more details about the 
gait phases and calculation of the EKAM and muscle co-contraction please see sections 3.14, 3.15 
and 3.16. Other kinematic and kinetics variables were calculated, and the results were presented 
in the Appendix D. Overall, most variables in the within-session and between-session reliability 
showed excellent reliability ranging from ICC=0.63 to ICC=0.99. Furthermore, most of the other 
kinematic and kinetics variables showed low SEM. 
 Data analysis 
To calculate the within-session reliability, the means of five trials from the first session and the 
second session were used. Five minutes separated the first and second session in the within session 
reliability. Markers were not removed and this was purely to replicate the crossover study which 
will be conducted following this study where participant will be randomly given 4 conditions 
without removing the markers. The between-day reliability was calculated by the mean of 5 trials 
from session one and session two with 7 days in between. The data was exported to excel after 
being processed in Qualisys Track Manager Software and VISUAL3D (V6, C-Motion inc. USA) 
programs. 
 Statistical analysis 
To explore the reliability of the test and re-test of a single point in the waveforms intra-class 
correlation coefficient (ICC) was used. Two-way mixed effects ICC mode was used in the current 
study to assess relative reliability. This model is the appropriate method for the current study since 
the principle investigator performed all the measurements, however the results of this study could 
not be generalised to other investigators (Koo & Li, 2016; Shrout & Fleiss, 1979). ICC is a unitless 
measurement, which shows to what extent the measurement of the variables is in agreement 
(Shrout & Fleiss, 1979). ICC values range from 0 to 1 with a higher value representing better 
reliability. The results of the ICC have been interpreted according to the criteria in the Table 3-9. 
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Table 3-9 ICC value and corresponding interpretation (Koo & Li, 2016). 
ICC results Interpretation 
ICC lower than 0.50 Poor reliability 
ICC between 0.50 to 0.75 Fair reliability 
ICC between 0.75 to 0.90 Good reliability  
ICC Higher than 0.90 Excellent reliability  
ICC appears to be easily interpreted, however, when ICC is used alone it cannot provide a full 
picture of the reliability since it does not provide the amount of disagreement between the 
measurements and is not in the unit of measurement. Therefore, using standard error of 
measurement (SEM), which provides the amount of disagreement between the measurements, is 
important (Rankin & Stokes, 1998). Calculating the SEM is very useful and important for 
practitioners who want to determine individual improvements (Munro, Herrington, & Carolan, 
2012). The SEM was computed to determine the absolute reliability, with low values representing 
good reliability. This was used to help the researcher estimate the real change and determine the 
measurement error (Baumgartner, 1989). SEM was calculated using this formula: SD pooled * √ 
(1-ICC) (Denegar & Ball, 1993). 
The smallest detectable difference (SDD) was also calculated to represent the practical 
measurement error (Portney & Watkins, 2009). In other words, the amount of change in the 
measurement outcome is required to be determined so that the real change in the measurement 
achieved due to treatment effects rather than measurement error variation can be identified. 
Calculating SDD is essential especially for intervention studies. Without knowing the 
measurement error, it is difficult to confirm that these changes were caused by the treatment and 
not due to measurement error, such as static alignment or marker placements (Ford, Myer, & 
Hewett, 2007; Malfait et al., 2014; Whatman, Hing, & Hume, 2011). Small detectable differences 
were calculated based on the following equation: SDD = 1.96 * SEM * √2 (Kropmans, Dijkstra, 
Stegenga, Stewart, & de Bont, 1999). 
SDD and SEM are expressed in the same unit as the measurement tool used (Newton-meter per 
kilogram for joint moment and degree for joint angle) (Blankevoort, van Heuvelen, & Scherder, 
2013; Bruton, Conway, & Holgate, 2000). 
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To assess EMG reliability between-day and within-day, the coefficient of multiple correlations 
(CMC) was used. CMC determines the degree of consistency and agreement in the waveform 
between different sessions. CMC has been used in previous studies by Kadaba (1990) and 
Growney et al. (1997) to assess the reliability of measurement tools. CMC provides a value 
between 0 and 1 with no unit. The closer the result to 1, the greater the agreement between the 
sessions (test, re-test) will be, and values higher than 0.80 represent high reliability (Collins et al., 
2009; Growney, Meglan, Johnson, Cahalan, & An, 1997). To assess if there is a significant 
difference in walking speed between both sessions two-tailed, paired t-test was used if the data 
was normally distributed and Wilcoxon’s signed rank test was used if not (Nayak & Hazra, 2011). 
3.18.3 Result  
Participants demographics characteristics are presented in the Table 3-10. There was no significant 
difference in walking speed for both within-session (p=0.48) and between-session (p=0.78) (Table 
3-11). 
Table 3-10 Healthy participants’ demographics characteristics. 
Task  
Mean (SD) 
Number of 
subjects 
Age 
(Years) 
Mass 
(Kg) 
Height 
(M) 
BMI 
(Kg/m²) 
Walking (within-session) 8.00 31.5 (6.14) 
69.5 
(12.35) 
1.71 
(0.06) 
23.68 
(3.99) 
Walking (between-session) 15.00 31.93 (5.54) 
70.18 
 (10.44) 
1.71 
(0.05) 
24.03 
(3.07) 
 
Table 3-11 Walking speed in healthy participants. 
Speed (m/s).  Mean (SD) Test Re-test P-value 
Walking (within-session) 1.23 (0.14) 1.19 (0.16) 0.48 
Walking (between-session) 1.27 (0.15) 1.26 (0.14) 0.78 
 
During level walking, the within-session reliability results (ICC= 0.99) were higher than for 
between-session (ICC=0.96 to 0.99) for all variables. The standard error of measurement for 
EKAM (1st peak, trough, 2nd peak) for within-session reliability and between-session reliability 
ranged from 0.005 to 0.2 Nm/Kg. The small detectable difference (SDD)for within-session 
reliability were lower than between-session EKAM (see Table 3-12). 
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The coefficient of multiple correlation showed good within-session reliability for the muscles 
activity during walking ranging from (0.84 to 0.94) (see Table 3-13). Between-session reliability 
in walking showed the same range as within-session (0.84 to 0.94) (see Table 3-13). Medial 
hamstring and lateral hamstring showed the lowest CMC in walking for both within-session and 
between-session reliability. The highest within-session CMC value was for lateral and medial 
gastrocnemius muscles during walking. Similar trend was noticed for between-session CMC 
during walking, as the lateral and medial gastrocnemius showed the best CMC during walking.  
Table 3-12 Within-session and between-session reliability for EKAM during walking for healthy participants. 
Within-session (Nm/Kg), ICC Mean 95% CI of ICC SEM SDD 
Knee y moment (first Peak) 0.99 0.55 0.99-0.99 0.005 0.01 
Knee y moment (Trough) 0.99 0.25 0.98-0.99 0.01 0.02 
Knee y moment (second Peak) 0.99 0.43 0.96-0.99 0.01 0.03 
Between-session (Nm/Kg), ICC Mean 95% CI of ICC SEM SDD 
Knee y moment (first Peak) 0.98 0.47 0.94-0.99 0.02 0.06 
Knee y moment (Trough) 0.96 0.18 0.87-0.99 0.01 0.04 
Knee y moment (second Peak) 0.98 0.36 0.95-0.99 0.01 0.03 
 
Table 3-13 Within-session and between-session reliability of muscles activity (EMG) in stance phase during walking 
for healthy. 
Muscle (Within-session) CMC mean 
LG 0.94 
LH 0.84 
LQ 0.92 
MG 0.93 
MH 0.89 
MQ 0.91 
Muscle (Between-session) CMC mean 
LG 0.94 
LH 0.85 
LQ 0.93 
MG 0.91 
MH 0.84 
MQ 0.91 
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3.18.4 Discussion 
The aim of this study was to examine the reliability of EKAM and EMG during walking. 
Additionally, the calculation of the standard error of measurement and small detectable difference 
for EKAM variables during walking was completed. 
Generally, the results of ICC for EKAM (1st peak, trough, 2nd peak) for within-session and 
between-session are excellent in walking (0.96 to 0.99). However, 1st peak, trough and 2nd peak of 
the within-session ICC results for were higher than for between-session. Previous studies have 
shown a similar trend during walking (Growney et al., 1997; Kadaba et al., 1989), running (Ferber, 
McClay Davis, Williams, & Laughton, 2002) and vertical jump (Ford et al., 2007). 
Several factors might have contributed to the difference in reliability, such as static alignment, 
marker placement and difficulty of the task  (Ferber et al., 2002; Ford et al., 2007; Manal, McClay, 
Stanhope, Richards, & Galinat, 2000). In 1989, Kadaba attributed between-session variability in 
3D gait analyses to marker reapplication. In this study, only one observer applied the markers 
during both sessions. The high ICC between-session and within-session reflect high consistency 
in marker placement by the observer.  
The high reliability of Knee adduction moments (1st peak, trough, and 2nd peak) during walking 
indicates good repeatability and the usefulness of such an outcome in clinical application and 
research. SEM of knee adduction moment during walking ranged from 0.005 Nm/kg to 0.02 
Nm/kg and revealed that the measurement, indicating low measurement error. This finding is 
consistent with the previous studies that show good reliability for EKAM in healthy individuals 
(Andrews et al., 1996; Growney, Meglan, Johnson, Cahalan, & An, 1997; Kadaba et al., 1989a) 
during walking.  
The reliability of within-session and between-session EMG Vestus Medials, Vestus lateralis, 
Medial Hamstring, Lateral Hamstring, Medial Gastrocnemius and Lateral Gastrocnemius ranged 
from 0.84 CMC to 0.94 CMC. The current study’s EMG results indicate good reliability and 
therefore can be used.  
Kadaba et al. (1989) showed higher than 0.8 for CMC for between- and within-session reliability 
for all muscles, except medial hamstring between-session (0.76). The EMG results from this study 
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(within-session and between-session CMC) during walking showed even higher results than 
Kadaba (1989). This difference might be due to electrode placement position, as the previous study 
placed the electrodes on muscle motor points, which increases the variables and produces less 
stable results than using SENIAM guidelines, as used in the current study (Hermens, Freriks, 
Disselhorst-Klug, & Rau, 2000). Other studies have investigated the reliability of EMG between- 
and within-session (Kadaba, Wootten, Gainey, & Cochran, 1985; Winter & Yack, 1987), however 
a direct comparison cannot be made due to using different statistical methods. 
The current study provides reference values for SEM and SDD during walking, which may be 
useful for evaluating intervention results. SEM is useful for determining the improvement by a 
clinician (Domhldt, 2005). The SEM calculation depends on the standard deviation of the outcome 
measurements and allows the researcher and clinician to be 68% confident that the true value lies 
within + or – 1 SEM. SDD is more conservative than SEM, and if outcomes improve more than 
SDD, confidence will increase to 95%, therefore this change is not caused by participant variability 
or measurement error (Atkinson & Nevill, 1998; Portney & Watkins, 2009). The SEM value for 
the first peak knee adduction moment during walking was 0.005 Nm/kg for within-session and 
0.02 Nm/kg for between-session.  
One limitation of the study is that the generalisability of results is restricted to similar laboratory 
settings, the model, and the researcher’s ability to apply markers, although the results are consistent 
with the previous literature. Furthermore, this study has standardised the shoes of the participants, 
which does not reflect shoes used in everyday life. 
3.18.5 Conclusion 
Based on the results of the current study, several points can be highlighted. Firstly, the 1st peak, 
trough and 2nd peak adduction moment shows excellent reliability and low SEM, therefore it can 
be used to evaluate treatment effect within-session and between-session. Secondly, EMG can be 
used to investigate treatment effect within-session and between-session, as all muscles showed 
good CMC. 
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 Test–retest reliability for individuals affected with knee osteoarthritis.  
3.19.1 Introduction 
The aim of the main study in this thesis was to investigate the effect of combined treatment (lateral 
wedge insole + simple sleeve) on EKAM, pain, muscle co-contraction, balance, pain pressure 
threshold and functional tests, and compare it to each treatment. The measurement for each 
treatment will be taken at baseline and after six weeks. Changes in the outcome results after using 
the treatment needed to be caused by the treatment and not by measurement error. 
Clinical gait analysis is considered a reliable outcome measurement to assess any alteration in the 
lower limb caused by any pathological disorder, such as knee osteoarthritis (McGinley, Baker, 
Wolfe, & Morris, 2009; Zeni & Higginson, 2009). Gait analysis can be affected by several factors 
such as marker placement, data processing and faulty equipment errors, and can be controlled to 
reduce measurement errors (Schwartz et al., 2004). Several studies have shown encouraging results 
in the test and re-test reliability of gait measurement in healthy participants (Andrews et al., 1996; 
Kadaba et al., 1989) and OA patients (Birmingham et al., 2007). 
EMG is commonly used as an outcome measurement to assess muscle function in individuals 
affected with pathology by assessing the muscle’s electrical signal (Dowling, 1997). The 
electrodes should overlay the muscle of interest to provide a valid signal and, to achieve a reliable 
signal, the electrode should be positioned in the same place over time. Previous studies have shown 
encouraging results regarding the reliability of the EMG in healthy individuals (Kadaba et al., 
1989) and individuals affected with knee OA (Hubley-Kozey, Robbins, Rutherford, & Stanish, 
2013). 
Balance is considered a complex neuromuscular process, which includes motor, sensory and 
integrated components. The inability to maintain a stable body over the supported base (leg) is 
defined as balance defect. Balance deficit is considered to be a risk factor in falling among elderly 
individuals and individuals with knee osteoarthritis (Hinman et al., 2002; Wegener, Kisner, & 
Nichols, 1997) and should therefore be assessed. Balance can be affected by many factors such as 
the ageing process, muscle weakness and/or proprioceptive impairment (Koceja, Allway, & Earles, 
1999; Lin, Lin, Lin, & Jan, 2009; Slemenda et al., 1997). Several methods have been used to assess 
  123 
balance, which included expensive and inexpensive methods. The Star Excursion Balance Test 
(SEBT) has been used to assess balance in healthy individuals with good reliability (Kinzey & 
Armstrong, 1998; Munro & Herrington, 2010). To the best of our knowledge there is no previous 
study that assesses the reliability of SEBT in individuals with medial knee osteoarthritis. 
The ability to perform daily activity (physical function) is considered one of the main outcomes 
for individuals with knee and hip osteoarthritis (Bellamy et al., 1997). Physical activities are 
concerned with the ability to move around and perform daily activities. Physical disability affects 
independence and quality of life, which increases the risk of morbidity and mortality (Hofman, 
Grobbee, de Jong, & van den Ouweland, 1991; Jette & Branch, 1985). In 2013, the Osteoarthritis 
Research Society International (OARSI) recommended set physical function tests to be used for 
testing physical ability in individuals with knee osteoarthritis (Dobson et al., 2013). Thirty-second 
chair-stand test, 40-metre fast-paced walk test and a stair-climb test have been used in previous 
studies to evaluate the effects of treatment in individuals with knee osteoarthritis (Dobson et al., 
2013). The reliability for such outcomes were encouraging (Gill & McBurney, 2008a; Kennedy et 
al., 2005; Wright et al., 2011). However, different application methods between sessions can affect 
the reliability of results in such tests and increase measurement error such as application procedure. 
Knee pain pathophysiology is complex and local contributors probably involve raised mechanical 
stress on intra-articular and pre-articular tendons and ligaments, intra-osseous pressure, and 
synovial inflammation (Brandt et al., 2008; Dieppe & Lohmander, 2005; Kidd, 2006). Pain is 
considered to be subjective and relies on patients’ self-reported outcomes in individuals with knee 
osteoarthritis. Although, self-reported outcome measurement is important, other physiological and 
psychological aspects might affect the result and make it difficult to be interpreted. Therefore, 
other objective outcome measurements are needed, such as pain pressure threshold. Previous 
studies have shown that individuals with osteoarthritis have a lower pain pressure threshold than 
the control group (Arendt-Nielsen et al., 2010; Imamura et al., 2008; Wessel, 1995). Furthermore, 
a high ICC was identified by a previous study for using such measurement, which indicated the 
importance of using it (Mutlu & Ozdincler, 2015). However, the use of such a device is based on 
the individual applying the pressure and thus needs to be consistent.  
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Therefore, this study firstly investigated the reliability of EKAM (1st peak, trough, 2nd peak, KAAI) 
and EMG during walking in individuals with knee osteoarthritis. Secondly, it investigated the 
reliability of the star excursion balance test, pain pressure threshold, 30-second chair-stand test, a 
stair-climb test and 40-metre fast-paced walk test. This study was an important step before starting 
any study. It aimed to measure the treatment effect, because changes in outcome results might be 
due to inconsistent methods of application, rather than to the treatment itself. This study would, 
therefore, examine the intra-rater reliability between days measured one week apart. This will help 
to improve the researcher’s understanding of measurement error.  
3.19.2 Methods  
The participants’ data collection was conducted in the Hail gait laboratory at Hail University and 
in the Brain Blatchford gait laboratory at Salford University. 
 Inclusion and exclusion criteria 
To take part in this study, each participant had to be between 35 and 85 years old affected with 
medial knee OA. For more details regarding the definition of medial knee OA please see the 
inclusion and exclusion in section 3.5.1.2. 
 Study design 
This is a study to examine the reliability of clinical and biomechanical outcome measurement 
amongst individuals affected with knee osteoarthritis over a week. 
 Test procedure 
Balance assessment 
Dynamic balance was assessed by using a modified star excursion balance test (SEBT). After an 
explanation of the procedure the participants were asked to maintain a single-leg stance on the 
affected leg. Depending on the direction to be tested, either facing the bar anteriorly (A) or with 
their side to the bar medially (B), they were asked to reach as far as possible along the bar by 
pushing a small block on the bar as far as possible and return the reaching leg back to the centre 
(see Figure 3-12). Anterior and medial directions were used in SEBT to reduce the length of the 
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session by not applying testing all directions and present of muscle weakness in quadriceps and 
gluteus muscles which targeted by these directions. The participants were asked to perform the test 
barefoot, keep their heel of the stance leg on the platform at all times, bend their knee of the stance 
leg, push the block gradually but not suddenly, and not slide it by stepping on it. If any of these 
instructions were not carried out by the participants, the trial was repeated. Each participant started 
with four training trials in each direction. To facilitate the comparison between groups the distance 
was normalised to the limb length, which was measured from the anterior superior iliac spine to 
the medial malleolus.   
 
 
Figure 3-12 Star excursion balance test. 
Pain pressure assessment: 
Each participant was asked to lie on their side on the bed and the Algometer’s probe was held 
perpendicular to the area which was tested (see Figure 3-13). Pain pressure threshold is defined as 
the lowest pressure intensity at which pain is felt. Each participant was instructed to say “stop” 
when the first sensation of pain was felt. Each patient was given two trials before starting the tests. 
The area that was tested was the medial side of the knee (medial condyle), as this is considered the 
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most painful area and medial malleolus as reference pain-free area (Wylde, Palmer, Learmonth, & 
Dieppe, 2011). Each test was performed three times and the average was calculated for each site. 
 
                                                    Figure 3-13 Pressure gauge. 
Physical function tests 
• Forty-metre fast-paced walk test 
Each participant was asked to walk 10 metres, four times, which was marked by a tape on the 
floor. Cones were placed two metres beyond the starting and the finishing lines so participants 
could turn safely around them. Each participant was instructed to walk and turn around the cones 
three times to finish the 40 metres. The instructions were as follows: “Walk as quickly as you can 
but as safely as you can without running.” Each participant was given time to practice for two trials 
before starting the test. The time was measured by stopwatch and the time after passing the lines 
(finish, start) to turn around the cones was calculated by pausing the stopwatch. The distance (40 
metres) was then divided by the time each participant took to finish the 40 metres to be expressed 
as speed (m/s).  
• Thirty-second chair-stand test 
This test represents the number of counts that each participant can do to stand and sit on a chair in 
30 seconds as fast as possible. A 43 cm high chair without arms was placed against the wall. Each 
participant was asked to start from sitting to standing with his/her hips with knees fully extended 
and sit back with his/her bottom fully touching the chair and his/her hands crossed over the chest. 
This counted as one trial.  If the participant could not perform any one trial, then the score was 
zero and an adapted test was used. In this case, using the hand against the legs or the use of an 
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assisted device as normally used in real life such as a walking aid was allowed. Two practice trials 
were done before starting the real test to ensure understanding. 
• A stair-climb test 
In this test, the time taken by each participant to ascend nine steps and then descend the same steps 
was measured in seconds. Each participant was asked to ascend and descend the nine steps as 
quickly and safely as possible. The use of handrails and assisted devices was allowed as needed. 
Two practice trials were done with the researcher walking behind each participant to check for 
safety and ensure understanding. 
Kinematic and kinetic data collection 
In brief, two systems were used in this study the first one is the Brain Blatchford gait analysis lab 
and the second one is Hail University gait analysis lab. The Brain Blatchford gait lab is 10 T30/40 
camera motion capture system with four Kistler force plates while Hail lab is 10 Bonita camera 
motion capture system with two AMTI force plates. Data were captured in both labs at a sampling 
rate of 100 Hz for kinematics and 1000 Hz for kinetics. The systems were calibrated and the 
laboratory were prepared before the subject’s arrival (section 3.8). The informed consent form was 
signed after the test procedure was explained to the participant and enough time to ask and think 
was allowed. Each participant was asked to change into T-shirt and short to start the testing 
procedure. In order to enable the participant to familiarise him/herself with the equipment and test 
procedure, each was given enough time to practice before starting the test. The 40-metre fast-paced 
walk test, 30-second chair-stand test and star excursion balance test was explained to the 
participant and collected in order. After the electrodes were applied on the following muscles: LH, 
MH, LG, MG, LQ and MQ (section 3.10). MVIC was collected for these muscles using the same 
method described in section 3.11. The markers were applied, and five successful trials were 
collected. Finally, the stair-climb test was collected in the stair. A successful trial requires an 
occurrence of the complete stance phase on a force plate (AMTI) within each participant’s self-
selected speed. The same procedure and order of the tests were applied for each participant after a 
week. For more information about the method, please see sections 3.14, 3.15 and 3.16. All 
participants wore their own shoes for both session and only SEBT test were collected barefoot. 
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 Variables of interest 
Variables which were assessed in this reliability study were EKAM (1st peak, trough, 2nd peak, 
KAAI) and EMG. Muscle co-contraction in early-, mid- and late- stance phases between the 
following muscles LQ/LH, LQ/LG, MQ/MH and MQ/MG reliability were calculated in current 
study. Pain pressure threshold, balance (anterior and medial directions) and functional tests (40-
metre fast-paced walk test, 30-second chair-stand test, a stair-climb test) were included as clinical 
outcomes in current reliability study. For more details about the gait phases and calculation 
EKAM, muscle co-contraction please see sections 3.14, 3.15 and 3.16. Other kinematic and 
kinetics variables were calculated, and the results were presented in the Appendix D. Generally, 
most kinematics and kinetics variables showed high reliability (ICC>0.90) and low SEM. 
 Data analysis 
To calculate the between-day reliability, five trials from the first session and the second session 
were used. The data were exported to Microsoft Excel after being processed in Qualisys Track 
Manager, Vicon nexus Software and C3D programs. To explore the reliability of the test, re-testing 
of a single point in the waveforms and muscle co-contraction, intra-class correlation coefficient 
(ICC two-way mixed effects model) was used. The results of the ICC have been interpreted 
according to the criteria in Table 3-7. The SEM was computed to determine the absolute reliability. 
The small detectable difference (SDD) was also calculated to represent the practical measurement 
error (Portney & Watkins, 2009). To assess EMG reliability between days, the coefficient of 
multiple correlations (CMC) was used. To assess if there is a significant difference in walking 
speed between each session, a two-tailed, paired t-test was used if the data were normally 
distributed and Wilcoxon’s signed rank test was used if not (Nayak & Hazra, 2011). 
 Statistical analysis 
All statistical analysis in the current study was conducted using Microsoft Excel version 15.29.1 
for Mac, and SPSS version 23 for Mac. The means of five trials from the first session and the 
second session after seven days were used to compute the between-day reliability.  
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3.19.3 Results 
Nine individuals with confirmed medial knee osteoarthritis were recruited and completed this 
study. Six participants were collected in the Hail University gait lab and three in the Brian 
Blatchford gait lab. Both labs have the same gait operation system (Vicon) and EMG system 
(Delsys). Each participant was tested and re-tested after 7 days in the same lab and the data from 
both labs were combined to calculate the reliability in current study. The individuals’ 
demographics are represented in the following Table 3-14. Walking speed did not change between 
the first and the second session (p-value=0.82) (Table 3-15). 
Table 3-14 Participants’ demographics characteristics for participants with knee OA. 
Number of 
subjects  
Mean (SD) 
Gender Age (Year) 
Height 
(M) 
Mass 
(Kg) 
BMI 
(Kg/m²) 
Affected 
side 
9 All male 49 (6.06) 
1.72 
(0.05) 
89.36 
(15.74) 
30.28 
(5.28) 
Right (5) 
Left (4) 
 
Table 3-15  Walking speed in participants with knee OA 
Mean (SD) Test  Re-test  P-value 
Speed (m/s) 1.23 (0.24) 1.23 (0.24) 0.82 
 
 Test re-test reliability for external knee adduction moment (1st peak, trough, 2nd peak, 
KAAI) 
The mean, CI, SEM, SDD and ICC for the first peak, trough and second peak knee adduction 
moment during walking for individuals with medial OA are represented in the following Table 
3-16. Generally, between-days reliability EKAM in osteoarthritis participants are excellent ranged 
from ICC =0.96 to ICC=0.99.  
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Table 3-16 Between-day reliability for EKAM during walking for participants with knee OA. 
First peak, trough and second peak 
(Nm/Kg), KAAI (Nm/kg*s) ICC mean 95% CI of ICC SEM SDD 
Knee y moment (first Peak) 0.97 0.61 0.86-0.99 0.019 0.05 
Knee y moment (Trough) 0.96 0.32 0.82-0.99 0.021 0.06 
Knee y moment (second Peak) 0.96 0.41 0.83-0.99 0.02 0.05 
KAAI  0.99 0.26 0.94-0.99 0.009 0.02 
 
 Test and re-test reliability for EMG 
The reliability of the muscle activity amongst individuals with osteoarthritis showed good CMC 
for the following muscles: LG, LH, LQ, MG, MH, and MG, ranging from 0.83 CMC to 0.87 CMC. 
The mean CMC and SD for each muscle is demonstrated in the following Table 3-17. The muscle 
co-contraction reliability for most phases and between most muscles were good to excellent, 
ranging from 0.79 to 0.98 ICC. In early-stance, LQ/LQ and MQ/MH reliability were poor to “fair”, 
ICC 0.27 and 0.67 respectively (Table 3-18). 
Table 3-17 Between day reliability of muscles activity EMG in a stance during walking for participants with knee OA. 
 
 
 
 
 
 
 
 
 
 
 
 
Muscle (between-day) CMC Mean CMC SD 
LG 0.85 0.05 
LH 0.87 0.05 
LQ 0.84 0.06 
MG 0.84 0.10 
MH 0.85 0.05 
MQ 0.83 0.10 
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Table 3-18 Between-day reliability of muscles co-contraction in a stance during walking for participants with knee 
OA. 
Stance phase Variables ICC Mean 95% CI of ICC SEM SDD 
Early-stance 
LQ/LH 0.79 0.40 0.07-0.93 0.05 0.14 
LQ/LG 0.27 0.20 -2.22-0.84 0.06 0.17 
MQ/MH 0.67 0.25 -4.48-0.93 0.03 0.09 
MQ/MG 0.88 0.14 0.46-0.97 0.01 0.03 
Mid-stance 
LQ/LH 0.93 0.15 0.69-0.98 0.01 0.02 
LQ/LG 0.98 0.14 0.92-0.99 0.003 0.01 
MQ/MH 0.97 0.08 0.84-0.99 0.003 0.01 
MQ/MG 0.88 0.07 0.48-0.97 0.007 0.02 
Late-stance 
LQ/LH 0.84 0.08 0.29-0.96 0.009 0.03 
LQ/LG 0.81 0.08 0.14-0.96 0.01 0.04 
MQ/MH 0.88 0.05 0.49-0.97 0.005 0.01 
MQ/MG 0.96 0.09 0.80-0.99 0.004 0.01 
 
 Test and re-test reliability for the modified star excursion balance test. 
Normalised results from the modified start excursion test reliability for the affected leg are 
represented in the Table 3-19. The data showed excellent reliability with ICC above 0.92 for 
normalised modified star excursion in anterior and the medial directions. 
Table 3-19 Between-day reliability of balance test for participants with knee OA. 
Balance Direction ICC Mean 95% CI of ICC SEM SDD 
Normalised data to leg 
length (%) 
Anterior 0.96 74.67 0.83-0.99 2.12 5.88 
Medial 0.93 79.78 0.69-0.98 2.97 8.24 
 Test and re-test reliability for three functional activity tests. 
The ICC, mean, CI, SEM and SDD for the 30-second chair-stand test, stair-climb test and 40-metre 
fast-paced walk test are illustrated in Table 3-20. The ICC value for the three functional tests (30-
second chair-stand test, stair-climb test and 40-metre fast-paced walk test) were excellent, at 0.92, 
0.95 and 0.92 respectively. 
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Table 3-20 Between-day reliability of three functional tests for participants with knee OA. 
Functional tests ICC Mean 95% CI SEM SDD 
30-second chair-stand test (repetition) 0.92 11.67 0.81-0.99 0.86 2.38 
Stair-climb test (second) 0.95 9.91 0.80-0.99 0.60 1.67 
40-metre fast-paced walk test (m/s) 0.92 1.65 0.64-0.98 0.04 0.1 
 
 Test and re-test reliability for the pain pressure threshold test. 
The results of the pain pressure threshold test demonstrated high ICC for both the medial condyle 
(0.92 ICC) and medial malleolus (0.96 ICC). The ICC, mean, CI, SEM and SDD for pain pressure 
threshold are presented in the following table Table 3-21. 
Table 3-21 Between-day reliability of pain pressure threshold for participants with knee OA. 
Pain pressure threshold (N/Cm²) ICC Mean 95% CI SEM SDD 
Medial condyle 0.92 7.06 0.65-0.98 0.59 1.63 
Medial malleolus 0.96 8.38 0.82-0.99 0.49 1.35 
 
3.19.4 Discussion 
The aims of the current study were to examine the reliability of biomechanical and clinical 
outcomes, which would be used in the main study (OA study). Additionally, to calculate the 
standard error of measurement and small detectable difference for each outcome among 
individuals with knee OA. The rationale for this study was to make sure that all the changes, which 
would be monitored after the six weeks of treatment for individuals with knee OA, are a real 
change and not caused by measurement error.   
In 2010, a systematic review was conducted to evaluate the psychometric properties for gait 
outcomes among individuals with knee and hip OA (Ornetti et al., 2010). The study stated that 
there is limited number of studies to make conclusion and more studies are needed to investigate 
the reliability. Generally, the results of ICC for between-days EKAM (1st peak, trough, 2nd peak, 
KAAAI) are excellent in walking (0.96 to 0.99). High between-day reliability indicates that the 
marker application method achieved a good accuracy and low measurement error. 
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Previous studies have stated that several factors might contribute to a difference in reliability 
results such as marker placement and static alignment (Ferber et al., 2002; Ford et al., 2007; Manal, 
McClay, Stanhope, Richards, & Galinat, 2000). Kadaba et al. (1989) stated that the variability 
between 3D gait outcomes may be causes of the marker’s reapplication. In this study, only one 
observer applied the markers during both sessions. The high between-day ICC reflect high 
consistency in marker placement by the observer. 
Knee adduction moment showed excellent reliability with value 0.97, 0.96 and 0.96 to the first 
peak, trough and the second peak respectively. This represents good reliability for such an outcome 
and supports the use of this outcome in clinical practice and research. These findings are consistent 
with previous studies that show good reliability for EKAM in healthy individuals (Andrews et al., 
1996; Growney, Meglan, Johnson, Cahalan, & An, 1997; Kadaba et al., 1989a) and individuals 
with knee osteoarthritis (Asay, Boyer, & Andriacchi, 2013; Birmingham, Hunt, Jones, Jenkyn, & 
Giffin, 2007; Robbins, Astephen Wilson, Rutherford, & Hubley-Kozey, 2013) during walking. 
This is the first study to calculate the ICC, SEM and SDD in one study among individual with 
medial knee OA. 
The reliability of between-day EMG signals from Vestus Medials, Vestus lateralis, Medial 
Hamstring, Lateral Hamstring, Medial Gastrocnemius, and Lateral Gastrocnemius ranged from 
0.83 CMC to 0.87 CMC. Kadaba et al. (1989) showed similar results for between-day reliability 
except medial hamstring (0.76 CMC). This might have been caused by placing the electrode in the 
motor unit, which increases the variability and reduces the reliability of the signals (Hermens et 
al., 2000). Other studies have investigated the reliability of between- and within-day EMG 
(Hubley-Kozey et al., 2013; Kadaba et al., 1985; Mohr, Lorenzen, Palacios-Derflingher, Emery, 
& Nigg, 2018; Winter & Yack, 1987), however a direct comparison could not be made due to the 
use of different statistical methods. Muscle co-contraction reliability was good to excellent 
(ICC>0.79) for all muscles except LQ/LQ and MQ/MH in early-stance, where the ICC was poor 
(ICC=0.27) and fair (ICC=0.67) respectively. Previous study to the OA population calculated the 
ICC for muscle co-contraction and showed high reliability, ranging from 0.76 to 0.89 (Hubley-
Kozey et al., 2013). However, direct comparison could not be made since this study calculated the 
muscle co-contraction in the whole stance phase and did not divide the stance into three sub phases 
as in this study. 
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The star excursion balance test and retest reliability results showed excellent reliability for both 
normalised and non-normalised data in anterior and medial directions above ICC 0.92. 
Interestingly, the star excursion balance test in the anterior direction was more reliable than in the 
medial direction. This might be caused by the pain as the subject is standing on the affected side 
and the load is high on the medial side. This is the first study to examine the reliability of the star 
excursion test in individuals with medial knee osteoarthritis. 
Previous healthy studies showed good reliability in the star excursion balance test in the anterior 
direction ICC=0.87 (Kinzey & Armstrong, 1998) and the medial direction ICC=0.86 (Munro & 
Herrington, 2010). The slightly lower results among the previous researches may be caused by 
different reasons. This study standardised a position to the static foot by line to make sure repeated 
foot placement and standardised the test direction order. Secondly, this study included OA subjects 
while previous studies included healthy participants. Healthy subjects might be able to reach 
longer distances than participants with OA, which increases the variability in the tests. 
The usefulness and importance of functional performance tests to investigate the effect of physical 
training and rehabilitation is well established (Augustsson & Thomeé, 2000; Tegner, Lysholm, 
Lysholm, & Gillquist, 1986). Previous studies have used functional performance tests to evaluate 
the physical performance in individuals at high risk or with knee osteoarthritis (Sharma et al., 
2003). The current study showed excellent reliability in the 30-second chair-stand test (ICC=0.92), 
stair-climb test (ICC=0.95) and 40-metre fast-paced walk test (ICC=0.92). 
In 2005, Kennedy et al. assessed the reliability of several functional tests in individuals with hip 
and knee osteoarthritis (Kennedy et al., 2005). Their reliability results from the 40-metre fast-
paced walk test and the stair-climb test were ICC=0.91 and ICC=0.90, respectively which agree 
with current study. A more recent study showed ICC=0.95 and ICC=0.81 for the 40-metre fast-
paced walk test and 30-second chair-stand test, respectively (Wright et al., 2011). The difference 
in the 30-second chair-stand test reliability results between this study and previous study can be 
attributed to a difference in population (hip OA). Furthermore, high ICC was identified for the 30-
second chair-stand test at three-time line, ranging from 0.95 to 0.99 in individuals with knee and 
hip osteoarthritis waiting for joint replacement, which agreed with this study’s results in showing 
excellent reliability (Gill & McBurney, 2008). 
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Pain pressure threshold showed excellent reliability over a week for the medial condyle and medial 
malleolus in the affected leg. Interestingly, the medial condyle (ICC=0.92) showed lower 
reliability value than the medial malleolus (ICC=0.96). This might be explained by the variation 
in pain pressure threshold on the affected knee from one day to other.  
Previous studies showed excellent reliability for the pain pressure threshold over the medial 
condyle ranging from 0.84 to 0.97 (Mutlu & Ozdincler, 2015; Pelfort et al., 2015) and the medial 
malleolus ranging from 0.93 to 0.98 (Mutlu & Ozdincler, 2015). Although the pain pressure 
threshold in this study and previous studies is reliable, it may be affected by several factors: age 
and gender were identified to affect the pain pressure threshold (Chesterton, Barlas, Foster, Baxter, 
& Wright, 2003; Magerl et al., 2010). In 1988, Cornwall and Doniri stated that the level of anxiety 
and anticipation may also affect pain pressure threshold sensitivity (Cornwall & Donderi, 1988). 
The current study provides reference values for SEM and SDD for clinical and biomechanical 
outcomes among individuals with knee OA, which may be useful for evaluating intervention 
results in future studies. Furthermore, this study has used participants’ own shoes, which reflect 
shoes used in everyday life. 
As with any study, there were limitations that the generalisability of results was restricted to similar 
laboratory settings, the model, and the researchers’ ability to apply markers, although the results 
are consistent with previous literature. Secondly, the time between the first and the second tests 
was relatively short (7 days), which might create a familiarisation effect, and this should be 
controlled by providing sufficient practice. Finally, the sample size could be criticised, although 
excellent ICC and low SEM in most of the variables were identified. 
3.19.5 Conclusion 
Based on the results of the current study, several points can be highlighted. Firstly, EKAM (1st 
peak, trough, 2nd peak, KAAI) show excellent reliability and low SEM, therefore it can be used to 
evaluate between-days treatment effects. Secondly, EMG can be used to investigate treatment 
effect between-day, as all muscles showed good CMC. ICC for LQ/LH, LQ/LG, MQ/MH and 
MQ/MG indicate good between-day reliability in all phases except for LQ/LG and MQ/MH in the 
early-stance phase.  Finally, the star excursion test, the functional tests (40-metre fast-paced walk 
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test, 30-second chair-stand test, stair-climb test) and pain pressure threshold are reliable with low 
measurement error and can be used to evaluate the clinical efficacy of treatment.   
 Summary of chapter 
This chapter has presented the methodology undertaken to assess the biomechanical and clinical 
outcomes. Furthermore, the definition and calculation methods for the desired variables were 
clearly stated. The participant selection criteria for defining healthy and knee OA participants were 
described. The healthy reliability study showed that EKAM, and most kinetics and kinematics 
outcomes are highly reliable outcomes within session and between sessions. The second reliability 
study showed a similar finding, exhibiting excellent reliability in the biomechanical and clinical 
outcomes among individuals with knee OA. This means that most biomechanical outcomes in 
healthy people and individuals with knee OA and all clinical outcomes in individuals with knee 
OA can be used to investigate the treatment efficacy with high accuracy. The next chapters take 
this into consideration and investigates the effects of LWI and simple knee sleeve in healthy people 
and individuals with knee OA using outcomes with good to excellent reliability. 
 
. 
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 The immediate effect of single and combined 
treatments on knee kinematics and kinetics on healthy 
during walking 
 Chapter overview 
This chapter aims to fill the gap in the literature concerning sleeve, LWI and combined treatment 
and how this can be tested on healthy individuals before implementing it on individuals with 
medial knee OA. The introduction concludes with the aims and hypotheses of the study. The 
methods section relates the design of the study and recruitment plan, as well as giving brief 
descriptions of the laboratory and gait analysis method. Then, the statistical approach used to 
investigate the hypothesis is described in detail. The following section gives the detailed results 
based on a scientific statistical method. This chapter then ends with a discussion and conclusion, 
where the results are interpreted and compared with those of previous studies, while clinical 
applications are explained. 
 Background 
Osteoarthritis (OA) is considered the most prevalent type of musculoskeletal disease, affecting 
millions of individuals and reducing their quality of life through disability (Lawrence et al., 2008). 
It is considered a worldwide health problem that affects approximately 8% to 15% of the 
population (Rat et al., 2006). In a previous study in the United Kingdom, 1 out of every 10 
individuals between 35 and 75 was found to be affected by OA (Sangha, 2000). OA is one of the 
most common secondary causes of death due to disability. Recent reports indicate that people with 
knee OA are at high risk of cardiovascular disease due to disability and inactivity (Nüesch et al., 
2011). 
Several surgical techniques are used to treat individuals with knee OA. However, there are some 
individuals for whom surgery is not appropriate (e.g. too young) or who do not want surgery 
(Bhatia et al., 2013; Marks & Penton, 2004). Therefore, conservative management should be the 
primary consideration when treating individuals with medial knee OA. 
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Conservative management approaches have not been fully validated in the scientific literature. It 
is therefore important to know which techniques will have the most impact on individuals’ pain 
and functional independence, two of the primary concerns of sufferers.  
Valgus knee braces and lateral wedge insoles are common modalities used to treat individuals with 
medial knee OA. There is supporting evidence that using combined treatments during walking 
leads to a greater reduction in external knee adduction moment (EKAM) than using a single 
treatment. Three studies investigated the combination of a lateral wedge insole and a valgus knee 
brace (Al-Zahrani et al., 2013b; Fu et al., 2015; Moyer et al., 2013). In all these, this combination 
resulted in a greater reduction in first or second EKAM than individual treatment. However, 
compliance was lower in the combined treatment group (valgus brace and LWI) than in the single 
treatment group (LWI).  
Several studies have investigated the effect of using lateral wedge insoles on individuals with knee 
OA. No difference was found between lateral wedge insoles and control treatments, such as neutral 
insoles, with regard to pain (Baker et al., 2007; Barrios et al., 2009; Bennell et al., 2011; Campos 
et al., 2015; Maillefert et al., 2001; Pham et al., 2004). One of the potential uses of lateral wedge 
insoles that has been shown to have a positive mechanical response is to combine them with a 
device that has better pain-relieving results.  
A simple knee sleeve is another option that has been used to treat individuals with knee OA. 
Several studies have investigated the effect of knee sleeves on individuals with knee OA resulting 
in decreased pain (Bryk et al., 2011; Kirkley et al., 1999; Mazzuca et al., 2004; Schween et al., 
2015), improved quality of life (Kirkley et al., 1999), improved stability (Schween et al., 2015), 
improved function (Bryk et al., 2011; Kirkley et al., 1999), and decreased muscle co-contraction 
(Collins et al., 2011). They also showed proprioceptive improvements in partial weight bearing 
tasks (Collins et al., 2011b) and improvement in static and dynamic balance (Chuang et al., 2007) 
and knee flexion angles (Collins et al., 2013, 2011). 
Improving muscle co-contraction is considered an important factor, as increased medial muscle 
co-contraction has been correlated with medial cartilage volume loss rates in individuals with knee 
OA and varus alignment (Hodges et al., 2015). It is believed that increased muscle co-contraction 
comes at the expense of higher joint loading (Lloyd & Buchanan, 2001; Meyer et al., 2013; 
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Schipplein & Andriacchi, 1991) and increases OA risk (Heiden et al., 2009; Wu et al., 1990; Zeni 
et al., 2010). 
Two studies investigated the effect of knee sleeve on EKAM during walking in individuals with 
knee OA. The results were contradicting with one study showing significant reduction by 10.1% 
(Schween et al., 2015) while other one did not show any significant change (Collins et al., 2014). 
Combining lateral wedge insoles and a simple knee sleeve may be a good option to treat individuals 
with knee OA. With this combination of reduced muscle co-contraction, simple knee sleeve use, 
and the EKAM via the lateral wedge insole, it may be possible to achieve a consistent reduction 
in pain and loading. However, before conducting the study in individuals with knee OA one step 
can be taken. This step is to investigate what can the sleeve offer in kinematics, kinetics and muscle 
co-contraction in a healthy cohort without impairment. Recent literature review study showed that 
only 4 studies investigated the effect the knee sleeve on kinematics and kinetics (Mohd Sharif, 
Goh, Usman, & Wan Safwani, 2017). Of which three were in individuals with knee OA during 
walking (Collins et al., 2014, 2011; Schween et al., 2015) and in healthy during descending and 
landing (Giotis et al., 2011). Further research revealed one study which investigated the effect of 
the knee sleeve on walking and single leg hopping among healthy (Ko et al., 2017). This study 
only looked at segments angle (thigh, shank, foot) in relation to the floor and did not included the 
knee joint angles or moments. Therefore, there is a clear need for a study which look to the effect 
of the knee sleeve on healthy. 
Interestingly, several studies investigated the effect of LWI in healthy individuals and showed a 
reduction in EKAM (Crenshaw et al., 2000; Jones et al., 2013c; Kakihana et al., 2005, 2004; 
Nakajima et al., 2009). To the best of our knowledge no previous study did investigated the effect 
of LWI on muscle co-contraction among healthy or individuals with knee OA. looking at muscle 
co-contraction is important since increase the muscle co-contraction may lead to higher joint 
loading (Lloyd & Buchanan, 2001; Meyer et al., 2013; Schipplein & Andriacchi, 1991) and was 
correlated with progression of the knee OA (Hodges et al., 2015). Furthermore, no study has 
investigated the effect of a combined treatment using a simple knee sleeve and a lateral wedge 
insole on kinematics, kinetics, and muscle activity during walking in healthy which highlight the 
need for more studies.  
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Therefore, determining whether a lateral wedge insole, a simple knee sleeve, or a combined 
approach reduces loads during walking is warranted. In the present study, the immediate effect of 
treatment conditions will be investigated first in healthy participants. After that, if the experiment 
yields promising results in healthy participants, participants with knee OA will be recruited. 
 Purpose of the study 
The purpose of the study was to investigate the effect of four treatment conditions (combined 
treatment, simple knee sleeve, lateral wedge insole and control) and assess their impact on knee 
loading (first peak EKAM, trough EKAM, second peak EKAM, knee adduction angular impulse 
(KAAI)), ground reaction force (GRF), knee flexion moment, knee joint angles in sagittal plane 
(knee flexion angle at initial contact, maximum knee flexion angle at loading response, minimum 
knee flexion angle at mid-stance, maximum knee flexion angle at swing), frontal plane range of 
motion (ROM), and muscle co-contraction. 
 Aims and hypotheses of the study 
The following are the aims and primary hypotheses of the study: 
- To investigate the effect of combined treatment (lateral wedge insole and simple knee sleeve) 
and individual treatment on EKAM. 
- Null hypothesis: There is no significant immediate change in knee loading (first peak EKAM, 
trough EKAM, second peak EKAM, KAAI) when using the combined treatment (lateral wedge 
insole, simple knee sleeve) or individual treatment compared to individual treatment, combined 
treatment or no treatment. 
- To investigate the effect of the combined treatment (lateral wedge insole and simple knee 
sleeve) and individual treatment on muscle co-contraction. 
- Null hypothesis: There is no significant immediate change in muscle co-contraction when 
using the combined treatment (lateral wedge insole, simple knee sleeve) or individual treatment 
compared to individual treatment, combined treatment or no treatment. 
Secondary hypothesis of the study: 
  141 
- To investigate the effect of combined treatment (lateral wedge insole and simple knee sleeve) 
and individual treatment on GRF, knee flexion moment, knee joint angles in sagittal plane (knee 
flexion angle at initial contact, maximum knee flexion angle at loading response, minimum 
knee flexion angle at mid-stance, maximum knee flexion angle at swing), and frontal plane 
ROM. 
- Null hypothesis: There is no significant immediate change in GRF, knee flexion moment, knee 
joint angles in sagittal plane (knee flexion angle at initial contact, maximum knee flexion angle 
at loading response, minimum knee angle at mid-stance, maximum knee flexion angle at swing) 
and ROM of the knee joint angle in frontal plane when using the combined treatment (lateral 
wedge insole, simple knee sleeve) or individual treatment compared to individual treatment, 
combined treatment or no treatment. 
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 Methods 
The participants’ data collection was conducted in Hail gait laboratory at Hail University.  
4.5.1 Population 
Healthy adult participants aged 20 to 60 years old were included in the study. For more details 
about the inclusion and exclusion criteria which define healthy please see section 3.5.1.1. 
 
4.5.2 Study design and randomisation 
This randomised crossover study investigated the immediate effect of four treatment conditions on 
healthy individuals during walking. The four treatment conditions were as follows: a five-degree 
lateral wedge insole (Figure 4-1), a simple knee sleeve (Figure 4-2), combined treatment (lateral 
wedge insole, simple knee sleeve) (Figure 4-1, Figure 4-2) and control (no treatment). Participants 
were randomly assigned to a treatment condition using randomisation blocks. For more details 
about the rationale for the appropriate selection criteria which has been used to select the LWI and 
the knee sleeve please see sections 3.6.1 and 3.6.3. 
 
Figure 4-1 Lateral wedge insole used in the study. 
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Figure 4-2 Knee sleeve used in the study. 
In brief, a 10-Bonita-camera Vicon analysis system with two AMTI force plates was used. Data 
was captured at 100 Hz for kinematics and 1000 Hz for kinetics. Following calibration (section 
3.8.2, the markers were applied to the individual base of the CAST model (section 3.9). Surface 
electromyography electrodes were applied on the following muscles: LH, MH, LG, MG, LQ and 
MQ (section 3.10). MVIC was collected for these muscles (section 3.11).  
The participants were asked to walk on a 12-metre walkway at their own self-selected speed. All 
participants were asked to perform five successful walking trials. A successful trial required the 
occurrence of contact on the force plate (AMTI), within 5% of each participant’s self-selected 
speed. 
The biomechanical results were computed based on data collected under the following four 
conditions: 
• lateral wedge insole (LWI) 
• simple knee sleeve (Sleeve) 
• Combination of the lateral wedge insole and the simple knee sleeve (Sleeve+LWI) 
• Participants own shoes (control) 
4.5.3 Variables of interest 
The variables of interest were walking speed, peak knee flexion moment, EKAM (first peak, 
trough, second peak, KAAI), GRF (first peak, trough, second peak), knee flexion angle at initial 
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contact, maximum knee flexion angle at loading response, minimum knee flexion angle at mid-
stance, maximum knee flexion angle at swing and knee frontal plane ROM. Muscle co-contraction 
in the early-stance, mid-stance and late-stance were among the variables of interest for the 
following pairs of muscles: LQ/LH, LQ/LG, MQ/MH and MQ/MG. For more details please see 
sections 3.14 and 3.15. 
4.5.4 Data analysis  
After processing the walking data using the Vicon nexus and Visual 3D programs, the data were 
exported to an Excel sheet. To select the appropriate statistical test, the data were checked for 
normality using a Shapiro–Wilk test. Repeated measures ANOVA was used to investigate the 
effect of treatments on the interested outcomes. A Friedman test was used with non-normally 
distributed variables. All kinematics, kinetics and walking speed data were normally distributed. 
The muscle co-contraction data were not normality distributed for most muscles and phases, except 
for mid-stance LQ/LH co-contraction in all groups.  
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 Results 
The number of subjects and their age, height, mass and body mass index (BMI) are presented in 
Table 4-1 
Table 4-1 Participants’ demographics characteristics. 
Number of subjects 
Mean (SD) Age (Years) Mass (Kg) Height (M) BMI (Kg/m²) 
19 21.95 (0.91) 64.88 (13.86) 1.69 (0.07) 22.56 (4.19) 
 
A repeated measures ANOVA showed no significant difference in speed during walking (p=0.77) 
between all treatment conditions (Table 4-2). 
Table 4-2 Walking speed. 
Speed (m/s) 
Mean (SD) 
Combined 
treatments 
Lateral wedge 
insole 
Simple knee 
sleeve Control 
Walking 1.13 (0.15) 1.14 (0.14) 1.13 (0.15) 1.14 (0.15) 
 
4.6.1 Knee joint moments and GRF 
The peak knees flexion moment showed no significant difference between treatment conditions 
during walking (p=0.09) (Figure 4-3, Table 4-3). 
A repeated measures ANOVA showed significant changes across treatment conditions in the first 
peak EKAM (p<0.01). In the frontal plane, a pairwise comparison showed significant reduction in 
the first peak EKAM for the combined treatment compared to the control treatment (5.39%; mean 
difference 0.03 (0.04) Nm/kg, p=0.02). The LWI treatment showed a significant reduction in the 
first peak EKAM compared to the control treatment (8.46%; mean difference 0.04 (0.04) Nm/kg, 
p<0.01) and the sleeve treatment (6.37%; mean difference 0.03 (0.03) Nm/kg, p<0.01). No 
significant changes in the trough EKAM were found between treatments, based on a repeated 
measures ANOVA (p=0.18). The second peak EKAM showed a significant difference between 
treatment conditions during walking (p<0.01). A pairwise comparison showed a significant 
reduction in the second EKAM for the LWI treatment (4.91%; mean difference 0.02 (0.03) Nm/kg, 
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p=0.02;) compared to the control treatment and the sleeve treatment (6.68%; mean difference 0.02 
(0.03) Nm/kg, p=0.01) (Figure 4-4, Table 4-3). 
The KAAI showed significant change across treatment conditions as identified by a repeated 
measures ANOVA (p<0.01). This changes in KAAI was identified to be as a significant reduction 
for the combined treatment (mean difference 0.01 (0.01) Nm/kg*s, p<0.01) and the LWI treatment 
(mean difference 0.01 (0.01) Nm/kg*s, p=0.02) compared to the sleeve treatment by 4.92% and 
5.64%, respectively (Figure 4-5, Table 4-3). 
The first peak GRF, trough and second peak GRF did not differ significantly across treatments 
during walking (p=0.43, 0.08, 0.30 respectively) (Figure 4-6, Table 4-3). 
Table 4-3 Knee moments, KAAI and ground reaction force during walking. 
Variable  
Mean (SD) Sleeve + LWI LWI Sleeve Control 
Peak Flexion Moment 
(Nm/Kg) -0.48(0.25) -0.46(0.22) -0.46(0.25) -0.47(0.26) 
1st Peak EKAM (Nm/Kg) 0.46(0.14) ¶ 0.44(0.14) ¶W 0.47(0.15) 0.49(0.16) 
Trough EKAM (Nm/Kg) 0.23(0.09) 0.23(0.10) 0.24(0.10) 0.24(0.10) 
2nd Peak EKAM (Nm/Kg) 0.33(0.12) 0.32(0.12) ¶W 0.34(0.13) 0.34(0.14) 
KAAI (Nm/kg*s) 0.16(0.07) W 0.16(0.07) W 0.17(0.07) 0.17(.07) 
GRF 1st Peak (BW) 1.08(0.07) 1.07(0.06) 1.07(0.07) 1.08(0.07) 
GRF Trough (BW) 0.82(0.06) 0.82(0.06) 0.82(0.06) 0.81(0.06) 
GRF 2nd Peak (BW) 1.09(0.07) 1.07(0.06) 1.07(0.07) 1.08(0.07) 
¶  significant compared to control 
W significant compared to sleeve 
l significant compared to LWI  
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Figure 4-3 Knee joint moment in sagittal plane during walking. 
 
 
Figure 4-4 Knee joint moment in frontal plane during walking. 
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Figure 4-5 Knee adduction angular impulse (KAAI) during walking. 
 
 
 
Figure 4-6 Vertical ground reaction force (GRF) during walking. 
4.6.2 Knee kinematics 
Regarding the sagittal plane, a repeated measures ANOVA showed no significant changes between 
treatments in knee flexion angle at initial contact (p=0.55), maximum knee flexion angle at loading 
response (p=0.60) or minimum flexion angle at mid-stance (p=0.81). However, the maximum 
flexion angle at late-swing showed significant changes across treatment conditions (p<0.01). A 
pairwise comparison showed a reduction for the combined treatment compared to the control 
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treatment (2.07%; mean difference 1.45 (2.07) degrees, p<0.01) and to the LWI treatment (1.71%; 
1.25 (1.83) degrees, p<0.01) and for the sleeve treatment compared to the control treatment (mean 
difference 1.2 (1.7) degrees, p<0.01; 1.56 (2.25) degrees, p<0.01)  and the LWI treatment (2.2%; 
mean difference 1.56 (2.25) degrees, p<0.01) (Figure 4-7, Table 4-4).  
A repeated measures ANOVA showed a significant change in knee frontal ROM across treatments 
(p<0.01). The knee frontal plane ROM showed a significant reduction for the combined treatment 
compared to the control treatment (14.83%; mean difference 2.19 (2.71) degrees) and the LWI 
treatment (11.98%; mean difference 1.50 (1.91) degrees, p<0.01) and for the sleeve treatment 
compared to the control (7.61%; mean difference 1.31 (1.71) degrees, p<0.01) and LWI treatment 
(11.29%; mean difference 1.71 (2.21) degrees, p<0.01) (Figure 4-8, Table 4-4).  
Table 4-4 Knee joint angles in sagittal plane and ROM in frontal plane during walking. 
Variable LWI + Sleeve LWI Sleeve Control 
Knee angle at initial contact 
(degree) 2.12 (3.03) 2.31(3.10) 1.95 (3.38) 2.06 (3.35) 
Maximum knee flexion peak 
angle at loading response 
(degree) 
8.98 (7.03) 8.74(6.82) 8.96 (7.22) 8.61 (7.13) 
Minimum knee flexion angle 
at mid-stance (degree) 2.68 (4.47) 2.63 (4.44) 2.82 (4.72) 2.76 (4.57) 
Maximum knee flexion peak 
angle at swing (degree) 
68.16 (4.87) 
¶l 70.30 (4.80) 
67.88 (4.83)  
¶l 70.33 (4.33) 
ROM of the knee joint angle 
in frontal plane (degree) 
9.81 (.3.35) 
¶l 12.49 (3.63) 
10.46 (3.57) 
¶l 12.96 (4.13) 
¶  significant compared to control 
W significant compared to sleeve 
l significant compared to LWI  
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Figure 4-7 Knee joint angle in sagittal plane during walking. 
 
 
Figure 4-8 Knee joint angle in frontal plane during walking. 
4.6.3 Muscle Co-Contraction 
There was no significant reduction in LQ/LH co-contraction between treatments in the early and 
mid-stance phases (p≥0.05). However, the late-stance phase showed a significant difference 
between the treatments during walking (p=0.02). A pairwise comparison showed a reduction for 
the sleeve treatment compared to the LWI treatment (median difference 0.003, p=0.03) and nearly 
to be significant compared to the control treatment (p=0.07). The LQ/LG co-contraction showed 
no significant difference between all treatments in the early-, mid- and late-stance phases (p≥0.05). 
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In the early, mid- and late-stances, there was no significant difference in MQ/MH co-contraction 
and MQ/MG co-contraction between the treatments during walking (p≥0.05) (Table 4-5, Table 
4-6). 
Table 4-5 Mean muscle co-contraction in walking across conditions. 
Muscles Period condition LWI + Sleeve LWI Sleeve Control 
LQ/LH Mid-Stance 
Mean 0.027 0.028 0.028 0.028 
SD 0.019 0.022 0.022 0.025 
 
Table 4-6 Median muscle co-contraction in walking across conditions. 
Muscles Period condition LWI + Sleeve LWI Sleeve Control 
LQ/LH 
Early-
stance 
Median 0.079 0.077 0.086 0.086 
Range 0.011-0.332 0.014-0.337 0.011-0.374 0.013-0.298 
Late-
Stance 
Median 0.020 0.021 0.018 l 0.020 
Range 0.012-0.033 0.013-0.038 0.011-0.034 0.013-0.043 
LQ/LG 
Early-
stance 
Median 0.067 0.081 0.071 0.084 
Range 0.011-0.190 0.013-0.179 0.011-0.215 0.013-0.171 
Mid-
Stance 
Median 0.022 0.028 0.021 0.020 
Range 0.008-0.239 0.008-0.183 0.008-0.265 0.007-0.223 
Late-
Stance 
Median 0.015 0.017 0.016 0.016 
Range 0.007-0.046 0.009-0.041 0.007-0.076 0.007-0.040 
MQ/MH 
Early-
stance 
Median 0.032 0.037 0.047 0.035 
Range 0.007-0.242 0.005-0.192 0.004-0.148 0.006-0.209 
Mid-
Stance 
Median 0.012 0.011 0.013 0.011 
Range 0.004-0.060 0.003-0.049 0.004-0.047 0.004-0.046 
Late-
Stance 
Median 0.014 0.014 0.012 0.014 
Range 0.004-0.073 0.005-0.049 0.004-0.058 0.004-0.052 
MQ/MG 
Early-
stance 
Median 0.065 0.046 0.070 0.049 
Range 0.008-0.164 0.005-0.144 0.005-0.141 0.007-0.173 
Mid-
Stance 
Median 0.033 0.023 0.019 0.020 
Range 0.003-0.087 0.003-0.099 0.003-0.121 0.012-0.033 
Late-
Stance 
Median 0.017 0.016 0.019 0.018 
Range 0.003-0.056 0.004-0.381 0.003-0.295 0.003-0.435 
¶  significant compared to control 
W significant compared to sleeve 
l significant compared to LWI  
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 Discussion 
The purpose of this study was to examine the impact of knee sleeve on biomechanical outcomes 
during walking to be taken to the next stage of the study in individuals with knee OA. Furthermore, 
to examine the effect of LWI and combined treatment on kinematic, kinetics, GRF and muscle co-
contraction in healthy.    
Regarding the first aim of the study, the first peak EKAM showed a significant reduction for the 
combined treatment and the LWI treatment compared to the sleeve treatment and the control 
treatment. This reduction was seen in the first peak EKAM for the LWI (8.46%) and the combined 
treatment (5.39%) compared to the control treatment and for the LWI treatment (6.37%) compared 
to the sleeve treatment. Although the reduction in the first peak EKAM (0.03 Nm/kg) for the 
combined treatment compared to the sleeve treatment did not reach statistical significance, it 
passed the measurement error (0.01 Nm/kg) for within session, which indicates a real reduction.  
The trough EKAM did not show any statistically significant changes with the LWI treatment or 
the combined treatment, and the reduction in trough EKAM did not pass the measurement error. 
In contrast, only the LWI treatment resulted in a significant reduction in the second peak EKAM 
compared to the sleeve treatment (4.91%) and the control treatment (6.68%). The combined 
treatment resulted in a reduction in second peak EKAM compared to the control treatment and the 
sleeve treatment and passed the measurement error but was not statistically significant.  
No significant difference was found in walking speed for any of the treatments during walking. 
This indicates that the significant reduction in EKAM was a result of using the lateral wedge insole 
rather than changes in walking speed or GRF. EKAM is determined by multiplying the GRF by 
the moment arm. Therefore, if the GRF did not change as a result of speed, then the moment arm 
must have decreased. 
The decreased EKAM with LWI use in this study could be due to three main factors—an increase 
in the ankle eversion angle, an increase in the ankle eversion moment and shifting the centre of 
foot pressure laterally. Previous studies involving LWI use showed an increase in the ankle 
eversion angle with LWI use by changing the foot orientation relative to the floor (Butler, Barrios, 
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Royer, & Davis, 2009; Chapman et al., 2015). Furthermore, an increase in the eversion moment 
(Abdallah & Radwan, 2011; Chapman et al., 2015; Mølgaard & Kersting, 2013; Pagani, Hinrichs, 
& Brüggemann, 2012) and laterally shifting in centre of pressure (Chapman et al., 2015; Hinman 
et al., 2012; Kakihana et al., 2005; Leitch et al., 2011) have been found by previous research. 
Although the eversion moment increase might cause discomfort and increase the load on the ankle 
joint with long-term LWI use, incorporating the medial arch might reduce the risk by redistributing 
the force alongside the sole of the foot. 
Several studies have revealed a significant reduction in EKAM with LWI use in healthy people, 
which is in total agreement to with the current study (Crenshaw et al., 2000; Jones et al., 2013c; 
Kakihana et al., 2005, 2004; Nakajima et al., 2009). Jones et al. (2013c) showed significant 
reductions in the first peak (8.5%) and second peak (12.5%) with 5-degree LWI among healthy 
individuals. Although the reduction in the second peak was higher in Jones et al. (2013c), this 
could be due to differences between the studies, as the current study did not control the shoes, 
while Jones et al. (2013c) used ECCO Zen shoes; it could also be due to a difference in 
demographic characteristics between studies. Direct comparison with the rest of the studies of 
healthy populations could not be carried out, since different methods were used in the calculation 
of EKAM. Kakihan et al. (2005) calculated the average EKAM when using LWI (6 degree) 
attached to the foot by tape compared with no LWI and showed 10.4% reduction. Crenshaw et al. 
(2000) showed a significant reduction after using thin a flexible shoe in peak EKAM between LWI 
(6 degree) and no LWI, amounting to 6.65%. In 2009, Nakaima et al. (2009) conducted a study 
and showed a significant reduction in peak EKAM (8.8%) with LWI (6 degree) compared with a 
flat insole. 
Studies of LWI in individuals with knee OA showed similar reduction in first peak EKAM of 
5.85% (Chapman et al., 2015), 5.6% (Kakihana et al., 2005) and 5.21% (Jones et al., 2014). 
Hinman et al. (2008) also obtained a similar result in the first peak (5.4%) and the second peak 
(5.1%) with LWI use in individuals with knee OA. Another study by Hinman et al. (2009) showed 
a greater reduction in the first peak (12%) and the second peak (14%). This difference in reduction 
could be attributed to the difference in population between the current study and the study by 
Hinman et al. (2009). Hinman et al. (2009) recruited subjects with versus knee alignment and pain.  
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Similar to the previous healthy studies, some subjects showed no difference in EKAM (increase 
or no change) with LWI use (Crenshaw et al., 2000; Jones et al., 2013c; Nakajima et al., 2009). 
Studies in individuals with knee OA showed similar trend with some subjects characterised as non-
responder (Butler et al., 2007; Crenshaw et al., 2000; Hinman et al., 2008a, 2008b, 2012; Kakihana 
et al., 2005, 2007; Kerrigan et al., 2002). This is believed to have been caused by the ankle joint 
position variation in the frontal plane while walking. In 2015, Chapman et al. concluded that the 
ankle joint plays an important role in responders and non-responders. Furthermore, individuals 
with more everted ankles during walking without LWI were more likely to show a reduction in 
EKAM. 
KAAI is known to be more sensitive than EKAM in detecting the differences between knee OA 
severity (Kean et al., 2012; Thorp et al., 2006). During walking, both the combined treatment and 
the LWI treatment resulted in a significant reduction in KAAI of 4.92% and 5.64% compared to 
the sleeve treatment. Although the KAAI decreased in the combined treatment and the LWI 
treatment compared to the control treatment, it did not reach statistical significance level.  
Interestingly, the reduction in KAAI with LWI use were found in individuals with knee OA of 
6.3% (Hinman et al., 2012), 5.2% (Hinman et al., 2009), 7.95% (Chapman et al., 2015), 6.38% 
(Jones et al., 2013) and 6.29% (Jones et al., 2014). However, direct comparison to previous studies 
cannot be made due to the difference in population (knee OA compared to current study (healthy). 
Interestingly, the knee sleeve did not result in any significant reduction in EKAM compared to the 
control treatment during walking. Nor did the sleeve reduce the KAAI during walking. A 
comparison to other healthy studies unfortunately cannot be made due to the lack for similar study 
in healthy participants. Current study results were similar to previous knee OA study which 
showed no significant change in maximum EKAM in the first and second halves of the stance 
phase (Collins et al., 2014). This contradicts a previous study by Schween et al. (2015) which 
showed a significant reduction with sleeve use in the first peak EKAM and KAAI of 10.1% and 
12.9%, respectively. This might be explained by several factors, such as using different types of 
sleeves and different populations (knee OA). Previous studies have shown that individuals with 
knee OA suffer from joint laxity (Sharma et al., 1999; Wada, Imura, Baba, & Shimada, 1996), 
which might explain the reduction in the previously mentioned study.  
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In terms of muscle co-contraction, sleeve use might result in a decrease, as seen in the late-stance 
phase LQ/LH co-contraction compared to LWI use during walking. To the best of our knowledge 
this is the first study to investigate the effected of LWI, sleeve and combined treatment on muscle 
co-contraction among healthy and therefore direct comparison cannot be made. A previous knee 
OA study showed a significant decrease in LQ/LH co-contraction with sleeve use during walking 
(Collins et al., 2011). Although the current study has shown a reduction between the same muscles 
in the late-stance phase, a direct comparison cannot be made due to different phase calculations, 
the different populations and different normalisation methods. Collins et al. (2011) divided the 
stance phase into two phases, used a knee OA population and normalise on maximum activity 
during control trials. The current study used three stance phases, recruited healthy subjects and 
normalised on MVIC.  
A reduction in muscle co-contraction was not expected in this study, as all participants were 
healthy (normal muscle co-contraction was therefore expected). A previous study showed that 
increased muscle co-contraction correlated with medial cartilage volume loss rates in individuals 
with knee OA and varus alignment (Hodges et al., 2015). Therefore, if a similar reduction was 
seen in an OA population the reduction in co-contraction might be clinically important and 
decrease knee OA progression. 
The current study results show a significant reduction in ROM of the knee joint angle in frontal 
plane with the combined treatment and the sleeve treatment compared to the control and LWI 
treatments during walking. Further investigation showed that this reduction was during both 
maximum and minimum adduction angles. No comparison could be made to healthy study because 
no previous study included this outcome as a variable in healthy studies. Collins et al. (2014) 
showed a reduction in maximum adduction angle and minimum abduction angle with sleeve use 
in individuals with knee OA. It could be that the sleeve provides frontal plane knee stability. The 
current study’s population was healthy and did not complain of any knee disability or laxity. 
Therefore, the use of a sleeve in individuals with knee OA could be beneficial, as a previous study 
has shown that individuals with knee OA have frontal plane knee laxity, which correlates with 
greater muscle activity (Lewek et al., 2004a). Even though the reduction in the knee frontal plane 
ROM is appearing to be in the swing phase, this phase is important since the foot contact the 
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ground after that phase. Therefore, this may help to support the knee and reduce the high muscle 
co-contraction might be due to the laxity in individuals with medial knee OA. 
Knee flexion moment showed no significant changes with the sleeve treatment or the combined 
treatment in current study. To the best of the authors knowledge only one study investigated the 
effect of sleeve on healthy and direct comparison cannot be made since this study only looked to 
the kinematics. Previous study in individuals with knee OA showed a significant increase in knee 
flexion moment with sleeve use (Collins et al., 2014), which might be caused due to an increase 
in the knee sagittal plane angle. Increasing the flexion moment might cause an increase in the 
compression force on the knee, as the contact area is smaller due to the greater flexion angle 
(Costigan, Deluzio, & Wyss, 2002; Taylor, Heller, Bergmann, & Duda, 2004). An increase in the 
knee flexion angle causes the quadriceps to work harder to pull the tibia upward and foreword 
(Costigan et al., 2002). The results of the current study regarding the knee flexion moment were 
expected, as there were no changes in the knee flexion angle at initial contact, the maximum knee 
flexion peak angle at loading response or the minimum flexion angle at mid-stance. 
A significant reduction was noticed in the maximum flexion angle at swing for the combined 
treatment and the sleeve treatment compared to the control and LWI treatments. The magnitude of 
reductions was between 2.13 degree to 2.45 degree which were greater than SEM and SDD for 
within session reliability indicating real reduction. This is believed to be caused by either the sleeve 
elasticity reducing the range of motion or the sleeve bunching at the back of the knee and 
preventing the participant from reaching their normal knee flexion angle at swing. A comparison 
with previous studies could not be made because no study on sleeves included this variable. 
Although the reduction in maximum knee flexion angle at swing was significant, the amount of 
reduction was small, up to 2.2%, and a similar reduction might not affect the gait. 
Of course, this study has several limitations. First, the investigator and participants were not 
blinded to the treatment conditions in the laboratory. However, being blinded to such treatments 
is difficult because the intervention is inserted in the shoes or is wrapped around the knee. 
However, kinematic and kinetic data were collected using an automatic measurement tool, which 
reduced assessor bias. 
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Secondly, the participants wore their own shoes during the session, which might affect the LWI 
effect. A previous study showed an interaction effect in relation to the shoes and EKAM (Mølgaard 
& Kersting, 2013), which may decrease LWI efficacy (Toda & Tsukimura, 2008). However, this 
might increase the generalisability of the data to other populations, as it reflected their daily life 
shoes use. Future studies could look at the effect of the same or different treatments with control 
shoes to eliminate the effect of other shoes on the treatment.  Thirdly, this study evaluated one type 
of sleeve and LWI, but other types might have a different effect. Therefore, this study’s results 
only apply to the same sleeve and LWI type, and other studies should assess different types of 
sleeves and LWIs. This study calculated EKAM responses to LWI and sleeve use during walking 
only. Therefore, future studies should calculate EKAM reduction across different activities instead 
of just walking to be more representative of everyday life activities.  
Finally, this study investigated the impact of combined and single treatments on healthy 
individuals, and apart from LWI use, the impact of combined treatment use on the medial knee 
OA population is not known. Therefore, further studies should look at the impact of combined 
treatments on short- and long-term clinical and biomechanical outcomes. 
 Conclusion 
Compared to walking with normal shoes, the LWI reduced EKAM and KAAI during walking. The 
sleeve was not found to change the EKAM during walking. Furthermore, use of the sleeve reduced 
frontal plane knee ROM during walking. Muscle co-contraction showed significant reduction with 
sleeve use compared to LWI condition and was border significant compared to control condition. 
This might indicate extra benefit from combining the sleeve with the LWI especially for 
individuals with knee OA as they suffer from high muscle co-contraction. GRF and walking speed 
were not affected between the conditions. 
After considering all the weaknesses and strengths of the study, the main conclusion is that 
combining the sleeve with the LWI might increase the benefit of the LWI. Sleeve use will help 
individuals with knee OA to reduce their pain and may reduce loading throughout providing 
stability and reducing the muscle co-contraction. Therefore, it may be beneficial to combine the 
sleeve with LWI for individuals with medial knee OA, as EKAM and muscle co-contraction have 
been linked to knee OA progression and symptoms. 
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 Effect of a lateral wedge insole and simple knee 
sleeve as a single and combined treatment in 
biomechanical and clinical outcomes in individuals with 
knee osteoarthritis (The IN-SLEEVE study). 
 Chapter overview 
This chapter will present the main study where by the comparison of single and combined 
treatment in individuals with medial knee OA will be assessed. This follow on from the previous 
healthy study in chapter four but in this chapter, it will be assessing both the immediate time point 
and also following an intervention period.  
 Introduction 
Osteoarthritis (OA) is considered to be the most prevalent type of musculoskeletal disease 
(Lawrence et al., 2008). In a previous study in the United Kingdom, 1 out of every 10 individuals 
between 35 and 75 was found to be affected by OA (Sangha, 2000). Although OA occurs in many 
joints, the knee joint is affected most commonly (Newman et al., 2003). 
There are several surgical techniques used to treat individuals with knee OA. However, for some 
individuals, surgery is not appropriate (e.g. the patient is too young), while others simply do not 
want surgery (Bhatia et al., 2013; Marks & Penton, 2004). Therefore, conservative management 
should be the primary consideration when treating individuals with medial knee OA. Several 
conservative approaches are considered options to treat individuals with knee OA. However, they 
have not been fully validated in the scientific literature. Therefore, other treatment approaches 
should also be considered. The valgus knee brace, lateral wedge insoles, and simple knee sleeves 
are common conservative approaches to treating individuals with knee OA. Previous research 
shows that combined treatment (lateral wedge insole, valgus knee brace) reduces EKAM by more 
than single treatment (Al-Zahrani et al., 2013b; Fu et al., 2015; Moyer et al., 2013). The main 
drawback of using a valgus knee brace is the low compliance rate (Barnes et al., 2002; Jones et al., 
2013; Wilson et al., 2011). Therefore, in the long term, participants usually use lateral wedge 
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insoles and lose the valgus knee brace effect on loading and pain (Barnes et al., 2002; Jones et al., 
2013; Wilson et al., 2011). This can be attributed to several factors, such as skin irritation, 
mechanical problems, poor fit, awkward shape, difficulties taking the brace off and putting it on, 
difficulties wearing the brace with clothes, and brace bulkiness (Barnes et al., 2002; Fu et al., 2015; 
Giori, 2004; Squyer et al., 2013; Van Raaij et al., 2010).  
Lateral wedge insoles have been used extensively with knee OA patients and have been proven to 
reduce knee loading. However, when compared with the results of neutral wedge insoles, no 
significant difference in pain levels was identified (Baker et al., 2007; Barrios et al., 2009; Bennell 
et al., 2011; Campos et al., 2015; Maillefert et al., 2001; Pham et al., 2004). Therefore, lateral 
wedge insoles could be a good treatment option if combined with another treatment that targets 
pain. Previous studies have shown that simple knee sleeve use decreases pain (Bryk et al., 2011; 
Cudejko et al., 2017; Kirkley et al., 1999; Mazzuca et al., 2004; Schween et al., 2015), improves 
quality of life (Kirkley et al., 1999), improves stability (Cudejko et al., 2017; Schween et al., 2015), 
improves function (Bryk et al., 2011; Cudejko et al., 2017; Kirkley et al., 1999), improves 
proprioception (Collins et al., 2011b), and decreases muscle co-contraction in individuals with 
knee OA (Collins et al., 2011; Collins et al., 2013). Muscle co-contraction is considered an 
important factor since muscle activity is correlated with the progression of knee OA (Hodges et 
al., 2015). Therefore, combining lateral wedge insoles with simple knee sleeves may be a good 
option. Through this combination of reduced muscle co-contraction, simple knee sleeve use, and 
the EKAM via the lateral wedge insole, it may be possible to achieve consistent reductions in pain 
and loading. No study has investigated the effect of combined treatments on kinematics, kinetics, 
and muscle activity during walking. Although healthy individuals do not have knee laxity or high 
muscle co-contraction, our previous study, which included healthy participants, showed that using 
the sleeve treatment reduced muscle co-contraction, and frontal plane ROM. Therefore, combining 
the sleeve with LWI may result in higher reduction in pain combined by reduction in loading 
thought reducing EKAM and muscle co-contraction. 
 Purpose of the study 
The purpose of the study is to compare the clinical and biomechanical outcomes of three treatment 
groups of individuals with knee OA (simple knee sleeve, lateral wedge insole, and a combined 
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treatment of simple knee sleeve and lateral wedge insole). This trial is registered in the clinical 
trials website with study registration number NCT03225911.  
 Aims and hypothesis of the study 
The aim of this study was to understand the effects of combined treatments (simple knee sleeve, 
lateral wedge insole) and to compare its effectiveness to that of the lateral wedge insole and sleeve 
in individuals with medial knee osteoarthritis. 
1- To investigate the effect of combined treatments (lateral wedge insole and simple knee 
sleeve) and individual treatment on EKAM 
Null hypothesis: There is no significant difference in EKAM when using combined treatments 
(lateral wedge insole and simple knee sleeve) compared to individual treatment (lateral wedge 
insole or simple knee sleeve) (immediate, 6 weeks). 
2- To investigate the effect of combined treatments (lateral wedge insole and simple knee 
sleeve) and individual treatment on pain 
Null hypothesis: There is no significant difference in pain after 6 weeks when using combined 
treatments (lateral wedge insole and simple knee sleeve) compared to individual treatment (lateral 
wedge insole or simple knee sleeve). 
3- To investigate the effect of combined treatments (lateral wedge insole and simple knee 
sleeve) and individual treatment on muscle co-contraction 
Null hypothesis: There is no significant difference in muscle co-contraction when using combined 
treatments (lateral wedge insole and simple knee sleeve) compared to individual treatment (lateral 
wedge insole or simple knee sleeve) (immediate, 6 weeks). 
4- To investigate the effect of combined treatments (lateral wedge insole and simple knee 
sleeve) and individual treatment on balance 
  161 
Null hypothesis: There is no significant difference in dynamic balance after 6 weeks when using 
combined treatments (lateral wedge insole and simple knee sleeve) compared to individual 
treatment (lateral wedge insole or simple knee sleeve). 
5- To investigate the effect of combined treatments (lateral wedge insole and simple knee 
sleeve) and individual treatment on pain pressure threshold 
Null hypothesis: There is no significant difference in pressure pain threshold after 6 weeks when 
using combined treatments (lateral wedge insole and simple knee sleeve) compared to individual 
treatment. 
6- To investigate the effect of combined treatments (lateral wedge insole and simple knee 
sleeve) and individual treatment on functional tests (40-metre fast-paced walk test, 30-
second chair-stand test, stair-climb test) 
Null hypothesis: There is no significant difference in functional tests (40-metre fast-paced walk 
test, 30-second chair-stand test, a stair-climb test) after 6 weeks when using combined treatments 
(lateral wedge insole and simple knee sleeve) compared to individual treatment (lateral wedge 
insole or simple knee sleeve). 
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 Methods 
5.5.1 Research environment  
Participants’ data collection was conducted in Hail University gait lab and the Brain Blatchford 
gait lab. For more details about the gait labs please see section 3.2. 
5.5.2 Participants 
Individuals aged 35 to 85 years old who had been diagnosed with medial knee osteoarthritis were 
eligible. For more details about the inclusion and exclusion criteria please see section 3.5.1.2. For 
more details about the recruitment procedure please see section 3.4. 
5.5.3 Sample size and recruitment 
As this was the first study to embark on this challenging design, a convenient sample size was 
recruited.: 
5.5.4 Study design 
This was a randomised study involving parallel groups, which investigated the immediate and 
short-term (6 weeks) effects of three treatments on individuals with knee osteoarthritis while 
walking. Potential participants underwent a screening via telephone or interview to ensure they 
fulfilled the study criteria. Eligible participants were then assigned a treatment group using 
randomisation blocks via the website randomisation.com. The treatments were lateral wedge 
insoles (Figure 5-1), simple knee sleeves (Figure 5-2), and a combined treatment (lateral wedge 
insole and simple knee sleeve).  
5.5.5 Treatment groups  
• Lateral wedge insole group (LWI). 
• Simple knee sleeve group (Sleeve). 
• Combined group (Sleeve + LWI). 
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5.5.6 Treatments 
5.5.7 Lateral wedge insole 
Five-degree, full-length, arch-supported lateral wedge insoles were used in this study (Figure 5-1). 
For more details about the rational for selecting this type of LWI please see section 3.6.1. 
 Application and Duration of use of lateral wedge insole 
The optimal duration of the lateral wedge insole use per day was suggested to be between 5 and 
10 hours, based on an experimental study (Toda et al., 2005). Each participant was instructed to 
insert a pair of lateral wedge insoles into his or her shoes for 5 to 10 hours daily. 
 
Figure 5-1 Salford lateral wedge insole. 
5.5.8 Simple Knee sleeve 
A short knee sleeve with no metal support (Figure 5-2) was used current study and for more 
details regarding the selection criteria used to select the knee sleeve please see section 3.6.3. 
 Knee sleeve application 
The application of the simple knee sleeve was performed by the researcher. The researcher asked 
the participant if the sleeve was not too tight. If the participant replied yes, the test was carried out. 
However, if the participant replied no, the researcher loosened the sleeve until the participant felt 
comfortable, but not too loose. 
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Figure 5-2 Simple knee sleeve used in this study. 
  
 Duration of use 
No previous study has been identified which specifies the duration of use for a simple knee sleeve. 
Therefore, duration of use of the sleeve will be based on valgus knee brace use, at four hours daily 
during activity and work, as this was identified as significantly reducing pain (Barnes, Cawley, & 
Hederman, 2002).  
5.5.9 Participants compliance  
Each participant was asked to keep a note of the daily use of the treatment to make sure about 
compliance.   
5.5.10 Procedure 
Individuals who met the criteria had the study explained to them and they received a participant 
information sheet and a health history questionnaire. If they agreed to participate and were eligible 
for the study, they were given an appointment at the gait laboratory. Upon attending the gait 
laboratory, they had any questions answered and signed the informed consent form. One copy was 
given to the participant and one was kept in the study file. The participants were informed that 
they were free to withdraw at any point of time from the study, without any disadvantage to them. 
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1. First visit (week 0) 
Individuals who were willing to participate were contacted for a first-visit appointment, and the 
KOOS questionnaire was given. Each participant was given a second appointment seven days after 
the first (Figure 5-3). 
2. Second visit (week 1) 
During the second visit, each participant underwent a general assessment, in which height and 
mass were recorded. The KOOS questionnaire and PASE were completed, and each participant 
was asked to change into shorts and a T-shirt. Two baselines of pain measurement were 
incorporated into this study to account for any possibility of pain fluctuation. The first one was 
given in the first appointment (week 0) and the second one was introduced in the second visit 
(week 1) before starting the trial. Results of 40-metre fast-paced walk test, 30-second chair-stand 
test and stair-climb test were obtained after two practical trials, according to the procedure 
mentioned previously according to the method section 3.19.2.3. The star excursion balance was 
measured in anterior and medial directions after four practical trials in each direction according to 
the method in section 3.19.2.3. Pain pressure threshold was measured in the medial condyle and 
the medial malleolus after two practical trials following the method in section 3.19.2.3. Following 
this, the gait analysis and EMG data were collected with and without the prescribed device. Each 
participant received the allocated treatment to be used for 6 weeks.  
3. Third visit (week 6) 
At the third visit, KOOS and PASE questionnaire responses were obtained. Then each step in the 
second visit was conducted again, following the same order and procedure. The gait analysis was 
conducted with the treatment only after 6 weeks. 
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Figure 5-3 Diagram of the study protocol. 
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Questionnaire: 
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a valid and reliable outcome 
measurement in knee OA individuals (Collins, Misra, Felson, Crossley, & Roos, 2011). KOOS 
consists of five subscales, namely pain (9 questions), symptoms (7 questions), activities of daily 
living (17 questions), sport and recreation (5 questions) and quality of life (4 questions). The 
maximum score for each KOOS subscale is 100, indicating no problem, while 0 indicates extreme 
problems. The KOOS score was calculated based on the Excel scoring sheet provided by 
http://www.koos.nu/index.html. 
The Physical Activity Scale for the Elderly (PASE) is a widely used questionnaire in research for 
assessing individuals’ physical activity level (Chmelo et al., 2013). PASE is valid, reliable and 
sensitive for detecting changes in individuals with knee OA (Martin et al., 1999; Washburn & 
Ficker, 1999). PASE combines information from light, moderate and high levels of physical 
activity during household, occupational and leisure activities in the past 7 days. The PASE score 
ranges from 0 to 400, with a higher score indicating higher physical activity. Based on the total 
score, the participant can be classified to have low (31–120 points), moderate (124–242 points) or 
high physical activity (>242 points) (Lin et al., 2013). The score was calculated based on the 
scoring sheet provided by http://www.neriscience.com/. 
5.5.11 Assessment of biomechanical response 
In brief, two gait analysis system were used. A 10 T30/40 camera motion-capture system with four 
Kistler force plates was used at the Salford gait lab, and a 10 Bonita camera motion-capture system 
with two AMTI force plates was used at the Hail gait lab. Data was captured at 100Hz for 
kinematics and 1000Hz for kinetics. The systems were calibrated, and the laboratories were 
prepared for the subject’s arrival (section 3.8). Electrodes were applied to the following muscles: 
LH, MH, LG, MG, LQ, and MQ based on SEINAM guidelines (section 3.10). MVIC was collected 
for quadriceps at a 45-degree angle and for gastrocnemius from standing and hamstrings at a 55-
degree angle (section 3.11). According to the CAST method, markers were attached to ASIS, PSIS, 
GT, IC, lateral femoral condyle, medial femoral condyle, lateral malleolus, medial malleolus, 
Calcaneus, fifth metatarsal head, second metatarsal head, and first metatarsal head in both limbs. 
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Cluster plates were applied to the pelvis, thigh, and shank to track the segment’s movement in both 
limbs. For more details about markers and clusters please see section 3.9. 
The participants were asked to walk on a 12-metre walkway at their own self-selected speed using 
their own shoe. All participants were asked to perform five successful walking trials. A successful 
trial required an occurrence of the contact phase on the force plate at self-selected speed with the 
effected limb. Each participant was asked to bring the same shoe which used at baseline testing to 
the next appointment. 
5.5.12 Outcomes 
 Primary outcomes 
These outcome measures enabled us to test hypotheses 1, 2 and 3 concerning the effect of the 
combined treatment (lateral wedge insole + simple knee sleeve versus single treatments alone) on 
clinical, biomechanical outcomes and muscle co-contraction variables. 
The primary outcome measures that were assessed were:  
• External knee adduction moment (EKAM) 
The change in all aspects of EKAM (first peak, trough, second peak, EAAI) during level walking 
was investigated at baseline (week 1) without and with treatment use and 6 weeks with treatment 
use. 
• Pain 
The changes in knee pain between baseline (before providing the treatment in week1) and week 6 
was investigated using the knee injury and osteoarthritis score (KOOS).  
• Muscle co-contraction 
The changes in muscle co-contraction between MQ/MH, LQ/LH, MQ/MG and LQ/LG were 
investigated at three stages (early-stance 0–33, mid-stance 34–67, and late-stance 68–100) while 
walking at baseline (week 1) without and with treatment use and 6 weeks with treatment use. 
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 Secondary outcomes 
• Dynamic balance 
The modified star excursion balance test was used to investigate the effect of treatment in the 
anterior and medial directions balance. The balance was measured at baseline (week 1) before 
providing the treatment and after 6 weeks. 
• Pressure pain threshold 
The effect of the treatment on the pain pressure threshold was investigated using an algometer 
applied to medial side of the knee and the medial side of medial malleolus at baseline (before 
providing the treatment in week 1) and 6 weeks. 
• Physical function tests  
The effect of the treatment on three functional tests (40-metre fast-paced walk test, 30-second 
chair-stand test, and a stair-climb test) was investigated. The test was introduced at baseline (before 
providing the treatment in week 1) and after 6 weeks of treatment. 
• Physical activity scale for elderly (PASE) and other KOOS subscales (symptoms, ADL, 
Sport, QOL) 
The effect of the treatment on PASE and other KOOS subscales was investigated. The 
questionnaires were introduced at baseline (before providing the treatment in week 1) and after 6 
weeks. 
 Other data 
• GRF, spatio-temporal, kinematic and kinetics of the knee and ankle  
The effect of the treatment on the GRF (the first peak, trough, the second peak), knee joint angles 
in frontal plane (maximum and minimum), spatio-temporal (speed, stance time, swing time), knee 
joint angles in sagittal plane (knee angle at initial contact, maximum  flexion  angle at loading 
response, minimum flexion angle at mid-stance, maximum flexion angle at swing), knee joint 
moments in sagittal plane (extension moment, flexion moment), ankle angles in sagittal and frontal 
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planes (maximum, minimum), ankle moment in frontal and sagittal plane (maximum, minimum), 
centre of foot pressure (early-stance, mid-stance and late-stance) and ROM for the knee and ankle 
in sagittal and frontal plane were measured at baseline (with and without the treatment in week 1) 
and after 6 weeks (with the treatment). All the results are presented in Appendix E. 
5.5.13 Data processing 
After collecting five successful trials, the data was processed by Vicon Nexus Software and Visual 
3D programs and exported to an Excel spreadsheet. Kinetics data was normalised to the gait cycle 
while kinematics, GRF and muscle activity data were normalised to the stance phase. SEBT was 
normalised to each individual leg length measured form anterior superior iliac spine to the medial 
malleolus. For more details about the gait events calculation and data processing please see 
sections 3-14 and 3-15. The magnitude of change was calculated by subtracting each participant’s 
result for the specified outcome after immediate use and/or 6 weeks from baseline data. The 
magnitude of change was calculated in EKAM, KOOS pain, muscle co-contraction, balance, 
functional tests, PASE and KOOS subscales of symptoms, ADL, sport and quality of life. To 
calculate the pain fluctuation, the pain value in week 1 was subtracted from week 0 for each 
participant. The results were squared to eliminate negative value; then the square root was taken, 
and the average was taken as fluctuation in pain. The 6 weeks treatment effect on LQ/LG and 
MQ/MH was not investigated since these outcome measurements showed low ICC in chapter 3 
and only immediate effect were included in the statistical analysis. 
5.5.14 Statistical analysis 
Statistical analysis in the current study was performed using Excel (version 15.29.1) for Mac, and 
SPSS (version 23) for Mac. The means of five trials for each test were used. The normality of the 
data was checked using the method in section 3.16. In the current study, there are two independent 
factors and one dependant factor. The independent factors are first, within the group with either 
three levels as in kinematics, kinetics data (three time points) or two levels as in the questionnaire 
and functional tests (two time points), and second, between the groups with three levels (three 
groups). The dependant factor is the outcome of interest (i.e., EKAM or pain). Therefore, two-way 
mixed ANOVA (ANOVA), comparing mean differences within and between groups (time), was 
performed on each variable. One-way ANOVA was used to determine if the groups were different 
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at baseline, after immediate use of the treatment, and after 6 weeks’ use of the treatment. To 
identify the effect of the treatment within each group, either repeated-measures ANOVA (three 
time points) or paired sample t-test (two time points) was used, based on the time point. The 
magnitude of reduction after immediate use of the treatment and/or 6 weeks use in the intersected 
variable was compared between the groups via one-way ANOVA. 
To apply two-way mixed ANOVA, the data should be approximately normally distributed and 
have equal covariance matrix and equal variance between the groups. If one of the previous 
conditions was not met, several steps were followed to solve the problem. As there is no equivalent 
non-parametric test for two-way mixed ANOVA either to apply transformation (RMS, Log10, Ln, 
Reciprocal) to the data to meet the broken condition or to break down the analysis into “between 
the groups” and “within the groups” without using two-way mixed ANOVA were applied. This 
was conducted with either via using parametric (repeated-measures ANOVA or paired sample t-
test for within the groups and one-way ANOVA for between the groups) or non-parametric (the 
Friedman test and the Wilcoxon test for within the groups and the Kruskal-Wallis test for between 
the groups), based on the normality test. 
Bonferroni adjustment was used on post hoc comparison in the two-way mixed ANOVA, repeated-
measures ANOVA, the Friedman test, and the Kruskal-Wallis test to reduce type 1 errors. If 
Bonferroni adjustment failed, other adjustments (Sidak, LSD) were used. For one-way ANOVA, 
Turkey adjustment was used. 
Most of the data had equal variance and covariance matrices and normally or mildly to moderately 
deviated from normality. The ANOVA model is considered as a robust against moderate deviation 
in normality (Ghasemi & Zahediasl, 2012) and superior to the majority of assumption violations 
(Lix, Keselman, & Keselman, 1996). If the data were severely deviated, had unequal covariance 
or unequal variance, or all of these, this is discussed in detail in the results section. The significance 
in this study was considered to be at alpha level 0.05. 
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 Results 
The following section represents the results of the study, which compares lateral wedge insole, 
sleeve, and combined (lateral wedge insole and sleeve) treatments groups. The results are 
organised so the primary outcomes are explained first, followed by the secondary outcomes. 
5.6.1 Participant 
Thirty-four participants with confirmed painful medial knee OA (31 males and 3 females) were 
recruited for this study. They were assigned randomly into three groups with 11 in the combined 
treatment group, 11 in the sleeve group, and 12 in the LWI group. Demographic details are 
described in Table 5-1. Interestingly, there was no significant difference between the groups in 
age, height, mass, or BMI. 
Table 5-1 Baseline demographic characteristic of the groups. 
Variables Combined group Sleeve group LWI group P-value 
Age (mean years ± 
SD) 54.36 (10.19) 56.27 (11.97) 55.08 (10.37) 
 
0.92 
Height (mean M ± SD) 1.72 (.10) 1.73 (.09) 1.70 (.08) 0.58 
Mass (mean Kg ± SD) 87.05 (14.32) 88.68 (9.78) 85.31 (20.07) 0.87 
BMI (mean  
Kg/m² ± SD) 29.19 (2.87) 29.72 (4.49) 29.52 (6.33) 0.95 
Affected side 
L=left R= Right 
L=5 knees, R=6 
knees 
L=7 knees, R=4 
knees 
L=7 knees, R=5 
knees 
 
Total number (male, 
female) 
11 (10 males,1 
female) 
11 (10 males,1 
female) 
12 (11 males,1 
female) 
 
All participants completed the trials with good compliance with the treatment. Furthermore, there 
was no significant difference between the groups in the daily use of the treatment across 6 weeks 
or the comfort of the treatment (Table 5-2). 
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Table 5-2 Treatments users comfort and adherence to assigned group. 
Variables Combined group Sleeve group LWI group P-value 
Use (hours/day (± SD)) 5.27 (0.65) 5.14 (1.14) 5.96 (1.08) 0.11 
Comfort (out of ten ± SD) 7.7 (1.06) 8.0 (1.01) 8.2 (1.11) 0.56 
 
5.6.2 Comparison between combined treatment group, LWI group and sleeve group at 
baseline (week 1) for the primary outcomes 
At the baseline assessment, EKAM, KAAI, and pain between the sleeve group, the LWI group, 
and the combined group (sleeve and LWI) showed no significant difference (Table 5-3). 
Table 5-3 Mean (SD) of the speed, EKAM, KAAI and pain outcomes at baseline and P-value for the groups. 
Variables 
Mean (± SD) 
P-value 
Combined group Sleeve group LWI group 
Speed (m/s) 1.22 (0.18) 1.15 (0.24) 1.15 (0.24) 0.69 
EKAM (Nm/Kg) 0.59 (0.11) 0.51(0.15) 0.50 (0.12) 0.21 
EKAM (%Bw.Ht) 3.50 (0.65) 3.01 (0.92) 3.03 (0.75) 0.26 
KAAI  
((Nm/kg).s) 0.23 (0.08) 0.20 (0.08) 0.20 (0.10) 0.69 
Pain (KOOS) 52.27 (15.90) 58.84 (16.93) 51.62 (13.99) 0.49 
 
Knee co-contraction: 
There was no significant difference in the muscle co-contraction between the combined group, the 
sleeve group, and the LWI group at baseline in all gait phases and among all measured muscles 
(Table 5-4). 
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Table 5-4 Mean (SD) of muscle co-contraction in early, mid and late stance phases at baseline and P-value. 
Muscle co-
contraction 
Combined 
group 
Sleeve 
group LWI group 
P-value 
Parametric test 
(one-way 
ANOVA) 
P-value Non-
parametric 
test (Kruska-
wallis) 
Early-stance 
LQ vs. LH 0.29 (0.21 0.45 (0.34) 0.40 (0.36) 0.47 0.49 
LQ vs. LG 0.24 (0.18) 0.38 (0.28) 0.35 (0.19) 0.28 0.39 
MQ vs. MH 0.19 (0.13) 0.38 (0.31) 0.26 (0.17) 0.18 0.23 
MQ vs. MG 0.14 (0.16) 0.18 (0.10) 0.26 (0.37) 0.49 0.26 
Mid-stance 
LQ vs. LH 0.13 (0.13) 0.17 (0.11) 0.20 (0.20) 0.57 0.58 
LQ vs. LG 0.18 (0.15) 0.22 (0.15) 0.26 (0.22) 0.60 0.75 
MQ vs. MH 0.07 (0.07) 0.10 (0.03) 0.11 (0.10) 0.47 0.14 
MQ vs. MG 0.12 (0.10) 0.17 (0.14) 0.17 (0.14) 0.66 0.65 
Late-stance 
LQ vs. LH 0.06 (0.06) 0.09 (0.06) 0.06 (0.03) 0.27 0.28 
LQ vs. LG 0.08 (0.06) 0.15 (0.13) 0.11 (0.12) 0.39 0.48 
MQ vs. MH 0.04 (0.03) 0.08 (0.04) 0.08 (0.06) 0.06 0.06 
MQ vs. MG 0.08 (0.06) 0.11 (0.07) 0.13 (0.14) 0.44 0.39 
 
5.6.3 Fluctuation of the pain from week 0 to week 1 
The pain was measured one week before the start of the trial and at the start of the trial to account 
for pain fluctuation. The t-test showed no significant difference between week 0 and week 1 in 
pain. The fluctuation in pain is 2.15 units on the KOOS pain subscale (Table 5-5). 
Table 5-5 Mean (SD) of pain from week 0 to week 1. 
Mean (SD) Week 0 Week 1 Fluctuation T-test p-value 
pain 53.35 (14.49) 54.17 (15.48) 2.29 (3.38) 0.24 
 
5.6.4 Knee moment in frontal plane  
First peak of EKAM: 
Two way-mixed ANOVA 
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When assessing the EKAM, the ANOVA showed that the group has no significant effect on 
EKAM (p=0.28), while the time has significant effect on EKAM (P<0.01) and there was a 
significant interaction between groups and time (p=0.02). The descriptive data is presented in 
Table 5-6. 
Within each group: 
Repeated measures ANOVA showed a significant reduction in EKAM across time for combined 
groups (P<0.01) and LWI groups (P<0.01) but not the sleeve group (p=0.85). Pairwise comparison 
showed significant reduction in EKAM after immediate use of combined treatment (mean 
difference 0.05 (0.03)) by 8.17% and 6 weeks (mean difference 0.07 (0.05)) by 12.30% compared 
to shod only at baseline (P<0.01, P<0.01) respectively. Furthermore, pairwise comparison 
identified the reduction to be with immediate LWI use (mean difference 0.05 (0.03) P<0.01) by 
10.88% and 6 weeks (mean difference 0.06 (0.03) P<0.01 compared to baseline by 14.88% (Figure 
5-4). 
Between the groups: 
One-way ANOVA was conducted to identify if there is any difference in EKAM between the 
groups at baseline, immediate effect and 6 week and revealed no significant difference between 
the groups in all timelines (p=0.21, p=0.26, p=0.28). 
Trough: 
Two way-mixed ANOVA 
ANOVA showed that there is no significant interaction between group and time (p=0.31) and the 
group has no significant effect on trough (p=0.79). The time has shown significant effect on trough 
(P<0.01). The descriptive data is presented in Table 5-6. 
Within each group 
The data from the combined group (p=0.01) and the LWI group (P<0.01) showed significant 
changes in trough across time via using repeated measures, while the data for the sleeve group did 
not (p=0.16). In the combined group, the trough showed significant reduction after 6 weeks 
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compared to the baseline (mean difference 0.05 (0.06) p=0.04) by 16% but not to the immediate 
effect (p=0.06). The LWI group showed significant reduction in trough with LWI use immediately 
((mean difference 0.03 (0.03), p=0.01) by 11.04% and after 6 weeks (mean difference 0.05 (0.06) 
P<0.01) 27.96% compared to shod only at baseline (Figure 5-4). 
Between the groups 
When comparing the groups at baseline, after immediate use of the treatment and after 6 weeks 
with one-way ANOVA no significant difference was identified (p=0.78, 0.70, 0.84). 
2nd peak of EKAM: 
Two way-mixed ANOVA 
The data showed no significant effect for the group on the EKAM with p-value equal to 0.49. 
ANOVA showed that the time had significant effect on EKAM (P<0.01) with no interaction effect 
(p=0.13). The descriptive data is presented in Table 5-6. 
Within each group 
In the combined group, the data showed significant effect for time (p=0.01) and pairwise 
comparison identified the reduction as reaching significant level between baseline and 6 weeks 
only (mean difference 0.06 (0.06), p=0.03) by 11.65% and not between baseline and immediate 
effect (p=0.07). The sleeve group showed no significant effect on the EKAM with p-value equal 
to 0.54. The data of the LWI group showed significant effect of time on EKAM (p=0.01) and the 
pairwise comparison showed significant reduction in EKAM with LWI immediate use (mean 
difference 0.03 (0.03), p=0.01) by 8.87% compared to baseline and after 6 weeks compared to 
baseline (mean difference 0.05 (0.06), p=0.04) by 15.70% (Figure 5-4).  
Between the groups 
There was no significant difference in EKAM between the groups at baseline (p=0.32), immediate 
(p=0.49) and 6 weeks’ treatment (p=0.66). 
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Table 5-6 Mean (SD) of EKAM (1st peak, trough, 2nd peak) for combined, sleeve and LWI groups. 
Mean 
(SD). 
Nm/kg 
 
Week one Week 6 
Combined group Sleeve group LWI group Combined group 
Sleeve 
group 
LWI 
group 
Shod 
Shod + 
combined 
treatment 
Shod 
Shod + 
sleeve 
treatment 
Shod shod + LWI 
Shod + 
combined 
treatment 
Shod + 
sleeve 
shod + 
LWI 
1st Peak 0.59 (0.11) 
0.54 
(0.12) Q 
0.51 
(0.15) 
0.51 
(0.17) 
0.50 
(0.12)  
0.45 
(0.12) Q 
0.52 
(0.09) Q 
0.50 
(0.17) 
0.43 
(0.12) Q 
Trough 0.33 (0.13) 
0.31 
(0.12) 
0.29 
(0.14) 
0.28 
(0.16) 
0.29 
(0.16) 
0.25 
(0.16) Q 
0.28 
(0.13) Q 
0.27 
(0.16) 
0.24 
(0.17) Q 
2nd Peak 0.43 (0.16) 
0.41 
(0.15) 
0.34 
(0.12) 
0.34 
(0.14) 
0.38 
(0.15) 
0.35 
(0.15) Q 
0.37 
(0.14) Q 
0.33 
(0.15) 
0.32 
(0.15) Q 
Q significant compared to baseline 
 
  
Figure 5-4 Mean (SD) of knee joint moment in frontal plane for combined (a), sleeve (b) and LWI (c) groups. 
 
Knee adduction angular impulse (KAAI): 
Two way-mixed ANOVA 
To assess the knee loading across the gait cycle, knee adduction angular impulse (KAAI) was used. 
The data for KAAI showed no significant effect for the group (p=0.75). The ANOVA showed no 
significant interaction between groups and time (p=0.10), while the time was found to have 
significant effect on KAAI (P<0.01). The descriptive data is presented in Table 5-7. 
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Repeated-measures ANOVA showed significant changes across time in KAAI for the combined 
group (P<0.01) and the LWI group (P<0.01), but not for the sleeve group (p=0.65). Pairwise 
comparison showed significant reduction in KAAI after 6 weeks of combined treatment compared 
to shod only at baseline (mean difference 0.03 (0.02), P<0.01) by 12.20%, but not for the 
immediate use compared to shod only at baseline (p=0.13). In the LWI group, the reduction was 
identified between immediate use compared to shod at baseline (mean difference 0.02 (0.01), 
P<0.01) by 9.31% and at 6 weeks compared to shod at baseline (mean difference 0.03 (0.03), 
p=0.01) by 15.56% (Figure 5-5). 
Between the groups  
One-way ANOVA showed no significant difference in EKAM between the groups at baseline 
(p=0.69), immediate effect (p=0.71), and after 6 weeks (p=0.77). 
Table 5-7 Mean (SD) of KAAI for combined, sleeve and LWI groups. 
Mean 
(SD). 
Nm/kg*s 
Week one Week 6 
Combined group Sleeve group LWI group Combined group 
Sleeve 
group 
WLI 
group 
Shod 
Shod + 
combined 
treatment 
Shod 
Shod + 
sleeve 
treatment 
shod 
shod + 
LWI 
treatment 
Shod + 
combined 
treatment 
Shod + 
sleeve 
treatment 
shod + 
LWI 
treatment 
KAAI  0.23 (0.08) 
0.22 
(0.08) 
0.20 
(0.08) 
0.20 
(0.08) 
0.20 
(0.10) 
0.19 
(0.10) Q 
0.20 
(0.07) Q 
0.19 
(0.09) 
0.18 
(0.09) Q 
Q significant compared to baseline 
 
 
Figure 5-5 Mean (SD) of KAAI for combined (a), sleeve (b) and LWI (c) groups. 
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The magnitude of change in EKAM and KAAI: 
One-way ANOVA was used to assess if the magnitude of change in EKAM (first peak, trough, 
second peak) and KAAI across two timelines (immediate and 6 weeks) was significantly different 
between the groups. The descriptive data is presented in Table 5-8. 
First peak EKAM 
A Significant change was identified in the first peak EKAM between the groups with immediate 
use of the treatments (P<0.01). Pairwise comparison showed significantly higher reduction in first 
peak EKAM for the combined group (P<0.01) and the LWI group (P<0.01) compared to sleeve 
group. The magnitude of change in first peak EKAM after 6 weeks was significantly different 
between the groups (p=0.01), and pairwise comparison showed higher reduction in first peak 
EKAM for the combined group (p=0.02) and the LWI group (p=0.03) compared to the sleeve 
group. 
Trough 
The magnitude of change in trough was not statistically significant between the groups after 
immediate use of treatment (p=0.14) or 6 weeks’ use (p=0.31) (Table 5-8). 
Second peak EKAM 
The magnitude of change in second peak EKAM after immediate use of treatment was significant 
between the groups (p=0.04). Pairwise comparison showed higher reduction in the LWI group 
(p=0.04) than the sleeve group, but not in the combined group compared to the sleeve group 
(p=0.13). In contrast, the magnitude of reduction in second peak EKAM after 6 weeks’ treatment 
was not significant between the groups (p=0.10) (Table 5-8). 
KAAI 
The immediate magnitude of change in KAAI was significant between the groups (p=0.03). 
Pairwise comparison showed higher reduction in the LWI group (p=0.03) than the sleeve group, 
but not in the combined group compared to the LWI group (p=0.21). In contrast, the 6 weeks’ 
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magnitude of reduction in KAAI was not statistically significant between the groups (p=0.08) 
(Table 5-8).  
Table 5-8 Mean (SD) of magnitude of change in EKAM (1st peak, trough, 2nd peak) and KAAI for combined, sleeve 
and LWI groups. 
Variable 
Mean (SD). 
Immediate magnitude of change 6 weeks’ magnitude of change 
Combined 
group 
Sleeve 
group LWI group 
Combined 
group 
Sleeve 
group LWI group 
1st Peak EKAM 
(Nm/kg) 
-0.05 (0.03) 
W -0.00 (0.03) 
-0.05 (0.03)  
W 
-0.07 (0.05) 
 W -0.01 (0.06) 
-0.07 (0.06) 
W 
Trough (Nm/kg) -0.02 (0.03) -0.01 (0.03) 0.03 (0.03)  0.05 (0.06) -0.02 (0.05) -0.05 (0.04) 
2nd peak EKAM 
(Nm/kg) -0.02 (0.03) -0.00 (0.03) 
-0.03 (0.03) 
W -0.06 (0.06) -0.01 (0.04) -0.05 (0.06) 
KAAI (Nm/kg*s) -0.01 (0.02) -0.00 (0.01) -0.02 (0.01) W -0.03 (0.02) -0.01 (0.03) 0.03 (0.03) 
W significant compared to sleeve 
5.6.5 Knee pain (KOOS) 
Two way-mixed ANOVA 
The results showed that the group (p=0.69) had no significant effect on the knee pain, and there 
was no significant interaction between the group and time (p=0.08). ANOVA showed significant 
effect for the time (P<0.01) on the knee pain. The descriptive data is presented in Table 5-9.  
Within each group 
The t-test showed significant reductions in knee pain after 6 weeks of treatment in the combined 
group (P<0.01), the sleeve group (P<0.01), and the LWI group (p=0.01) compared to the baseline. 
Between the groups 
A one-way ANOVA showed no significant difference in the knee pain between the groups at 
baseline (p=0.49) or 6 weeks (p=0.59).  
The magnitude of change in pain 
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When the magnitude of change in the knee pain was compared between the groups via one-way 
ANOVA, the result revealed no significant difference (p=0.08).  
Extra-analysis 
Further analysis was conducted to compare the magnitude of change between each two groups 
separately. The results showed that the combined group showed significantly higher magnitude of 
reduction in knee pain than the sleeve group (P=0.01), while the LWI group did not (P=0.31). 
Table 5-9 Mean (SD) of KOOS pain score for combined, sleeve and LWI groups. 
Mean 
(SD) 
Combined group 
 
Sleeve group 
 
LWI group 
 
Magnitude of change between 
baseline and week 6 
 
Baseline Weeks 6 Baseline Weeks 6 Baseline Weeks 6 
Combined 
group 
 
Sleeve 
group 
 
LWI 
group 
 
KOOS 
knee 
pain 
52.27 
(15.90) 
68.94 
(17.43) 
Q 
58.84 
(16.93) 
65.40 
(15.03) 
Q 
51.62 
(13.99) 
62.50 
(11.81) 
Q 
16.67 
(11.04) 
6.57 
(5.01) 
10.88 
(12.78) 
Q significant compared to baseline 
5.6.6 Muscle co-contraction 
Early-stance 
LQ/LH: 
Two way-mixed ANOVA 
The ANOVA showed that there was no significant interaction between the group and the time 
(p=0.19). There was no significant effect for the group (p=0.29) and time (p=0.36) on the early-
stance LQ/LH co-contraction. The descriptive data is presented in Table 5-10.  
Within each group 
No change in the early-stance LQ/LH co-contraction across time was identified as an effect of the 
treatment in combined group (p=0.13), sleeve group (p=0.37) and LWI group (p=0.30) when 
conducting repeated measures ANOVA. 
Between the groups 
  182 
No significant difference was identified in the early-stance LQ/LH co-contraction via one-way 
ANOVA between groups at baseline (p=0.47), immediate effect (p=0.42) and 6 weeks (p=0.09).  
LQ/LG:  
The data showed mild to moderate deviation in normality and inequality of covariance. The 
transformation (RMS) were successful in reducing the deviation or even produce normality 
(Log10, Ln) and correct for inequality of covariance (RMS, Log10, Ln). However, all tests results 
(transformed data, non-transformed data) agreed therefore non-transformed data were used due to 
the ease of interpretation. 
Two way-mixed ANOVA 
There was no significant effect for the group (p=0.36) and time (p=0.36) on the early-stance 
LQ/LG co-contraction. No interaction between the group and the time was identified (p=0.14). 
The descriptive data is presented in Table 5-10. 
Within each group 
Paired sample t-test showed no significant change in the LQ/LG after immediate use of the 
treatment in combined group (p=0.42), sleeve group (p=0.15) and LWI group (p=0.98). 
Between the groups  
One-way ANOVA showed no significant difference in the early-stance LQ/LG co-contraction 
between groups at baseline (p=0.28) and immediate effect (p=0.50).  
MQ/MH 
The data showed mild deviation in normality in the sleeve group and inequality of variance and 
covariance. The transformation (RMS, log10) were successful produce normality and correcting 
the inequality of variance and covariance. Although equality of variance and covariance were 
achieved via data transformation, using the transformed data was not preferred due to the 
disagreement between the tests. When comparing the treatment effect within the combined and the 
sleeve groups parametric and non-parametric tests showed significant reduction in co-contraction 
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with immediate use. However, when this applied to the transformed data this effect of the treatment 
seems to be disappear. The combined group is normally distributed and since parametric and non-
parametric tests agreed the parametric tests were used due to the ease of interpretation and the 
transformation was not used. 
Within each group 
Paired sample t-test showed significant reduction in the early-stance MQ/MH co-contraction after 
immediate use of the combined group (p=0.04) and the sleeve group (p=0.03) compared to the 
baseline. However, the LWI group did not show any significant change (p=0.24). The descriptive 
data is presented in Table 5-10.  
Between the groups 
One-way ANOVA showed no significant difference in the early-stance MQ/MH co-contraction 
between the groups in the baseline (p=0.18) and immediate effect (p=0.13). 
MQ/MG. 
The data showed moderate to severe deviation in normality and inequality of covariance. The 
transformation (RMS, log10, Ln) were successful in reducing the deviation in normality as in 
(RMS) or even produce normality (Log10, Ln) and correcting the inequality of covariance (RMS, 
log10, Ln). The results of two way-mixed ANOVA, one-way ANOVA and repeated measures 
ANOVA for the transformed data were similar when all test applied on the non-transformed data 
or even the non-parametric test. Therefore, using parametric on the non-transformed data was 
preferred since all tests produced the same results and for the ease of interpretation.  
Two way-mixed ANOVA 
There was no significant effect for the group (p=0.54) and time (p=0.60) on the early-stance 
LQ/LG co-contraction. Neither there was interaction between the time and the group (p=0.39). 
The descriptive data is presented in Table 5-10.  
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Within each group 
Repeated measures ANOVA showed no significant change in the early-stance LQ/LG co-
contraction after using the treatment in the combined group (p=0.94), the sleeve group (p=0.33) 
and the LWI group (p=0.36).  
Between the groups 
One-way ANOVA showed no significant difference in the early-stance LQ/LG co-contraction 
between the groups at baseline (p=0.49) immediate effect (p=0.51) and 6 weeks (p=0.57). 
Table 5-10 Mean (SD) of muscles co-contraction in early stance phase for combined, sleeve and LWI groups. 
Q significant compared to baseline 
 
Mid-stance: 
LQ/LH 
The data showed moderate to high deviation in normality and inequality of variance. The 
transformation (RMS, log10, Ln, reciprocal) failed to correct the significant difference in variance. 
Therefore, two way-mixed ANOVA couldn’t be used, and comparing between and within the 
groups via non-parametric test was the solution since the data showed moderate to severe deviation 
in normality. 
Early-
stance 
Mean 
(SD) 
Week one Week 6 
Combined group Sleeve group LWI group Shod + 
combined 
treatment 
Shod + 
sleeve 
treatment 
shod + 
LWI 
treatment Shod 
Shod + 
combined 
treatment 
Shod 
Shod + 
sleeve 
treatment 
Shod 
shod + 
LWI 
treatment 
LQ  
vs.  
LH 
0.29 
(0.21) 
0.27 
(0.22) 
0.45 
(0.34) 
0.44 
(0.31) 
0.40 
(0.36) 
0.40 
(0.33) 
0.21 
(0.18) 
0.37 
(0.27) 
0.46 
(0.30) 
LQ  
vs. 
LG 
0.24 
(0.18) 
0.25 
(0.21) 
0.38 
(0.28) 
0.34 
(0.21) 
0.35 
(0.19) 
0.35 
(0.19) 
   
MQ 
vs. 
MH 
0.19 
(0.13) 
0.16 
(0.10) 
Q 
0.38 
(0.31) 
0.32 
(0.27) 
Q 
0.26 
(0.17) 
0.24 
(0.18) 
   
MQ 
vs. 
MG 
0.14 
(0.16) 
0.14 
(0.18) 
0.18 
(0.10) 
0.16 
(0.09) 
0.26 
(0.37) 
0.24 
(0.29) 
0.14 
(0.10) 
0.20 
(0.13) 
0.18 
(0.13) 
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Within each group 
The Friedman test showed no significant changes within the combined group (p=0.18) or the sleeve 
group (p = 0.10). However, the LWI group showed significant changes in the mid-stance LQ/LH 
co-contraction (p=0.05). Pairwise comparison adjusted to Bonferroni showed significant increase 
in the mid-stance LQ/LH co-contraction after 6 weeks’ LWI use compared to immediate use 
(p=0.04). The descriptive data is presented in Table 5-12. 
Between the groups 
The Kruskal-Wallis test showed no significant difference between the groups at baseline (p=0.58), 
immediate effect (p = 0.65), or 6 weeks (p=0.23) in the mid-stance LQ/LH co-contraction.  
LQ/LG 
The data showed mild to moderate deviation in normality in the combined group and the LWI 
group and inequality of covariance. The transformation (RMS, log10, Ln, reciprocal) failed to 
correct the significant difference in covariance. Therefore, two way-mixed ANOVA couldn’t be 
used, and the comparing between and within the groups using either parametric or non-parametric 
testing was the solution. Both methods were applied and revealed different results when comparing 
the effect of the treatment within the sleeve group. The parametric test showed significant changes 
after sleeve use while the non-parametric test did not show any changes. Since the sleeve group 
was normally distributed and was the only group showing changes when using parametric tests, 
the parametric test appeared to be more appropriate. 
Within each group 
Repeated-measures ANOVA showed no significate difference for the time within the combined 
group (p=0.28) or the LWI group (p=0.24). However, the sleeve group showed significant 
difference for time (p=0.02). Bonferroni and Sidak adjustments failed to show any significant 
difference within time for the sleeve group while LSD showed significant reduction in co-
contraction in the sleeve group after 6 weeks compared to baseline (p=0.03). The descriptive data 
is presented in Table 5-11.  
Between the groups 
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One-way ANOVA showed no significant difference between the groups at baseline (p=0.60), 
immediate use of the treatment (p=0.51), or after 6 weeks (p=0.12). 
MQ/MH  
The data showed moderate to severe deviation in normality and inequality of variance. All 
transformation failed to produce equality of variance; non-parametric tests were used because of 
the severity of deviation from normality. The Friedman test was used to test the effect of the 
treatment within each group separately, and the Kruskal-Wallis test was used to test the difference 
between the groups. 
Within each group 
The Friedman test showed no significant changes in the mid-stance MQ/MH co-contraction after 
using the treatment in the combined group (p=0.91), the sleeve group (p=0.31), or the LWI group 
(p=0.10). The descriptive data is presented in Table 5-12.  
Between the groups 
The Kruskal-Wallis test showed no significant difference in the mid-stance MQ/MH co-
contraction between the groups at baseline (p=0.14), immediate effect (p=0.30), or 6 weeks 
(p=0.48) in the mid-stance MQ/MH co-contraction. 
MQ/MG  
The data showed mild to moderate deviation in normality and inequality of covariance. Although 
log10 and Ln transformations were successful in correcting the requirement for two way-mixed 
ANOVA (normality, covariance), non-parametric tests were used. This is because of the 
disagreement between the non-parametric tests and the transformed data when comparing the 
effect of the treatment within the groups. The transformed data showed significant change within 
the combined group while non-parametric test in the non-transformed data did not show any 
change. Therefore, comparing within and between the groups via using non-parametric tests 
seemed more appropriate. 
Within each group 
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The Friedman test showed no significant difference in the mid-stance MQ/MG co-contraction after 
using the treatment for the combined group (p=0.70), the sleeve group (p=0.15), or the LWI group 
(p=0.92). The descriptive data is presented in Table 5-12.  
Between the groups 
The Kruskal-Wallis test showed no significant difference in the mid-stance MQ/MG co-
contraction between the groups at baseline (p=0.65), immediate effect (p=0.85), or 6 weeks 
(p=0.93). 
Table 5-11 Mean (SD) of muscles co-contraction in mid-stance phase for combined, sleeve and LWI groups. 
Q significant compared to baseline 
 
Table 5-12 Median (Range) of muscles co-contraction in mid-stance phase for combined, sleeve and LWI groups. 
Mid-
stance 
Median 
 
Combined group Sleeve group LWI group Shod + 
combined 
treatment 
Shod + 
sleeve 
treatment 
shod + 
LWI 
treatment Shod 
 
Shod + 
combined 
treatment 
Shod 
 
Shod + 
sleeve 
treatment 
Shod 
 
shod + 
LWI 
treatment 
LQ  
vs.  
LH 
0.07 0.07 0.18 0.11 0.13 0.09 0.05 0.08 
0.21 
µ 
max 0.45 0.43 0.37 0.31 0.65 0.65 0.32 0.29 0.98 
min 0.02 0.01 0.04 0.04 0.02 0.02 0.02 0.02 0.03 
MQ  
vs.  
MH 
0.05 0.04 0.09 0.08 0.08 0.07 0.04 0.07 0.06 
max 0.26 0.27 0.16 0.14 0.38 0.26 0.29 0.23 0.32 
min 0.01 0.01 0.05 0.04 0.02 0.01 0.01 0.02 0.02 
MQ  
vs.  
MG 
0.11 0.13 0.11 0.14 0.14 0.12 0.10 0.12 0.15 
max 0.39 0.28 0.45 0.39 0.50 0.47 0.79 0.36 0.50 
min 0.03 0.03 0.03 0.03 0.01 0.01 0.02 0.01 0.01 
µ significant compared to immediate use  
Mid-
stance 
Mean 
(SD) 
Week one Week 6 
Combined group Sleeve group LWI group Shod + 
combined 
treatment 
Shod + 
sleeve 
treatment 
shod + 
LWI 
treatment 
Shod 
 
Shod + 
combined 
treatment 
Shod 
 
Shod + 
sleeve 
treatment 
Shod 
 
shod + 
LWI 
treatment 
LQ  
vs.  
LG 
0.18 
(0.15) 
0.18 
(0.15) 
0.22 
(0.15) 
0.20 
(0.14) 
0.26 
(0.22) 
0.26 
(0.22) 
0.14 
(0.14) 
0.12 
(0.07)  
Q 
0.30 
(0.26) 
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Late-stance: 
LQ/LH 
Two way-mixed ANOVA 
The group (p=0.53) and time (p=0.18) had no significant effect on the late-stance LQ/LH co-
contraction. ANOVA showed no significant interaction between the group and time (p=0.05). The 
descriptive data is presented in Table 5-13. 
Within each group 
Repeated-measures ANOVA showed no significant changes after using combined treatment 
(p=0.69), sleeve treatment (p=0.10), or LWI treatment (p=0.07) in the late-stance LQ/LH co-
contraction.  
Between the groups 
One-way ANOVA showed no significant difference in the late-stance LQ/LH co-contraction 
between the groups at baseline (p=0.27), immediate effect (p=0.73), and 6 weeks (p=0.40). 
LQ/LG: 
The data showed moderate to severe deviation in normality and inequality of covariance. The 
transformation (RMS, reciprocal) were successful to reduce the deviation in normality or even 
show normally distributed data (log10, Ln). Furthermore, the transformations were successful to 
show equality of covariance (RMS, log10, Ln). However, the results of non-parametric test within 
the sleeve group contradict the parametric test on the transformed data. The sleeve group showed 
sever deviation in normality. Therefore, the using the non-parametric test seemed to be more 
appropriate.   
Within each group 
No significant changes were identified after using the combined treatment (p=0.76), sleeve 
treatment (p=0.06) or LWI treatment (p=0.31) in the late-stance LQ/LG co-contraction. The 
descriptive data is presented in Table 5-14.  
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Between the groups 
When comparing the groups in late-stance LQ/LG co-contraction at baseline, after immediate use 
of the treatment, and after 6 weeks’ use of the treatment, no significant difference was identified 
with the Kruskal-Wallis test (p=0.48, 0.20, and 0.28, respectively). 
MQ/MH: 
The data showed moderate to severe deviation in normality and inequality of covariance and 
variance. Although log10 and Ln transformations were successful in correcting the requirement 
for two way-mixed ANOVA (normality, covariance, variance), non-parametric tests were used. 
This is because of the disagreement between the non-parametric tests and the parametric test on 
the transformed data when comparing the effect of the treatment within sleeve group. The non-
parametric test showed significant change were the transformed data were nearly to be significant. 
Therefore, comparing within and between the groups via using non-parametric tests seemed more 
appropriate. 
Within each group 
Friedman test showed no significant effect in the late-stance MQ/MH co-contraction on the 
combined group (p=0.53) or the LWI group (p=0.37). In contrast, the sleeve group showed 
significant time effect in the late-stance MQ/MH co-contraction (p=0.02). Adjusted pairwise 
comparison showed significant reduction after 6 weeks of sleeve use compared to baseline 
(p=0.02). The descriptive data is presented in Table 5-14.  
Between the groups 
The Kruskal-Wallis test showed no significant difference in the late-stance MQ/MH co-contraction 
between the groups at baseline (p=0.06), immediate effect (p=0.09), and 6 weeks (p=0.47). 
MQ/MG  
The data showed severe deviation in normality and inequality of variance and covariance. The 
transformation (RMS, log10, Ln, reciprocal) failed to correct the significant difference in 
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covariance and variance, and because of the severe deviation in the natural data, the non-parametric 
tests were the most appropriate test to be chosen. 
Within each group 
The Friedman test showed no significant difference after treatment in the combined group (p=0.06) 
or the LWI group (p=0.56) in the late-stance MQ/MG co-contraction. However, the sleeve group 
showed significant changes in the late-stance MQ/MG co-contraction (p=0.04). Pairwise 
comparison adjusted to Bonferroni failed to show any significant difference while the non-adjusted 
test showed significant reduction after 6 weeks of sleeve use compared to baseline (p=0.03) and 
immediate effect (p=0.02) in the late-stance MQ/MG co-contraction. The descriptive data is 
presented in Table 5-14.  
Between the groups 
The Kruskal-Wallis test showed no significant difference between the groups at baseline (p=0.39), 
immediate effect (p=0.25), and 6 weeks (p=0.66) in late-stance MQ/MG co-contraction. 
Table 5-13 Mean (SD) of muscles co-contraction in late-stance phase for combined, sleeve and LWI groups. 
 
 
 
 
 
 
 
 
 
 
 
Late-
stance 
Mean 
(SD) 
Week one Week 6 
Combined group Sleeve group LWI group Shod + 
combined 
treatment 
Shod + 
sleeve 
treatment 
shod + 
LWI 
treatment Shod 
Shod + 
combined 
treatment 
Shod 
Shod + 
sleeve 
treatment 
Shod 
shod + 
LWI 
treatment 
LQ  
vs.  
LH 
0.06 
(0.06) 
0.05  
(0.04) 
0.09 
(0.06) 
0.07 
 (0.04) 
0.06 
(0.03) 
0.06 
 (0.04) 
0.05 
 (0.04) 
0.07  
(0.06) 
0.08  
(0.06) 
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Table 5-14 Median (Range) of muscles co-contraction in late-stance phase for combined, sleeve and LWI groups. 
Mid-
stance 
Median 
 
Combined group Sleeve group LWI group Shod + 
combined 
treatment 
Shod + 
sleeve 
treatment 
shod + 
LWI 
treatment Shod  
Shod + 
combined 
treatment 
Shod 
 
Shod + 
sleeve 
treatment 
Shod 
 
shod + 
LWI 
treatment 
LQ  
vs.  
LG 
0.06 0.05 0.09 0.07 0.06 0.06 0.05 0.06 0.06 
max 0.18 0.27 0.41 0.94 0.44 0.35 0.16 0.20 0.18 
min 0.02 0.01 0.04 0.04 0.02 0.02 0.01 0.02 0.02 
MQ  
vs.  
MH 
0.04 0.03 0.06 0.05 0.05 0.04 0.04 
0.04 
Q 0.04 
max 0.09 0.09 0.14 0.10 0.16 0.13 0.09 0.19 0.09 
min 0.01 0.01 0.04 0.02 0.01 0.01 0.01 0.01 0.01 
MQ  
vs.  
MG 
0.06 0.05 0.09 0.14 0.06 0.07 0.03 
0.06 
Q µ 0.06 
max 0.20 0.25 0.23 0.32 0.45 0.46 0.26 0.21 0.20 
min 0.02 0.02 0.03 0.04 0.01 0.01 0.01 0.01 0.02 
Q significant compared to baseline 
µ significant compared to immediate use 
The magnitude of change in the muscles co-contraction 
Early-stance  
The immediate and 6 weeks’ magnitude of change in early-stance muscle co-contraction did not 
reach statistical significance level between the groups (p≥0.05). The descriptive data is presented 
in Table 5-15. 
Mid-stance 
The immediate magnitude of change in mid-stance LQ/LH, LQ/LG, MQ/MH and MQ/MG co-
contraction also did not show any significant difference (p≥0.05) while at 6 weeks, there was a 
significant difference in LQ/LH and LQ/LG between the groups (p<0.05). Pairwise comparison 
showed significantly greater reduction in LQ/LH for the sleeve group (p=0.03) and the combined 
group (p=0.04) than for the LWI group. For the LQ/LG muscle co-contraction, only the sleeve 
group showed significantly greater reduction than the LWI group (p=0.04). The descriptive data 
is presented in Table 5-15..  
Late-stance 
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In the late-stance, the magnitude of change showed significant difference between the group after 
6 weeks use of treatment in the LQ/LH and LQ/LG (p<0.05). Pairwise comparison showed 
significant greater reduction in late-stance LQ/LH and LQ/LG for sleeve group compared to LWI 
group (p=0.049, p=0.04). The descriptive data is presented in Table 5-15. 
Table 5-15 Mean (SD) of the magnitude of changes for muscles co-contraction in early, mid and late stance phases 
for combined, sleeve and LWI groups. 
 
Phase 
 
Muscles 
Immediate magnitude of change 6 weeks magnitude of change 
Combined 
group 
Sleeve 
 group 
LWI 
 group 
Combined 
group 
Sleeve 
group LWI group 
 
Early-
stance 
 
 
LQ/LH -0.02 (0.09) -0.02 (0.14) -0.01 (0.07) -0.08 (0.15) -0.09 (0.24) 0.05 (0.17) 
LQ/LG 0.01 (0.05) -0.05 (0.10) -0.00 (0.05) -0.02 (0.15) -0.05 (0.16) -0.02 (0.15) 
MQ/MH -0.04 (0.05) -0.06 (0.08) -0.02 (0.06) -0.02 (0.14) -0.09 (0.21) -0.04 (0.08) 
MQ/MG -0.00 (0.03) -0.02 (0.04) -0.02 (0.08) -0.00 (0.11) 0.02 (0.10) -0.08 (0.28) 
 
Mid- 
stance 
 
 
LQ/LH -0.02 (0.04) -0.04 (0.06) -0.03 (0.08) -0.04 (0.09 l 
-0.05 (0.07) 
l 0.08 (0.16) 
LQ/LG -0.00 (0.04) -0.02 (0.07) -0.00 (0.06) -0.05 (0.14) -0.10 (0.13) l 0.04 (0.12) 
MQ/MH -0.00 (0.01) -0.01 (0.02) -0.01 (0.04) -0.00 (0.04) -0.02 (0.06) -0.02 (0.03) 
MQ/MG -0.00 (0.04) -0.03 (0.07) -0.01 (0.03) 0.06 (0.22) -0.04 (0.09) -0.00 (0.06) 
 
Late- 
stance 
 
 
LQ/LH -0.01 (0.02) -0.02 (0.03) -0.00 (0.02) 0.06 (0.22) 
-0.04 (0.09) 
l -0.00 (0.06) 
LQ/LG -0.01 (0.04) 0.04 (0.19) -0.00 (0.03) -0.01 (0.04) 
-0.06 (0.08) 
l 0.02 (0.09) 
MQ/MH -0.00 (0.01) -0.01 (0.02) -0.01 (0.01) -0.00 (0.03) -0.02 (0.04) -0.01 (0.03) 
MQ/MG -0.00 (0.03) 0.03 (0.08) 0.01 (0.03) -0.01 (0.05) -0.03 (0.07) 0.02 (0.13) 
l significant compared to LWI  
5.6.7 Dynamic balance test results 
Anterior direction balance (normalised to leg length) 
Two way-mixed ANOVA 
The group had no significant effect on the normalised anterior direction balance test (p=0.15), and 
there was no interaction effect (p=0.82). The time showed significant effect on the normalised 
anterior direction balance (p<0.01). The descriptive data is presented in Table 5-16. 
Within each group 
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The t-test showed significant improvement in the normalised anterior direction balance test for the 
combined group (p=0.02) and the LWI group (p=0.02), but not for the sleeve group (p=0.11). 
Between the groups 
There was no significant difference between the groups at baseline (p=0.37) or after 6 weeks of 
treatment (p=0.06) in the normalised anterior direction balance test.  
Magnitude of change between the groups 
The magnitude of change in the normalised anterior direction balance test after 6 weeks of 
treatment was not significant between the groups (p=0.82) 
Medial direction balance (normalised to leg length) 
Two way-mixed ANOVA 
ANOVA showed no significant interaction between the group and time (p=0.77) and no group 
effect (p=0.61) on the normalised medial direction balance. However, the time showed significant 
effect (p<0.01). The descriptive data is presented in Table 5-16. 
Within each group 
After 6 weeks of treatment, the combined group showed significant improvement in the normalised 
medial direction balance test compared to baseline (p=0.02), but the sleeve group (p=0.11) and the 
LWI group (p=0.10) did not. 
Between the groups 
The data showed that there was no significant difference in the normalised medial direction balance 
test between the groups at baseline (p=0.56) or after 6 weeks (p=0.75).  
Magnitude of change between the groups 
The magnitude of change in the normalised medial direction balance test after 6 weeks of treatment 
was not significantly different between the groups (p=0.77). 
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Table 5-16 Mean (SD) of dynamic balance tests for combined, sleeve and LWI groups. 
Mean 
(SD) 
Combined group Sleeve group LWI group Magnitude of change between baseline and week 6 
Baseline Weeks 6 Baseline Weeks 6 Baseline Weeks 6 Combined group 
Sleeve 
group 
LWI 
group 
Anterior 
(% to leg 
length) 
71.50 
(13.82) 
79.21 
(6.43) 
Q 
64.28 
(9.82) 
70.68 
(5.63) 
70.03 
(12.22) 
75.36 
(10.05) 
Q 
7.71 
(8.83) 
6.40 
(11.26) 
5.32 
(6.55) 
Medial 
(% to leg 
length) 
73.14 
(11.52) 
79.84 
(9.20) 
 Q 
69.87 
(8.32) 
76.59 
(9.18) 
74.88 
(11.96) 
79.14 
(11.91) 
6.70 
(7.90) 
6.72 
(12.06) 
4.26 
(8.20) 
Q significant compared to baseline  
5.6.8 Pain pressure threshold results 
Two way-mixed ANOVA 
The interaction effect between the group and intervention time was not significant for the pain 
pressure threshold in the medial condyle pressure threshold or the medial malleolus pressure 
threshold (p≥0.05). Neither the group nor the time had any significant effect on the medial condyle 
pressure threshold or the medial malleolus pressure threshold (p≥0.05). The descriptive data is 
presented in Table 5-17. 
Within each group 
After 6 weeks of treatment, no significant changes were identified in the medial condyle pain 
pressure threshold or the medial malleolus pain pressure threshold in the combined group, the 
sleeve group, or the LWI group (p≥0.05). 
Between the groups 
Comparing the groups at baseline and after 6 weeks of treatment revealed no significant difference 
between the groups in the medial condyle pain pressure threshold or the medial malleolus pain 
pressure threshold (p≥0.05). 
Magnitude of change between the groups 
The magnitude of change in the pain pressure threshold in the medial condyle and medial malleolus 
between the groups did not reach significant levels (p≥0.05). 
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Table 5-17 Mean (SD) of pain pressure threshold tests for combined, sleeve and LWI groups. 
Mean 
(SD) 
Combined group Sleeve group LWI group Magnitude of change between baseline and week 6 
Baseline Weeks 6 Baseline Weeks 6 Baseline Weeks 6 
Combined 
group 
 
Sleeve 
group 
 
LWI 
group 
 
Medial 
condyle 
(N/Cm²) 
7.23 
(1.87) 
6.78 
(.74) 
6.04 
(1.38) 
6.27 
(1.33) 
6.19 
(1.79) 
6.34 
(1.78) 
-0.45 
(1.59) 
0.23 
(1.26) 
0.15 
(1.19) 
Medial 
malleolus 
(N/Cm²) 
7.77 
(0.85) 
7.99 
(1.75) 
6.71 
(1.42) 
7.07 
(1.50) 
8.16 
(1.87) 
7.00 
(1.64) 
0.22 
(1.49) 
0.37 
(1.17) 
-1.16 
(2.34) 
 
5.6.9 Functional tests results 
Thirty-second chair-stand test 
Two way-mixed ANOVA 
ANOVA showed no significant effect for the groups (p=0.62), and there was no interaction 
between group and time (p=0.80). The time showed significant effect on the stair 30-second chair-
stand test (p<0.01). The descriptive data is presented in Table 5-18. 
Within each group 
The t-test showed significant improvement in the 30-second chair-stand test for the combined 
group (p=0.048) and the LWI group (p=0.02) after 6 weeks of treatment, but not for the sleeve 
group (p=0.14).  
Between the groups 
One-way ANOVA showed no significant difference in the number of repetitions for the 30-second 
chair-stand test between the groups at baseline (p=0.66) or 6 weeks (p=0.61). 
Magnitude of change between the groups 
When comparing the magnitude of change between the groups, no significant difference was 
identified (p=0.80). 
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40-metre fast-paced walk test 
Two way-mixed ANOVA 
The data showed that the group had no significant effect on 40-metre fast-paced walk test speed 
(p=0.77), and there was no interaction between groups and time (p=0.72). The time showed 
significant effect on the 40-metre fast-paced walk test speed (p=0.03). The descriptive data is 
presented in Table 5-18. 
Within each group 
After 6 weeks of treatment use no significant change was observed with in the combined group 
(P=0.10), sleeve group (p=0.21) and LWI (p=0.49) compared to baseline.  
Between the groups 
The difference in the 40-metre fast-paced walk test speed between the groups did not reach a 
statistically significant level at baseline (p=0.80) or after 6 weeks of treatment (p=0.73). 
Magnitude of change between the groups 
The magnitude of change (improvement) in 40-metre fast-paced walk test speed after 6 weeks’ 
treatment was not significant between the groups (p=0.72). 
A stair-climb test  
The data showed normal distribution; however, the variance was unequal. The transformation 
(RMS, log10, Ln, reciprocal) failed to correct the significant difference in variance. Therefore, 
two-way mix ANOVA couldn’t be used, and comparing between and within the groups using 
parametric testing was the solution since the data was normally distributed. The descriptive data 
is presented in Table 5-18. 
Within each group 
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The time spent to ascend and descend nine steps significantly decreased after 6 weeks of combined 
treatment use (p<0.01), but not after sleeve use (p=0.15) or LWI use (p=0.51) when tested via t-
test. 
Between the groups 
One-way ANOVA showed no significant difference between the groups at baseline (p=0.94) or 6 
weeks (p=0.31) in the time spent to ascend and descend nine steps. 
Magnitude of change between the groups 
When comparing the magnitude of change in time after for stair-climb test treatment between the 
groups, no significant difference was identified (p=0.49). 
Table 5-18 Mean (SD) of functional tests results for combined, sleeve and LWI groups. 
Q significant compared to baseline 
 
 
 
 
 
Mean 
(SD) 
Combined group Sleeve group LWI group 
Magnitude of change between 
baseline and week 6 
 
Shod + 
combined 
treatment 
 
Shod + 
sleeve 
treatment 
 
shod + 
LWI 
treatment 
Baseline Week  6 Baseline 
Week 
6 Baseline 
Week 
6 
30-seond 
chair-
stand test 
(count) 
11.64 
(2.85) 
12.68 
(4.06) 
Q 
11.26 
(2.90) 
11.96 
(3.16) 
12.38 
(3.18) 
13.42 
(3.23) 
Q 
1.05 
(1.54) 
0.69 
(1.44) 
1.04 
(1.37) 
40-metre 
fast-
paced 
walk 
(m/s) 
1.67 
(0.35) 
1.76 
(0.30) 
1.60 
(0.29) 
1.66 
(0.29) 
1.68 
(0.29) 
1.72 
(0.26) 
0.09 
(0.17) 
0.07 
(0.16) 
0.04 
(0.18) 
Stair-
climb 
test 
(second) 
10.95 
(1.71) 
9.02 
(1.44) 
Q 
11.23 
(2.72) 
10.63 
(2.75) 
10.86 
(3.12) 
10.04 
(2.85) 
-1.93 
(1.91) 
-0.60 
(1.29) 
-0.82 
(4.12) 
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 Discussion 
Nonsurgical orthotic management of knee osteoarthritis, such as lateral wedge insoles (LWI) and 
knee sleeve are recommended by National Institute for Health and Care Excellence (NICE) and 
Osteoarthritis Research Society International (OARSI) guidelines (ACR, 2012; Buttgereit, 
Burmester, & Bijlsma, 2015; McAlindon et al., 2014; NICE, 2014) . 
The reduction in the knee loading with lateral wedge insole use has been proven in the majority of 
clinical trials, with pain and functional improvement compared to baseline. However, when the 
lateral wedge insole was compared to the control treatment (neutral insole), which does not reduce 
the knee loading, the pain reduction does not appear. Therefore, the conflict between the clinical 
and biomechanical trials makes the adoption of the treatment to the clinical practice quite 
challenging since clinicians are driven by pain reduction more than loading reduction. Previous 
studies have found that combining the LWI with the valgus knee brace provides more reduction in 
pain and knee loading. However, the compliance with valgus knee brace is low because of its size 
and the difficulty of applying it, which shows the failure of adopting this in clinical practise. 
Therefore, there is a need for better treatment to help reduce knee pain and loading and provide 
functional improvement. The simple knee sleeve has been identified as a good treatment targeting 
pain and muscle co-contraction (loading). The simple knee sleeve could be a good treatment for 
reducing pain and loading and providing further functional improvement if combined with the 
lateral wedge insole. Therefore, this study investigated the effect of combined treatment (lateral 
wedge insole and simple knee sleeve) and compared it to each treatment individually after 
immediate use and after 6 weeks.  
At baseline, there was no significant difference between the groups in demographic characteristics, 
EKAM, muscle co-contraction, or pain.  
Thirty-four participants were enrolled in this study: thirty-one males and three females. The mean 
age was 55.24 (10.55) years (age range 40–77 years), the mean height was 1.72 (0.09) metres 
(height range 1.54–1.9 m), the mean mass was 86.96 (15.05) kg (mass range 45.6–123.9 kg), and 
the mean BMI was 29.48 (4.69) kg/m² (BMI range 19.23–40 kg/m²). The mean of EKAM, KAAI, 
and knee pain at baseline were 0.53 (0.13) Nm/kg, 3.18 (0.81) %Bw.ht, 0.21 (0.08) (Nm/kg).s, and 
54.17 (15.48), respectively. 
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The EKAM value (0.53 Nm/kg) for the current OA study population is in agreement with previous 
studies by Arazpour et al. (2013), Fu et al. (2015), Maly et al. (2002), Jones et al. (2013), and 
Toriyama et al. (2011), where EKAMs were 0.56 Nm/kg, Nm/kg to 0.57 Nm/kg, 48 Nm/kg, 0.55 
to 0.56 Nm/kg, and 0.54 Nm/kg, respectively. Collins et al. (2014), Hinman et al. (2008) and 
Schween et al. (2015) studies showed higher EKAM at baseline than the current study 
(3.72%Bw.ht, 3.60 %Bw.ht, 0.85 Nm/kg respectively). This might be explained by the higher 
walking speed at baseline than in the current study (1.32m/s) or different in demographic 
characteristics. Furthermore, a lower EKAM (0.46 Nm/kg) was identified in a previous study than 
in the current study, which might be explained by lower walking speed (0.98 m/s) (Laroche et al., 
2014). As anticipated, the knee adduction angular impulse (KAAI) in this study was similar to that 
in previous studies by Jones et al. (2013) where KAAI were 0.24 (Nm/kg).s respectively. 
Henriksen et al. (2010) showed that KOOS pain in mild knee OA (K/L≤2) was 57.9 while in more 
severe OA (K/L>2) it was 53. (Henriksen, Graven-Nielsen, Aaboe, Andriacchi, & Bliddal, 2010)  
The current population in this study recorded a baseline of 54 for KOOS pain which aligns with 
the previous study.  
Interestingly, the proportion of females to males was greater in most previously motioned knee 
OA studies (Arazpour et al., 2013; Collins et al., 2014; Fu et al., 2015; Henriksen et al., 2010; 
Toriyama et al., 2011). This is in contrast to current study, which included more males than 
females; this may reduce the generalisability of the results, especially for female knee OA 
populations. Although the studies of Jones et al. (2013), Maly et al. (2002) and Schween et al. 
(2015) had higher ratios of males to females, the proportions of females to males were higher than 
in current study. The age in previous OA studies ranged from 50 to 68.43 years, with most of the 
study participants around 59 years old, while the body mass index ranged from 23 Kg/m² to 32.42 
Kg/m², with most studies in the middle range (28 Kg/m²). The current study age (55.24 years old) 
and body mass index (29.48 Kg/m²) agreed with previous studies. Therefore, the baseline data for 
age and body mass index, EKAM, KAAI, knee injury and osteoarthritis outcome score for pain 
agreed with previous literature. This indicates that the current knee OA population is a typical 
medial OA population and allows us to broaden the knowledge in this context.  
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5.7.1 Summary of the result on EKAM, muscle co-contraction, pain, balance, physical 
function tests, PASE and other KOOS subscales 
The following is a brief summary of the results at both the immediate phase of the trial and also 
the short-term effects of the treatments.  
 Immediate effect of treatment use 
After immediate use of the assigned treatment, there was significant reduction in first peak EKAM 
for the combined group and the LWI group compared to baseline. In the trough and second peak 
EKAM, only the LWI group showed significant reduction compared to baseline; the combined 
group was bordering significance level. When comparing between the groups, there was no 
significant difference identified in the first peak, trough, or second peak EKAM. KAAI showed 
significant reduction in the LWI group, compared to baseline with no significant difference 
between the groups. The immediate magnitude of change between the groups was significantly 
higher in first peak EKAM for the combined and LWI groups compared to the sleeve group and 
in second peak EKAM, and KAAI for the LWI group compared to sleeve group. 
In muscle co-contraction, only MQ/MH early-stance muscle co-contraction reduced significantly 
after immediate use of the combined treatment and the sleeve compared to the baseline but not the 
LWI, with no significant difference between the groups. No significant difference in the magnitude 
of change in muscle co-contraction was identified between the groups. 
 After 6 week of treatment use 
After using the assigned treatment for 6 weeks, there was a significant reduction in the first peak 
EKAM, trough, second peak EKAM, and KAAI for the LWI and combined groups compared to 
baseline, with no significant difference between the groups. The combined and LWI groups 
showed significantly higher magnitude of change in first peak EKAM than the sleeve group, but 
not in trough, second peak EKAM, or KAAI.  
Significant reductions in pain were identified in the LWI group, the sleeve group, and the 
combined group compared to baseline, with no significant difference between the groups. The 
magnitude of change in pain was not significant when comparing all groups one test. However, 
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when comparing each two groups separately, only the combined group showed significantly higher 
magnitude of change than the sleeve group. 
From a functional improvement perspective, after 6 weeks of treatment, only the combined group 
showed a significant reduction in the time needed to ascend and descend nine steps, with no 
difference between the groups. The combined and LWI groups showed significant increases in the 
maximum number of repetitions achieved by the participants standing from and sitting in a chair 
in 30 seconds, with no significant difference between the groups. No statistically significant 
change in the 40-metre fast-paced walk test was observed compared to baseline or between the 
groups, with only the combined group showing nearly significant reduction compared to baseline. 
The magnitude of change in the stair-climb test, the 30-second char-stand test, and the 40-metre 
fast-paced walk test did not show statistical difference between the groups. 
Significant improvements were seen in the anterior direction balance test for the combined group 
and LWI group compared to baseline. No significant difference was identified between the groups; 
neither did the magnitude of change show any significant results. In the medial direction balance 
test, only the combined group showed significant improvements compared to baseline, with no 
significant difference between the groups. The magnitude of change in the medial direction 
balance test was not significant between the groups.  
In mid-stance muscle co-contraction, only the sleeve group showed a significant reduction in 
LQ/LG after 6 weeks compared to baseline. In contrast, the LWI group showed significant 
increases in mid-stance LQ/LH muscle co-contraction after 6 weeks compared to immediate use. 
In the late-stance, the sleeve group showed significant reduction in muscle co-contraction after 6 
weeks of treatment use compared to baseline between the following muscles: MQ/MH, and 
MQ/MG, compared to immediate use of the treatment between the following muscles: MQ/MG. 
The magnitude of change showed significant higher reduction in mid-stance LQ/LH muscle co-
contraction in the sleeve group and the combined group compared to the LWI group. Furthermore, 
the sleeve group showed a significantly higher magnitude of change in LQ/LG muscle co-
contraction after 6 weeks of treatment than the LWI group. In the late-stance phase, only sleeve 
group showed significant higher magnitude of change in muscle co-contraction compared to LWI 
group between the following pairs LQ/LH and LQ/LG. 
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The results achieved in the current study will now be discussed in terms of where they fit within 
the current literature, concentrating on the specific hypotheses stated earlier in the chapter. 
5.7.2 Effect of the treatment on EKAM 
Null hypothesis: There is no significant difference in EKAM when using combined treatments 
(lateral wedge insole, simple knee sleeve) compared to individual treatment (lateral wedge insole 
or simple knee sleeve) (immediate, 6 weeks). 
This hypothesis was partially rejected, as there was no significant difference between the groups 
in any part of EKAMs (first peak, trough, second peak, KAAI) between the groups after immediate 
use of the treatment or after 6 weeks. However, the magnitude of change in first peak EKAM was 
significantly higher for the combined and LWI groups than the sleeve group. In second peak 
EKAM and KAAI, the magnitude of change was statistically significant higher for the LWI group 
compared to sleeve group.  
The non-significant difference observed between the groups after immediate and 6 weeks use of 
treatments in EKAM value may be partially explained by three factors. First, the combined group 
had slightly higher EKAM at baseline than the other groups, but the difference was not statistically 
significant and could be explained by a non-significant slightly higher walking speed (1.22 m/s) 
than the other groups (1.15 m/s) or biomechanical factors such as increased varus angle. Secondly, 
ANOVA test rely on the basic concept that if there is no within-group variability (different between 
subject in the same groups and the same time), then any between-group variability counts (different 
between groups or time). Therefore, with a high variability within the group, the statistical power 
is reduced. Thirdly, the low sample size in each of the group might contribute to the non-significant 
difference. When looking at EKAM using different methods, the magnitude of change and not the 
real value of EKAM after immediate and 6 weeks using one-way ANOVA, the test showed 
significant differences between the groups. 
The combined and LWI groups showed a significant reduction in EKAM compared to baseline, 
and the mechanism that underlies this is by laterally shifting the centre of foot pressure. This shifts 
the GRF more laterally and therefore reduces the moment arm. When considering the centre of 
foot pressure, the combined group and the LW group showed lateral shifting in early-, mid- and 
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late-stance phases during walking (Appendix E). The maximum effect of the lateral wedge insole 
occurs in the early-stance phase where the first peak is. This can be explained by the design of the 
LWI as the inclination at the heel is 5 degrees, gradually decreasing to 0 at the metatarsal head. 
The LWI group and combined group showed reduction in all aspects of EKAM (first peak, trough, 
second peak, KAAI) compared to baseline. This reduction in EKAM translates into potential 
reductions in knee loading and therefore may reduce the disease progression (Miyazaki et al., 
2002).  
The reduction in EKAMs in the combined group and the LWI group ranged from 8.17% to 14.88% 
compared to baseline for first peak EKAM and 9.31% to 15.56% compared to baseline for KAAI. 
The reduction in this study is generally in agreement with previous studies investigating the effect 
of the lateral wedge insole (Butler et al., 2009; Chapman et al., 2015; Fu et al., 2015; Hinman et 
al., 2012; Hinman et al., 2008a; Jones et al., 2013a, 2013b; Kerrigan et al., 2002). Percentages of 
reduction in first peak EKAM similar to those in the current study were seen in previous studies: 
12% (Hinman et al., 2008a), 13.7% (Fu et al., 2015), 10% (Butler et al., 2009), and 12% (Jones et 
al., 2013b). Furthermore, Jones et al. (2013b) conducted two-week crossover trials and showed a 
16.1% reduction in KAAI, which is in agreement with the current study.  
Interestingly, in a randomised crossover study by Chapman et al. (2015), the reduction in first peak 
EKAM with lateral wedge insole use was found to be 5.85% in the whole group. The study 
highlighted that some participants showed an increase in EKAM with the lateral wedge insole; 
when this population was excluded, the reduction increased to 11.39%.  
Other studies have shown lower EKAM reductions than the current study for first peak EKAM 
(5.8%) and KAAI  (6.3%) (Hinman et al., 2012b); peak EKAM (6%) (Kerrigan et al., 2002); 
and 4.84% first peak EKAM and 6.38% KAAI on the affected side (Jones et al., 2013a). This 
difference in EKAM reduction in previous studies to current study can be attributed to several 
factors such as presence or absence of the arch support, including some participants who did not 
respond to the treatment, difference in insole materials, different in footwear used. 
The current study used lateral wedge insoles with medial arch supports while Hinman et al. (2012b) 
did not use arch supports. A previous study showed that a lateral wedge insole with an arch has a 
better effect biomechanically among healthy on EKAM than a lateral wedge insole with no arch 
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(Nakajima et al., 2009). Jones et al. (2015) showed that LWI with arch produced comparable 
results in EKAM and KAAI to LWI with no arch. However, LWI with arch showed higher comfort 
score that LWI with no arch and significantly reduced in pain with LWI compared with no arch 
LWI.   
Several studies have identified inconsistencies in EKAM reduction among individuals. This 
suggests that some individuals exhibit more benefit from using LWI than others (Hinman et al., 
2008; Kakihana et al., 2007; Kutzner et al., 2011). Recent studies identified that individuals with 
higher peak ankle eversion angle at EKAM are more likely to be among responders (EKAM 
reduced with LWI use). This might be due to a limited range of motion in non-responders, which 
limits ankle pronation and therefore limits the ability of the LWI to alter the knee loading 
(Chapman et al., 2015). Hinman et al, (2012) showed that some participants experience an increase 
in EKAM with LWI which was not observed in current study. 
Participants in the current study used their own shoes while Jones et al. (2013b) standardised the 
shoes. The type of footwear used was found to affect EKAM, muscle power, and activity. 
Interaction between LWI and shoe was found, which means that LWI effect is dependent on 
footwear (Mølgaard & Kersting, 2013) and may decrease LWI efficacy (Toda & Tsukimura, 
2008). The current study used LWI with a durometer score of 70 while previous studies used lateral 
wedge insoles with lower density, such as Hinman et al. (2012), with a durometer score of 57.5, 
and Kerrigan et al. (2002), with a durometer score of 55. Different LWI materials showed 
significant differences in outcome, even though the same angulation was used. This shows that 
higher-density materials might improve stability, comfort, and deformability more than low-
density materials (Toda & Tsukimura, 2004a). 
The current study results show that using the sleeve did not show any significant change in any 
part of EKAM (1st peak, trough, 2nd peak, KAAI). Previous study by Collins et al. (2014) showed 
no significant change in the first peak EKAM and the second peak EKAM with immediate sleeve 
use among individuals with knee OA which agree with current study results. However, contrasting 
results which showed significant reduction in first peak EKAM (10.1%) with immediate use of the 
simple knee sleeve in the OA population. Several reason can be attributed to this such as difference 
in the type of the sleeve, difference in demographic characteristics (lower BMI, lower age). 
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Another potential reason is that Schween et al. (2015) participants had higher maximum adduction 
angle in the first 50% of the stance phase (14.1 degree) compared to current study (approximately 
3 degree) which provide more room for the sleeve to reduce the high varus. 
Maintaining the reduction in EKAM over time is important if you aim to reduce the knee OA 
progression. Hinman, et al. (2009) conducted a study to investigate if the EKAM reduction caused 
by lateral wedge insoles persists after one month and concluded that the reduction in EKAM did 
not appear to decline over time. The current study shows that the LWI group and the combined 
group showed an immediate reduction of 8.17% and 10.88%, respectively, and a 6-week reduction 
of 12.30% and 14.18%, respectively, which is consistent with previous study conclusions. 
Putting the reduction in EKAM in clinical view, previous studies showed that EKAM and KAAI 
are associated with cartilage thickness loss in the knee over 12 months (Bennell et al., 2011) and 
24 months (Chang et al., 2015). Furthermore, the reduction in joint space width after 6 years among 
individuals with knee OA was correlated with peak EKAM (Foroughi et al., 2009). Interestingly, 
a 1% increase in EKAM was shown to increase the risk of progression by 6.46 times (Miyazaki et 
al., 2002). Therefore, the reduction in the current study with LWI use either in the LWI group or 
the combined group may reduce or delay the progression of the knee OA but this would need to 
be confirmed in a longer term study assessing structural aspects of the knee joint which was outside 
the remit of this thesis. 
5.7.3 Effect of the treatment on pain 
Null hypothesis: There is no significant difference in pain after 6 weeks when using combined 
treatments (lateral wedge insole, simple knee sleeve) compared to individual treatment (lateral 
wedge insole or simple knee sleeve). 
One of the primary aims of prescribing an intervention in an individual with knee osteoarthritis is 
to reduce the pain and if the pain reduced it is hoped to be a combined with physical function 
improvement. Therefore, it is important to understand the change in pain in each group. When 
comparing each group to its baseline all the groups showed a significant reduction in pain, which 
was higher than pain fluctuation 2.15 units of pain in KOOS. However, when all the groups were 
compared after 6 weeks no significant difference was detected, neither was there any significant 
  206 
difference in the magnitude of the pain change between the groups. Therefore, the null hypothesis 
was accepted in regards to there being no significant difference in pain between the groups.  
Previous studies showed significant improvement in pain with lateral wedge insole use compared 
to baseline which is in agreement in general with current study results (Ashraf et al., 2014; Barrios 
et al., 2009; Campos et al., 2015; Fu et al., 2015; Hatef et al., 2014; Hinman et al., 2008b; Jones et 
al., 2013b; Rubin & Menz, 2005).  
In contrast, two studies showed no significant reduction in pain with lateral wedge insole use 
compared to baseline (Baker et al., 2007; Bennell et al., 2011). Several reason for not identifying 
a reduction in can be highlighted. First; the biomechanical effectiveness (EKAM reduction) which 
is considered as the mechanism of pain reduction was not mentioned. Therefore, it is not known if 
the LWI used provided EKAM reduction. Secondly, use of LWI with low density, 57.5 durometer 
in Bennell et al. (2011) study and 48 durometer in Baker et al. (2007), compared to current study 
70 durometer. Thirdly, Baker et al. (2002) did not mentioned the comfort of the LWI while Bennell 
et al. (2011) showed back and foot pain with LWI use. Intermittingly. Jones et al. (2014) showed 
strong correlation between LWI comfort and pain rating. Therefore, pain response may be affected 
with LWI comfort. Finally, Bennell et al. (2011) measured the pain at baseline and after 12 months 
and it is not known if there is any change in between.  
Sleeve use showed significant improvement in pain compared to baseline which was similar to 
previous studies (Bryk et al., 2011; Mazzuca et al., 2004; Schween et al., 2015). Schween et al. 
(2015) investigated the immediate effect of the knee sleeve and showed small significant reduction 
in pain. One of the limitations of the study is not measuring the pain before providing the treatment 
and instead the authors provided the participants with 10 visual analogue scale (VAS) after 
wearing the sleeve. The authors used a visual analog scale where number 5 indicated no change in 
pain compared to before the treatment. The authors showed a significant reduction in pain (5.5) 
after the sleeve use. This reduction in pain is roughly 10%, which is similar to that in the current 
study (11.6%). The participants’ ability to remember the pain before the treatment may have been 
affected by memory issues, and therefore, measuring the pain before providing the treatment was 
a better option. 
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Bryk et al. (2011) invesigated the immediate effect of knee sleeve on the knee pain during Stair 
Climb Power Test. The results showed significant reduction in both (dominant and non-dominant 
leg) by 1 point on a 10-point VAS. Futhermore, the effect of heat-retairning sleeve and simple 
sleeve was investigated on a double blind randomised control trial. The treatments was provided 
for 4 weeks and both group had significant improvement in pain by 16% for heat-retairning sleeve 
and and 9% for simple sleeve with no significant difference between the groups (Mazzuca et al., 
2004). 
Only one study was identified which investigated the effect of combining an elastic knee sleeve 
and a lateral wdge insole with subtalar strap (Keyaki & Toda, 2010). This LWI is incorporate an 
elastic strap to fix the subtalar joint. The aim of the study was to investigate if adding the simple 
knee sleeve provided futher pain reduction when walking on uneven ground over 4 weeks. The 
sample was divided into 3 groups; control group (LWI with stap), treatment group1 (LWI with 
stap + long sleeve) and treatment group 2 (LWI with stap + short sleeve). All the group showed 
significant reduction in pain compared to baseline with no futher details between the groups. 
However, the number of participants who were able to walk on unevn ground without knee pain 
increased significantly in both treatment groups but not in control group.  
However, looking further into the results, it could be seen that there was a further reduction in pain 
seen for the combined group. When looking to the percentage of reduction compared to baseline, 
the sleeve group showed 11.16%, LWI group showed 21.1% while the combined group showed 
31.88%. The reduction in combined group seems to be as accumulative reduction from LWI group 
and sleeve group which agree with the study above. Further analysis was undertaken out to 
compare each of the two groups separately with a t-test, whist this is understood it could create a 
type 1 error, this seemed sensible to determine if there really was a difference. The results revealed 
statistically significant magnitude of change reductions in pain for only the combined group 
compared to sleeve group. This does provide some support that combining a lateral wedge insole 
and simple knee sleeve could provide further pain reduction than single treatment alone. 
Interestingly, NICE guidelines recommendation highlighted the need for more trials investigating 
the effect of the combined treatment and stated that individuals with OA may receive several 
treatments at the same time in their OA journey. Therefore, it is important to understand if 
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combined treatment provide better effect. Furthermore, NICE recommended LWI to be used in 
adjunct to other treatment and using sleeve could be an option (NICE, 2014). 
Other potential causes which might affect the pain results is using the subjective knee pain score 
(self-reported questionnaires) which have been identified to be affected by human memory, which 
might be weak in older population, and lead to providing inaccurate answers. However, this is 
believed to have minimal effect or no effect on the results as all the groups has similar age. 
Furthermore, the reduction in pain may be affected by placebo effect which can be defined as an 
improvement in an individual’s symptoms (i.e. knee pain) caused by using placebo due to 
individual’s expectation. Placebo effect is not believed to affect the study results as all subjects 
were randomly allocated to the treatment and had no knowledge about other treatment conditions. 
However, all of the treatments are designed for knee osteoarthritis and thus a reduction in clinical 
symptoms was expected. Further randomised clinical trials that evaluate combined treatments with 
neutral insoles may be a future direction.      
5.7.4 Effect of the treatment on muscle co-contraction 
Null hypothesis: There is no significant difference in muscle co-contraction when using combined 
treatments (lateral wedge insole, simple knee sleeve) compared to individual treatment (lateral 
wedge insole or simple knee sleeve) (immediate, 6 weeks). 
Muscle co-contraction has been identified to be higher in individuals with knee osteoarthritis 
(Childs et al., 2004; Hubley-Kozey et al., 2009; Zeni et al., 2010), which could come at the expense 
of higher joint loading (Lu et al., 1997; Trepczynski et al., 2014). Additionally, increased levels of 
muscle co-contraction have been associated with greater changes in degeneration (Hodges et al., 
2015). Therefore, targeting muscle co-contraction is seen as a sensible option with the treatments.   
This study showed significant reductions in muscle co-contraction with sleeve use in early-, mid- 
and late-stance phases compared to baseline, while the combined group showed a reduction in co-
contraction only in the early-stance phase compared to baseline. The LWI group showed a slight 
increase in mid-stance muscle co-contraction after 6 weeks compared to immediate LWI use but 
not baseline. When comparing the groups after immediate and 6 weeks’ use of the treatment, no 
significant differences were identified. However, the magnitude of change after 6 weeks was 
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significantly higher in the mid-stance LQ/LH co-contraction for the sleeve and combined groups 
than for the LWI group and in mid-stance LQ/LG co-contraction for the sleeve group compared to 
the LWI group. In the late-stance, the sleeve group showed significantly higher magnitude of 
change than the LWI group in both LQ/LH and LQ/LG. Therefore, the null hypothesis was 
partially rejected as the magnitude of change in co-contraction reached significant levels.  
When looking at the muscle co-contraction data, the LQ/LH co-contraction while walking was 
higher than MQ/MH co-contraction for all groups in early- and mid-stance phases. This is in 
agreement with previous research, which showed higher VL/LH co-contraction than VM/MH co-
contraction in the early-stance phase (Andriacchi, 1994; Hubley-Kozey et al., 2009; Ramsey et al., 
2007) and mid-stance phase (Schmitt & Rudolph, 2007) while walking. The internal moment plays 
an important role in providing an abduction moment to resist the varus position in the knee, which 
occurs due to EKAM attempt to adduct the shank. Therefore, if the agonist muscle cannot resist 
the EKAM, the co-contraction between agonist and antagonist muscles is important to stabilise the 
joint (Schipplein & Andriacchi, 1991). Collins et al. (2011) conducted a study to investigate the 
effect of the knee sleeve and electrical stimulation on muscle co-contraction and impulsive 
loading. The study results showed significant reduction in the LQ/LH co-contraction in the first 
half and second half of the stance phase. In the current study, the data shows a reduction in LQ/LH 
muscle co-contraction with sleeve use (immediate, week 6) in early-, mid-, and late-stance phases 
compared to baseline, but it did not reach significance. This might propose a decrease in the 
internal moment (muscles) to resist the external moment (EKAM), due to the support that is 
provided to the knee joint with sleeve use, making the muscles more relaxed.  
There are several plausible explanations for the reduction in muscle co-contraction with sleeve 
use. Firstly, providing stabilisation of the knee OA reduces the space between the medial condyles, 
therefore reducing the soft tissue stabilisation (ligaments). This leads to an increase in the demand 
on the active stabilisation (muscles) to provide support to the joint. Lewek et al. (2004a) showed 
a correlation between the knee joint laxity and VM/MG co-contraction. Secondly, providing self-
reported stability, since previous research showed that individuals with self-reported instability 
affecting their ADL had higher medial muscle co-contraction than individuals (Lewek et al., 2005).  
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It has been proposed that reducing the muscle co-contraction may lead to a reduction in the knee 
OA progression (Pagani et al., 2012). Our results show significant reduction in muscle co-
contraction while walking with sleeve use, which may indicates a reduction in the total knee 
compartment loading (Trepczynski et al., 2014). Therefore, combining the sleeve with the lateral 
wedge insole may provide further reduction in knee loading and reduce the knee OA progression. 
The combination of reduced muscle co-contraction and reduced EKAM as in the combined group 
could be a proposed mechanism to reduce the medial knee compartment loading (Trepczynski et 
al., 2014).  However, this speculation needed to be confirmed in medium-long term studies where 
structural, clinical and biomechanical outcomes are collated. 
5.7.5 Effect of the treatment on dynamic balance 
Null hypothesis: There is no significant difference in dynamic balance after 6 weeks when using 
combined treatments (lateral wedge insole, simple knee sleeve) compared to individual treatment 
(lateral wedge insole or simple knee sleeve). 
Dynamic balance in the current study was measured in the anterior and medial directions. Previous 
studies have shown that individuals with knee OA have balance defects (Hinman et al., 2002; 
Wegener, Kisner, & Nichols, 1997), with balance impairments identified to increase the risk of 
falling and disability in the elderly (Dionyssiotis, 2012). 
Although all groups showed an increase in dynamic balance in both directions, only the combined 
and LWI groups showed statistically significant increases. Dynamic balance was improved 
significantly for the combined group in anterior and medial directions compared to baseline by 
13.73% and 10.45%. The LWI group showed significant improvement in anterior direction 
dynamic balance by 8.83% Interestingly, the amount of the improvement in balance for all the 
groups exceeded the measurement error (chapter 3), which indicates real improvement. 
When the groups were compared after 6 weeks, no significant differences were identified; neither 
did the magnitude of change in balance show any significant difference between the groups. 
Therefore, the null hypothesis was accepted in terms of there being no significant difference in 
balance between the groups. The specific cause of balance impairment is not yet clear; however, 
there are several components that have been found to affect balance. Previous research highlighted 
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that the aging process, knee pain, muscle weakness, and/or proprioceptive impairment have an 
effect on balance (Hassan et al., 2001; Koceja et al., 1999; Lin et al., 2009; Slemenda et al., 1997). 
Therefore, the improvement in dynamic balance could be explained by the significant pain or 
muscle co-contraction reduction. The reduction in pain may have allowed the participants to load 
their knees and/or bend their knees more during the test. This explanation is in agreement with a 
previous study, which found that higher pain in an OA individual with muscle weakness is 
associated with balance impairment (Hassan et al., 2001).  
Another potential reason to enhance balance is the reduction in muscle co-contraction. Hertel et 
al. (2000) stated that SEBT requires neuromuscular control and muscle co-contraction on the 
standing leg. Previous studies show an increase in muscle co-contraction in individuals affected 
with knee OA, the current study shows significant reduction in muscle co-contraction with sleeve 
use. The relation between the dynamic balance and muscle co-contraction has not been 
investigated. However, the reduction in co-contraction might lead to selective muscle activation, 
which leads to better dynamic balance. 
Limited research has investigated the effect of conservative treatment on SEBT among individuals 
with knee OA. Only one study was identified that has investigated the effect of exercise for 
individuals with knee OA on dynamic balance (Al-Khlaifat et al., 2016). The results showed 
significant improvement in anterior and medial directions balance tests after the exercise program. 
The current study results are in agreement with the previous study, which highlights that combined 
treatments might have a similar effect on dynamic balance. The clinical implication of increasing 
the dynamic balance could transfer to a reduction of the risk of falling and therefore enhance safety. 
5.7.6 Effect of the treatment on pain pressure threshold 
Null hypothesis: There is no significant difference in pain pressure threshold after 6 weeks when 
using combined treatments (lateral wedge insole, simple knee sleeve) compared to individual 
treatment (lateral wedge insole or simple knee sleeve). 
Individuals with knee OA have been found to have low pressure pain thresholds compared to 
healthy individuals (Arendt-Nielsen et al., 2010; Imamura et al., 2008). Furthermore, symptomatic 
knee osteoarthritis was identified to correlate with pain pressure threshold while radiological knee 
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OA was not (Goode, Shi, Gracely, Renner, & Jordan, 2014). This highlights the importance of 
investigating the effect of the treatment on the pain pressure threshold. In 2015, Mutul and 
Ozdincler conducted research to investigate the reliability of pain pressure threshold and the effect 
of physiotherapy treatment on pain pressure threshold among individuals with knee OA. Their 
results showed a change in pain pressure threshold over the medial condyle with large effect size. 
Two major limitations in this study: first, not mentioning what type of physiotherapy was used as 
a treatment and second, not mentioning if the change in pain pressure threshold reached significant 
levels. The current study did not show any change in pain pressure threshold after 6 week of 
treatment, which contradicts the previous study. This can be attributed to several factors. The 
current study population had a pain pressure threshold of 6.46 N/Cm² before the treatment, which 
is higher than previous study’s pre-treatment value of 5.47 N/Cm². Secondly, the type of treatment 
might be a key factor. The previous study used physiotherapy as a treatment, which might have 
included hydrotherapy or electrical therapy, which might have had a direct effect on the sensation. 
Thirdly, the time might play an important factor. Current study treatment period is 6 weeks and 
perhaps more time is needed to show a reduction in pain pressure threshold.  
The current study showed that the pain pressure threshold in the medial condyle and the medial 
malleolus did not change significantly after the treatment within each group or between the groups 
after the treatment. Neither has the magnitude of changes reached significant levels between the 
groups. Therefore, the null hypothesis was accepted in terms of there being no significant 
difference in the pain pressure threshold between the groups. 
Not finding a change in the pain pressure threshold after the treatment might indicate a good result. 
Since there is no change in the sensitivity of the patient to the pain (threshold) while the pain 
severity is reduced, this might indicate a real change in pain caused by load reduction rather than 
the sensitivity of pain change. Interestingly, the pain pressure threshold in the medial condyle is 
lower than in the medial malleolus in all the groups, which is consistent with the previous study 
(Mutlu & Ozdincler, 2015). This might indicate local sensitisation as previous research mentioned 
that hypersensitivity on the affected side might indicate local sensitisation while to the distal part 
might indicate central and peripheral sensitisation (Arendt-Nielsen & Yarnitsky, 2009). This local 
sensitisation might be a protective mechanism to reduce the damage on the joint. Mechanical 
stress, intra-osseous pressure, and synovial inflammation have been proposed to be local 
contributors to pain (Brandt et al., 2008; Dieppe & Lohmander, 2005; Kidd, 2006). Another 
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possible explanation could be that the medial condyle has more pain receptors than the medial 
malleolus.  
5.7.7 Effect of the treatment on functional tests 
Null hypothesis: There is no significant difference in functional tests (40-metre fast-paced walk 
test, 30-second chair-stand test, a stair-climb test) after 6 weeks when using combined treatments 
(lateral wedge insole, simple knee sleeve) compared to individual treatment (lateral wedge insole 
or simple knee sleeve). 
Functional tests have been identified as important outcomes among individuals with knee 
osteoarthritis to measure the subjects’ ability to move around and perform daily activities (Bennell, 
Dobson, & Hinman, 2011; Dobson et al., 2013). The 40-metre fast-paced walk test, the 30-second 
chair-stand test, and the stair-climb test are activities that have been found to be affected in 
individuals with knee osteoarthrosis and have a good response as a measure of treatment efficacy 
(Bennell et al., 2011). One of the main aim of providing intervention is reduce pain and improve 
function. The data showed that combined treatment showed significant improvement in the stair-
climb test and the 30-second chair-stand test compared to baseline, while the LWI group showed 
significant improvement only in the stair-climb test. The sleeve group did not show any significant 
change compared to baseline. When comparing the groups after the treatment, no significant 
difference was identified, nor did the magnitude of change reach a significant level. Therefore, the 
null hypothesis was accepted. 
The improvement in functional tests with treatment could be a result of the pain reduction. As the 
pain reduced, the participants were more willing to load their joints to perform faster. For the 40-
metre fast-paced walk test, no group showed significant improvement, and this could be because 
walking is easier than performing other tasks and needs more improvement in pain or is not as 
affected as other tasks. Perhaps more time was needed to show significant improvement since the 
improvement in the combined treatment nearly passed the measurement error.  
Limited researches have investigated the effect of LWI or sleeve on the functional tests, which 
highlights the importance and strength of the current study (Baker et al., 2007; Barrios et al., 2009; 
Kirkley et al., 1999). Kirkley et al. (1999) investigated the effect of the valgus brace and the sleeve 
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on individuals with knee osteoarthritis against a control group. Treatment time was 6 months, and 
the results revealed no significant difference between the groups in a 30-second stair-climb test 
and a 6-minute walking test. The study did not mention if the results within the groups reached 
significant levels or not. Barrios et al. (2009) and Baker et al. (2007) compared the effect of the 
lateral wedge insole and the neutral wedge insole on clinical outcomes and functional tests. Baker 
et al. (2007) conducted a randomised crossover study for 6 weeks with 4 weeks washout. No 
significant difference was identified between the treatment groups in a 50-foot walking time test 
or a 5-minute chair-stand time test, and the authors did not mention if the LWI group showed 
significant difference compared to baselines. Barrios et al. (2009) conducted a randomised parallel 
group study for a year. The results showed significant improvement in a 6-minute walking-distance 
test and a stair negotiation test for both groups compared to baseline with no significant difference 
between the groups. One of the major limitations of both studies was not including the 
biomechanical effect of the treatment, which is considered the mechanism by which the LWI 
targets the loading.  
It is hoped that, with functional improvement observed in two functional tests with combined 
treatment, patients are better able to perform in these activities of daily living. Intermittently, 
although there was no significant difference between the groups, the combined group showed 
significant improvement in two functional tests where the other groups did not. This shows a trend 
toward better improvement with combined treatment. 
5.7.8 PASE scale and other KOOS subscales (Appendix E) 
Symptoms, ADL, sports and recreation activity, and quality of life subscales of KOOS showed 
significant improvement in all the groups (combined group, LWI group, sleeve group) compared 
to their baselines. However, when comparing between the groups, no significant difference was 
identified after 6 weeks, nor did the magnitude of change show any significant difference. This 
improvement in KOOS subscales is thought to be caused by the pain reduction, which is caused 
by EKAM and/or muscle co-contraction reduction. Therefore, pain reduction is reflected in 
symptoms, ADL, sports activity, and quality of life.  
Most previous studies of lateral wedge insoles used the WOMAC questionnaire, which consists of 
three subscales: pain, function, and symptoms. WOMAC subscales are included in KOOS, where 
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WOMAC function equals ADL in KOOS, WOMAC pain is included in KOOS pain, and WOMAC 
stiffness is included in KOOS symptoms (Engelhart et al., 2012). KOOS was used by one study, 
and the aim of the study was to compare the effect of concurrent use of ankle support with lateral 
wedge insole (Segal et al., 2009). Therefore, the authors reported differences between the groups 
rather than within the groups. Other studies showed significant reduction in WOMAC function 
and/or WOMAC stiffness subscales with the use of lateral wedge insoles (Ashraf et al., 2014; 
Barrios et al., 2009; Fang et al., 2006). An improvement in WOMAC function and stiffness 
subscales with lateral wedge insole use was reported in two studies (Maillefert et al., 2001; Pham 
et al., 2004). However, this improvement was not mentioned if reached statistical significant level 
or not, and this might be because the main aim of both studies was to compare neutral insoles and 
lateral wedge insoles. Jones et al. (2013b) compared the effect of the valgus brace and the lateral 
wedge insole. The results showed significant improvement in pain and function with the lateral 
wedge insole and valgus brace compared to baseline, with no significant difference between the 
treatments. The stiffness subscale did not show any significant reduction, which could be attributed 
to the short treatment period (2 weeks) compared to the current study (6 weeks). 
To the best of our knowledge, only one study that investigated the effect of the sleeve on WOMAC 
pain, function, and stiffness subscales could be identified (Kirkley et al., 1999). The study showed 
significant improvement in the function subscale compared to the control group, but not the 
stiffness subscale. Our results in ADL subscale are consistent with their function results. However, 
our function subscales, which include WOMAC stiffness, show significant improvement with 
sleeve use compared to baseline, which is in contrast to the previous study. This might be because 
KOOS symptoms subscale has the stiffness questions from KOOS and other questions which 
might be more sensitive to detect the changes. Other possible explanations are using a different 
sleeve and a different treatment period.  
Interestingly, all the groups showed an improvement in PASE but not a significant one compared 
to baseline except the combined group. This is thought to be caused by the pain reduction. The 
higher increase in PASE for the combined group than the other groups and the significance 
compared to baseline might be explained by using two treatments: the lateral wedge insole, which 
reduces the EKAM and therefore reduces the pain, and the sleeve, which provides a sense of 
stability and reduces the muscle co-contraction and therefore reduces the pain. This improvement 
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in physical activity level would be seen as a positive effect of the combined treatment. From a 
public health perspective, this means that the participant is more active, which improves his or her 
well-being and general level of social interaction. This change might be more pronounced in future 
studies if more participants were included and the treatment duration was longer. 
Interestingly, this increase in physical activity may cause hinder the reduction in pain via 
increasing the cumulative loading on the knee and therefore reduce the effect of combined 
treatment on pain. This also could be a contributing factor in not finding a significant difference 
between in pain after 6 weeks between the groups.  
Bennell et al. (2011) investigated the effect of the lateral wedge insole and showed non-significant 
reduction in PASE after 12 months of treatment, which contradicts the current study, which shows 
a slight increase. One of the main disadvantages of the previous study was not including the 
biomechanical effect of the LWI (EKAM), which is considered the main mechanism to reduce the 
loading. Therefore, it is not known if the lateral wedge insole used reduced the EKAM. This is the 
first study that investigated the effect of combined treatment (lateral wedge insole and simple knee 
sleeve) on physical activity level. Therefore, comparison could not be made to the previous studies.  
The clinical importance of increasing activity level lies in the high risk of other diseases, such as 
diabetes, obesity, and cardiovascular disease, with inactivity (Warburton et al., 2006). Therefore, 
reducing inactivity via combined treatment may lead to reduced risk of weight gain and 
cardiovascular disease and improved muscle power (Bravata et al., 2007; Warburton et al., 2006). 
Furthermore, increasing activity time is important for cartilage structure as a previous study found 
association between physical activity level and cartilage volume loss, where low-activity 
participants showed higher cartilage volume loss (Lin et al., 2013; Stehling et al., 2011). 
Interestingly, absence of the knee normal loading in cases of spinal cord injuries was found to 
cause cartilage atrophy (Vanwanseele, Eckstein, Knecht, Stüssi, & Spaepen, 2002). 
5.7.9 Secondary kinematic and kinetic outcomes (Appendix E) 
Treatments for knee osteoarthritis, if effective, may also result in changes in angles and moments 
(kinematics and kinetics) during walking. Thus, it is important in understanding the mechanism of 
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effect of the interventions to explore for differences in these variables. On the whole, there were 
only a minimal set of differences between-visits.  
In spatiotemporal characteristics, the swing time showed significant reduction in the LWI group 
after immediate use of treatment and 6-week use compared to baseline, while stance time increased 
with immediate use of the combined treatment compared to baseline. A previous knee OA study 
showed significant reduction in stance time in the affected limb compared to the contralateral side 
(Mootanah et al., 2013). Therefore, this might indicate that the participants might be more willing 
to load their joints, which could be due to pain reduction caused by the reduction in loading. 
Kinematics 
The knee angle at initial contact in the sagittal plane showed a significant time effect with 
immediate and 6-week reduction compared to baseline. However, this reduction is not thought to 
be that important since the mean difference is small with both the immediate effect (0.38 degrees) 
and the 6-week effect (1.02 degrees) and did not exceed the measurement error (1.04 degrees).  
Ankle frontal plane ROM showed time effect with significant increase with immediate and 6-week 
use of the treatment compared to baseline. Use of the lateral wedge insole could explain this 
finding by placing the foot in a more everted position. Maximum eversion angle showed significant 
time effect with significant increase with immediate use of treatment by mean difference of 1 
degree. This amount of change is believed to be too small and barely exceeded the measurement 
error (0.90 degrees). When looking at each group individually, the LWI group showed significant 
increase in ankle ROM frontal plane with immediate and 6-week use of treatment compared to 
baseline, which can be explained by the use of the lateral wedge insole. However, one can ask why 
the combined group did not show the same although they also used the lateral wedge insole. LWI 
group ankle frontal plane ROM (12.51 degrees) was slightly lower than that of the combined group 
(13.75 degrees) and the sleeve group (13.34 degrees) at baseline, which provided more room for 
improvement. The ankle frontal plane ROM after 6 weeks of treatment was similar among the 
lateral wedge insole group (14.98 degrees), the combined group (14.42 degrees), and the sleeve 
group (14.16 degrees). 
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Finally, the centre of foot pressure showed significant lateral shifting in all phases with immediate 
use of the LWI and combined treatment compared to baseline and with the combined treatment 
after 6 weeks compared to baseline. This is the mechanism that is provided by the LWI to reduce 
the EKAM. Previous studies showed similar shifting in the centre of foot pressure, which is 
consistent with the current study (Hinman et al., 2012b; Jones et al., 2013c).  
Kinetics  
External knee extension moment in the combined group was higher at baseline than in the LWI 
group. This is believed not to have affected our experiment since this moment is not one of our 
main outcomes and is generated by initial contact. Furthermore, the combined group showed 
significant reduction in extension moment with immediate use of treatment compared to baseline 
and week 6. This could be explained by the reduction in speed in this group, which was nearly 
significant (p=0.055). Interestingly, this happened even though participants were given enough 
time to practice before starting the real trials, and it could be due to having two treatments, and the 
individuals felt that different to their normal walking (not comfortable). Most important, this was 
not observed after 6 weeks. 
The second peak of GRF (push-off|) showed a significant increase in the combined and sleeve 
groups with immediate and 6-week use of the treatment and in the LWI group with immediate use 
of the treatment. A previous study showed similar results in terms of significant increase in loading 
and push-off GRF with brace use (Richards, Sanchez-Ballester, Jones, Darke, & Livingstone, 
2005). These results possibly reflect an improvement in participants’ ability to push off using the 
affected leg. These increases in push-up force could be due to the biomechanical changes 
(reduction in loading), the physiological changes (reduction in muscle co-contraction), and the 
clinical changes (pain reduction).  
For the same reason (reduction in speed with immediate use of the combined treatment), the 
combined group showed a significant reduction in ankle dorsiflexion moment with immediate use 
of treatment but not after 6 weeks. In addition, ankle plantar flexion moment showed significant 
change in the combined group, which could not be identified with any adjustment. Therefore, this 
change is too small to be identified, and the reduction in speed could be the cause.  
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Lateral wedge insole group showed significant increase in the ankle eversion moment after 6 weeks 
compared to the baseline and shifting the centre of pressure more laterally is believed to be 
responsible for this increase. The combined group did not show this change although they used the 
LWI, which can be explained by the slightly lower ankle eversion moment in the LWI group than 
in the combined group at baseline, which provided more room for increase in the LWI group.  
5.7.10 Limitations of the study  
As with any study, this one had limitations. First, the assessor and the participants were not blind 
to the type of treatment used in the gait lab. However, to reduce the bias, the participants were told 
that all types of treatment are effective with knee osteoarthritis. Gait data was collected with an 
automatic measurement instrument, so the bias was low in terms of the investigator. The 
questionnaires for the study were collected without comment to the participants and were analysed 
at the end of the study without knowledge of the biomechanical data. 
This study used parallel design in which the participants were randomly allocated to one type of 
treatment. The participants then followed the treatment, and their responses to the allocated 
treatment were monitored. At the end of the study, the groups were compared to investigate the 
effect of the treatments. This study design is commonly used in clinical trials to compare two or 
three types of treatment without any fear of learning effect or carryover effect, which may be 
experienced in crossover design. Therefore, to conduct a crossover study, longer periods between 
treatments are needed. These are called washout periods, and they reduce the carryover effect. The 
randomisation is considered the most important aspect to reduce the risk of bias and ensure the 
results are accurate with parallel group design. The parallel design was chosen over crossover 
design because parallel design does not require an equal number of participants in each group, has 
no learning or carryover effects, and requires shorter periods of time than crossover design. The 
researcher has limited time since this study is a part of his thesis. 
This study has a low sample size, and this could be a cause of accepting the null hypothesis as with 
pain. However, the researcher included all possible participants who met the inclusion and 
exclusion criteria in the limited study time. Observed power was calculated with SPPS for pain. 
The observed power was 0.49 for the interaction effect, which indicates low power. Power 
calculation was conducted via G-power to investigate how many participants were needed in each 
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group to find statistically significant differences interaction effect with an 80% power and an alpha 
level equal to 0.05 (Prajapati, Dunne, & Armstrong, 2010). The results revealed that 59 participants 
were needed to achieve 80% power, which was rounded to 60, with 20 participants in each group. 
More males than females were included in this study although both genders were invited equally. 
The duration of the treatment in the current study was 6 weeks, and it is likely that better results might 
be obtained in a longer period of time. The researcher measured the immediate biomechanical effect 
of the treatment and the effect after 6 weeks, which allowed a comparison to be made. However, 
clinical outcomes were only measured at baseline and after 6 weeks, and future studies are needed to 
collect data in between for better understanding of the results. Other outcome measurements were not 
included in the study, such as structural progression of the OA, because of limited time and resources. 
More than 6 weeks are needed to measure structural changes unless expensive MRI is used. 
Interestingly, when evaluating the role of a patellofemoral brace it was shown that this reduced 
patellofemoral bone marrow lesion size and pain after 6 weeks compared to control group with no 
treatment (Callaghan et al., 2015). However, to conduct such trial requires the use of MRI which is 
costly.  
Lastly, not including a control group with no treatment is a limitation to current study since all groups 
showed significant improvement in pain. Including such group will allow to more confidence that 
changes are caused by treatment and these changes are not observed in the control group. However, 
since the aim from combining the LWI and sleeve was to provide further reduction in pain compared 
to LWI and the limited time we though that including control group is not important. 
 Conclusion  
The aims of this study were to determine whether combining the lateral wedge insole with the knee 
sleeve provides greater improvement in pain than individual treatment (knee sleeve or lateral 
wedge insole) and whether these improvements are concurrent with knee loading reduction and 
muscle co-contraction reduction among individuals with medial knee OA. The literature review 
identified that while many studies have shown the biomechanical effects of the lateral wedge insole 
and the pain effect compared to baseline, the clinical effect (pain) was not significantly different 
than that of the control group (neutral insole). Combing the lateral wedge insole with the valgus 
brace showed better results than individual treatment. However, previous studies have showed a 
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low compliance with the valgus brace. Therefore, the simple knee sleeve could be an attractive 
solution if combined with the lateral wedge insole. No previous studies have investigated the effect 
of combining the knee sleeve and the lateral wedge insole on biomechanics, pain, muscle co-
contraction, and clinical outcomes in one study. It was hypothesised that combining the lateral 
wedge insole with the simple knee sleeve would have an effect on knee loading, pain, muscle co-
contraction, and clinical outcomes. 
The results of this study found that combining the lateral wedge insole with the simple knee sleeve 
is not superior in pain reduction to single treatment (simple knee sleeve or lateral wedge insole). 
However, there is a trend toward better improvement in pain and clinical outcomes as the combined 
treatment reduced EKAM by insole and muscle co-contraction by knee sleeve.  
The low statistical power might have caused accepting the overall null hypothesis in this study and 
thus future studies should include more subjects to test this hypothesis. Furthermore, structural 
changes need to be assessed in future studies to identify if the combined treatment (lateral wedge 
insole and knee sleeve) can reduce knee OA progression. 
It is also unknown if other types of sleeve might provide better clinical outcomes than the sleeve 
used in the current study. Therefore, future studies might investigate this. However, combining 
exercise with the simple knee sleeve and LWI might be an attractive and superior treatment to 
exercise alone as previous studies showed a reduction in co-contraction and pain with exercise but 
were not effective on knee loading (EKAM). In conclusion, the results of this study do give rise to 
a future combined study looking at simple and effective combined treatments for medial knee 
osteoarthritis.  
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 General conclusion and future studies  
 Summary  
The aim of this thesis was to determine the effectiveness of combined treatment (LWI and simple 
knee sleeve) on biomechanical and clinical outcomes and compare it to each treatment 
individually. In this thesis, the primary outcome measures of EKAM, pain and muscle co-
contraction were assessed alongside other clinical outcomes (i.e. balance, functional tests). 
The main driver for the current thesis is based on my own clinical and personal experience. As I 
am working as a lecturer and physiotherapist in Saudi Arabia, the standard and the core 
physiotherapy treatment for knee OA is exercises according to the Ministry of Health’ guideline 
in Saudi Arabia. My mother was diagnosed with knee OA 10 years ago and is suffering from it. 
This has motivated me to read more about the topic in order to deliver optimal treatment for such 
sufferers. In addition to physiotherapy treatment, analgesic medication is provided to patients to 
reduce pain, which may lead to increased loading and place the patient at higher risk of 
progression. Interestingly, previous research has shown that pathological loading is a key factor in 
the progression of knee OA. Therefore, targeting loading and pain may help reduce knee OA 
progression and improve physical activity levels. If it were possible to slow the progression, the 
cost of OA would be reduced, and if we were able to improve physical activity levels, the risk of 
complication and death due to inactivity would be reduced. 
Previous studies have shown that using biomechanical treatment such as LWI in individuals with 
knee OA reduces pain and joint loading (EKAM) significantly compared to baseline. However, 
pain reduction was not superior with LWI compared to the control treatment (neutral insole), which 
do not target EKAM. This may affect patient compliance and the treatment decisions of health 
practitioners, as they are driven by pain more than by mechanics. Reduction in pain and loading 
may be possible if LWI are combined with another treatment. This idea is in the line with NICE 
guidelines, which advocates the use of combined treatment, stating that patients naturally use 
combined treatments in their journey, and there is a need for more trials to investigate the effect of 
combined treatment (NICE, 2014). Previous studies have supported this idea, showing better 
effects for combined treatment (LWI + valgus brace) than for single treatment (Al-Zahrani et al., 
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2013b; Moyer et al., 2013). However, compliance with the valgus brace is low (Barnes, Cawley, 
& Hederman, 2002; Jones et al., 2013; Wilson et al., 2011), and there is no clinical benefit with 
no use. A more straightforward and easier option is a simple knee sleeve, which has been shown 
to reduce knee pain (Cudejko et al., 2018b) and muscle co-contraction (Collins et al., 2011).. 
Therefore, this thesis aimed to investigate the combined effect of LWI and a simple knee sleeve 
and compare this to the effect of each treatment individually among healthy individuals 
(biomechanical outcomes) and individuals with medial knee OA (biomechanical and clinical 
outcomes). 
To test the effect of any treatment on the outcome, the outcomes that are chosen should be reliable 
and sensitive to detect the change. Therefore, in chapter three, test re-test reliability studies were 
undertaken. The first study was to investigate reliability on healthy individuals, while the second 
one was on individuals with knee OA. The results revealed that most of the clinical and 
biomechanical outcomes have excellent reliability with low SEM. This made it possible to take 
the outcomes with good reliability forward to the next step to test the hypotheses. Furthermore, 
this allowed the researcher to make sure that changes observed later had already passed the 
measurement error. In addition to the reliability study in chapter three, it was necessary to choose 
the right LWI and sleeve based on selection criteria. The literature on LWI enabled the researcher 
to select the right LWI. However, there is limited research on knee sleeves, which motivated the 
design of clinical selection criteria based on a clinical overview to improve compliance. Three 
sleeves were selected and the sleeve that provided the best comfort and ease of use was chosen as 
the treatment in the current thesis. 
Before applying this treatment to individuals with knee OA, it was necessary to investigate the 
effect on healthy subjects (chapter four). This was as a concept prove study and to make sure not 
to place individuals with knee OA at any risk. Furthermore, there is limited knowledge about the 
effect of sleeves on EKAM, which highlights the importance of this study. Nineteen healthy 
participants were recruited to investigate the immediate effects of the four treatment conditions 
(knee sleeve, LWI, simple knee sleeve and LWI, control) in a randomised crossover study. The 
results of this study showed that LWI reduce EKAM, while knee sleeves were able to reduce the 
frontal plane knee ROM. Both effects were observed in the combined group, which might provide 
support and help reduce joint loading in individuals with knee OA. 
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In chapter five, following on from the previous study of healthy subjects, the effect of combining 
a simple knee sleeve with LWI was investigated in individuals with medial compartment OA. 
Thirty-four participants affected by medial knee OA were recruited and randomised into 3 groups, 
with 11 in the combined group, 11 in the sleeve group, and 12 in the LWI group. Each participant 
was assessed at baseline without the treatment, immediately after use of the treatment at baseline 
and after 6 weeks. The results showed no significant difference between the groups at baseline, 
which allowed a valid comparison to be conducted. The LWI group showed a significantly higher 
magnitude of change in EKAM than the sleeve group. The sleeve group showed a significantly 
higher magnitude of change in muscle co-contraction than the LWI group. The combined group 
showed both of the effects that were observed in the LWI and sleeve groups (EKAM and muscle 
co-contraction reduction). In the combined treatment group, the pain was reduced more than in the 
other groups (LWI, sleeve), which is thought to be due to combining the effect of both treatments, 
although the difference was not statistically significant. Most other outcomes (functional tests) 
followed the pain outcome by showing a better trend for the combined treatment group. 
This is the first study of its kind in Saudi Arabia. It highlights the need for the Ministry of Health 
to adopt biomechanical treatments such as LWI and knee sleeves to treat knee OA. This 
recommendation is further supported considering the low cost of both treatments and the low 
likelihood of adverse events. However, the main challenge in promoting such treatment is to 
improve the awareness of physiotherapists and clinical practitioners about biomechanical 
treatments. This can be achieved by conducting workshops and courses to improve 
physiotherapists’ and clinical practitioners’ understanding of biomechanical treatments and their 
mechanisms in treating individuals with knee OA. 
This study data will allow a multicentre trial with a larger sample and including a structural change 
outcome (i.e. MRI) to be conducted by the Ministry of Health in Saudi Arabia. Perhaps the next 
step is conducting a study that investigates the effect of combined treatment (LWI and simple knee 
sleeve) with physiotherapy treatment and compares it to physiotherapy treatment alone. This may 
help in further reducing knee OA pain by targeting it from different prospective, improving muscle 
strength, reducing pathological loading and improving physical activity levels. All of these factors 
may in turn have a high benefit for patients by reducing the progression of the disease and the 
effects of physical inactivity, which will lead to reducing expenditures on OA. 
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 Thesis novelty and strength 
No previous study has investigated the effect of combining LWI and a simple knee sleeve on 
biomechanical and clinical outcomes among individuals with knee OA. Thus, this is the first study 
to investigate the effect of combined treatment on the kinematics, kinetics and muscle co-
contraction in individuals with medial knee OA. Interestingly, this is the first study to investigate 
the effect of LWI in muscle co-contraction amongst individuals with knee OA. Moreover, this is 
the first study to compare the effects of LWI, a knee sleeve and combined treatment (LWI, simple 
knee sleeve) in individuals with knee OA. Conducting this trial is important for clinical practice 
because direct comparisons help practitioners identify the best treatment.  
This is the first study to investigate the effect of combined treatment (LWI and simple knee sleeve) 
and single treatment (LWI or simple knee sleeve) on dynamic balance (excursion balance test), 
functional tests and pain pressure threshold in individuals with medial knee OA and to compare 
combined treatment to each treatment individually.  
This is the first study to assess the effect of combined treatment (LWI and simple knee sleeve) in 
healthy individuals. Therefore, this is the first study to investigate four treatment conditions in 
kinematic, kinetics and muscle co-contraction while walking in a randomised crossover study. This 
involves EKAM, KAAI, KFM, muscle co-contraction, and knee sagittal and frontal angles. This 
is also the first study to investigate the effect of LWI and sleeves in muscle co-contraction among 
healthy individuals.  
This is the first study that has examined the reliability of dynamic balance via the modified star 
excursion test among individuals with medial knee OA. Furthermore, the reliability of muscle co-
contraction divided into three phases has not been previously investigated in individuals with 
medial knee OA. This will help researchers in future studies determine the reliability of these 
measurement and the measurement error.  
The outcome measures in the current thesis were selected based on the hypotheses. For example, 
EKAM was selected to reflect internal loading, as previous studies have shown that EKAM is 
correlated with loading and is a valid and reliable measurement for joint loading (Kutzner et al., 
2013; Schipplein & Andriacchi, 1991). Furthermore, muscle co-contraction has recently been 
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found to correlate with loading (Brandon et al., 2014; Sritharan et al., 2017; Winby et al., 2013) 
and may cause higher loading even if EKAM remains the same (Lu et al., 1997; Trepczynski et 
al., 2014). Moreover, Walter et al. (2010) highlighted that a reduction in EKAM may not guarantee 
a reduction in loading due to the increase in the knee flexion moment. This highlights the 
importance of combining several outcomes in the same study as EKAM, muscle co-contraction 
and the knee flexion moment, as it is important that a reduction in one outcome that reflects internal 
loading is not offset by an increase in another one. This underscores the strength of the current 
thesis for gaining a full picture and a better view of what is going on with treatment. This thesis 
will therefore add much knowledge to the current literature concerning healthy individuals and 
individuals with knee OA, which can help to inform practice for clinicians and experimenters. 
 Future studies 
In chapters four and five, the effect of LWI was investigated in healthy individuals and in 
individuals with knee OA while walking. However, to gain a better picture of the effect of LWI, 
one should look across activities rather than at only one activity to represent loading in everyday 
activities such as ascending and descending and going from sitting to standing. Stair negotiation 
is a frequent and common activity that is physiologically and biomechanically more challenging 
than level walking (Andriacchi, Andersson, Fermier, Stern, & Galante, 1980; Nadeau, McFadyen, 
& Malouin, 2003). In 2008, a study characterised knee loading across different activities (walking, 
ascending, descending, golf swings, sit to stand and stand to sit) and showed that ascending and 
descending stairs yields the highest knee compression force compared to other activities 
(Mündermann et al., 2008b). This higher loading in the stair negotiation activity might explain the 
result of a more recent study that showed that knee pain is more likely to first appear in the stair 
negotiation activity among individuals with knee OA or at high risk of knee OA (Hensor, Dube, 
Kingsbury, Tennant, & Conaghan, 2015). Trepczynski et al. (2014) stated that stair negotiation 
showed the highest medial compression force across activities, and it might offer increased 
sensitivity for the differential treatment effect.  
The study population in the current thesis were mostly male; only three females were included. 
This was due to regulations for male practitioners treating females in Saudi Arabia. A previous 
meta-analysis study showed that females have a higher prevalence, incidence and severity of knee 
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OA than males do (Srikanth et al., 2005b). Furthermore, recent studies have shown that females 
with knee OA are more prone to central sensitisation than males are (Bartley et al., 2016; Dell’Isola 
& Steultjens, 2018). The cause of gender differences in OA is not fully understood and could be 
attributed to hormonal, anatomical and genetic differences (Hame & Alexander, 2013). 
Interestingly, previous studies have shown contradicting results regarding EKAM, with one study 
showing no gender differences in EKAM among individuals with knee OA (McKean et al., 2007), 
while another study did show gender differences (Sims et al., 2009). However, the most important 
finding is that LWI is expected to reduce the EKAM with no difference between gender, which 
was shown in Chapman et al.’s (2015) study. While it was out of my control, including mostly 
males does affect the external validity of the study. The generalisability of the current thesis is 
therefore reduced, and the current results are more applicable to males. Future studies should 
include an equal or slightly higher number of females to males; Arthritis Research (2012) has 
shown that a slightly higher number of females are affected with knee OA compared to males in 
the UK. This will help improve the generalisability and applicability of the results to the general 
population. 
In the main study (OA study), the combined treatment (LWI and knee sleeve) and the individual 
treatments were conducted over 6 weeks, and it is not known if a longer period would provide 
better results. Therefore, future studies should investigate the effects of longer intervention periods 
to investigate whether pain and muscle co-contraction decrease further over time. 
In the study of healthy individuals and the knee OA study, the effect of a specific knee sleeve was 
based on a clinical selection criterion focusing on compliance. However, based on previous 
literature on knee sleeves, several mechanisms can be highlighted that may help in pain reduction 
(improve joint proprioception, reduce muscle co-contraction, improve joint stability and self-
confidence, joint compression) (Figure 3-5). Therefore, to gain more pain reduction and functional 
improvement these mechanisms should be the focus of the selection criteria in future studies. 
Moreover, it is not known if other types of sleeve provide different results. Therefore, future 
studies should compare the effects of different types of sleeves on biomechanical and clinical 
outcomes. 
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Interestingly, as stated earlier, several mechanisms could be attributed to pain reduction and 
improvement of physical function with sleeve use in knee OA individuals. Therefore, it is 
important for future studies to investigate the sleeve design and what can be changed to provide 
more pain reduction and more functional improvement. For example, proprioception could be 
improved by adding textured textile to the sleeve, and the effect could be measured by measuring 
joint position sense and movement sense. Other aspects of sleeve design that might help improve 
joint stability, muscle co-contraction and joint compression should be investigated, including 
materials and tightness of the sleeve. A study with a randomised crossover design should 
investigate this. This study design is superior to other designs because it controls between subject 
factors that might influence the results. The study should include outcomes such as muscle activity, 
joint ROM and a subjective questionnaire to measure stability and compression. One of the most 
important aspects of such a design is controlling for the carry-over effect by providing a sufficient 
wash-out period. 
One of the most important factors for physiotherapists is patient compliance with treatment 
because if patients are not using a treatment, there is no point in providing it. Sleeve design may 
play a key role in patient compliance and should be a focus of future studies. Based on the current 
study and previous experience, several factors can be pointed out, such as sleeve materials, ease 
of use, sleeve weight and sleeve thickness. The ideal sleeve design may be one that wraps around 
the joint, as this easier for knee OA patients than slip-on sleeves with soft materials and rubber 
edges to prevent the sleeve from moving down during activity. In addition, the sleeve should be 
light and thin so it is easy to wear under clothes like jeans, and it should not be too long, as a 
previous study showed that a long sleeve has less compliance that a short one (Keyaki & Toda, 
2010).   
Balance is controlled by the integration of sensory and motor neuromuscular components, and 
proprioception is among these factors and was measured in the current thesis. One of the main 
limitations of the current study is that the direct effect of treatment on proprioception via joint 
position sense and motion sense was not measured. It might be that the contribution of knee 
proprioception has a small effect on balance and therefore improvement in proprioception cannot 
be seen in dynamic balance unless a high change occurs. In addition, it might be that change in 
proprioception measured directly (motion sense, joint position sense) has better clinical value and 
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correlates with pain more than dynamic balance. Future studies should investigate the direct effect 
of treatment on proprioception.  
In experimental studies, the success of the treatment may depend on the treatment itself or on the 
selected population. Several studies have suggested that OA is a group of disorders with a similar 
end-point result (Dell’Isola, Allan, Smith, Marreiros, & Steultjens, 2016; Dell’Isola & Steultjens, 
2018; Paul A. Dieppe & Lohmander, 2005). These groups of disorders are called phenotypes and 
can be defined as the "observable properties of an organism" (Rieger, Michaeli, & Green, 1991). 
A recent systematic review identified and summarised previous knee OA study phenotypes 
(Dell’Isola et al., 2016). The study concluded that there are 6 phenotypes: chronic pain, 
inflammatory, metabolic, bone and cartilage mechanism, minimal joint disease and mechanical 
overload. Therefore, in order to optimise the treatment efficacy, it is necessary to tailor the 
treatment to each phenotype, which is consistent with the recommendation in the NICE guidelines 
(Driban, Sitler, Barbe, & Balasubramanian, 2010; Felson, 2010; Hinman & Crossley, 2007). The 
applicability of these phenotypes in the field was tested in a recent study, and the results showed 
that 84% of the patients were successfully allocated to one or more than one phenotype (complex 
OA) (Dell’Isola & Steultjens, 2018). Interestingly, in the chronic phenotype group, more females 
were allocated than males compared to other groups, and the widespread pain in this group 
indicates sensitivity and central sensitisation problems. Therefore, the success of the treatment 
may rely on the phenotype, and future studies should address these criteria in their participant 
selection to see if better improvement can be achieved. 
Current knee OA studies included the PASE questionnaire as a measurement for physical activity. 
Although physical activity was not neglected and was measured, more objective outcomes (i.e. 
accelerometers) might give better results. The questionnaire results might have been affected by 
patient recall, which could have affected the overall findings. This is less likely to be the case in 
the current study, as only the combined treatment group showed significant improvement in 
physical activity levels. However, using an activity monitor would help calculate cumulative 
loading, which is thought to increase the risk of knee OA (Coggon et al., 2000; Vignon et al., 
2006). This significant increase in physical activity in combined group could be a cause of not 
finding significant differences in pain between the groups. The basic mechanism behind this is that 
as pain decreases, participants become more active and load their joints more, which increases 
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their pain level. Therefore, one can assume if participants’ activity level is sustained, more 
reduction in pain would be seen.  
The current study used a parallel group design; however, this study design could be improved by 
using a crossover design, which would provide further control for between-subject variability. 
However, such a design needs to be carefully planned, and a suitable washout period is needed to 
prevent any carryover effect. It is recommended that future studies implement such a design to 
gain stronger evidence.  
Finally, the effect of combined treatment on structural changes has not been measured in the 
current study. The aim behind targeting joint loading (EKAM, muscle co-contraction) is to reduce 
the progression of the disease, and future studies should include structural changes such as bone 
marrow lesions as outcomes in a long-term study. If the combined treatment in the current study 
indeed reduces loading, a change in a bone marrow lesion would be seen. 
In summary, regarding the combined treatment, this study is only the beginning in this area. Future 
studies are needed to further investigate the effect of combined treatment longitudinally with a 
larger sample. The next study could be a randomised clinical trial to investigate the effect of 
combined treatment on individuals’ treatment and control treatment (no treatment). While this 
study most importantly assesses clinical findings, the mechanism of treatment should also be 
assessed biomechanically, structurally (MRI changes, e.g., bone marrow lesions) and determine 
changes in physical behaviour patterns (activity monitor). 
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 Reliability studies results for kinematics, kinetics and GRF 
data. 
Healthy reliability study: 
 
 
Within-session reliability for joints angles in gait cycle during walking for healthy participants. 
Walking - Joint Angle in degree 
(Within-session) ICC Mean 95% CI of ICC SEM SDD 
Hip x angle (1st peak) 0.99 30.88 0.98-0.99 0.49 1.35 
Hip x angle (Trough) 0.99 -6.35 0.97-0.99 0.43 1.20 
Hip x angle (2nd peak) 0.99 35.76 0.99-0.99 0.30 0.83 
Hip y angle (Maximum) 0.98 5.86 0.87-0.99 0.45 1.23 
Hip y angle (Minimum) 0.99 -7.67 0.98-0.99 0.23 0.64 
Hip z angle (Maximum) 0.97 3.54 0.82-0.99 1.06 2.93 
Hip z angle (Minimum) 0.98 -8.37 0.91-0.99 0.83 2.30 
Knee x angle (Initial contact) 0.96 2.09 0.82-0.99 0.69 1.91 
Knee x angle (Loading response) 0.96 17.99 0.80-99 1.00 2.76 
Knee x angle (Mid-stance) 0.97 5.57 0.87-0.99 0.63 1.74 
Knee x angle (Swing) 0.96 71.58 0.78-0.99 0.75 2.08 
Knee y angle (Maximum) 0.98 7.78 0.89-0.99 0.69 1.93 
Knee y angle (Minimum) 0.92 -3.70 0.61-0.99 1.11 3.06 
Knee z angle (Maximum) 0.99 1.76 0.98-0.99 0.22 0.61 
Knee z angle (Minimum) 0.98 -17.22 0.91-0.99 0.68 1.87 
Ankle x angle (Minimum) 0.99 19.45 0.97-0.99 0.26 0.71 
Ankle x angle (Maximum) 0.85 -9.50 0.26-0.97 0.76 2.12 
Ankle y angle (Maximum) 0.99 8.52 0.96-0.99 0.39 1.09 
Ankle y angle (Minimum) 0.94 -5.27 0.70-.99 0.41 1.15 
X=sagittal plane (flexion-extension), Y=frontal plane (adduction-abduction), Z=transverse plane 
(internal rotation-external rotation) 
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Within-session reliability for joints moments and ground reaction force in stance during walking 
for healthy participants. 
Walking - Joint Moment (Nm/Kg) 
and GRF (*BW) (Within-session) ICC Mean 95% CI of ICC SEM SDD 
Hip x moment (Maximum) 0.99 1.12 0.97-0.99 0.03 0.07 
Hip x moment (Minimum) 0.97 -0.61 0.86-0.99 0.03 0.07 
Hip y moment (1st Peak) 0.99 0.88 0.92-0.99 0.01 0.04 
Hip y moment (Trough) 0.99 0.55 0.95-0.99 0.01 0.03 
Hip y moment (2nd Peak) 0.99 0.89 0.96-0.99 0.01 0.03 
Hip z moment (Maximum) 0.99 0.26 0.98-0.99 0.01 0.02 
Hip z moment (Minimum) 0.99 -0.12 0.94-0.99 0.01 0.02 
Knee x moment (Maximum) 0.98 0.54 0.87-0.99 0.02 0.04 
Knee x moment (Minimum) 0.97 -0.66 0.87-0.99 0.03 0.08 
Knee z moment (Maximum) 0.99 0.06 0.93-0.99 0.005 0.01 
Knee z moment (Minimum) 0.99 -0.16 0.99-0.99 0.004 0.01 
Ankle x moment (Maximum) 0.98 1.53 0.90-0.99 0.03 0.07 
Ankle x moment (Minimum) 0.97 -0.21 0.86-0.99 0.01 0.03 
Angle y moment (Maximum) 0.98 0.11 0.92-0.99 0.01 0.03 
Ankle y moment (Minimum) 0.95 -0.16 0.74-0.99 0.02 0.06 
GRF (1st Peak) 0.99 1.10 0.96-0.99 0.01 0.02 
GRF (Trough) 0.99 0.72 0.96-0.99 0.01 0.02 
GRF (2nd Peak) 0.99 1.08 0.97-0.99 0.01 0.02 
X=sagittal plane (flexion-extension), Y=frontal plane (adduction-abduction), Z=transverse plane 
(internal rotation-external rotation) 
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Between-session reliability for joints angles in gait cycle during walking for healthy participants. 
Walking – Joint Angle in degree 
(Between-session) ICC Mean 95% CI of ICC SEM SDD 
Hip x angle (1st peak) 0.92 33.74 0.76-0.97 2.20 6.10 
Hip x angle (Trough) 0.86 -4.81 0.59-0.95 2.25 6.25 
Hip x angle (2nd peak) 0.88 39.64 0.65-0.96 2.63 7.29 
Hip y angle (Maximum) 0.83 6.40 0.49-0.94 0.98 2.71 
Hip y angle (Minimum) 0.73 -7.41 0.20-0.91 1.21 3.35 
Hip z angle (Maximum) 0.91 6.07 0.73-0.97 1.81 5.03 
Hip z angle (Minimum) 0.92 -7.35 0.75-0.97 1.84 5.09 
Knee x angle (Initial contact) 0.79 1.55 0.38-0.93 2.22 6.16 
Knee x angle (Loading response) 0.91 17.55 0.73-0.97 2.10 5.81 
Knee x angle (Mid-stance) 0.85 4.98 0.60-0.95 1.61 4.46 
Knee x angle (Swing) 0.82 72.40 0.46-0.94 2.38 6.61 
Knee y angle (Maximum) 0.94 8.41 0.82-0.98 1.31 3.63 
Knee y angle (Minimum) 0.81 -4.68 0.45-0.94 1.24 3.45 
Knee z angle (Maximum) 0.67 2.39 0.01-0.89 1.97 5.47 
Knee z angle (Minimum) 0.79 -18.15 0.37-0.93 2.20 6.10 
Ankle x angle (Minimum) 0.90 20.47 0.70-0.97 0.67 1.85 
Ankle x angle (Maximum) 0.86 -11.46 0.60-0.96 1.30 3.59 
Ankle y angle (Maximum) 0.96 7.11 0.88-0.99 0.65 1.80 
Ankle y angle (Minimum) 0.82 -5.32 0.46-0.94 0.76 2.10 
X=sagittal plane (flexion-extension), Y=frontal plane (adduction-abduction), Z=transverse plane 
(internal rotation-external rotation) 
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Between-session reliability for joints moments and ground reaction force in stance during 
walking for healthy participants. 
Walking - Joint Moment (Nm/Kg) 
and GRF (*BW) (Between-session) ICC Mean 95% CI of ICC SEM SDD 
Hip x moment (Maximum) 0.98 1.13 0.92-0.99 0.05 0.14 
Hip x moment (Minimum) 0.94 -0.65 0.81-0.98 0.04 0.11 
Hip y moment (1st Peak) 0.96 0.85 0.87-0.99 0.03 0.09 
Hip y moment (Trough) 0.94 0.48 0.81-0.98 0.03 0.08 
Hip y moment (2nd Peak) 0.94 0.85 0.82-0.98 0.04 0.10 
Hip z moment (Maximum) 0.94 0.30 0.83-0.98 0.03 0.07 
Hip z moment (Minimum) 0.86 -0.11 0.57-0.95 0.03 0.08 
Knee x moment (Maximum) 0.94 0.55 0.83-0.98 0.03 0.08 
Knee x moment (Minimum) 0.88 -0.64 0.64-0.96 0.08 0.23 
Knee z moment (Maximum) 0.78 0.06 0.35-0.93 0.02 0.05 
Knee z moment (Minimum) 0.93 -0.17 0.80-0.98 0.02 0.05 
Ankle x moment (Maximum) 0.97 1.51 0.90-0.99 0.03 0.08 
Ankle x moment (Minimum) 0.86 -0.22 0.59-0.95 0.02 0.06 
Angle y moment (Maximum) 0.75 0.08 0.24-0.91 0.03 0.09 
Ankle y moment (Minimum) 0.63 -0.17 -0.11-0.88 0.05 0.15 
GRF (1st Peak) 0.99 1.11 0.96-0.99 0.02 0.04 
GRF (Trough) 0.96 0.70 0.88-0.99 0.02 0.05 
GRF (2nd Peak) 0.98 1.08 0.94-0.99 0.01 0.04 
X=sagittal plane (flexion-extension), Y=frontal plane (adduction-abduction), Z=transverse plane 
(internal rotation-external rotation) 
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Knee OA reliability study: 
 
 
Between-day reliability for joints ROM in a gait cycle during walking for participants with knee 
OA. 
ROM in degree ICC Mean 95% CI of ICC SEM SDD 
Hip x ROM 0.97 40.80 0.97-0.99 1.15 3.18 
Hip y ROM 0.96 12.82 0.93-0.99 0.94 2.61 
Hip z ROM 0.90 11.66 0.57-0.97 0.79 2.20 
Knee x ROM 0.99 70.53 0.97-0.99 0.84 2.31 
Knee y ROM 0.87 10.81 0.43-0.97 1.29 3.57 
Knee z ROM 0.92 18.90 0.64-0.98 1.10 3.04 
Ankle x ROM 0.93 31.85 0.70-0.98 1.16 3.21 
Ankle y ROM 0.96 13.50 0.83-0.99 0.62 1.71 
X=sagittal plane (flexion-extension), Y=frontal plane (adduction-abduction), Z=transverse plane 
(internal rotation-external rotation) 
 
Between-day reliability for joints angles during walking in a gait cycle during walking for 
participants with knee OA. 
Joint angle in degree ICC mean 95% CI of ICC SEM SDD 
Hip x angle (1st peak) 0.96 33.77 0.82-0.99 1.24 3.45 
Hip x angle (Trough) 0.98 -0.14 0.89-0.99 1.10 3.06 
Hip x angle (2nd peak) 0.91 40.64 0.619-0.98 1.96 5.44 
Hip y angle (Maximum) 0.79 5.60 -0.57-0.96 1.23 3.42 
Hip y angle (Minimum) 0.76 -7.12 -0.64-0.95 2.05 5.68 
Hip z angle (Maximum) 0.77 2.35 -0.02-0.95 2.41 6.69 
Hip z angle (Minimum) 0.83 -9.31 0.23-0.96 2.12 5.88 
Knee x angle (Initial contact) 0.91 -0.08 61-98 1.57 4.36 
Knee x angle (Loading response) 0.97 14.00 85-99 1.24 3.45 
Knee x angle (Mid-stance) 0.97 6.60 87-99 1.06 2.94 
Knee x angle (Swing) 0.97 67.95 85-99 1.44 3.99 
Knee y angle (Maximum) 0.84 6.49 0.27-0.96 1.42 3.95 
Knee y angle (Minimum) 0.43 -4.03 -1.84-0.49 2.08 5.78 
Knee z angle (Maximum) 0.90 -1.33 0.55-0.98 1.34 3.70 
Knee z angle (Minimum) 0.90 -20.24 0.54-0.98 1.39 3.86 
Ankle x angle (Minimum) 0.96 -11.53 0.84-0.99 1.03 2.85 
Ankle x angle (Maximum) 0.96 20.33 0.82-0.99 0.73 2.02 
Ankle y angle (Maximum) 0.93 7.34 0.70-0.98 0.90 2.49 
Ankle y angle (Minimum) 0.58 -6.16 -0.85-0.91 0.84 2.34 
X=sagittal plane (flexion-extension), Y=frontal plane (adduction-abduction), Z=transverse plane 
(internal rotation-external rotation) 
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Between-day reliability for joints moments and ground reaction force in a stance during walking 
for participants with knee OA. 
Joint Moment (Nm/Kg), KAAI 
(Nm/kg*s) and GRF (*BW) ICC mean 95% CI of ICC SEM SDD 
Hip x moment (Maximum) 0.95 1.00 0.76-0.99 0.062 0.17 
Hip x moment (Minimum) 0.92 -0.81 0.64-0.98 0.072 0.20 
Hip y moment (1st Peak) 0.70 0.97 -0.37-0.93 0.089 0.25 
Hip y moment (Trough) 0.92 0.63 0.64-0.98 0.036 0.10 
Hip y moment (2nd Peak) 0.82 0.84 0.18-0.96 0.050 0.14 
Hip z moment (Maximum) 0.94 0.36 0.71-0.99 0.025 0.07 
Hip z moment (Minimum) 0.93 -0.07 0.68-0.98 0.011 0.03 
Knee x moment (Maximum) 0.99 0.49 0.93-0.99 0.017 0.05 
Knee x moment (Minimum) 0.98 -0.53 0.91-0.99 0.041 0.11 
Knee z moment (Maximum) 0.99 0.08 0.95-0.99 0.005 0.01 
Knee z moment (Minimum) 0.90 -0.13 0.53-0.98 0.020 0.05 
Ankle x moment (Maximum) 0.94 1.45 0.74-0.99 0.038 0.11 
Ankle x moment (Minimum) 0.94 -0.21 0.73-0.99 0.025 0.07 
Angle y moment (Maximum) 0.83 0.16 0.26-0.96 0.030 0.08 
Ankle y moment (Minimum) 0.90 -0.10 0.55-0.98 0.016 0.04 
GRF (1st  Peak) 0.96 1.15 0.80-0.99 0.023 0.06 
GRF (Trough) 0.98 0.78 0.93-0.99 0.020 0.05 
GRF (2nd Peak) 0.99 1.08 0.95-0.99 0.007 0.02 
X=sagittal plane (flexion-extension), Y=frontal plane (adduction-abduction), Z=transverse plane 
(internal rotation-external rotation) 
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 Main study kinematics, kinetics, GRF, COP and PASE data and 
other KOOS subscales data. 
- Knee moment in sagittal plane  
- External knee extension moment: 
The data showed mild deviation in normality and inequality of variance. The transformations 
(RMS, log10, Ln) were successful in producing equality of variance. The results of two way-mixed 
ANOVA, between groups test (one-way ANOVA), and within group test (repeated-measures 
ANOVA) for the transformed data and the non-transformed data were similar. Furthermore, the 
non-parametric tests between and within groups were similar to the parametric tests (transformed 
and non-transformed). Therefore, for easier interpretation of the results, the parametric test was 
used on the non-transformed data. The descriptive data is presented in Table E-1. 
Within each group 
Repeated-measures ANOVA showed a significant effect for the time within the combined group 
(p<0.01) but not for the sleeve (p=0.57) or LWI (p=0.17) group. Immediate effect in the combined 
group showed significant lower extension moment compared to baseline (p<0.01) and after 6 
weeks (p=0.02) (Figure E-1). 
Between the groups 
One-way ANOVA showed significant difference between the groups in the knee extension 
moment at baseline (p=0.01) but not after immediate use of the treatment (p=0.07) or after 6 
weeks’ use (p=0.06). Pairwise comparison showed that the combined group had significantly 
higher extension moment compared to the LWI group only (p=0.04).  
- Knee flexion moment 
Two way-mixed ANOVA 
ANOVA showed no significant effect for groups in the knee flexion moment (p=0.24). Neither the 
time (p=0.45) nor the interaction between group and time showed any significance (p=0.40). The 
descriptive data is presented in Table E-1.  
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Within each group 
Repeated-measures ANOVA showed no significant effect for the time within the combined group 
(p=0.75), the sleeve group (p=0.94), or the LWI group (p=0.19) (Figure E-1). 
Between the groups 
One-way ANOVA showed no significant difference between the groups in the baseline (p=0.27), 
immediate effect (p=0.25), or 6 weeks (p=0.20). 
Table E-1 Mean (SD) of knee joint moments in frontal plane for combined, sleeve and LWI groups. 
Mean 
(SD). 
Nm/kg 
Week one Week 6 
Combined group Sleeve group LWI group Combined group 
Sleeve 
group 
LWI 
group 
Shod 
Shod + 
combine
d 
treatment 
Shod 
Shod + 
sleeve 
treatment 
shod 
shod + 
LWI 
treatment 
Shod + 
combined 
treatment 
Shod + 
sleeve 
treatment 
Shod + 
LWI 
treatme
nt 
Maximum 
extension 
moment 
0.41 
(0.15) 
l 
0.34 
(0.11)  
Q t 
0.43 
(0.20) 
0.41 
(0.15) 
0.27 
(0.09) 
0.28 
(0.10) 
0.39 
(0.13) 
0.41 
(0.13) 
0.30 
(0.10) 
Maximum 
flexion 
moment 
-0.61 
(0.34) 
-0.62 
(0.35) 
-0.41 
(0.27) 
-0.42 
(0.28) 
-0.56 
(0.26) 
-0.59 
(0.25) 
-0.63 
(0.36) 
-0.41 
(0.25) 
-0.51 
(0.22) 
l significant compared to LWI  
Q significant compared to baseline 
t significant compared to 6 weeks 
 
 
Figure E-1 Mean (SD) of knee joint moment in frontal plane for combined (a), sleeve (b) and LWI (c) 
groups. 
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- Vertical GRF 
The EKAM is contributed to from the magnitude of the GRF Therefore, it is important to monitor 
the GRF and assess if any change occurred between the groups and across time within each group. 
- First peak of GRF 
Two way-mixed ANOVA 
The groups (p=0.33) and time (p=0.58) had no significant effect on first peak GRF. There was no 
significant interaction between group and time on the first peak GRF (p=0.38). The descriptive 
data is presented in Table E-2. 
Within each group 
No significant difference was identified within the combined group (p=0.60), the sleeve group 
(p=0.55), or the LWI group (p = 0.19) via repeated measures ANOVA (Figure E-2).  
Between the groups 
One-way ANOVA showed no significant difference between the groups in the first peak GRF at 
baseline (p=0.29), immediate (p=0.38), or 6 weeks (p=0.33). 
- GRF trough 
Two way-mixed ANOVA 
The data showed that the group had no significant effect on trough GRF (p=0.38). Neither the time 
(p=0.56) nor the interaction between the time and group (p=0.46) showed any significant change. 
The descriptive data is presented in Table E-2.  
Within each group 
Repeated-measures ANOVA was conducted and showed no significant change within the 
combined group (p=0.44), the sleeve group (p=0.53), or the LWI group (p=0.57) (Figure E-2). 
Between the groups 
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No significant difference was identified between the groups in the trough at baseline (p=0.25), 
immediate (p=0.52), or 6 weeks (p=0.43) using one-way ANOVA. 
- Second peak of GRF 
Two way-mixed ANOVA 
The groups had no significant effect on the second peak of GRF (p=0.40), and there was no 
significant interaction between group and time (p=0.23). The time showed significant effect on 
second peak EKAM (p<0.01). The descriptive data is presented in Table E-2. 
Within each group 
Repeated-measures ANOVA showed significant difference within the combined group, the sleeve 
group, and the LWI group, with p-value equal to p<0.01, p<0.01, and p=0.02, respectively. 
Pairwise comparison showed significant increase in second peak GRF for the combined group 
between baseline and immediate effect (p<0.01) and baseline and 6 weeks (p<0.01). Similar results 
were revealed by pairwise comparison for the sleeve group, showing significant increase in second 
peak GRF between baseline and immediate effect (p=0.03) and baseline and 6 weeks (p=0.03). In 
the LWI group, only the immediate use showed significant increase in second peak GRF compared 
to baseline (p=0.048) as identified by pairwise comparison (Figure E-2). 
Between the groups 
One-way ANOVA showed no significant difference in the second peak EKAM between the groups 
at baseline (p=0.45), immediate (p=0.38), and 6 weeks (p=0.33). 
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Table E-2 Mean (SD) of GRF (1st peak, trough, 2nd peak) for combined, sleeve and LWI groups. 
Mean 
(SD). 
*BW 
Week one Week 6 
Combined group Sleeve group LWI group Combined group 
Sleeve 
group 
LWI 
group 
Shod 
Shod + 
combined 
treatment 
Shod 
Shod + 
sleeve 
treatment 
shod 
shod + 
LWI 
treatment 
Shod + 
combined 
treatment 
Shod + 
sleeve 
treatment 
shod + 
LWI 
treatm
ent 
1st peak 1.17 (0.08) 
1.16 
(0.08) 
1.10 
(0.12) 
1.10 
(0.13) 
1.12 
0.12 
1.11 
(0.11) 
1.17 
(0.10) 
1.11 
(0.14) 
1.10 
(0.11) 
Trough 0.75 (0.07) 
0.77 
0.08 
0.81 
(0.09) 
0.81 
(0.11) 
0.80 
(0.08) 
0.80 
(0.08) 
0.76 
(0.09) 
0.80 
(0.12) 
0.81 
(0.07) 
2nd 
peak 
1.05 
(0.05) 
1.16 
(0.08)  
Q 
1.02 
(0.08) 
1.10 
(0.13)  
Q 
1.05 
(0.07) 
1.11 
(0.11)  
Q 
1.17 
(0.10) 
 Q 
1.11 
(0.14)  
Q 
1.10 
(0.11) 
Q significant compared to baseline 
 
 
 
Figure E-2 Mean (SD) of GRF for combined (a), sleeve (b) and LWI (c) groups. 
 
- Kinematics results: 
- Temporal and special data: 
- Speed: 
Two way-mixed ANOVA 
There was no significant effect for the duration of intervention (time) and the groups (combined 
group, sleeve group, LWI group) on the walking speed (p=0.51 and p=0.86, respectively). Neither 
was there any interaction between group and time (p=0.06). The descriptive data is presented in 
Table E-3.  
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Within each group 
The treatment had no significant effect on the speed within the groups (combined group, p=0.06; 
sleeve group, p=0.53; LWI group, p=0.70).  
Between the groups 
The difference in speed between the groups did not reach significant levels at baseline (p=0.69), 
immediate effect (p=0.97), or after 6 weeks (p=0.75) when conducting one-way ANOVA. 
- Stance time 
Two way-mixed ANOVA 
For the stance time, the group had no significant effect (p=0.98); neither was there a significant 
interaction between group and time (p=0.47) while the time showed significant effect (p=0.013). 
The descriptive data is presented in Table E-3. 
Within each group 
Repeated-measures ANOVA showed a significant difference in the time within the combined 
group (p=0.04). However, no significant change was observed for the sleeve group (p=0.51) or the 
LWI group (p=0.21). Bonferroni and Sidak adjustments failed to show any significant difference 
within the combined group. Further investigation showed significant increase in stance time only 
between baseline and immediate effect (p=0.02) using LSD adjustment. 
Between the groups 
When comparing the groups at baseline (p=0.92), immediate effect (p=0.89), and after 6 weeks 
(p=0.96), one-way ANOVA showed no significant difference in the swing time.  
- Swing time 
Two way-mixed ANOVA 
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There was no significant effect on swing time for the groups (p=0.48), and the time showed no 
significant effect on swing time (p=0.49). However, there was an interaction between group and 
time (p=0.02) on the swing time. The descriptive data is presented in Table E-3. 
Within each group 
Repeated-measures ANOVA showed no significant difference to the time with the combined 
group (p=0.26) or the sleeve group (p=0.61). The LWI group showed significant effect to the swing 
time (p=0.02). However, Bonferroni and Sidak adjustments failed to show any significant 
difference within the LWI group times. Further investigation showed significant reduction in 
swing time between baseline and immediate effect (p=0.03) and baseline and 6 weeks (p=0.04) 
using LSD adjustment. 
Between the groups 
One-way ANOVA showed no significant difference between the groups across the three timelines 
(baseline, p=0.29; immediate effect, p=0.48; 6 weeks, p=0.43).  
Table E-3 Mean (SD) of temporal and spatial data for combined, sleeve and LWI groups. 
Q significant compared to baseline 
- Knee angle in sagittal plane: 
Two way-mixed ANOVA 
Mean 
(SD). 
 
Week one Week 6 
Combined group Sleeve group LWI group Combined group 
Sleeve 
group 
LWI 
group 
Shod 
Shod + 
combine
d 
treatment 
Shod 
Shod + 
sleeve 
treatment 
Shod 
shod + 
LWI 
treatment 
Shod + 
combined 
treatment 
Shod + 
sleeve 
treatment 
Shod + 
LWI 
treatmen
t 
Speed 
(m/s) 
1.22 
(0.18) 
1.16 
(0.15) 
1.15 
(0.24) 
1.17 
(0.23) 
1.15 
(0.24) 
1.15 
(0.24) 
1.22 
(0.17) 
1.15 
(0.26) 
1.17 
(0.21) 
Stance 
time  
(second) 
0.69 
(0.07) 
0.73 
(0.06) 
Q 
0.70 
(0.07) 
0.71 
(0.06) 
0.71 
(0.11) 
0.73 
(0.12) 
0.71 
(0.08) 
0.72 
(0.07) 
0.72 
(0.10) 
Swing 
time  
(second) 
0.43 
(0.04) 
0.43 
(0.03) 
0.42 
(0.03) 
0.42 
(0.02) 
0.45 
(0.04) 
0.43 
(0.03) 
Q 
0.44 
(0.04) 
0.42 
(0.03) 
0.43 
(0.03) 
Q 
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The group had no significant effect and ANOVA showed no interaction between group and time 
on the knee angle at initial contact, the maximum knee flexion angle at loading response, the 
minimum knee flexion angle at mid-stance, the maximum knee flexion angle at swing, or the knee 
sagittal plane ROM (p≥0.05). The time showed no significant effect on the knee maximum flexion 
angle at loading response, the minimum knee flexion angle at mid-stance, the maximum knee 
flexion angle at swing, or the knee sagittal plane ROM (p≥0.05). In contrast the time showed 
significant effect on the knee angle at initial contact (p<0.05). (Table E-4).  
Within each group 
Repeated measures ANOVA showed no significant difference in the time for the combined group, 
the sleeve group, or the LWI group in the knee angle at initial contact, the maximum knee flexion 
angle at loading response, the minimum knee flexion angle at mid-stance, the maximum knee 
flexion angle at swing, or the knee sagittal plane ROM (p≥0.05) (Figure E-3) 
Between the groups 
The initial contact angle, the maximum knee angle at loading response, the knee extension angle 
at mid-stance, maximum knee flexion angle at mid swing, and the knee ROM showed no 
significant difference between the groups at baseline, immediate effect, or 6 weeks (p≥0.05) 
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Table E-4 Mean (SD) of knee joint angles in sagittal plane for combined, sleeve and LW groups. 
 
 
Figure E-3 Mean (SD) of knee joint angle in sagittal plane for combined (a), sleeve (b) and LWI (c) groups. 
- Knee angle in frontal plane: 
- Maximum adduction angle 
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Mean 
(SD). 
degree 
Week one Week 6 
Combined group Sleeve group LWI group Combined group 
Sleeve 
group 
LWI 
group 
Shod 
Shod + 
combined 
treatment 
Shod 
Shod + 
sleeve 
treatme
nt 
Shod 
shod + 
LWI 
treatme
nt 
Shod + 
combined 
treatment 
Shod + 
sleeve 
treatment 
Shod + 
LWI 
treatment 
IC 2.75 (4.04) 
2.30 
(3.93) 
-1.29 
(4.85) 
-1.80 
(4.87) 
-0.12 
(3.38) 
-0.29 
(3.50) 
1.49 
(4.29) 
-1.88 
 (5.92) 
-1.33  
(3.27) 
Maximum 
flexion 
angle at 
lading 
response 
16.18 
(7.11) 
16.57 
(7.27) 
12.62 
(7.4) 
12.34 
(7.45) 
17.28 
(6.57) 
17.44 
(6.93) 
15.58 
 (7.53) 
12.35 
(7.29) 
16.24 
(6.07) 
Minimum 
mid-
stance 
flexion 
angle 
5.31 
(6.00) 
6.22 
(5.74) 
5.12 
(5.1) 
4.50  
(4.86) 
9.95 
(8.82) 
10.22 
(8.84) 
4.57 
(6.09) 
5.57  
(5.57) 
9.32  
(8.00) 
Maximum 
flexion 
angle at 
swing 
67.73 
(4.59) 
68.52 
(4.54) 
64.42 
(5.6) 
63.58 
(5.79) 
66.40 
(6.27) 
67.61 
(5.89) 
67.49 
 (4.82) 
62.67 
(4.96) 
66.82 
(5.45) 
ROM 68.15 (4.76) 
68.56 
(3.83) 
66.49 
(6.43) 
65.72 
(6.16) 
63.54 
(7.85) 
64.89 
(7.51) 
67.96  
(4.42) 
64.89 
(4.96) 
64.67 
(6.13) 
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Two way-mixed ANOVA 
The group and time showed no significant effect on the maximum adduction angle, maximum 
abduction angle, or the knee frontal plane ROM (p≥0.05). Neither was there any interaction 
between the group and the time on the maximum adduction angle, maximum abduction angle, or 
knee frontal plane ROM using ANOVA (p≥0.05). The descriptive data is presented in Table E-5. 
Within each group 
Repeated-measures ANOVA showed no significant change in the maximum adduction angle, 
maximum abduction angle, or the knee frontal plane ROM after using the treatment within the 
combined group, sleeve group, or LWI group (p≥0.05) (Figure E-4). 
Between the groups 
The difference in the maximum adduction angle, maximum abduction angle, and knee frontal 
plane ROM between the groups was not statistically significant at baseline, immediate use, or after 
6 weeks (p≥0.05). 
Table E-5 Mean (SD) of knee joint angles in frontal plane for combined, sleeve and LWI groups. 
 
Mean 
(SD). 
degree 
Week one Week 6 
Combined group Sleeve group LWI group Combined group 
Sleeve 
group 
LWI 
group 
Shod 
Shod + 
combined 
treatment 
Shod 
Shod + 
sleeve 
treatment 
Shod 
shod + 
LWI 
treatment 
Shod + 
combined 
treatment 
Shod + 
sleeve 
treatment 
Shod + 
LWI 
treatment 
Maximum 
adduction 
7.44 
(4.60) 
6.23 
(4.56) 
6.31 
(6.31) 
5.42 
(5.70) 
5.68 
(4.18) 
5.33 
(3.81) 
7.53 
(5.28) 
6.48 
(6.25) 
5.70 
(4.86) 
Maximum 
abduction 
-4.91 
(3.98) 
-4.05 
(3.67) 
-4.70 
(4.72) 
-4.64 
(4.87) 
-5.91 
(4.20) 
-6.37 
(4.22) 
-3.04 
(3.51) 
-4.95 
 (5.26) 
-7.33 
(5.02) 
ROM 12.35 (3.08) 
10.28 
(3.58) 
11.01 
(3.56) 
10.06 
(2.60) 
11.59 
(3.73) 
11.70 
(3.82) 
10.58 
(3.25) 
11.42 
(4.11) 
13.03 
(4.48) 
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Figure E-4 Mean (SD) of knee joint angle in sagittal plane for combined (a), sleeve (b) and LWI (c) groups. 
- Ankle angle in sagittal plane 
Two way-mixed ANOVA 
The group and time had no significant effect and ANOVA showed no interaction between group 
and time in the ankle maximum dorsiflexion angle, maximum planter flexion angle, or ankle 
sagittal plane ROM (p≥0.05). The descriptive data is presented in Table E-6. 
Within each group 
Repeated-measures ANOVA showed no significant change within the combined group, the sleeve 
group, and the LWI group in the ankle maximum dorsiflexion angle, maximum planter flexion 
angle, or ankle sagittal plane ROM (p≥0.05) (Figure E-5). 
Between the groups 
The ankle maximum dorsiflexion angle, maximum planter flexion angle, and ankle sagittal plane 
ROM did not differ between the groups at baseline, immediate effect, or 6 weeks (p≥0.05). 
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Table E-6 Mean (SD) of ankle joint angles in sagittal plane for combined, sleeve and LWI groups. 
 
 
Figure E-5 Mean (SD) of ankle joint angle in sagittal plane for combined (a), sleeve (b) and LWI (c) groups. 
- Ankle angle in frontal plane. 
Two way-mixed ANOVA 
The interaction between the group and time was not significant in the maximum inversion angle, 
maximum eversion angle, or ankle frontal plane ROM (p≥0.05). The data showed that the group 
had no significant effect on the maximum inversion angle, maximum eversion angle, or ROM 
(p≥0.05). The time showed significant effect on the maximum inversion angle and ROM (p<0.05) 
but not on the maximum eversion angle (p≥0.05). The descriptive data is presented in Table E-7. 
Within each group 
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Mean (SD). 
degree 
 
Week one Week 6 
Combined group Sleeve group LWI group  
Shod + 
combine
d 
treatment 
 
Shod + 
sleeve 
treatment 
 
shod + 
LWI 
treatment 
Shod 
Shod + 
combine
d 
treatment 
Shod 
Shod + 
sleeve 
treatmen
t 
Shod 
shod + 
LWI 
treatmen
t 
Maximum 
dorsiflexion 
19.87 
(2.62) 
20.21 
(2.52) 
18.79 
(2.08) 
18.17 
(2.50) 
19.83 
(3.29) 
20.23 
(3.72) 
20.11 
(2.31) 
19.95 
(3.31) 
20.17 
(3.73) 
Maximum 
plantar 
flexion 
-8.40 
(4.09) 
-8.00 
(3.61) 
-8.75 
(4.16) 
-9.22 
(4.73) 
-8.37 
(4.66) 
-7.58 
(4.45) 
-8.60 
(4.22) 
-7.82 
(3.90) 
-8.13 
(4.94) 
ROM 28.27 (4.82) 
28.20 
4.73) 
27.54 
(3.32) 
27.38 
(3.31) 
28.57 
(2.35) 
28.16 
(3.27) 
28.72 
(5.08) 
27.77 
(3.29) 
28.79 
(3.36) 
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After using the treatment for 6 weeks, there was no statistically significant effect on the maximum 
inversion angle or the maximum eversion angle in all groups (p≥0.05). The ankle frontal plane 
ROM showed significant change within the LWI group (p<0.05), but not for the combined group 
or the sleeve group (p≥0.05). Pairwise comparison showed significant increase in ankle frontal 
plane ROM between baseline and immediate effect (p<0.01) and between baseline and 6 weeks 
(p<0.01) (Figure E-6). 
Between the groups 
The difference between the groups in the maximum inversion angle, maximum eversion angle, 
and ROM at baseline, after immediate use of the treatment, and after 6 weeks’ use of the treatment 
did not reach a statistically significant level (p<0.05). 
Table E-7 Mean (SD) of ankle joint angles in frontal plane for combined, sleeve and LWI groups. 
Q significant compared to baseline 
 
Mean 
(SD). 
degree 
 
Week one Week 6 
Combined group Sleeve group LWI group  
Shod + 
combined 
treatment 
 
Shod + 
sleeve 
treatmen
t 
 
shod + 
LWI 
treatment 
Shod 
Shod + 
combined 
treatment 
Shod 
Shod + 
sleeve 
treatment 
Shod 
shod + 
LWI 
treatment 
Maximum 
inversion 
9.00 
(3.67) 
9.60 
(4.11) 
7.96 
(2.74) 
9.48 
(4.70) 
8.60 
(3.35) 
9.49 
(3.23) 
9.75 
(3.67) 
9.05 
(3.41) 
10.26 
()3.58 
Maximum 
eversion  
-4.74 
(2.04) 
-5.09 
(2.22) 
-5.37 
(2.34) 
-5.34 
(3.05) 
-3.85 
(2.52) 
-4.56 
(2.81) 
-4.67 
(2.23) 
-5.10 
(1.97) 
-4.84 
(2.98) 
ROM 13.75 (3.32) 
14.69 
(3.28) 
13.34 
(2.26) 
14.82 
(3.09) 
12.51 
(2.87) 
13.94 
(3.36) 
Q 
14.42 
(4.55) 
14.16 
(3.10) 
14.98 
(3.96) 
Q 
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Figure E-6 Mean (SD) of ankle joint angle in frontal plane for combined (a), sleeve (b) and LWI (c) groups. 
- Foot centre of pressure 
Two way-mixed ANOVA 
ANOVA showed that the group had no significant effect, and there was no significant interaction 
between group and time on the early-, mid- and late-stance COP (p ≥ 0.05). The time showed 
significant effect on early-stance COP, mid-stance COP, and late-stance COP (p < 0.05). The 
descriptive data is presented in Table E-8. 
Within each group 
Repeated measures ANOVA showed significant time effect for the combined and LWI groups in 
the early-stance COP (p<0.05), mid-stance COP (p<0.05), and late-stance COP (p<0.05), but not 
for the sleeve group (p≥0.05). Pairwise comparison showed significant lateral shifting in COP in 
the combined and LWI groups after immediate treatment compared to baseline in early-stance 
COP (p=0.01, p<0.01), mid-stance COP (p<0.01, p=0.041), and late-stance COP (p<0.01, p=0.04). 
After 6 weeks of treatment, only the combined group showed significant lateral shifting compared 
to baseline in early-stance (p=0.02), mid-stance (p<0.01), and late-stance (p<0.01) COP (Figure 
E-9). 
Between the groups 
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No statistical difference was identified in early-stance, mid-stance, or late-stance COP between 
the groups at baseline, immediate effect, and 6 weeks (p ≥ 0.05). 
 
Table E-8 Mean (SD) of centre of foot pressure in early, mid and late stance phases for combined, sleeve 
and LWI groups 
 
 
 
Figure E-7 Mean (SD) of centre of foot pressure for combined (a), sleeve (b) and LWI (c) groups. 
- Kinetics data of the ankle: 
- Ankle moment in sagittal plane.  
- Ankle dorsiflexion moment 
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Mean 
(SD). 
Cm 
Week one Week 6 
Combined group Sleeve group group  
Shod + 
combined 
treatment 
 
Shod + 
sleeve 
treatment 
 
shod + 
LWI 
treatment 
Shod 
Shod + 
combined 
treatment 
Shod 
Shod + 
sleeve 
treatment 
Shod 
shod + 
LWI 
treatment 
Early-
stance  
1.08 
(0.36) 
1.35 
(0.45) 
Q 
1.34 
(0.70) 
1.34 
(0.65) 
1.17 
(0.53) 
1.52 
(0.60)Q 
1.38 
(0.32) 
Q 
1.38 
(0.49) 
1.39 
(0.46) 
Mid-
stance  
0.46 
(0.43) 
1.02 
(0.45) 
Q 
0.74 
(0.55) 
0.83 
(0.60) 
0.55 
(0.40) 
0.98 
(0.45)Q 
1.02 
(0.28) 
Q 
0.97 
(0.45) 
0.88 
(0.52) 
Late-
stance  
-0.64 
(0.61) 
-0.11 
(0.69) 
Q 
-0.46 
(0.65) 
-0.27 
(0.74) 
-0.43 
(0.56) 
-0.08 
(0.62)Q 
-0.05 
(0.55) 
Q 
-0.23 
(0.58) 
-0.14 
(0.66) 
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Two way-mixed ANOVA 
The data showed no significant effect on the ankle dorsiflexion moment for the groups (p=0.84). 
ANOVA showed significant time effect (p=0.04) but no interaction between time and group 
(p=0.07). The descriptive data is presented in Table E-9. 
Within each group 
Repeated-measures ANOVA showed significant time effect for the combined group (p<0.01) but 
not for the sleeve group (p=0.63) or the LWI group (p=0.30). Pairwise comparison showed 
significant reduction in ankle dorsiflexion moment with immediate use of the combined treatment 
(p<0.01) but not after 6 weeks (p=0.06) (Figure E-8). 
Between the groups 
One-way ANOVA showed no significant difference between the groups in the ankle dorsiflexion 
moment at baseline (p=0.60), immediate effect (p=0.90), or after 6 weeks (p=0.89). 
- Plantar flexion moment 
Two way-mixed ANOVA 
There was no significant interaction between group and time (p=0.23); neither the group (p=0.84) 
nor the time (p=0.23) had a significant effect on the ankle plantar flexion moment. The descriptive 
data is presented in Table E-9. 
Within each group 
Repeated-measures ANOVA showed significant time effect for the combined group (p=0.049), 
but not for the sleeve group (p=0.56) or the LWI group (p=0.53). Pairwise comparison adjusted to 
Bonferroni, Sidak, and LSD failed to identify any significant change within the combined group 
(Figure E-8). 
Between the groups 
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One-way ANOVA showed no significant difference between the groups in ankle plantar flexion 
moment at baseline (p=0.87), immediate effect (p=0.80), or after 6 weeks (p=0.65). 
Table E-9 Mean (SD) of sagittal plane knee moments for combined, sleeve and LWI groups. 
Mean (SD). 
Nm/kg 
  
  
Week one Week 6 
Combined group Sleeve group LWI group Combined group 
Sleeve 
group 
LWI 
group 
Shod 
Shod + 
combine
d 
treatmen
t 
Shod 
Shod + 
sleeve 
treatmen
t 
Shod 
shod + 
LWI 
treatmen
t 
Shod + 
combined 
treatment 
Shod + 
sleeve 
treatmen
t 
shod + 
LWI 
treatmen
t 
Maximum 
plantarflexio
n moment 
-0.20 
(0.07) 
-0.21 
(0.06) 
Q 
-0.19 
(0.13) 
-0.20 
(0.12) 
-0.21 
(0.10) 
-0.23 
(0.11) 
-0.24 
(0.07) 
-0.20 
(0.13) 
-0.21 
(0.10) 
Maximum 
dorsiflexion 
moment 
1.38 
(0.16) 
1.32 
(0.17) 
1.30 
(0.17) 
1.32 
(0.17) 
1.32 
(0.20) 
1.29 
(0.22) 
1.34 
(0.14) 
1.31 
(0.19) 
1.31 
(0.20) 
 
 
Figure E-8 Mean (SD) of sagittal plane ankle moment for combined (a), sleeve (b) and LWI (c) groups. 
- Ankle moment in frontal plane: 
- Ankle inversion moment 
The data showed mild to moderate deviation in normality in the sleeve group and inequality of 
variance. The transformation (RMS, log10, Ln, reciprocal) failed to correct the significant 
difference in variance and the deviation in normality. Therefore, two way-mixed ANOVA could 
not be used, and two choices were available to compare time within each group and among the 
groups via non-parametric (Friedman test, Kruskal-Wallis test) or parametric (repeated-measures 
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ANOVA, one-way ANOVA) testing. When comparing the treatment effect within each group via 
the non-parametric test, the LWI group showed significant reduction in inversion moment after 
immediate use of the treatment compared to baseline. However, this is not believed to be accurate 
since the LWI and combined groups were normally distributed, and the results of the parametric 
test revealed no significant changes. Therefore, the parametric test was preferred since the changes 
were only in the normally distributed group when using the non-parametric test. 
Within each group 
Repeated-measures ANOVA showed no significant changes in the inversion moment within the 
combined group (p=0.07), the sleeve group (p=0.06), or the LWI group (p=0.18). The descriptive 
data is presented in Table E-10. 
Between the groups 
One-way ANOVA showed significant difference between the groups in inversion moment at 
baseline (p=0.048), but not for immediate effect (p=0.49) or after 6 weeks (p=0.11). All 
adjustments failed to identify any changes between the groups (Figure E-9) 
Ankle eversion moment 
The data showed mild to moderate deviation in normality in the sleeve group and the combined 
group and inequality of covariance. The transformation (RMS, log10, Ln, reciprocal) failed to 
correct the significant difference in normality and covariance. Therefore, two way-mixed ANOVA 
could not be used, and two choices were available to compare time within each group and between 
the groups via non-parametric (Friedman test, Kruskal-Wallis test) or parametric (repeated-
measures ANOVA, one-way ANOVA) testing. When comparing the groups at baseline, 
immediate effect of treatment, and after 6 weeks of treatment, both parametric and non-parametric 
tests revealed similar results. However, when the effect of the treatment within each group was 
investigated, parametric testing showed a significant increase in eversion moment after 6 weeks 
use of LWI compared to baseline, while non-parametric testing showed a significant increase in 
eversion moment after immediate use of LWI compared to baseline. Choosing parametric tests 
was thought to be more appreciate since the LWI group data was normally distributed and the 
change was only observed in this group. 
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Within each group 
Repeated-measures ANOVA showed no change after using the treatment in the combined group 
(p=0.35) or the sleeve group (p=0.07). However, the LWI group showed significant change in 
eversion moment (p=0.03). Pairwise comparison showed significant increase in eversion moment 
only after 6 weeks compared to baseline (p=0.03). The descriptive data is presented in Table E-
10. 
Between the groups 
One-way ANOVA showed no significant difference in the eversion moment between the groups 
in baseline (p=0.76), immediate effect (p=0.88), or after 6 weeks (p=0.78) (Figure E-9). 
Table E-10 Mean (SD) of ankle joint moments in frontal plane for combined, sleeve and LWI groups. 
Mean (SD). 
Nm/kg 
Week one Week 6 
Combined group Sleeve group LWI group Combined group 
Sleeve 
group 
LWI 
group 
Shod 
Shod + 
combined 
treatment 
Shod 
Shod + 
sleeve 
treatment 
shod 
shod + 
LWI 
treatment 
Shod + 
combined 
treatment 
Shod + 
sleeve 
treatment 
shod + 
LWI 
treatment 
Maximum 
inversion 
moment 
0.18 
(0.16) 
0.14 
(0.13) 
0.08 
(0.06) 
0.09 
(0.07) 
0.16 
(0.10) 
0.12 
(0.10) 
0.14 
(0.13) 
0.05 
(0.07) 
0.12 
(0.09) 
Maximum 
eversion 
moment 
-0.12 
(0.06) 
-0.14 
(0.08) 
-0.13 
(0.09) 
-0.13 
(0.09) 
-0.11 
(0.04) 
-0.14 
(0.07) 
-0.13 
(0.06) 
 
-0.15 
(0.08) 
-0.15 
(0.05) 
Q 
Q significant compared to baseline 
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Figure E-9 Mean (SD) of ankle joint moment in frontal plane for combined (a), sleeve (b) and LWI (c) 
groups. 
- KOOS Symptoms, ADL, sport, QOL subscales and PASE scale: 
Two way-mixed ANOVA 
ANOVA showed no significant interaction, and the group had no effect on KOOS symptoms, 
ADL, sport, QOL subscales, or PASE scale (p≥0.05). The time showed significant effect on the 
KOOS symptoms, ADL, sport, and QOL subscales (p<0.05), but not for PASE (p≥0.05). 
descriptive data is presented in Table E-11. 
Within each group 
Significant improvement was identified after 6 weeks of LWI, sleeve, and combined treatment use 
compared to the baseline in KOOS symptoms, ADL, sport, and QOL subscales (p<0.05). 
Interestingly, only the combined group showed significant increase in PASE compared to baseline 
(p<0.05). 
Between the groups 
One-way ANOVA showed no significant difference between the groups at baseline and after 6 
weeks of treatment in KOOS symptoms, ADL, sport, QOL subscales, or PASE scale (p≥0.05). 
Magnitude of change between the groups 
When the magnitude of change in KOOS symptoms, ADL, sport, QOL subscales, and PASE scale 
were compared between the groups, no significant difference was identified (p≥0.05).  
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Table E-11 Mean (SD) of symptoms, ADL, sport and QOL KOOS subscales and PASE for combined, sleeve and LWI 
groups. 
Mean 
(SD) 
Combined group Sleeve group LWI group Magnitude of change between baseline and week 6 
Baseline Weeks 6 Baseline Weeks 6 Baseline Weeks 6 
Combined 
group 
 
Sleeve 
group 
 
LWI 
group 
 
Sympt
oms 
62.01 
(20.16) 
72.73 
(16.23) 
Q 
67.86 
(18.14) 
73.70 
(21.56) 
Q 
55.06 
(16.71) 
64.29 
(21.70) 
Q 
10.71 
(9.72) 
5.84 
(6.24) 
9.23 
(10.38) 
ADL 56.95 (18.49) 
71.79 
(17.07) 
Q 
61.23 
(21.89) 
70.45 
(20.13) 
Q 
65.69 
(17.88) 
73.04 
(16.45) 
Q 
14.84 
(11.44) 
9.22 
(9.37) 
7.35 
(8.78) 
Sport 27.27 (12.52) 
44.55 
(16.65) 
Q 
28.64 
(13.06) 
37.27 
(13.11) 
Q 
28.75 
(17.73) 
36.25 
(26.55) 
Q 
17.27 
(14.21) 
8.64 
(7.10) 
10.00 
(15.52) 
QOL 34.09 (14.62) 
45.45 
(18.35) 
Q 
44.32 
(21.19) 
51.70 
(19.18) 
Q 
35.42 
(17.74) 
42.19 
(22.79) 
Q 
11.36 
(10.76) 
7.39 
(4.69) 
6.77 
(10.13) 
PASE 92.86 (49.06) 
113.04 
(47.67) 
Q 
86.69 
(63.74) 
94.13 
(55.49) 
98.80 
(62.01) 
104.69 
(77.81) 
20.17 
(29.85) 
7.44 
(25.51) 
5.88 
(45.00) 
Q significant compared to baseline 
